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Introduction: Dyspnea is a common presenting complaint for many patients in the emergency department.
Case Presentation: A 55-year-old man with type I diabetes presented to the emergency department with 
one month of intermittent palpitations and dyspnea. His lungs were clear to auscultation, and his chest 
radiograph was normal.  
Discussion: This case takes the reader through the differential diagnosis and systematic work-up of 
dyspnea with discussion of the diagnostic study, which ultimately led to this patient’s diagnosis and 
successful treatment. [Clin Pract Cases Emerg Med. 2020;4(2):111–115.]   
Keywords: Clinicopathological cases; cardiology; epidemiology.
CASE PRESENTATION (Dr. Eric R. Friedman):
A 55-year-old man presented to the emergency department 
(ED) of an urban, academic, medical center with intermittent 
palpitations (fast beats accompanied by a “pounding” sensation 
in the chest) for the prior month. Palpitations were most 
noticeable at night but had become more severe and constant 
over the preceding three days. He also reported shortness of 
breath while supine in bed and lightheadedness with exertion. 
The patient is an avid hiker, so he only presented once his 
dyspnea prevented him from completing a typical family hike. 
He denied any chest pain, fevers, weight loss, syncope, leg 
swelling, cough, nausea, vomiting, or rashes.
The patient was diagnosed with type 1 diabetes mellitus 
when he was 30 and has a history of hypertension. He was taking 
insulin glargine nightly with sliding-scale insulin aspart during 
meals and had recently switched from ramipril to losartan 50 
milligrams (mg) daily due to nocturnal cough. He denied any 
drug, alcohol, or tobacco use. His father died suddenly at age 42 
due to a heart attack. He denied any allergies. 
The patient’s vital signs on presentation were as follows: 
temperature 97.2 degrees Fahrenheit; blood pressure 131/83 
millimeters of mercury (mm Hg); pulse 55 beats per minute, 
respiratory rate 18 breaths per minute; and oxygen saturation 
University of Maryland Medical Center, Department of Emergency Medicine, 
Baltimore, Maryland
University of Maryland School of Medicine, Department of Emergency Medicine, 
Baltimore, Maryland
*
†
99% on room air, with a body mass index of 28.6 kilograms 
per meters squared. Physical exam revealed a well-developed 
and well-nourished male patient in no acute distress. His head 
was normocephalic and atraumatic. His eye exam was normal 
with pupils that were equal, round, and reactive to light. No 
scleral icterus was seen. His neck was supple and had normal 
range of motion. There was no jugular venous distension seen. 
The patient’s cardiac exam was notable for a bradycardic and 
irregularly irregular heartbeat without a murmur. His lungs 
were clear to auscultation bilaterally, and no wheezes or rales 
were heard. The patient’s abdomen was soft, non-tender, and 
non-distended. His extremities were warm and well perfused, 
and without edema. The patient’s cranial nerves II-XII were 
intact, and gait and strength assessments were unremarkable. 
No pronator drift was seen. Skin was normal in appearance, 
without any lesions or rashes. The patient demonstrated a 
normal mood and affect throughout the history and exam.
A chest radiograph (CXR) and electrocardiogram (ECG) 
were obtained (Images 1 and 2, respectively). Laboratory 
studies (Table) were notable for a white blood cell count of 6.2 
thousand per microliter, hemoglobin of 15.1 grams per deciliter, 
platelets of 190,000 per microliter, glucose 250 milligrams per 
deciliter, negative troponin, B-type natriuretic peptide (BNP) 
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of 502 picograms per deciliter, a thyroid stimulating hormone 
level of 1.2 milli-international units per liter with free thyroxine 
of 1.4 nanomoles per liter, and a Borrelia Burgdorferi IgM/IgG 
(immunoglobulin) titer of 0.28, negative antinuclear antibody 
test. (The latter test resulted after the patient was admitted.) 
While in the ED the patient experienced an acute episode of 
palpitations. His rhythm, as recorded by telemetry, is shown in 
Image 3. An echocardiograph was performed, which showed 
severe global hypokinesis with a left ventricular ejection 
fraction (LVEF) of 15%, mild dilation, biatrial enlargement, and 
no pericardial effusion. 
FACULTY DISCUSSION (Dr. J. David Gatz): 
I can feel my own heart racing as I work through this case. 
A passionate hiker myself, I immediately empathize with this 
patient’s concern of diminishing trail endurance. It is all quite 
alarming for a relatively young gentleman who otherwise 
seems healthy and active. He goes outdoors frequently and 
only has two chronic medical problems – insulin-dependent 
diabetes and hypertension. He did have a recent medication 
change, from ramipril to losartan, but this seems unlikely to 
be significant. It is alarming that his father suffered a cardiac-
related death at such a young age (only 42 years old!) and 
raises the question of a potential hereditary component to this 
presentation. His reported symptoms unfortunately don’t give 
us much additional direction: A month of palpitations with 
some exertional pre-syncope and orthopnea are rather vague. 
On exam, the patient’s vital signs are frustratingly benign. 
The respiratory rate of 18 breaths per minute is probably 
just an estimated number and not directly measured. He is 
slightly bradycardic at 55 beats per minute, which may be 
due to his baseline level of athletic activity. He is slightly 
hypertensive, but this is a known diagnosis. His physical exam 
appears normal except for an irregular rhythm on cardiac 
assessment. His labs are mostly benign. Mild hyperglycemia 
is reasonable in the setting of his diabetes. His Lyme titers are 
within normal ranges. The patient’s BNP, while not drastically 
elevated, is certainly higher than what we would expect in an 
otherwise healthy individual without an existing cardiac or 
renal diagnosis.
The patient’s ECG is abnormal and difficult to 
interpret. At first glance it appears to show a sinus 
bradycardia with first-degree atrioventricular (AV) block. 
There is left ventricular hypertrophy with repolarization 
abnormalities, and a left anterior fascicular block. Then, 
as if by premonition, the patient experiences a ventricular 
tachycardia. Understandably this triggers additional work-up 
including a CXR and an echocardiogram.
This is a large amount of information to work through, 
and it becomes essential to not miss the forest for the trees. 
Combining the patient’s initially vague symptoms with the 
left ventricular hypertrophy on his ECG, elevated BNP, and 
dilated hypokinetic echo, it is clear that this patient has a 
cardiomyopathy. The question becomes why? Something 
has made his cardiac tissue structurally and functionally 
abnormal, yet in the absence of any known coronary artery 
disease, valvular disease, or hypertension (currently just 
on monotherapy with only mildly elevated pressures in 
the ED). Cardiomyopathy is typically thought of as falling 
within one of three general categories: hypertrophic, dilated, 
or restrictive.1 The patient’s ECG does not demonstrate 
the classic findings we would expect in a septal or apical 
variant of hypertrophic cardiomyopathy.2 While there is an 
Image 1. Electrocardiogram of a 55-year-old male with palpitations 
and dyspnea, taken while in the emergency department.
Image 2. Anterior-posterior chest radiograph of a 55-year-old 
male with palpitations and dyspnea.
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AV block and widened QRS complexes, the patient’s ECG 
lacks the small voltages typically associated with a restrictive 
cardiomyopathy. Given that the patient’s echo demonstrates 
global hypokinesis (not apical) and there are no known 
significant new stressors in his life, his presentation does not 
seem consistent with a stress (Takotsubo) cardiomyopathy. 
Given all of this, it seems reasonable to narrow our search to 
potential causes of dilated cardiomyopathy (DCM).
But the number of etiologies just within DCM is long.3 
There are many known infectious causes (bacterial, viral, 
spirochetal, rickettsial, mycotic, protozoal, helminthic), but 
the patient has no fevers, antecedent illnesses, or laboratory 
evidence of infection. Lyme disease is an exciting thought 
given the patient’s outdoor activities, but the patient’s Lyme 
titers are within normal limits. While deposition diseases 
(hemochromatosis/amyloidosis) can cause DCM, there is no 
ECG evidence or associated stigmata. Numerous medications 
(especially chemotherapeutics and antiretrovirals) are known 
to cause DCM, but the patient is not taking any of them. 
Similarly, the patient has no history to suggest ingestion 
or exposure to toxins that could potentially cause DCM. 
Laboratory results and history exclude DCM secondary to 
any profound electrolyte, renal, or nutritional abnormalities. 
Diabetes can cause DCM, and while we don’t have a 
hemoglobin A1c to show whether his diabetes is controlled 
or not, it would be unlikely for a patient to present with DCM 
without a history of coronary artery disease, myocardial 
infarction, or any of the more common complications of 
diabetes (e.g., peripheral neuropathy, diabetic nephropathy, 
and retinopathy). There is no evidence of additional endocrine 
or genetic disorder. This leaves one final major category of 
potential etiologies – autoimmune processes. 
The autoimmune diseases that cause DCM include 
systemic lupus erythematosus (SLE), dermatomyositis, 
scleroderma, rheumatoid arthritis, and sarcoidosis. SLE is less 
likely because the patient doesn’t have the classic symptoms, 
the rash, or nephritis. Similarly, the classic cutaneous 
findings of dermatomyositis and scleroderma are not present. 
Sarcoidosis, however, can be much more subtle. With this in 
mind, the patient’s CXR seems to provide an essential clue.
Hilar structures on CXRs can be confusing. This 
patient’s CXR demonstrates additional “lumpy and bumpy” 
radiodensities in the hilar areas. In contrast to the smooth 
contours of bilateral pulmonary artery enlargement, these 
findings are consistent with hilar adenopathy, a finding 
suggestive of a neoplastic, infectious (tuberculosis, 
histoplasmosis), and inflammatory processes like sarcoidosis.4 
And thus, while this has been a long and winding path 
through the woods, we appear to have finally stumbled into a 
clearing. Sarcoidosis uniquely unifies our clinical suspicion 
of a DCM with the patient’s CXR. Moreover, the patient is 
the appropriate age and has experienced many of the typical 
symptoms including heart failure, AV blocks, and arrythmias. 
Lab test Value Units Normal range
White blood cell count 6.2 K/mcL 4.5 - 11.0
Hemoglobin 15.1 g/dL 12.6 - 17.4
Hematocrit 43.7 % 37.0 - 50.0
Mean corpuscular volume 85.7 fL 80.0 - 96.0
Mean corpuscular 
hemoglobin
29.6 pg 28.0 - 33.0
Mean corpuscular 
hemoglobin concentration
34.6 g/dL 33.0 - 36.0
Platelets 190 K/mcL 153 - 367
Mean platelet volume 11.6 fL 9.4 - 12.4
Red cell distribution width 13.3 % 12.0 - 15.2
Sodium 141 mmol/L 136 - 145
Potassium 4.5 mmol/L 3.5 - 5.1
Chloride 105 mmol/L 98 - 107
Bicarbonate 27 mmol/L 21 - 30
Glucose 250 mg/dL 70 - 99
Creatinine 1.01 mg/dL 0.66 - 1.25
Blood urea nitrogen 16 mg/dL 7-20
Calcium 9.2 mg/dL 8.6 - 10.2
Total protein 6.1 g/dL 6.3 - 8.2
Albumin 3.4 g/dL 3.5 - 5.2
Bilirubin total 0.9 mg/dL 0.3 - 1.2
Alkaline phosphatase 63 units/L 38 - 126
Aspartate 
aminotransferase
25 units/L 17 - 59
Alanine aminotransferase 40 units/L 21 - 72
Thyroid stimulating 
hormone
1.2 mIU/L 0.47 - 4.68
T4 free 1.4 ng/dL 0.6 - 2.5
Magnesium 1.8 mg/dL 1.6 - 2.6
Phosphorus 4.2 mg/dL 2.5 - 4.5
Borrelia burgdorferi IgG/
IgM Total*
0.28
Anti-nuclear antibody Neg
Brain natriuretic peptide 502 pg/mL <900
Troponin <0.02 ng/mL <0.07
*The amount of immunoglobulin G or M that are reactive to 
Borrelia antigen, results < 0.9 of the laboratory standard are 
considered negative. 
K, thousand; mcL, microliter; g, grams; dL, deciliter; fL, femtoliter; 
pg: picogram; mmol, millimoles; L, liter; mg, milligrams; mIU, milli-
international unit; ng, nanograms; pg, picograms; mL, milliliter; ng, 
nanograms; Ig: immunoglobulin; Neg, nagative.
Table. Laboratory results of a 55 year-old male with palpitations 
and dyspnea.
Clinical Practice and Cases in Emergency Medicine 114 Volume IV, no. 2: May 2020
55-year-old Male with Exertional Dyspnea Friedman et al.
Confirming the diagnosis can be attempted by cardiac biopsy, 
the classic diagnostic test, but this seems excessively invasive. 
Cardiac magnetic resonance imaging (MRI), however, has 
reasonable accuracy and is therefore my preferred diagnostic 
test. Hopefully a correct diagnosis and treatment will let this 
patient return to the trail for, as astutely noted by Hippocrates, 
“Walking is man’s best medicine.”
CASE OUTCOME (Dr. Friedman):
The patient was admitted to the cardiology service. 
Cardiac catherization was considered, but the patient 
instead received a cardiac MRI that showed DCM with 
extensive enhancement involving inferoseptal, inferior, and 
inferolateral segments from base to apex and mediastinal 
lymphadenopathy, with a severely decreased ventricular 
function and a LVEF of 21%. The patient had multiple runs 
of ventricular tachycardia while admitted and consequently 
received an automated implantable cardioverter-defibrillator 
(AICD). A hilar lymph node biopsy showed non-caseating 
granulomatous inflammation and multinucleated giant cells, 
consistent with sarcoidosis. The patient was originally 
started on prednisone 40 milligrams (mg) for the sarcoidosis 
and alprazolam 1 mg as needed due to post-traumatic 
stress disorder from his recurrent AICD shocks. He has 
since transitioned to 1 gram of mycophenolate mofetil 
and prednisone 35 mg daily. He is doing well and has not 
experienced any recent shocks from his AICD.  
RESIDENT DISCUSSION:
Sarcoidosis has a protean presentation, and the incidence 
of the disease varies widely among different cultural and 
racial groups: 1-2 persons per 100,000 of Japanese descent 
are affected, while 35-80 per 100,000 African-American 
persons are affected.5 Cardiac sarcoidosis is relatively rare, 
occurring in less than 5% of all cases.5 Untreated cardiac 
sarcoidosis can result in sudden cardiac death from ventricular 
tachyarrhythmias or atrioventricular blocks, and should be 
considered in patients with unexplained low LVEF, unexplained 
sustained ventricular tachycardia, and new AV block (usually 
Mobitz type II second degree or third degree).6 Endomyocardial 
biopsy has the highest specificity for the diagnosis of cardiac 
sarcoidosis but is rarely performed given the comparative 
ease and lack of complications associated with cardiac MRI.7 
Cardiac MRI has an acceptably high sensitivity and specificity 
of 89% and 78%, respectively.7 Cardiac MRI will usually show 
multiple areas of enhancement in a non-infarct pattern and will 
show direct enhancement from the left ventricle, across the 
interventricular segment, into the right ventricle.8  
Early treatment with immunosuppressants such as steroids 
can help treat cardiac sarcoidosis. In one case, a 32-year-old 
man with cardiac sarcoidosis had complete resolution of his 
AV block and ventricular tachycardia within two weeks of 
initiating steroid treatment. Follow-up cardiac MRI showed 
no further uptake, consistent with resolution of his cardiac 
sarcoidosis.9 This case illustrates a rare, deadly disease that 
was fortunately recognized early. The correct treatment was 
started, which resolved his symptoms and dysrhythmias.  
FINAL DIAGNOSIS:
Cardiac sarcoidosis.
KEY TEACHING POINTS:
1. Consider cardiac sarcoidosis in younger patients 
presenting with symptoms of heart failure, 
arrhythmias, or syncope.
2. Up to a quarter of cardiac sarcoidosis cases may occur 
in the absence of any extracardiac involvement.
3. The most typical radiographic features of thoracic 
sarcoidosis include symmetric hilar and mediastinal 
lymphadenopathy.
The authors attest that their institution requires neither Institutional 
Review Board approval, nor patient consent for publication of this 
case report. Documentation on file.
Image 3. Patient’s cardiac rhythm during an episode of palpitations that occurred while he was in the emergency department. ”HR 105” 
refers to the patient’s heart rate.
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Case Presentation: A 55-year-old woman with a past medical history of hypertension, 
hyperlipidemia, and iron deficiency anemia presented to the emergency department with three days 
of headache, nausea, vomiting, and visual changes. Her vital signs were within normal limits. She 
was noted to have a left cranial nerve six palsy on exam.
 
Results: Her laboratory testing revealed leukocytosis, hyponatremia, and hypokalemia. A non-
contrast computed tomography scan of the head revealed an enlarged sella turcica and pituitary 
gland with hemorrhage and deviation of the optic chiasm.
 
Conclusion: Her symptoms improved and she was discharged from the hospital in stable condition. 
[Clin Pract Cases Emerg Med. 2020;4(2):116–120.]   
Keywords: headache; pituitary apoplexy; pituitary adenoma.
CASE PRESENTATION (Lana Shaker)
A 55-year-old woman presented to the emergency 
department (ED) with the chief complaint of headache for 
three days, associated with nausea, vomiting, and visual 
changes. The headache was described as being sudden in 
onset, constant, bilateral, retro-orbital, and throbbing. The pain 
was a six out of ten in intensity. The pain was not alleviated 
with over the counter acetaminophen use. She was not able 
to describe any alleviating or exacerbating factors. The visual 
changes were described by the patient as “blurry vision” and 
“double vision” affecting her left eye greater than her right. 
She reported photophobia and difficulty keeping the left eye 
open. The patient described this difficulty of keeping the 
eye open as a weakness and not secondary to pain. She had 
approximately five episodes of non-bloody and non-bilious 
vomiting over the past three days and reported inability to 
tolerate her home medications. She also reported a sore throat 
and cough productive of yellow sputum for the previous two 
to three days, but denied fever, chills, chest pain, hemoptysis, 
or dyspnea. 
Rutgers New Jersey Medical School, Department of Emergency Medicine, Newark, 
New Jersey
Her past medical history included essential hypertension, 
hyperlipidemia, and a remote history of uterine fibroids 
associated with iron deficiency anemia. Prescribed 
medications included losartan 25 milligrams (mg) and 
hydrochlorothiazide 12.5 mg. She had no known drug 
allergies, did not smoke, drink alcohol, or use illicit drugs. 
She was unemployed and lived alone. The patient was post-
menopausal and was pregnant three times- two of which were 
normal spontaneous deliveries with two living children and 
one prior abortion.
Vital signs were: temperature 98.8° Fahrenheit, heart 
rate 84 beats per minute, blood pressure 135/74 millimeters 
of mercury, respiratory rate of 18 breaths per minute and 
room air oxygen saturation 97%. Her body mass index was 
42 (normal 18.5-24.9). Complete physical examination was 
unremarkable except her left eye’s lateral gaze was restricted 
by approximately 25%. Her visual acuity was 20/25 and 
20/30, right and left eyes, respectively. Initial laboratory 
testing were resulted (Tables 1 and 2). An electrocardiogram 
was performed (Image 1).
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CASE DISCUSSION (Tiffany Murano)
In summary, this is a 55-year-old gravida 3 para 2 woman 
with a past medical history of hypertensiona and hyperlipidemia 
who presentes to the ED with a three day history of sudden 
onset bilateral retro-orbital headache with double vision. She 
reported a productive cough, which corresponded with the 
onset of the headache. Her physical examination was significant 
for restricted lateral gaze of the left eye with an otherwise 
normal neurologic examination. Her serum laboratory studies 
demonstrated hyponatremia and leukocytosis.
Headache is the fourth most common chief complaint in 
the ED and accounts for approximately 3% of ED visits in 
the United States.1 Headaches may be classified as primary 
(e.g., migraine, tension, cluster headaches). The differential 
diagnosis for headache is quite broad ranging from benign 
conditions such as tension headache to potentially life-
threatening conditions such as meningitis and stroke. When 
a patient presents to the ED with a headache, it is important 
to discern whether the onset of symptoms was progressive 
or sudden. Symptoms that occur suddenly, as with this 
patient, often indicates a vascular occlusion (e.g., thrombotic, 
embolic, or major vessel dissection events) or hemorrhage. 
The differential, cerebrovascular accident, arteriovenous 
malformation or a mass with a hemorrhagic component. 
Migraine headaches are not generally sudden in onset 
but can be associated with visual changes, photophobia, 
nausea, and vomiting. However, the patient has no prior 
history of migraine headaches, and a new diagnosis of 
migraine headaches at the age of 55 would be unusual. 
Optic neuritis can cause acute visual changes and eye pain. 
However, the visual changes are characterized by decreased 
visual acuity, visual field loss, photopsia, or color vision 
loss with pain in the affected eye with ocular movement.2 
There also may be an afferent pupillary defect. This patient 
demonstrated none of these findings. Moreover, this 
disease entity is more commonly in patients with a history 
of thrombophilia, taking oral contraceptives, pregnant, 
or post-partum and the majority of patients are under 
the age of 50 years which makes this diagnosis unlikely 
in this patient.3 Cavernous sinus thrombosis originating 
from a bacterial sinus infection can present with headache 
and ocular signs such as orbital pain but is typically not 
bilateral pain as described by this patient. Additionally, 
patients with cavernous sinus thrombosis may have 
proptosis, periorbital erythema and edema, and chemosis 
on exam, unlike this patient.4
The patient has restricted left eye extraocular movements 
on physical examination with diplopia. She complained of 
difficulty keeping her left open but had no ptosis noted on 
physical examination. The sixth cranial nerve (abducens) is 
responsible for abduction of the lateral rectus muscle that is 
necessary for horizonto-lateral gaze. Lesions that affect the 
sixth cranial nerve can cause impairment of lateral gaze as 
well as Horner’s syndrome (disruption of the sympathetic 
innervation of the sixth cranial nerve causing miosis, ptosis, 
and anhidrosis). Etiologies of Horner’s syndrome include 
pituitary lesions (e.g., infarction or hemorrhage), trauma, 
brachial plexus lesions, pathology to the lung apice, migraine 
mmol, millimoles; L, liter; mg, milligram; dL, deciliter; U, units; ng, 
nanogram; mL, milliliter.
Serum chemistry test Value (reference range)
Complete metabolic panel
Sodium 128 mmol/L (133-145)
Potassium 3.4 mmol/L (3.5-4.8)
Chloride 88 mmol/L (97-110)
Bicarbonate 27 mmol/L (23-30)
Blood urea nitrogen 7 mg/dL (6-20)
Creatinine 0.7 mg/dL (0.5-1.0)
Glucose 81 mg/dL (70-109)
Albumin 4.0 g/dL (3.5-5.2)
Bilirubin 1.0  mg/dL (<= 1.0)
Alkaline phosphatase 87 U/L (35-105)
Total protein 8.5  g/dL(6.0-8.3)
Aspartate transaminase 18 U/L (0-40)
Alanine aminotransferase 11 U/L (0-33)
Additional chemistries
Troponin <0.01 ng/mL (0.00-0.30)
Table 2. Chemistry results.
uL, microliters; g, grams; dL, deciliter.
Serum hematology test Value (reference range)
Complete blood cell count
White blood cells 14.9 x 103/uL (4.0-11.0)
Hemoglobin 14 g/dL (12.0-16.0)
Hematocrit 43% (36.0-48.0)
Platelets 225 x 103/uL (150-450)
Differential
Neutrophils 78% (35.0-80.0)
Lymphocytes 13% (20.0-50.0)
Monocytes 7% (2.0-12.0)
Eosinophils 0.6% (0.0-7.0)
Basophils 0.8% (0.0-2.0)
Table 1. Complete blood cell count.
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headache, idiopathic intracranial hypertension, and carotid 
artery pathology (e.g., ischemia or dissection). However, this 
patient presented with lateral gaze paralysis in the absence 
of Horner’s syndrome. Thus, there could be a structural 
cause-such as a pituitary macroadenoma with or without 
hemorrhage-preventing normal left lateral gaze. 
Another pertinent finding in this case is hyponatremia. 
Possible explanations for hyponatremia in conjunction with 
this clinical presentation and neurologic findings include 
syndrome of inappropriate antidiuretic hormone (SIADH), 
cerebral salt wasting (CSW), and adrenal insufficiency. 
Although all present with hyponatremia, CSW is associated 
with concomitant extracellular volume loss and hypovolemia 
while SIADH has normal to high extracellular volume 
and euvolemia. Urine electrolytes were not immediately 
available for this patient; however, she appeared to be 
clinically euvolemic. Adrenal insufficiency is an important 
cause of hyponatremia and may be primary (due to an 
adrenal cause), secondary (due to an anterior pituitary 
cause), or tertiary (due to a thalamic cause). Lesions in 
the pituitary result in a decrease in cortisol, increased 
adrenocorticotropin hormone (ACTH) and increased 
corticotropin-releasing hormone secretion (an anti-diuretic 
hormone secretagogue). Thyroid deficiency also may be seen 
in central adrenal insufficiency. 
In addition, pituitary apoplexy may present with headache, 
visual disturbance, and hypnoatremia as seen with this patient. 
The sudden onset of symptoms supports a vascular component-
either a hemorrhage or embolic vascular component. 
A computed tomography scan of the head would be an 
appropriate initial imaging modality to confirm this diagnosis. 
According to the American College of Emergency Physicians’ 
clinical policay for the evaluation and management of adult 
patients presenting to the ED with an acute headache, there 
is Level B evidence that supports obtaining an emergency, 
non-contrast computed tomography (CT) scan of the head 
for patients with sudden-onset headache and focal neurologic 
findings. Therefore, this test would be appropriate in this case.5
CASE OUTCOME (Lana Shaker)
A non-contrast CT scan of the head revealed an enlarged 
sella turcica and an enlarged pituitary gland measuring 2.0 
centimeters (cm) in its greatest superior to inferior extent, 3.3 
cm in its greatest transverse diameter and 1.3 cm in its greatest 
anterior to posterior extent. In the central and inferior portions 
of the enlarged pituitary gland, there is increased density 
consistent with hemorrhage. The floor of the sella turcica is 
not eroded, and the sphenoid sinus is well aerated. The optic 
chiasm is deviated superiorly bilaterally (Images 2 and 3). 
Neurosurgery and ophthalmology services were consulted, 
and the patient was admitted to the intensive care unit. Her 
gaze palsy continued to worsen over the subsequent 24 hours 
(hospital day (HD) 1).  Ophthalmology service was consulted 
and suggested that the patient likely had sixth cranial nerve 
palsy due to increased intracranial pressure. The neurosurgery 
team obtained a non-contrast magnetic resonance imaging 
(MRI) scan of the brain which demonstrated a pituitary 
macroadenoma displacing the optic chiasm. Additional serum 
laboratory studies were obtained to assess pituitary function 
and demonstrated normal thyroid stimulating hormone (TSH), 
low luteinizing hormone and cortisol levels, and an elevated 
prolactin level.
On HD 1, the patient also developed worsening 
hyponatremia and hypotension. She was administered 
Image 1. Normal sinus rhythm at 64 beats per minute with sinus arrhythmia.
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hydrocortisone 100 mg intravenously for a suspected 
acute ACTH deficiency leading to adrenal crisis. A 
plan was made for operative intervention. On HD 2 
she underwent a trans-sphenoidal surgical resection of 
the pituitary tumor. Over the subsequent six days, the 
patient’s headache and visual complaints improved. Her 
visual acuity improved to 20/25 bilaterally. Her extra-
ocular movements normalized with resolution of her 
cranial nerve six palsy. The hyponatremia resolved. 
However, she developed central hypothyroidism with 
both decreasing TSH and free thyroid hormone levels and 
was administered levothyroxine replacement. The patient 
was discharged on HD 8. Two week discharge follow up 
with neurosurgery, ophthalmology, and endocrinology 
services were unremarkable except for the thyroid hormone 
supplementation requirement. 
RESIDENT DISCUSSION
Pituitary apoplexy is an acute infarction or hemorrhage 
of the pituitary gland. In most cases, apoplexy involves 
a previously unrecognized pituitary adenoma.4 An abrupt 
increase of tissue volume within the sellar region can 
cause headache, visual impairment, cranial nerve palsies, 
impairment of consciousness, and pituitary hormone 
deficiencies.4 Pituitary apoplexy is rare with an estimated 
incidence of 0.17 episodes per 100,000 person-years but is 
life threatening and must be promptly recognized and treated.4 
Most commonly, pituitary apoplexy occurs in the fifth or 
sixth decade and has a slight male preponderance.4,5 Pituitary 
apoplexy can occur in non-adenomatous lesions including: 
hypophysitis, pituitary metastasis, craniopharyngioma, 
Rathke’s cleft cyst, and sellar tuberculoma.4 Macroadenomas 
are more susceptible to apoplexy than microadenomas.6 
Between 2 and 12% of patients with a pituitary adenoma 
experience apoplexy.7 Cavernous sinus invasion can be 
prognostic factor associated with pituitary apoplexy.6 
The mechanisms causing pituitary apoplexy include: 
tumor vascular occlusion due to tumor growth, pituitary 
stimulation (e.g., provocative testing or gonadotropin 
releasing hormone analogue use, surgery, closed trauma, 
acute increase in blood flow due to physical activity 
or systemic hypertension, or coagulation disturbances 
(e.g., thrombocytopenia or anticoagulation).6,7 
Macroprolactinomas and female gender have a greater 
association with hemorrhage.4 
Symptoms may arise within hours to days after the onset 
of apoplexy.4 Sudden increase in intrasellar pressure can cause 
hypopituitarism. Moreover, sudden increases in pressure on 
contents and in neural structures can cause: neural palsies 
(most commonly cranial nerves III, IV, V, or VI), visual field 
impairment and visual acuity deficiency (due to optic chiasm 
compression), consciousness reduction (due to pressure 
transmitted to the brainstem), chemical meningitis (from blood 
leakage into the subarachnoid space), and even hemispheric 
signs such as hemiplegia (from intracavernous carotid artery 
compression and vasospasm).6 
A high degree of suspicion is required to make the clinical 
diagnosis as these patients typically do not have a known 
history of pituitary disease.4 Common differential diagnoses 
include subarachnoid hemorrhage, meningitis, cavernous sinus 
thrombosis, and migraine.4 A CT scan of the head is more 
pragmatic to obtain but less sensitive to diagnose a pituitary 
lesion than brain MRI.6,8 
Hormonal pituitary evaluation is recommended as anterior 
pituitary deficiencies can occur in nearly 80% of patients.6 
ACTH deficiency can lead to adrenal crisis and is life 
threatening, requiring immediate glucocorticoid replacement.5 
Other deficiencies, such as hyperprolactinemia or 
hypothyroidism, may also occur.8 Hyponatremia is observed in 
up to 40% of cases and is due to decreased circulating cortisol 
in the setting ACTH deficiency or SIADH.6 
The first step in management of patients with 
pituitary apoplexy is hemodynamic stabilization. Patients 
may require correction of electrolye disturbances and 
corticosteroid administration. Further management may 
be either surgical or continued medical care, and some 
controversy exists regarding this issue.10 If consciousness 
or vision is impaired, surgical decompression is 
recommended.6,10 Pituitary deficiencies, however, do not 
generally recover.6 Outcome is variable and difficult to 
predict as patients may dramatically deteriorate from 
cerebral ischemia or subarachnoid hemorrhage or recover 
spontaneously without sequelae.7
FINAL DIAGNOSIS
Pituitary macroadenoma with apoplexy.
Image 2. Computed tomography of the head without contrast 
demonstrating enlarged pituitary gland with increased density 
consistent with hemorrhage (arrows).
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KEY TEACHING POINTS 
• Pituitary apoplexy can evolve in hours to days and is 
life threatening.
• Pituitary apoplexy is rare, most common in the fifth 
and sixth decade, and has a slight male preponderance. 
Pituitary adenomas, specifically macroadenomas, are at 
highest risk of apoplexy and is often a new diagnosis.
• The pathophysiology regarding pituitary apoplexy is 
associated with hypertension, coagulopathy, recent 
surgery or closed head trauma. 
• Symptoms and signs include: acute headache, nausea 
and vomiting, visual disturbances, ocular palsies, 
meningismus, and decreased level of consciousness.
• Head CT should be obtained immediately but brain 
MRI is most sensitive for the diagnosis of pituitary 
apoplexy and should be obtained if clinical suspicion is 
high despite non-diagnostic CT
• Treatment is comprised of circulatory support, 
electrolyte correction, corticosteroid administration 
when indicated, and potential surgical decompression.
• Outcome is variable, ranging from death or persistent 
neurological sequelae to spontaneous recovery.
The authors attest that their institution requires neither Institutional 
Review Board approval, nor patient consent for publication of this 
case report. Documentation on file.
Image 3. Computed tomography of the head without contrast 
demonstrating enlarged sella turcica and deviated optic chiasm 
(arrow).
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Introduction: Heroin can be adulterated with various substances that may or may not have 
pharmacological effects. Here we report a case series of 8 patients who presented to the emergency 
department after overdose with intravenous heroin preparation adulterated with the synthetic cannabinoid 
methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate (5F-MDMB-PINACA).
Case Series: Except for one patient, all of them presented with a typical initial opioid toxidrome 
consisting of central nervous system and respiratory depression along with pinpoint pupils. Naloxone 
was given to them, triggering severe agitation and combative behavior along with overlapping 
features of anticholinergic and sympathomimetic toxidrome. All patients required multiple doses of 
benzodiazepines. Three were successfully treated with physostigmine.
Discussion: 5F-MDMB-PINACA is a synthetic cannabinoid that was added to heroin in samples 
obtained from patients reported in this case series. Patients demonstrated significant agitation after 
receiving naloxone for opioid toxidrome, presumably because of the removal of the depressant effect 
of opioids, which unmasked the excitatory effects of the synthetic cannabinoids. Three patients 
required physostigmine along with the benzodiazepines for control of their agitation, urine retention 
and abnormal vitals, suggesting the possibility of an anticholinergic toxidrome to have developed in 
these patients.
Conclusion: Heroin contaminated with 5F-MDMB-PINACA exhibits variable severities of 
anticholinergic effects, some on presentation and others only after opiate antagonism. [Clin Pract 
Cases Emerg Med. 2020;4(2):121–125.]
Keywords: synthetic cannabinoids; heroin; physostigmine.
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INTRODUCTION
Heroin is often adulterated with a variety of substances 
including baking soda, caffeine, crushed analgesics, and 
scopolamine.1 We present a consecutive patient case series 
with similar presentations after overdose with intravenous 
(IV) heroin adulterated with the synthetic cannabinoid (SC) 
methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-
3,3-dimethylbutanoate (5F-MDMB-PINACA). Within three 
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CPC-EM Capsule
What do we already know about this clinical 
entity? 
Synthetic cannabinoids (SC) may be added 
as adulterants to opiates sold on the street, 
which can contribute to unpredictable 
clinical consequences. 
What makes this presentation of disease 
reportable? 
We report a case series of eight patients 
who had predominantly anticholinergic 
features after using heroin containing the SC 
5F-MDMB-PINACA. 
What is the major learning point? 
Patients using heroin containing SCs may 
exhibit severe agitation and hyperactive 
behavior following naloxone administration. 
How might this improve emergency 
medicine practice? 
Consider using physostigmine along with 
benzodiazepines in treating patients with 
severe agitation following naloxone-induced 
reversal of an opioid toxidrome.
months, eight patients presented to the emergency department 
(ED) after use of IV heroin with symptoms consistent with 
anticholinergic toxicity and variable requirement for naloxone 
administration by emergency medical services (EMS). 
CASE SERIES
Case 1
A 28-year-old man with a past medical history of bipolar 
disorder and polysubstance abuse including IV heroin, 
presented to the hospital by EMS after being found at home 
unresponsive. Family members found packets of drugs near 
the patient labelled “Santa Muerte (Image 1). On arrival, 
vital signs included a heart rate (HR) of 122 beats per 
minute, blood pressure (BP) 134/78 millimeters of mercury 
(mm Hg), respiratory rate (RR) of 38 breaths per minute, 
oral temperature 98.2 degrees Fahrenheit (F), and oxygen 
saturation (SpO2) 78% on non-rebreather mask. Physical 
exam included tachycardia, flushing, dry mucous membranes 
and mydriasis. The patient was initially given two milligrams 
(mg) of intranasal (IN) naloxone in the field by EMS 
secondary to central nervous system (CNS) and respiratory 
depression, with no response. He was given a second dose of 
two mg IN naloxone and became agitated and combative. 
The patient was intubated upon ED arrival for hypoxic 
respiratory failure. Chest radiograph showed signs of aspiration 
pneumonitis, which developed into acute respiratory distress 
syndrome (ARDS) requiring venovenous extracorporeal 
membrane oxygenation (VV-ECMO). Head computed 
tomography was negative for acute intracranial abnormality. 
Complete blood count (CBC) and basic metabolic panel (BMP) 
were unremarkable. Urine drug screen immunoassay was 
positive for cocaine, opiates, fentanyl, tetrahydrocannabinol 
(THC) and benzodiazepines. Comprehensive drug screen 
of the serum by liquid chromatography tandem mass 
spectrometry (LC-MS-MS) was positive for cocaine, heroin, 
6-monoacetylmorphine (6-MAM), fentanyl, THC, and 
alprazolam. The patient remained intubated on VV-ECMO 
for 12 days, after which he was extubated, removed off of 
VV-ECMO, and discharged on day 17. Laboratory analysis 
of the patient’s confiscated drug by gas chromatography-mass 
spectrometry (GC-MS) and liquid chromatography quadrupole 
time-of-flight  mass spectrometry (LCQ-TOF-MS) was positive 
for the novel SC 5F-MDMB-PINACA, heroin, and fentanyl. 
Case 2
A 25-year-old man with a past medical history of IV 
heroin use, presented to the ED by EMS after IV heroin use. 
The patient initially had CNS and respiratory depression in 
the field and was first given two mg of IN naloxone with no 
response, followed by a second dose of two mg IN naloxone, 
which made him anxious and tachycardic. Vital signs on 
Image 1. Packets of “Santa Muerte,” a street heroin adulterated 
with synthetic cannabinoid, that were retrieved from a patient 
found unresponsive at home.
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arrival to the ED included a HR of 102 beats per minute, BP 
of 146/89 mmHg, RR 24 breaths per minute, SpO2 98% on 
room air, and oral temperature 97.5º F. Physical exam was 
positive for flushing, tachycardia, and agitation. The patient 
was given 4 mg of lorazepam IV in the ED. He admitted to the 
use of an adulterated heroin “Santa Muerte.” CBC and BMP 
were unremarkable. Urine drug screen immunoassay was 
positive for opiates, amphetamine, barbiturates and cocaine. 
Symptoms improved after benzodiazepine treatment, IV 
fluids, and supportive care. He was admitted for 24 hours and 
discharged the following day with no further complications. 
Laboratory analysis of the patient’s confiscated drug by GC-
MS and LCQ-TOF was positive for the novel SC 5F-MDMB-
PINACA, heroin, and fentanyl.
Case 3
A 31-year-old man with a past medical history of IV 
heroin use, presented to the ED by EMS for CNS and 
respiratory depression after IV heroin use. The patient’s 
girlfriend provided the history that the patient was using a 
new type of heroin called “Santa Muerte.” The patient was 
given a total of four mg IN naloxone in the field, after which 
he became agitated, combative, and tachycardic. His vital 
signs on arrival included a HR of 163 beats per minute, BP 
of 131/81 mmHg, RR of 29 breaths per minute, SpO2 99% 
on room air, and oral temperature 98.8 degrees F. While 
in the ED, he continued to be agitated and combative. On 
examination, he was tachycardic and flushed with dilated 
pupils and a palpable full bladder in the suprapubic region. 
The patient was given a total of 10 mg of lorazepam with 
minimal improvement of his agitation, and he was later 
intubated for airway protection. Complete blood count (CBC) 
and basic metabolic panel (BMP) were unremarkable, and 
urine drug screening immunoassay was positive for opiates. 
Serum comprehensive drug screen by LC-MS-MS was 
positive for heroin, 6-MAM, fentanyl, and negative for any 
SCs. The patient later developed ARDS, requiring increased 
ventilator setting and was transferred to a tertiary center 
for VV-ECMO. Specialty laboratory testing of the patient’s 
confiscated drug by GC-MS and LCQ-TOF was positive for 
the novel SC 5F-MDMB-PINACA, heroin, and fentanyl. 
Case 4
A 25-year-old man presented to the hospital by EMS 
after IV heroin use. The patient was found with a drug packet 
labeled “Santa Muerte” in his pocket and had CNS and 
respiratory depression. He was given a total of four mg of IN 
naloxone, after which he became flushed, tachycardic, and 
agitated with dilated pupils. On arrival to the ED, his HR 
was 158 beats per minute, BP was 215/158 mmHg, RR was 
26 breaths per minute, SpO2 was 99% on room air, and oral 
temperature was 102.1º F. On exam, he had urinary retention 
and anhidrosis. He was given four mg of lorazepam and 
two mg of IV physostigmine, which treated his agitation. 
There was also marked improvement in anhidrosis and urine 
retention. He was admitted for 24 hours and discharged the 
following day with no further complications. Urine drug 
screen was positive for cocaine, opiates, and THC. Serum 
comprehensive toxicology analysis by LC-MS-MS was 
positive for 5F-MDMB-PICA(5F-ADB), heroin, 6-MAM, 
and fentanyl. Laboratory analysis of the patient’s confiscated 
drug by GC-MS and LCQ-TOF was positive for the novel SC 
5F-MDMB-PINACA, heroin, and fentanyl.
Case 5
A 45-year-old man was found down in the field agitated 
and tachycardic. On arrival to the ED, his HR was 124 
beats per minute, BP 140/82 mm Hg, RR 22 breaths per 
minute, oxygen saturation 99%, and oral temperature 99.3º 
F. On exam, he had pinpoint pupils with flushing of skin. 
He received midazolam five mg and olanzapine 20 mg 
intramuscular followed by diazepam 10 mg IV after which he 
calmed down. He was eventually started on dexmedetomidine 
infusion when his agitation returned. He was admitted for 24 
hours and discharged the following day with no complications. 
Urine drug screen was positive for opiates and fentanyl. He 
was found with a drug packet named “50 CAL” (Image 2), 
which was sent for GC-MS and LCQ-TOF and was found to 
be positive for 5F-MDMB-PINACA, heroin, and fentanyl.
Case 6
A 36-year-old man was found lying in the street 
unresponsive. He received eight mg of naloxone IN after 
which he became agitated. On arrival to the ED, his HR was 
130 beats per minute, BP 160/100 mm Hg, RR 24 breaths per 
minute, oxygen saturation 95% on 100 % oxygen, and oral 
temperature 98.6º F. Initial physical examination revealed 
Image 2. A “50 CAL” drug packet retrieved from a patient, which 
contained heroin, synthetic cannabinoid, and fentanyl.
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restlessness, confusion, and picking behavior. Patient also 
had bilaterally dilated pupils with urine retention on point-of-
care ultrasound. Considering an anticholinergic toxidrome, 
the emergency provider administered physostigmine two mg 
IV with improvement in agitation, picking behavior, urine 
retention, and relative constriction in pupillary diameter. 
He had received multiple doses of benzodiazepines prior 
to physostigmine. He was eventually intubated due to risk 
of aspiration from vomiting in the setting of altered mental 
status. His mental status and vitals improved the next day, 
following which he was extubated. CBC and BMP were 
unremarkable and urine drug screen was positive for opiates 
and fentanyl. The patient was found with a blue packet labeled 
“50 CAL,” which was found to be positive for fentanyl, 
heroin, and 5F-MDMB-PINACA on GC-MS and LCQ-TOF. 
Case 7
A 23-year-old woman was brought to the ED with severe 
agitation and combative behavior. Her initial vitals were HR 
156 beats per minute, BP 147/64 mm Hg, RR 20 breaths per 
minute, and oral temperature 101.5º F. Examination revealed 
bilaterally dilated pupils, flushed and dry skin, and urine 
retention on point-of-care ultrasound. The patient received 
Lorazepam four mg IV and physostigmine two mg IV after 
which her agitation subsided, urine retention improved, 
pupillary diameter decreased, and skin appeared less flushed 
and less dry. CBC and BMP were unremarkable while her 
urine drug screen was positive for opiates and fentanyl. She 
was admitted to the floor and discharged the next day. The 
patient reported consuming a substance from packets labeled 
“50 CAL.” The drug packets were not available for analysis. 
We were also unable to send her serum or urine for further 
comprehensive toxicology analysis. 
Case 8
A 27-year-old man was brought to the ED after IV heroin 
use. He was found to be in respiratory and CNS depression 
with pinpoint pupils in the field by the EMS. Naloxone 
four mg IN was given after which he became agitated. 
His vitals were HR 130 beats per minute, BP 130/94 mm 
Hg, RR 22 breaths per minute, and temperature of 99º F. 
Initial examination revealed dilated pupils, dry oral mucous 
membrane, and flushed skin. He received lorazepam 4 mg IV 
and physostigmine two mg IV after which he calmed down, 
pupils returned back to normal size, and heart rate came down 
to normal; he was admitted to the floor. Urine drug screen was 
positive for opiates and fentanyl. He reported having ingested 
drugs from packets labeled “Nick” and “50 CAL,” but they 
were unavailable for analysis. 
DISCUSSION
Heroin has been historically adulterated with a variety of 
substances including baking soda, caffeine, acetaminophen, 
diphenhydramine, scopolamine, fentanyl, and clenbuterol.1 These 
adulterants are usually added to increase profits by incorporating 
any substance that looks like the original substance and/or would 
have the same effect. In the months of April and August 2018, 
consumption of heroin that had been laced with the newer SC 
5F-MDMB-PINACA gave rise to a series of patients presenting 
to our ED with unique clinical manifestations.
SCs, by themselves, have been widely used as drugs of 
abuse since the early 2000s. They have been found to have 
more adverse clinical presentations than the active compound 
marijuana itself, owing to its full agonistic action on the 
cannabinoid receptor type 1 (CB1) and cannabinoid receptor 
type 2 (CB2) receptors, as compared to marijuana, which is 
only a partial agonist.2 Clinical effects of SC overlap with 
anticholinergic and sympathomimetic toxidromes.3,4 There 
have also been reported fatalities with SCs including 5F-ADB, 
5F-PB-22, and AB-CHMINACA.5
The patients reported in our case series took opioids 
containing 5F-MDMB-PINACA (Figure), which is a new 
generation SC. Except for patient 5, all of them presented 
with a typical initial opioid toxidrome consisting of CNS 
and respiratory depression along with pinpoint pupils. 
Naloxone, an opioid antagonist, was given to them, which 
triggered severe agitation and combative behavior along with 
overlapping features of anticholinergic and sympathomimetic 
toxidrome. This was presumably because of the removal of the 
depressant effect of opioids by the administration of naloxone 
that unmasked the effects of SC. 
All the patients required multiple doses of 
benzodiazepines. Three of the eight patients were 
successfully treated with physostigmine, which 
helped control the abnormal psychomotor activity and 
anticholinergic manifestations.  
The initial urine drug screen test used for all eight 
patients was an immunoassay-based screening test. Apart 
from morphine (opiates), it tests for fentanyl, buprenorphine, 
Figure. Chemical structure of the synthetic cannabinoid 
methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-
dimethylbutanoate.
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methadone, tramadol, cocaine, oxycodone, phencyclidine, 
amphetamines, barbiturates, benzodiazepines, and 
cannabinoids. The comprehensive serum drug screen 
performed in cases 1, 3 and 4 was through LC-MS-MS, which 
is an exceedingly sensitive and specific analytical technique 
that can precisely estimate the identities and concentrations of 
molecules within a sample.
The seized drug packets were analyzed at the Center 
for Forensic Science Research and Education, using GC-
MS and LCQ-TOF. The samples were prepared using acid/
base extraction prior to the analysis.6 The drug packets that 
were analyzed at this facility did not turn positive for any of 
the anticholinergic agents, thereby leading us to conclude 
that 5F-MDMB-PINACA potentially has anticholinergic 
manifestations that seem to be responding to physostigmine in 
our clinical experience.
CONCLUSION
Heroin contaminated with 5F-MDMB-PINACA 
exhibits variable severities of anticholinergic effects, some 
on presentation and others only after opiate antagonism. 
Synthetic cannabinoids affect cannabinoid CB1 and CB2 
receptors, potentially causing adrenergic stimulation, 
sedation, hallucinations, catecholamine release, and severe 
tachycardia.2-4 It is also possible that synthetic cannabinoids 
and/or their metabolites interact directly with acetylcholine 
receptors to cause anticholinergic effects. In our case 
series, we found that physostigmine was effective in 
reversing the anticholinergic effects and agitation in three 
out of the eight patients. 
The authors attest that their institution requires neither 
Institutional Review Board approval, nor patient consent for 
publication of this case report. Documentation on file.
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Introduction: Given concern for increased aerosolization during intubation of patients with severe 
acute respiratory syndrome coronavirus, we sought to create a portable, inexpensive, and easily 
constructed device to help protect healthcare workers.
Methods: A respiratory protection unit can be constructed in approximately 30 minutes and for less than 
50 United States dollars in materials, using polyvinylchloride pipe and automobile collision wrap.
Conclusion: This device provides possible increased protection during video laryngoscopy and can 
easily be replicated. [Clin Pract Cases Emerg Med. 2020;4(2):126–128]
Keywords: COVID-19; intubation; airway.
INTRODUCTION
Based on current evidence, the novel human coronavirus 
that is named severe acute respiratory syndrome coronavirus 
2 (SARS-CoV-2) has been found during experimentation 
to remain viable when aerosolized for three hours.1 Current 
US Centers for Disease Control and Prevention guidelines 
recommend use of the highest level of personal protective 
equipment (PPE) when performing aerosolization-potential 
procedures such as intubation.2 Limited studies have shown 
a possible benefit of barrier protection when performing 
endotracheal intubation.3 We sought to create an inexpensive 
and easily reproducible model that could be used in resource- 
poor or resource rich-environments, or when negative pressure 
rooms are unavailable due to patient volumes. 
METHODS
The following materials were used to construct the 
portable respiratory protection unit (PRPU): polyvinyl 
chloride (PVC) ½ inch pipe; PVC joints; and 36-inch wide 
automobile plastic collision wrap (Table).  
PVC pipe can be purchased in one 10-foot piece that 
can be cut up into 13 pieces with a miter saw or hacksaw. 
Completed box dimensions are 24 inches tall and 27 inches 
University of Missouri School of Medicine, Department of Emergency Medicine, 
Columbia, Missouri
Materials required
Miter saw or hacksaw
10 feet polyvinyl chloride ½-inch diameter pipe cut into these 
lengths:
#4 28-inch length 
#3 22-inch length
#2 20-inch length
#2 7.5 inch (top bars)
#2 11 inch (bottom bars)
#2 ½-inch “T” fitting
#4 90-degree fittings
#4 3-way fitting
36-inch automobile plastic collision wrap (one roll) 
Table. Materials required to construct a portable respiratory 
protection unit.
in length. Three-way fittings are used on superior surface 
for the four joints and two 90-degree fittings are used on 
base corners. On the posterior (caudal) surface, two “T” 
fittings are used. Following frame construction, automobile 
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What do we already know about this clinical 
entity? 
Given concern for healthcare worker exposure 
to aerosolization during intubation of the 
COVID+ patient, protective barriers have 
been suggested as a way to lessen risk.
What makes this presentation of disease 
reportable? 
We present an inexpensive device that requires 
little construction.
What is the major learning point? 
A portable respiratory protection unit can 
easily be replicated at low cost and used in 
the emergency department setting.
How might this improve emergency medicine 
practice? 
Healthcare workers can be provided with 
some protection during airway management.
collision wrap is used to cover each side. Collision wrap is 
often used in the automotive industry to cover broken car 
windows and is adhesive on one side. The adhesive side of 
the wrap faces into the box. Each box can be constructed in 
approximately 30 minutes by two people (Image 1). Total 
material cost is less than 50 US dollars.
During intubation, the box is laid over the patient to 
cover his head and upper chest. Using a knife or any other 
sharp device, two vertical incisions can be made to place 
hands through (Image 2). Equipment can be passed through 
either the incisions or under the bottom of the plastic 
covering. Ideally the intubation being performed would be 
video laryngoscopy so that the healthcare worker would 
not be required to be close to the patient’s oropharynx. 
Following intubation, the box could be removed or ventilator 
tubing could be passed through incisions in the plastic. 
To limit ventilator circuit disconnection, tubing could be 
passed underneath the frame. Following use, the automobile 
collision wrap can be discarded and the frame can be cleaned 
according to CDC guidelines with wipes or sprayed down 
with appropriate cleaning agent. Once dry, a new length of 
Image 1. Portable respiratory protection unit, constructed of 
PVC pipe and auto collision wrap, situated on a stretcher in 
correct position.
Image 2. Simulated intubation through incisions made in cephalad 
wall of portable respiratory protection unit.
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automobile collision wrap can again be used to cover sides 
of the device in preparation for the next patient.
DISCUSSION
The PRPU can be assembled rapidly and easily and 
materials should be readily available in most countries. If 
auto collision wrap is not readily available, a substitute plastic 
material could be used; however, depending on the opacity 
of the material it may further limit direct visualization of 
the patient. The PRPU use could be expanded beyond the 
emergency department setting. Other potential uses include 
protective covering for patients during emergency medical 
services transport or hospital transport.
LIMITATIONS
Given the ever-changing situation and time-sensitive 
nature of disseminating this model, we do not have time to 
trial this model. By no means does this model completely 
contain aerosol viral particles; therefore, appropriate personal 
protective equipment should still be worn when intubating any 
known positive or suspected SARS-CoV-2 patient. 
CONCLUSION
The PRPU is an inexpensive and quick to construct a 
protective device for healthcare workers to use during intubation 
of high-risk patients such as those with SARS-CoV-2 The device 
is easy to reuse and has many additional applications. 
Appendix. Find the video at: https://vimeo.com/403079338.
Documented patient informed consent and/or Institutional Review 
Board approval has been obtained and filed for publication of this 
case report.
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Introduction: Coronavirus disease 2019 (COVID-19) is caused by the virus known as severe acute 
respiratory syndrome coronavirus 2 (SARS-CoV-2).  Several case series from Italy and China have 
highlighted the lung ultrasound findings of this disease process and may demonstrate its clinical 
utility during the current pandemic.
Case Report: We present a case of a COVID-19 patient who presented to the emergency department 
twice within a 24-hour period with rapidly progressing illness. A multi-organ point-of-care ultrasound 
(POCUS) evaluation was used on the return visit and assisted clinical decision-making. 
Discussion: A multi-organ POCUS exam allows for quick assessment of acute dyspnea in the 
emergency department. As the lung involvement of COVID-19 is primarily a peripheral process it is 
readily identifiable via lung ultrasound. We believe that when applied efficiently and safely a POCUS 
exam can reduce clinical uncertainty and potentially limit the use of other imaging modalities when 
treating patients with COVID-19.
Conclusion: This case highlights the utility of an early multiorgan point-of-care assessment for 
patients presenting with moderate respiratory distress during the severe SARS-CoV-2 pandemic. 
[Clin Pract Cases Emerg Med. 2020;4(2):129–133]
Keywords: COVID-19; SARS-CoV-2; ultrasound; respiratory distress.
INTRODUCTION
Point-of-care ultrasound (POCUS) examinations 
of patients with acute respiratory distress have been 
demonstrated to be useful for patients with acute unexplained 
dyspnea in the emergency department (ED).1 Multiple 
previous ED studies have demonstrated the ability of 
clinicians to rapidly and accurately differentiate a cardiac 
etiology (specifically acute decompensated congestive heart 
failure) versus other causes of acute dyspnea.1,2 In our early 
experience during the severe acute respiratory syndrome 
coronavirus 2 (SARS-CoV-2) outbreak, with multiple patients 
presenting with acute dyspnea of suspected parenchymal 
Highland Hospital / Alameda Health System, Department of Emergency Medicine, 
Oakland, California
pulmonary pathology, we found that the prompt differentiation 
between an underlying cardiac versus pulmonary source can 
be instrumental in both triage and early resuscitation.
Early reports from China detailed the utility of computed 
tomography (CT) in demonstrating the classic multifocal, 
ground-glass opacities that are commonly present in patients 
with pulmonary manifestations of the rapidly progressing viral 
pandemic.3 Our early, multi-organ ultrasound first strategy 
in the evaluation of the severely dyspneic patient centers on 
not assuming all patients who arrive in our ED during this 
large wave of patients are purely pulmonary in nature (even 
though we recognize the high prevalence of disease), and 
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What do we already know about this clinical 
entity? 
The virus severe acute respiratory syndrome 
coronavirus 2 can cause severe pulmonary 
infection and inflammatory response in patients 
presenting during the coronavirus disease 
2019 (COVID-19) pandemic.
What makes this presentation of disease 
reportable? 
This case highlights the rapid progression of 
COVID-19 pneumonia and the utility of point-
of-care-ultrasound (POCUS) in excluding 
alternative causes of dyspnea.
What is the major learning point? 
Multiorgan-POCUS is useful for ED 
evaluation of dyspnea during the COVID-19 
pandemic due to the peripheral nature of lung 
involvement.
How might this improve emergency medicine 
practice? 
Multiorgan-POCUS has the potential to reduce 
diagnostic uncertainty in dyspneic patients and 
help limit use of other imaging modalities.
using a multi-organ POCUS examination to help guide initial 
treatment and resuscitation. We also believe that incorporating 
a system-based approach in this manner will allow a 
reduction in CT imaging and reduce the ever-present issues of 
departmental contamination and CT disinfection. 
Recent studies out of China have detailed ultrasound findings 
associated with coronavirus disease 2019 (COVID-19).4,5 
While these findings are not specific, they are likely clinically 
useful in patients with severe dyspnea in conjunction with a 
multi-organ evaluation of cardiac function and the inferior vena 
cava (IVC). Furthermore, we believe that these non-specific 
ultrasound findings can be used in conjunction with clinical and 
laboratory parameters to assist defining pulmonary involvement 
of SARS-CoV-2, especially as it typically involves peripheral 
lesions near the pleura, which are well demonstrated on lung 
ultrasound. Herein we present a case of SARS-CoV-2 related 
multifocal pneumonia diagnosed by POCUS in the ED during 
the initial triage of a return ED visit, which highlights its clinical 
utility and our proposed imaging pathway for evaluating patients 
with acute dyspnea during the current SARS-CoV-2 outbreak. 
CASE REPORT
A 56-year-old female with a past medical history of 
asthma and dyslipidemia presented to a community ED with 
one week of fever, non-productive cough, dyspnea, headache, 
nausea and vomiting. She denied smoking history or drug 
use. Travel history was significant for returning home from 
an amusement park in Los Angeles one week prior to onset of 
symptoms. Vital signs at triage were temperature (oral) 38.6° 
Celsius; heart rate 117 beats per minute; respiratory rate 20 
breaths per minute; and pulse oximetry 93% on room air. 
Clinical Course on First Emergency Department Visit
Significant laboratory results were as follows: rapid 
influenza diagnostic test was negative; white blood cells 11.7 
10*3 per microliter (mcL) (reference range 4.5-11.5 10*3/mcL), 
neutrophils relative 92% (reference 50-70%), lymphocyte 
absolute 0.55 10*3/mcL (reference 0.8-4.80 10*3 /mcL), 
and lactic acid was 1.0 millimoles per L (reference  0.5-2.2 
mmol). A two-view chest radiograph (CXR) was interpreted 
by the radiologist as pneumonia of the left lower lobe with 
interstitial changes (Image 1). After symptomatic therapy and 
a first dose of azithromycin, the patient was discharged home 
with instructions to continue antibiotic therapy and return for 
worsening symptoms. 
Clinical Course Second Emergency Department Visit
Approximately 12 hours after discharge the patient 
returned to the same ED with worsening dyspnea. Upon 
arrival she was noted to be ill appearing, tachypneic and with 
moderate respiratory distress despite similar triage vital signs 
as the initial ED visit. Her lung exam was significant for poor 
inspiratory effort and rhonchi at the bases. A multi-organ 
Image 1. Chest radiographs of the initial emergency department 
visit. Patient was dyspneic at the time. A) Posterior-anterior view 
demonstrating prominent interstitial markings in the mid and 
lower lung field bilaterally; and B) Lateral view with apparent 
area of retrocardiac opacity (arrow) likely representing an early 
consolidation in the left lateral lobe.
A B
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Image 2. Normal systolic ejection fraction determined by 
parasternal long-axis view.
Image acquisition via Sonosite X-Porte system using phased 
array probe.
POCUS exam was performed to determine the cause of the 
patient’s dyspnea. 
A cardiac parasternal long-axis view demonstrated normal 
systolic ejection fraction and no pericardial effusion (Image 
2). The IVC in the subxiphoid view showed greater than 50% 
collapse during inspiration (Image 3). A lung exam using a 
low frequency (5-2 megahertz) curvilinear transducer in the 
anterior, lateral, and posterior portions, showed the presence of 
diffuse scattered B-lines with small subpleural consolidations 
and effusions in each lung zone, with confluent B-lines in the 
posterior inferior lobes bilaterally (Image 4). POCUS findings 
were interpreted as the presence of a non-cardiogenic multifocal 
interstitial lung process with COVID-19 being high on the 
differential. The patient was placed in a negative pressure room, 
and all staff were informed to wear full personal protective 
equipment when interacting with the patient. 
Based on the POCUS multi-organ findings, the patient was 
resuscitated with an intravenous bolus normal saline and treated 
with broad-spectrum antibiotics (levofloxacin). SARS-CoV-2 
oropharyngeal and nasopharyngeal swabs were sent from the 
ED for testing. The infectious disease consultant agreed with 
a plan for admission and continuation of droplet, airborne, and 
contact precautions given the progression of symptoms and 
worsening respiratory status. She was admitted to a negative 
pressure room on the medical floor for continued therapy and 
monitoring of respiratory status. An eventual non-contrast CT of 
the chest demonstrated diffuse multifocal infiltrates (Image 5).
As an inpatient, the patient’s antibiotic regimen was adjusted 
to doxycycline and cefepime. She was under observation and 
Image 3. The inferior vena cava (arrow) was determined to be 
non-plethoric and collapsible with respiration. In this image, the 
inferior vena cava is surrounded by the liver (stars). 
Image acquisition via Sonosite X-Porte system using phased 
array probe.
isolation for six days at the hospital of presentation. At this point 
the SARS-CoV-2 testing had not yet resulted, but her clinical 
course had improved. She was discharged home with instructions 
to self-quarantine at home or return to the ED if symptoms 
worsened. SARS-CoV-2 testing resulted the day after discharge 
as positive for SARS-CoV-2 ribonucleic acid. 
DISCUSSION
During the current SARS-CoV-2 pandemic, prompt 
evaluation of patients in the ED presenting with acute dyspnea 
is imperative. Diagnostic testing of SARS-CoV-2 has been 
limited to date, and in our setting will not result during a 
typical ED visit. Likewise, serum laboratory markers for both 
SARS-CoV-2 associated pneumonia and non-SARS-CoV-2 
causes of acute dyspnea (decompensated heart failure, chronic 
obstructive pulmonary disease/asthma, pulmonary embolism) 
are non-specific, are also not immediately resulted, and are of 
limited value during the initial hospital presentation. 
The role of imaging during the SARS-CoV-2 outbreak is still 
being established. A study of patients diagnosed with COVID-19 
in Wuhan, China, demonstrated a progression of disease by 
CT imaging from early subclinical/asymptomatic patients with 
unilateral and multifocal ground-glass opacities to patients with 
less than one week of symptoms showing bilateral disease and 
transition to consolidation and interstitial changes.6 However, the 
American College of Radiology recently issued guidance that CT 
should not be used as a first-line test to diagnose acute SARS-
CoV-2 infection, and that limiting the use of portable radiography 
should be attempted to reduce transmission.7  
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Image 4. Confluent B-lines were seen in all lung fields with 
increased density in the posterior lateral sections. The arrows 
denote B-lines that were interpreted as pulmonary infiltrates due to 
depth and confluence. 
Image acquisition via Sonosite X-Porte system using curvilinear probe.
POCUS holds some distinct advantages over other imaging 
modalities especially in times of disaster or pandemic. The 
characteristic ultrasonographic findings of interstitial 
pneumonia near the pleura are accessible, rapidly attained and 
reliable markers of pathology. Lung ultrasound has been shown 
to be more sensitive than CXR for pneumonia and pulmonary 
edema.8,9 In our anecdotal experience, ultrasonographic features 
of COVID-19 may be detectable earlier or more reliably than 
on CXR. Additionally, while assessing for findings of interstitial 
pneumonia, basic cardiac and IVC imaging is easily obtainable 
and can offer information in regard to the presence of an 
alternative pathology and guide resuscitation. 
While the majority of patients infected with SARS-CoV-2 
will experience only mild illness, a subset will progress to 
multifocal pneumonia, acute respiratory distress syndrome, 
and cardiomyopathy10–12 pathologies that can be identified 
rapidly with POCUS.8,9,13–15
 
CONCLUSION
The above case highlights the utility of a multiorgan 
approach in the evaluation of the acutely dyspneic patient 
during the SARS-CoV-2 pandemic. Along with lung 
ultrasound findings that have been described in China and 
Italy, we believe that the evaluation of the heart and IVC 
are easily obtained and extremely useful for two important 
reasons. First, this approach allows to rapidly determine 
other common causes of dyspnea in the undifferentiated 
patient. Second, with a more protocolized pathway on 
early presentation, we hope to reduce the reliance on other 
Image 5. Computed tomography of the chest without contrast in 
an axial cut showing diffuse multifocal infiltrates (solid arrows) with 
areas of consolidation and increased infiltrates in the posterior 
segments (dashed arrows).
imaging modalities (chest radiographs and CT) in a time 
when infection control is imperative. In our experience, a 
multi-organ ultrasound first approach for all severely dyspneic 
patients is an ideal approach during the global SARS-CoV-2 
pandemic and especially as healthcare resources become 
increasingly strained.
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Urolithiasis is a condition with calculi commonly found within the kidney, ureter, or bladder. The 
urethra is an uncommon location of urolithiasis, with limited case reports and literature reviews of its 
presentation and management. Here we discuss a 24-year-old female who presented with urinary 
urgency, flank pain, and urinary retention for 12 hours. Physical exam showed a calculus at the 
urethral meatus. This case discusses the manual removal of a urethral calculus in a female patient 
with use of forceps, resulting in complete resolution of symptoms and urinary retention. [Clin Pract 
Cases Emerg Med. 2020;4(2):134–136.]
INTRODUCTION
Urolithiasis is a common condition seen in the emergency 
department (ED) that most often presents with calculi located in 
the kidney, ureter, or bladder. An obstructing calculi located at 
the urethra is an uncommon presentation where the management 
options are unique to its location.1 There are limited case reports 
and literature reviews of urethral calculi and management 
in the emergency setting. In this case report, we discuss the 
presentation, physical exam, imaging studies, diagnosis, and 
manual removal of a urethral calculi.   
CASE REPORT
A 24-year-old female with past medical history of 
nephrolithiasis presented to the ED complaining of urinary 
urgency, left flank pain, and urinary retention over the previous 
12 hours. She spontaneously passed a renal stone one week 
prior at home with planned follow-up with her urologist in three 
days. She had been taking nitrofurantoin over the past year as 
prophylaxis for recurrent urinary tract infections.
Initial vital signs included temperature of 37.1o Celsius 
(98.7o Ferenheit), heart rate 104 beats per minute, blood 
pressure 126/87 millimeters of mercury, and respiratory rate 
22 breaths per minute. Initial physical exam showed a mildly 
uncomfortable appearing female who was non-toxic. She had left 
flank tenderness to deep palpation with no midline bony spinal 
tenderness. Abdomen was soft, non-tender, and non-distended 
with no palpable pulsatile mass.
The patient’s blood work ordered by the triage physician was 
significant for a leukocytosis with white blood cell count of 14.3 
University of Las Vegas, Department Emergency Medicine, Las Vegas, Nevada
thousand per cubic millimeter (K/mm3) (reference range 3.7 to 
10.6 K/mm3). All other blood work was within normal limits, 
including a creatinine of 0.8 milligrams per deciliter (mg/dL) 
(reference range 0.6 to 1.5 mg/dL). Pregnancy test was negative. 
Computed tomography  (CT) of the abdomen and pelvis without 
contrast ordered by the triage physician showed a distended 
urinary bladder with multiple bladder stones and mild left 
hydroureter (Image 1).
No urine sample had been provided for a urine analysis 
after two hours of arrival and a catheter sample was ordered. The 
patient’s nurse reported difficulty finding the urethra for catheter 
placement and requested assistance. A pelvic exam was then 
performed showing a calculus at the urethral meatus (Image 2).
An initial attempt to manually remove the calculus using 
topical lidocaine gel and direct pressure on the stone through 
the vaginal canal was unsuccessful. A second attempt at 
calculus removal was successful by grasping the calculus with a 
hemostatic forceps (Image 3).
The patient was able to immediately void without difficulty 
after the 15 mm calculus was removed. She was discharged in 
improved condition with an outpatient urology follow-up.
DISCUSSION
Urolithiasis is a common condition with an increasing 
number of ED visits reported over the past decade.2 It is 
well established that stone size and location are the major 
determinant of spontaneous passage with most calculi less 
than 5 mm passing spontaneously and calculi more than 10 
mm unlikely to spontaneously pass.3,4 Additionally, there has 
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What do we already know about this clinical 
entity? 
Urethral calculi are an uncommon 
presentation of a urolithiasis, a common 
condition that most often presents with calculi 
located in the kidney, ureter, or bladder. 
What makes this presentation of disease 
reportable? 
An obstructing calculi located at the urethra 
is an uncommon presentation where the 
management options are unique to its location.
What is the major learning point? 
In specific cases, direct manual removal 
of a urethral calculus with forceps can 
be a definitive treatment while avoiding 
invasive treatment and possible associated 
complications.
How might this improve emergency 
medicine practice? 
This case discusses a possible solution in 
an uncommon presentation with limited 
case reports and literature reviews of 
urethral calculi and management in the 
emergency setting.
been an increase in prevalence of women diagnosed with 
urolithiasis in a previously male-predominant disease.5
Urethral calculi are the rarest presentation of urolithiasis 
with no established prevalence and no standardized 
management and treatment.1 In a literature review, we 
found the presentation and management of urethral calculi 
to be limited to case reports and small literature reviews. 
Additionally, the majority of case reports are of male patients. 
One case report documented a 22-year-old male presenting 
with penile pain and urinary retention, who was found to 
have a urethral calculus on bedside ultrasound and ultimately 
underwent lithotripsy by urology.5 Another reported a 54-year-
old male with a urethral calculus who underwent open 
surgery by urology for calculus removal.7 A final case report 
documented a 64-year-old female with urinary retention and 
a urethral calculus that could not be extracted manually. She 
required pneumatic lithotripsy through a rigid cystoscope 
under spinal anesthesia.8 
A study of 34 male patients with urethral stones showed 
a safe and effective treatment approach by retrograde 
manipulation of the calculi with a 16 French foley urethral 
catheter prior to endoscopic or extracorporeal shock wave 
lithotripsy.9 This approach requires general anesthesia and 
does carry intrinsic risk of bladder and urethral trauma.
CONCLUSION
Urethral calculus is a rare presentation of urolithiasis. This 
rare case demonstrates successful management of a urethral 
calculus in a female patient by manual removal of the calculus 
with forceps. In specific cases, direct manual removal of a 
Image 1. Computed tomography of the abdomen and pelvis with-
out contrast (coronal view) showing bladder calculi (white arrow) 
and hydroureter (red arrow).
Image 2. Urethral calculus at the urinary meatus on external 
pelvic exam (arrow).
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urethral calculus with forceps can be a definitive treatment 
resulting in complete resolution of symptoms and urinary 
retention while avoiding invasive procedures and possible 
associated complications.
Image 3. 15-millimeter urethral calculus post-manual removal.
Documented patient informed consent and/or Institutional Review 
Board approval has been obtained and filed for publication of this 
case report.
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This is a novel case report of a 44-year-old woman who presented to the emergency department 
with epigastric pain wrapping around to her back. She had no risk factors for cardiac disease, 
but her initial electrocardiogram (ECG) showed a Wellens syndrome pattern and she was taken 
urgently to the catheterization lab. After a negative catheterization, she underwent cardiac 
magnetic resonance imaging, which was positive for Takotsubo cardiomyopathy (TC). Ultimately, 
abdominal computed tomography revealed that she had cholecystitis, which likely was the cause 
of her TC and ECG changes. [Clin Pract Cases Emerg Med. 2020;4(2):137–141.]   
INTRODUCTION
Takotsubo cardiomyopathy (TC), also known as stress 
cardiomyopathy, is a rare but dangerous condition that can 
be encountered in the emergency department (ED). TC can 
be difficult to diagnose as it can present as chest pain or 
abdominal pain; it is often identified after the fact by way 
of cardiac magnetic resonance imaging. There are known 
electrocardiographic (ECG) changes as well as transthoracic 
echocardiogram findings, but these can be subtle.1,2 We present 
a case report of a middle-aged female who presented to the ED 
with abdominal pain and was found to have concerning changes 
on her ECG.
CASE REPORT
A 44-year-old female with past medical history significant 
for gastroesophageal reflux disease, depression, insomnia, and 
cervical cancer in remission presented in mid-December via 
private vehicle to the ED with epigastric pain since the prior 
evening. The patient had attempted treatment at home with 
over-the-counter antacids without relief. She described her 
pain as epigastric burning, wrapping around her chest to her 
back, with associated diaphoresis, nausea, and vomiting. She 
denied fevers, hematemesis, dysuria, or vaginal discharge. The 
patient’s cervical cancer had been treated with total abdominal 
hysterectomy, chemotherapy, and radiation. Her only daily 
medication was hormone replacement therapy. She reported 
Virginia Commonwealth University, Department of Emergency Medicine, 
Richmond, Virginia
drinking one alcoholic beverage per day but denied tobacco or 
drug use. Family history was notable for coronary artery disease 
in her mother, who died of a myocardial infarction at age 54.
The patient’s vital signs in triage were as follows: 
heart rate 77 beats per minutes; blood pressure 150/90 
millimeters of mercury; respiration rate 15 breaths per minute; 
temperature: 36.8º Celsius; and oxygen saturation 98%. Pain 
was 9/10 (epigastric). An ECG was immediately obtained 
(Image 1). The ECG showed possible ischemia due to deep 
t-wave inversions across leads V1-4, and the patient was 
placed on a cardiac monitor. 
The patient’s physical exam revealed marked right 
upper quadrant and epigastric tenderness with a positive 
Murphy’s sign. Her initial labs showed mild hyponatremia 
(133 milligrams [mg] per deciliter), leukocytosis (18.6 
thousand) and troponin-I of 0.18 (normal range: < 0.03 – 0.39 
nanograms per milliliter Cardiology was urgently consulted 
and a stat bedside transthoracic echo showed septal wall 
motion abnormalities, possible apical hypokinesis, and an 
estimated left ventricular ejection fraction (LVEF) of 45-50%. 
Repeat ECG during cardiology evaluation (Image 2) showed 
a new left bundle branch block (LBBB). Due to the new 
LBBB and t-wave inversions on initial ECG concerning for 
Wellens syndrome the patient was given 324 mg aspirin, 4000 
units heparin, 180 mg ticagrelor, and emergently taken to the 
catherization lab.  
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What do we already know about this clinical entity? 
Takotsubo cardiomyopathy (TC) can present in 
concert with a variety of other conditions and its 
presentation mimics acute coronary syndrome.
What makes this presentation of disease reportable? 
TC can present in a myriad of ways, in this case, 
due to cholecystitis. If TC is missed, it could lead 
to hemodynamic compromise and a potentially 
bad outcome. 
What is the major learning point? 
Cholecystitis can cause TC.
How might this improve emergency medicine 
practice? 
Providers should keep TC on the differential for 
patients presenting with chest pain, as well as those 
presenting with abdominal pain.
A left heart catheterization was performed and revealed 
no significant coronary artery disease. Upon admission 
to the cardiac intensive care unit (ICU), the patient 
continued to complain of epigastric pain for which she 
received acetaminophen/oxycodone, pantoprazole, and a 
gastrointestinal (GI) cocktail that helped relieve her pain. 
Chest and abdominal plain radiographs obtained shortly 
thereafter did not show any acute pathology.
That evening, the patient underwent computed tomography 
abdomen/pelvis with intravenous (IV) contrast, which 
demonstrated gallbladder wall thickening with gallstones in 
both the gallbladder and cystic duct. The patient was started 
on empiric IV piperacillin-tazobactam. Gastroenterology and 
general surgery were consulted. Overnight the patient remained 
afebrile and her pain fully resolved.  
To help elucidate the cause of the patient’s wall motion 
abnormalities, a cardiac magnetic resonance imaging (MRI) 
was performed the following day. The MRI was significant for 
apical ballooning of the left ventricle with an ejection fraction 
of 49% (Image 3). Based on these findings the patient was 
diagnosed with Takotsubo cardiomyopathy.
The patient was transferred from the cardiac ICU to 
the floor, and elected conservative management of her 
cholecystitis via dietary changes and surgical follow-up. At 
discharge on hospital day 3, she was started on metoprolol 
25 mg twice daily and lisinopril 5 mg daily for blood 
pressure control and cardiac remodeling protection. She 
underwent an outpatient laparoscopic cholecystectomy 
approximately two months later. At her three-month 
cardiology follow-up, the patient had persistent LBBB 
and her transthoracic echo showed LVEF of 55-60% with 
paradoxical septal wall motion, but there was no apical 
ballooning. At six months post-diagnosis, she had had no 
further episodes of TC.
DISCUSSION 
The patient’s chief complaint of epigastric pain has a wide 
differential that includes both abdominal and thoracic etiologies. 
Differential diagnoses include esophagitis, esophageal spasm, 
gastroesophageal reflux, gastritis, peptic ulcer disease, biliary 
colic, cholecystitis, cholangitis, esophageal rupture, pancreatitis 
and, because many of these conditions can mimic acute 
coronary syndrome (ACS), a consideration of myocardial 
Image 1. Initial electrocardiogram with Wellen’s syndrome morphology.
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ischemia is warranted. A meta-analysis of ACS presentations to 
both primary care and the ED found that for those presenting 
with epigastric pain, there was a 91% specificity (95% 
confidence interval [CI], 85.0-95.4) but only a 5% sensitivity 
(95% CI, 2.1-10.8)3 with relation to acute coronary ischemia. 
This, coupled with the National Registry of Myocardial 
Infarction II study, which found that 33% of patients with acute 
myocardial ischemia present without chest pain,4  places ACS in 
the differential for any patient who presents with GI symptoms. 
Additionally, women with acute coronary ischemia are more 
likely to present with atypical, non-chest pain and are at a 
higher risk of discharge from the ED, especially if they are <55 
years old (odds ratio [OR] [6.7], 95% CI, 1.3-32.5).5 
The patient’s initial ECG was concerning for Wellens 
syndrome, a condition most commonly associated with critical 
stenosis of the left anterior descending (LAD) artery and 
increased risk of anterior wall myocardial infarction if not treated 
with percutaneous coronary intervention. Wellens syndrome can 
present with one of two t-wave abnormalities: a biphasic T-wave 
(type A, sometimes referred to as a “saddle wave,” occurs in 
25% of cases) and a deeply inverted T-wave (type B, occurs in 
75% of cases).6 This change happens in V2-3 but may extend 
to V1-6. Wellens types A and B can be seen as T-wave changes 
along a continuum, as initial LAD occlusion will lead to type 
A changes and reperfusion can lead to type B changes. These 
changes can occur in a “stuttering” format if the LAD occlusion 
causes intermittent ischemia, with reoccurrences of type A and 
B morphologies.6 Wellens syndrome can also manifest due to 
vasospasm when no LAD stenosis is present.
TC is the cause of 1-2% of ACS presentations to the ED.1 
The prevalence of TC in the US is estimated to be 5.2 per 
100,000 women and 0.6 per 100,000 men.7 First investigated 
by Sato et al in 1990 in Japan, the entity of Takotsubo, or stress 
cardiomyopathy, was named due to the apical ballooning of the 
heart, which looks similar to a pot used to catch octopi.8 Often 
referred to as “broken heart syndrome,” it has been reported 
in post-menopausal women who have recently suffered severe 
emotional stress. Women >55 years old had 4.8 times higher odds 
for developing TC compared to those <55 years old.7 
TC diagnostic criteria include the following: 1) new 
concerning ECG changes (most commonly ST-segment 
elevation and/or T-wave inversions) or increased troponins 
(1.8x increase as opposed to the average 6x increase associated 
with myocardial infarction); 2) transient akinesis /dyskinesis 
of the left ventricle (typically apical); and 3) absence of >50% 
coronary artery stenosis or culprit lesion.1,2 While TC has been 
traditionally diagnosed via cardiac MRI, bedside transthoracic 
echocardiogram can be used to help diagnose it by noting apical 
ballooning that crosses several areas of cardiac perfusion when 
using the apical 4-chamber view.9  
Many etiologies have been proposed, most relating to 
catecholamine-induced vasospasm, and coronary artery 
spasm.10 Left ventricular outflow tract (LVOT) obstruction 
and estrogen deficiency are additional risk factors for 
the development of TC.11 Most TC patients will be 
hemodynamically stable upon presentation but approximately 
10% will present in cardiogenic shock.12 Factors associated 
with a shock presentation include atrial fibrillation (OR 
[2.03]; 95% CI, 1.22-3.40; P = 0.007), left ventricular ejection 
fraction <45% (OR [2.49]; 95% CI, 1.63-3.80; P <0.001), 
and catecholamine release (OR [2.84]; 95% CI, 1.96-4.12; P 
<0.001).12 LVOT obstruction is associated with 19% of TC-
Image 2. Electrocardiogram approximately one hour after arrival showing new left bundle branch block.
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induced cardiogenic shock.13 While there does not appear to be 
any increased mortality related to LVOT obstruction-related 
cardiogenic shock, the management is very different.12
Absence of LVOT obstruction is treated with 
cardiogenic inotropes (typically dobutamine) to increase 
cardiac output. Presence of LVOT obstruction is treated 
with fluid resuscitation to improve pre-load as long as 
pulmonary congestion is not present, along with beta-
blocker therapy to improve hemodynamics and potentially 
resolve the obstruction.13 It is, therefore, imperative 
that any patients in cardiogenic shock undergo stat 
echocardiogram to assess for LVOT obstruction as this will 
radically change their management.  
In our case report, the patient’s cholecystitis and the 
associated catecholamine surge due to pain likely caused her 
TC, which resulted in her ECG changes. While case reports have 
linked pancreatitis and concomitant Wellens syndrome with 
TC, our case is novel in that our patient presented with TC and 
Wellens syndrome due to acute cholecystitis.14  
CONCLUSION
Takotsubo cardiomyopathy can mimic the presentation 
of acute coronary syndrome and will often meet criteria for 
immediate catheterization. This case reports a type B Wellens-like 
ECG pattern and development of a new LBBB with related TC 
from acute cholecystitis. Emergency providers need to be aware 
of TC as it can present with or quickly develop into cardiogenic 
shock whose treatment hinges on the presence of LVOT 
Image 3. Sagittal magnetic resonance imaging showing apical 
ballooning of left ventricle.
obstruction. While cardiac MRI is still the gold standard for 
diagnosis of TC, bedside echocardiography can give the provider 
crucial information on the patient’s cardiac hemodynamics, 
helping direct the best management of TC until the patient can 
be transported to the catheterization lab or the cardiac ICU. 
Importantly, as in this case, the underlying cause of TC must also 
be found and managed, along with the TC itself.
Documented patient informed consent and/or Institutional Review 
Board approval has been obtained and filed for publication of this 
case report.
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Kawasaki disease (KD) is a rare vasculitis of childhood that is critical to recognize and treat due to 
associated morbidity and mortality. A six-year-old male presented to our emergency department (ED) 
afebrile but with reported recent fevers. Exam revealed jaundice and erythematous tongue with papules, 
and laboratory studies indicated a direct hyperbilirubinemia. Admitted for evaluation, he developed 
continuous fever, increasing maculopapular rash, and subsequent desquamation of hands and feet. He 
ultimately met criteria for incomplete KD, was treated with intravenous immunoglobulin, and avoided 
cardiac complications. This presentation of incomplete KD with hyperbilirubinemia is rare because the 
patient was afebrile at ED presentation. [Clin Pract Cases Emerg Med. 2020;4(2):142–145.] 
INTRODUCTION
Kawasaki disease (KD) is a systemic vasculitis affecting 
small and medium blood vessels. Originally characterized by 
Tomisaku Kawasaki in 1967, KD remains a challenging 
diagnosis based on clinical features. KD is relatively rare, with 
approximately 13.7 annual incidence per 100,000 in white 
children under five years of age. However, KD is a leading 
cause of acquired heart disease in North American and 
Japanese children, making KD identification an important area 
of interest for emergency providers.1
Classic KD is defined by a daily fever for greater than 
five days with at least four of five clinical criteria: bilateral 
bulbar conjunctival injection; oral mucosa involvement; 
peripheral edema; polymorphous rash; and cervical 
lymphadenopathy (with at least one > 1.5 centimeters [cm]). 
A diagnosis of incomplete KD can be made if two or three of 
the principal features are present in association with an 
echocardiogram showing coronary artery abnormalities or at 
least three of the following laboratory findings: albumin of 
three grams (g) per deciliter (dL) or less; anemia for patient’s 
age; platelet count 450,000 thousandths (K) per microliter 
(µL)or greater; white blood count (WBC) 15,000 K/µL or 
greater; elevation of alanine aminotransferase (ALT); and 
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§
sterile pyuria greater than or equal to 10 white blood cells 
per high-powered field.1-2
Untreated, KD may progress to cardiac involvement in 
25% of cases. This may include pericardial effusions, coronary 
artery aneurysms with rupture, cardiac ischemia, 
dysrhythmias, or even sudden death. Non-cardiac 
complications include peripheral vascular aneurysms or 
obstructions, nephritis, or sensorineural hearing loss.1-4 
Unfortunately, KD is difficult to diagnose in the emergency 
department (ED) because no single diagnostic test can 
efficiently establish the diagnosis of KD, and fever with rash 
is a common complaint. The diagnosis of incomplete KD has 
been associated with a delay in intravenous immunoglobulin 
(IVIG) treatment.1 To demonstrate the complexity of KD 
diagnosis, the following case study describes an afebrile 
presentation of incomplete KD in the setting of acute jaundice.
CASE REPORT
An otherwise healthy six-year-old male presented to the ED 
on day four of illness with fevers, sore throat, and dysuria with 
dark urine. The patient saw his primary care physician on day 
one of illness with a temperature of 101.4 degrees Fahrenheit 
(F) and was diagnosed with a nonspecific viral illness, but his 
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What do we already know about this clinical 
entity? 
There have been case reports of jaundice in 
Kawasaki disease (KD). However, since it is 
not part of the diagnostic criteria, it is often 
omitted from standard teaching.
What makes this presentation of disease 
reportable? 
This is only the second case report in 
United States’ literature of KD presenting 
with acute jaundice.  
What is the major learning point? 
Emergency physicians should consider 
atypical KD in the setting of unexplained 
acute jaundice. Patients may be afebrile at 
time of presentation.
How might this improve emergency 
medicine practice? 
Increased recognition of atypical KD can 
improve timely and accurate diagnosis, 
enabling earlier treatment and decreased 
complication rates.
symptoms continued to worsen despite supportive care. In the 
days following the office visit, he had temperatures to 102° F 
daily, and developed jaundice, a maculopapular rash, and an 
erythematous tongue with papules (Images 1 and 2). 
The patient presented at the ED without a fever in the 
setting of acetaminophen use at home (last dose unknown). 
History was obtained from the mother and patient, and they 
endorsed slight non-productive cough but otherwise denied 
associated symptoms. The patient was fully immunized and 
his past medical history was unremarkable. Initial ED exam 
revealed a well-appearing patient with temperature of 99.7° F, 
pulse 115 beats per minute, blood pressure 98/64 millimeters 
of mercury, respiratory rate 22 breaths per minute, oxygen 
saturation 97% on room air, and weight 19.7 kilograms. His 
head was atraumatic and normocephalic. However, his ear, 
nose, and throat exam revealed an erythematous tongue with 
flesh-colored papules (Image 1). His sclerae were icteric and 
injected without exudate, and the conjunctival injection spared 
the limbus (Image 2). No significant cervical 
lymphadenopathy was detected. 
Cardiac auscultation revealed a regular rate and rhythm 
without murmurs, and the lungs were clear bilaterally. His 
abdomen was non-tender even to deep palpation. Skin exam 
was notable for diffuse jaundice and an erythematous 
maculopapular rash to the abdomen and face, sparing the 
palms and soles. He was awake and alert, following 
commands, and answering questions appropriately for his age.
Initial laboratory values were obtained for diagnosis. A 
complete blood count had a leukocytosis to 16.3 thousandths K/
µL (normal range: 6.0-17.0 K/µL) with 86% neutrophils (35%-
45%), and platelet count of 369 K/µL (210-490 K/µL). Total 
bilirubin was elevated at 5.4 milligrams per deciliter (mg/dL) 
(0.3-1.8 mg/dL), and conjugated bilirubin was 2.9 mg/dL (0.0-0.3 
mg/dL). Hepatic panel revealed mild transaminitis (aspartate 
aminotransferase, alanine aminotransferase, and alkaline 
phosphatase, 59 units (U) per liter (L) (17-59U/L), 169 U/L 
(21-72U/L), and 425 U/L (150-380U/L), respectively. 
Urinalysis revealed trace protein, large bilirubin, no casts, 3-5 
red blood cells with trace hemolysis, and 3-5 white blood 
cells. An initial pharyngeal rapid strep test was negative. 
 The patient was admitted to the pediatric ward for 
antibiotics and serial exams, pending abdominal imaging, 
autoimmune testing, additional labs, viral serologies, and 
culture results. A comprehensive right upper quadrant 
ultrasound showed a normal appearing gallbladder and no 
intrahepatic or extrahepatic biliary ductal dilatation to suggest 
biliary obstruction. The chest radiograph noted possible right 
basilar airspace disease. However, given the lack of sputum, 
respiratory complaints, increased oxygen support, and the 
associated physical exam findings, pneumonia was considered 
to be inconsistent with the presentation. 
Erythrocyte sedimentation rate (ESR) was elevated at 113 
millimeters per hour mm/hr (0-10mm/hr) and C-reactive 
protein (CRP) was elevated at 3.5 milligrams (mg)/dL (less 
than 1.0mg/dL), consistent with possible KD.1 Gamma-
Image 1. Erythematous tongue with papules, on day of emergency 
department presentation (day 4 of illness).
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Image 2. Jaundice, icteric sclera, and conjunctival injection, day 
four of illness.
an autoimmune process, such as acute rheumatic fever. At ED 
presentation, the patient was afebrile and only had three primary 
criteria for the diagnosis of KD: conjunctivitis; strawberry 
tongue; and maculopapular truncal rash. An autoimmune 
process such as rheumatic fever was considered less likely as 
he had no arthralgias, and the rash was not the classic well-
demarcated, semi-annular rings of erythema marginatum. 
The recent fevers and elevated neutrophils increased the 
suspicion for infectious causes of unexplained jaundice. The 
patient was treated with penicillin for possible scarlet fever 
with associated hepatitis, pending streptococcal titers. Scarlet 
fever was considered a potential unifying diagnosis, as 
hepatitis with obstructive jaundice has been reported in cases 
of scarlet fever.5-6 Post-streptococcal glomerulonephritis was 
considered due to his tea-colored urine, but the laboratory 
values were inconsistent with the diagnosis. Viral etiologies 
such as mononucleosis were considered, but mononucleosis 
screen was negative. Cholecystitis with obstruction was 
considered, but the patient had no abdominal tenderness, and 
cholecystitis would be atypical in this age group.
As in other cases, the diagnosis of KD was difficult to 
make initially, but eventually the patient satisfied necessary 
criteria for incomplete KD. He had fever for greater than five 
days, conjunctival injection without exudate, oral mucosal 
involvement, a polymorphous rash with inguinal accentuation, 
cervical lymphadenopathy (although below the 1.5 cm 
criteria), and ultimately periungual desquamation. The ESR 
and CRP levels were elevated, which led physicians to look 
for supplemental laboratory criteria. The patient ultimately 
met four laboratory criteria: WBC greater than 15,000-K/µL; 
platelet count over 450,000-K/µL; an elevated ALT; and 
albumin less than 3.0 mg/dL.1
KD has previously been reported in patients with hepatitis 
and cholestatic jaundice. We identified nine previous case 
reports, with a total of 17 KD patients displaying jaundice.7-15 
Although rarely reported, KD is the most common cause of 
glutamyltransferase was elevated at 241U/L (15-73 U/L). 
Throat cultures, antistreptolysin O, hepatitis B surface antigen, 
hepatitis B core antibody, hepatitis A immunoglobulin (Ig) M, 
hepatitis C antibody, cytolomegalo virus IgG/IgM, 
toxoplasmosis IgG/IgM, monospot, blood cultures, and 
leptospirosis testing were negative, making infectious or 
post-infectious etiologies less likely. 
On day seven of illness (hospital day four), the patient 
developed bilateral cervical lymphadenopathy up to one 
centimeter, and his bilateral bulbar conjunctival injection 
worsened. Despite being afebrile at ED presentation, he 
continued to spike fevers in the hospital (until the sixth day of 
illness and third hospital day), despite administration of 
ibuprofen. During his admission, the patient had an elevated 
ALT, low albumin, thrombocytosis, and elevated WBC, thus 
meeting at least three supplemental criteria for KD, making 
incomplete KD the likely diagnosis. The case was discussed 
with a remote KD specialist, and the next day the patient was 
transferred to the intensive care unit for IVIG infusion. An 
echocardiogram was within normal limits, although limited by 
inability to assess the full length of the coronary arteries. The 
patient was initiated on aspirin 81 mg daily. He was 
discharged on low-dose aspirin with plans to obtain repeat 
outpatient echocardiograms. 
Two weeks after discharge, the patient was evaluated by a 
pediatric cardiologist. Desquamation of the hands and feet 
were noted (Image 3). Repeat formal echocardiogram was 
normal, without evidence of pericardial effusion or coronary 
dilation. Approximately two months after his illness, the 
majority of the patient’s symptoms had resolved and low-dose 
aspirin was discontinued. A repeat echocardiogram eight 
months after initial illness was normal, and a telephone 
follow-up at 10 months indicated that he continued to do well. 
DISCUSSION
KD is a rare but critical diagnosis for physicians to 
consider in ED settings. In our patient, many other diagnoses 
were considered but did not fit the clinical picture. The 
differential diagnosis included infectious causes, such as scarlet 
fever associated with hepatitis, viral hepatitis, or other viral 
syndrome, cholangitis, and non-infectious causes, such as 
KD, malignant or other biliary obstruction, drug reaction, or 
Image 3. Desquamation of feet, day 13 of illness.
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febrile obstructive jaundice following viral hepatitis. A tertiary 
pediatric clinic chart review study reported that one in five 
jaundice cases were “caused” by KD.13 A recent case report 
described KD presenting with fevers and acute acalculous 
cholecystitis that responded to medical treatment (IVIG and 
aspirin) in lieu of urgent surgical intervention.15 Systemic 
vasculitis may underpin both KD and some cases of jaundice, 
and our case adds to the growing body of literature showing 
an association between KD and jaundice. Further empirical 
evidence of an association between KD and jaundice might 
justify adding elevated bilirubin to the supplemental criteria 
for incomplete KD. 
CONCLUSION
This case of incomplete KD was particularly challenging 
to diagnose because the patient was afebrile at time of 
presentation. This case also illustrates the difficulty in 
diagnosing incomplete KD when other more common 
diagnoses may initially be considered more likely, as 
sometimes only two or three of the clinical criteria are 
apparent at initial presentation.13-14 This patient had incomplete 
KD with associated conjugated bilirubinemia, adding to a 
growing body of literature showing an association between 
jaundice and KD. Unexplained jaundice with associated 
features should prompt physicians to consider KD. This case 
and others emphasize the importance for emergency 
physicians to retain a high level of suspicion for KD when a 
child presents with febrile or afebrile obstructive jaundice.7-15 
Documented patient informed consent and/or Institutional Review 
Board approval has been obtained and filed for publication of this 
case report.
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Introduction: Tranexamic acid (TXA) is an antifibrinolytic agent currently approved and utilized 
in the treatment of dysfunctional uterine bleeding, traumatic extracranial hemorrhage, anterior 
epistaxis, and dental procedures on patients with hemophilia. There is a paucity of literature 
evaluating the use of TXA for hemostasis in patients on direct oral anticoagulants (DOACs).
Case Report: Our patient, a 72 year-old male on rivaroxaban, presented with persistent bleeding 
following a punch biopsy of the buccal mucosa. Given the site of bleeding, inability to effectively 
tamponade, patient’s anticoagulated state, and risk of impending airway compromise, a dressing was 
soaked with 500 milligram (mg) of TXA and was held in place with pressure using a makeshift clamp 
until a thrombus formed. Hemostasis was achieved preventing the need for acute ENTotolaryngologic 
intervention and/or intubation. The patient was observed in the medical setting overnight and discharged 
home without any recurrence of bleeding or adverse events.
Discussion: This case report describes our experience achieving hemostasis for an otherwise 
uncontrollable oral bleed in an anticoagulated patient on a DOAC who could not be reversed. 
Intervention is simple to perform, cost-effective, and requires few resources which are readily 
available in most emergency departments.
Conclusion: We report a novel application of TXA to control an oral mucosal bleed in an 
anticoagulated patient which was on a DOAC refractory to traditional measures. [Clin Pract Cases 
Emerg Med. 2020;4(2):146–149.]
Keywords: Tranexamic acid; direct oral anticoagulant; TXA; DOAC; hemostasis.
INTRODUCTION
Tranexamic acid (TXA) is an antifibrinolytic agent 
approved by the Food and Drug Administration for the 
treatment of cyclic, heavy menstrual bleeding and prevention 
of hemorrhage during tooth extractions in patients with 
hemophilia.1 Recently, TXA use has expanded rapidly for a 
variety of off-label indications and is now considered the 
antifibrinolytic of choice in patients who present to the 
emergency department (ED) with extracranial hemorrhage 
following a traumatic injury.2 Further analysis of the 
Yale School of Medicine, Department of Emergency Medicine, New Haven, Connecticut
Yale-New Haven Hospital, Department of Emergency Medicine, New Haven, Connecticut
*
†
CRASH-2 (Corticosteroid Randomization after Significant 
Head Injury) trial demonstrated a significant effect of TXA on 
favorable functional outcomes for the lowest-risk (<6% 
mortality) group. Due to its cost-effectiveness and exceptional 
safety profile TXA is recommended for patients presenting 
within three hours of sustaining a traumatic injury.3 
Atomized nasal TXA with external compression was 
proven to be as effective as standard nasal packing at 
hemostasis, superior at preventing rebleeding events within 
24 hours, and more comfortable than anterior nasal packing 
Volume IV, no. 2: May 2020 147 Clinical Practice and Cases in Emergency Medicine
Boccio et al. Topical TXA for Hemostasis of an Oral Bleed
CPC-EM Capsule
What do we already know about this 
clinical entity? 
Tranexamic acid (TXA) clinical 
applications include menstrual bleeding, 
dental extractions, anterior epistaxis, and 
traumatic extracranial hemorrhage.
What makes this presentation of disease 
reportable? 
Emergency department patients on direct 
oral anticoagulants (DOAC) may present 
with bleeding, which is refractory to 
traditional measures.
What is the major learning point? 
TXA was applied topically with no major 
adverse effects to achieve hemostasis of an 
oral bleed in a patient on DOAC who could 
not be reversed.
How might this improve emergency 
medicine practice? 
Further investigation into the use of 
topical TXA as a treatment option for 
refractory hemorrhage in patients on 
DOACs is warranted.
and traditional external compression in managing anterior 
epistaxis.4 The use of TXA, both systemically and topically, 
in the setting of dental extraction and orthognathic surgery 
has been documented in the literature.5 The use of TXA 
suspension-soaked gauze, made from crushed 500 milligram 
(mg) TXA tablets and water, applied directly to the extracted 
cavity to prevent bleeding has been successful in hemophilia 
patients undergoing dental procedures.6 The use of a 0.05% 
TXA irrigation solution following orthognathic surgery and 
5% TXA mouthwash administered after gingival 
manipulation and scaling in patients with hemophilia has 
also been shown to be effective in prevention and/or 
treatment of clinically significant oropharyngeal bleeding.7-8 
It is important to note, however, that each of these 
dosage forms requires manipulation of commercially 
available TXA products, and may not be ideal for urgent use 
in the ED setting. A recent Cochrane Review examined 
randomized controlled trials of people on continuous 
treatment with vitamin K antagonists (VKA) or direct oral 
anticoagulants (DOAC) undergoing oral or dental procedures 
using antifibrinolytic agents to prevent perioperative 
bleeding.9 Although the studies demonstrated a beneficial 
effect of locally applied TXA for patients on continuous 
VKAs, no eligible trials in people on continuous treatment 
with DOACs were identified.
CASE REPORT
A 72 year-old-male with known past medical history 
inclusive of right lower extremity deep vein thrombosis 
currently on the DOAC rivaroxaban, myelodysplastic 
syndrome status post stem cell transplant complicated by graft 
versus host disease (GVHD), hyperlipidemia, stage three 
chronic kidney disease, and type II non-insulin dependent 
diabetes mellitus presented to the ED with right buccal 
mucosa bleed after undergoing punch biopsy by dermatology 
six hours prior. The last administered dose of rivaroxaban was 
earlier the same morning, as he was not instructed to hold the 
dose because the diagnostic punch biopsy for GVHD workup 
was scheduled ad hoc while he was in the hospital for routine 
follow-up. Despite manually holding direct pressure with a 
paper towel over the bleeding site, the patient stated that he 
had been unable to achieve hemostasis, which was affecting 
his ability to speak and sleep due to the continuous need to 
spit out blood, prompting his visit to the ED. A single, folded, 
paper towel sheet became saturated and required exchange 
every 15 minutes. 
Review of systems was notable for oral bleeding, minor 
post-procedural pain (2/10 in severity) at the biopsy site, and 
three days of acute on chronic constipation, believed to be 
unrelated to his chief complaint. The patient denied shortness of 
breath, cough, hemoptysis, and dysphagia. On physical 
examination, the airway was intact, and there was an active, 
continual oozing of dark blood from a five-millimeter biopsy 
site along the right buccal mucosa. Due to the duration of 
bleeding and reported amount of saturated dressings, a complete 
blood count, general chemistry panel, and coagulation panel 
were drawn, which was notable for a hemoglobin and 
Image 1. (a)Tranexamic acid-soaked dressing held in placed with 
tongue depressors and (b) adhesive dressing over patient’s cheek.
A B
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hematocrit of 12.9 grams per deciliter (g/dL) [14-17.4g/dL] and 
37.6% [42-54%], respectively, with prothrombin time and 
international normalized ratio of 10.1 seconds [9.2-11.9 
seconds] and 0.91 [0.8-1.2], respectively. The patient was 
placed in an examination room with continuous wall suctioning 
and given a Yankauer suction tip to clear his oropharynx. 
Given the wide base of the biopsy site and lack of 
overlapping tissue, the wound was not amenable to 
hemostasis through placement of sutures. Thus, along with 
emergency pharmacy guidance and approval, a sterile 
4-inch x 4-inch gauze dressing was soaked with 500 mg [5 
milliliter (mL)] of 100 mg/mL TXA and placed over the 
bleeding site. The soaked gauze was held in place with 
pressure applied by two tongue depressors taped on one 
end with medical tape and held to the patient’s cheek with 
an adhesive dressing (Images 1A and 1B). After 30 
minutes, the device and gauze were removed, and a clot 
was visualized (Image 2). Due to the possibility of 
recurrent bleeding and impending airway compromise, the 
patient was admitted under the otolaryngology service for 
observation and was discharged from the hospital eight 
hours later without any significant rebleeding events. There 
was no 72-hour ED return visit noted within the health 
system’s electronic health records.
DISCUSSION
TXA is a lysine analog similar in chemical structure to 
aminocaproic acid, but with 10 times more potency in its 
affinity to both the strong and weak receptor sites of the 
plasminogen molecule. By competitively binding to 
plasminogen, TXA effectively blocks the conversion of 
plasminogen to plasmin, thereby preventing fibrinolysis 
and, in turn, promotes stabilization of the fibrin clot.10 The 
excellent safety profile of TXA is likely twofold: 
therapeutic doses do not cause platelet aggregation in vitro, 
and when applied topically there is little to no systemic 
absorption. In light of the proposed mechanism and known 
safety profile, we suggest further investigation into the use 
of topical TXA as a potential first-line or adjunctive 
treatment option for difficult to control or refractory 
hemorrhage in particular instances.
CONCLUSION
This case report addresses a novel application of TXA, a 
medication that has become increasingly popular in the ED 
setting to address a very prevalent issue among our 
anticoagulated patient population on DOACs, specifically 
achieving hemostasis that is refractory to more traditional 
measures. We describe our experience achieving hemostasis 
for an otherwise-uncontrollable oral bleeding event in a 
patient whose anticoagulated state could not be reversed. Our 
intervention is simple to perform and cost-effective 
(approximately $21.10 US dollars per 100mg/mL 10mL vial). 
It requires very few resources, which are readily available in 
most EDs and, most importantly, appears effective. We believe 
our methods are widely generalizable and can be easily 
assimilated into the armamentarium of emergency medicine 
providers in a wide range of clinical environments.
Documented patient informed consent has been obtained and 
filed for publication of this case report.
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Image 2. Visualized thrombus over punch biopsy site after being 
treated with pressure dressing soaked in 500 milligrams of 
tranexamic acid  and held in place for 30 minutes.
REFERENCES
1. Ker K, Edwards P, Perel P, et al. Effect of tranexamic acid on surgical 
bleeding: systemic review and cumulative meta-analysis. BMJ. 
2012;344:e3054.
Volume IV, no. 2: May 2020 149 Clinical Practice and Cases in Emergency Medicine
Boccio et al. Topical TXA for Hemostasis of an Oral Bleed
2. Roberts I, Perel P, Prieto-Merino D, et al. Effect of tranexamic acid on 
mortality in patients with traumatic bleeding: prespecified analysis of 
data from randomised controlled trial. BMJ. 2012;345:e5839.
3. Nishijima DK, Kuppermann N, Roberts I, et al. The effect of 
tranexamic acid on functional outcomes: an exploratory analysis of 
the CRASH-2 randomized controlled trial. Ann Emerg Med. 
2019;74(1):79-87.
4. Akkan S, Corbacioglu SK, Aytar H, et al. Evaluating effectiveness of 
nasal compression with tranexamic acid compared with simple nasal 
compression and merocel packing: a randomized controlled trial. Ann 
Emerg Med. 2019;7(1):72-8.
5. Wahl MJ. Dental surgery in anticoagulated patients. Arch Intern Med. 
1998;158(15):1610-6.
6. Coetzee MJ. The use of topical crushed tranexamic acid tablets to 
control bleeding after dental surgery and from skin ulcers in 
haemophilia. Haemophilia. 2007;13(4):443-4.
7. Borea G, Montebugnoli L, Capuzzi P, et al. Oral Surg Oral Med Oral 
Pathol. 1993;75(1):29-31.
8. Nuvvula S, Gaddam KR, Kamatham R. Efficacy of tranexamic acid 
mouthwash as an alternative for factor replacement in gingival 
bleeding during dental scaling in cases of hemophilia: a randomized 
clinical trial. Contemp Clin Dent. 2014;5(1):49-53.
9. Engelen ET, Schutgens RE, Mauser-Bunschoten EP, et al. 
Antifibrinolytic therapy for preventing oral bleeding in people on 
anticoagulants undergoing minor oral surgery or dental extractions. 
Cochrane Database Syst Rev. 2018;7:CD012293.
10. (2017). Cyklokapron® (tranexamic acid injection) [package insert]. 
New York, NY: Pharmacia & Upjohn Co, Division of Pfizer Inc.
Clinical Practice and Cases in Emergency Medicine 150 Volume IV, no. 2: May 2020
Case report
 
The Ultimate Poker Face: A Case Report of 
Facial Diplegia, a Guillain-Barré Variant
 
Joshua Lowe, MD
James Pfaff, MD 
Section Editor: Christopher Sampson, MD         
Submission history: Submitted October 14, 2019; Revision received February 4, 2020; Accepted February 7, 2020 
Electronically published April 23, 2020         
Full text available through open access at http://escholarship.org/uc/uciem_cpcem   
DOI: 10.5811/cpcem.2020.2.45556
Introduction: Facial diplegia, a rare variant of Guillain-Barré syndrome (GBS), is a challenging 
diagnosis to make in the emergency department due to its resemblance to neurologic Lyme disease.
Case report: We present a case of a 27-year-old previously healthy man who presented with 
bilateral facial paralysis.
Discussion: Despite the variance in presentation, the recommended standard of practice for 
diagnostics (cerebrospinal fluid albumin-cytological dissociation) and disposition (admission for 
observation, intravenous immunoglobulin, and serial negative inspiratory force) of facial diplegia are 
the same as for other presentations of GBS.
Conclusion: When presented with bilateral facial palsy emergency providers should consider 
autoimmune, infectious, idiopathic, metabolic, neoplastic, neurologic, and traumatic etiologies 
in addition to the much more common neurologic Lyme disease. [Clin Pract Cases Emerg Med. 
2020;4(2):150–153.]
Keywords: Facial Diplegia; Guillain-Barré variant.   
INTRODUCTION
Facial diplegia is a rare variant of Guillain-Barré 
syndrome (GBS) where patients present with bilateral facial 
paralysis and paresthesia. Patients usually present 1-28 days 
after onset of symptoms, occasionally with extremity 
paresthesia but often in isolation.2 This variant occurs in less 
than 1% of all GBS patients.1-2 The pathophysiology of the 
disease is due to the acute inflammatory demyelinating 
polyneuropathy subtype much more often than the acute motor 
axonal neuropathy subtype of GBS.2 Due to its resemblance to 
the far more prevalent neurologic Lyme disease, it can be a 
potential pitfall diagnosis for emergency providers. 
CASE REPORT
A 27-year-old male military recruit without significant 
previous medical history was transported to the emergency 
department (ED) by ambulance with a chief complaint of 
bilateral facial paralysis. A resident of Puerto Rico, the 
Brooke Army Medical Center, Department of Emergency Medicine, Fort Sam Houston, Texas
patient had recently traveled to San Antonio, Texas, for 
military exercises and received multiple vaccines five days 
prior to onset of symptoms. He began experiencing mild 
paresthesia in his hands and feet four days prior to ED 
presentation. He reported progressive neurologic signs and 
symptoms including being unable to close his eyes or mouth, 
which made sleeping and eating difficult, as well as right-
sided facial numbness. He went to the military medical clinic 
two days prior to ED presentation where he was diagnosed 
with a complex migraine and discharged to the barracks on 
quarters (strict bed rest) with ibuprofen and ondansetron and 
instructions to return for follow-up the next day to evaluate 
for resolution of symptoms.
During the subsequent ED visit his vital signs included a 
heart rate of 113 beats per minute, blood pressure 117/76 
millimeters of mercury, respiration 16 breaths per minute, 
and temperature 98.5 degrees Fahrenheit. His blood glucose 
was 116 milligrams per deciliter (mg/dL) (90-120 mg/dL). 
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What do we already know about this clinical 
entity? 
The treatment and disposition for all variants of 
Guillain-Barré syndrome (GBS) is the same. 
What makes this presentation of disease 
reportable? 
Facial diplegia is a rare variant of GBS that 
mimics a fairly common disease process in 
Lyme disease
What is the major learning point? 
This case demonstrates the differential 
diagnosis and diagnostic pitfalls associated 
with facial diplegia.
How might this improve emergency 
medicine practice? 
Clinicians should consider a thorough 
differential diagnosis for facial diplegia.
Physical exam revealed symmetric bilateral facial paralysis, 
causing difficulty in closing his eyelids and mouth, which 
resulted in injected conjunctiva with moderate tearing, and 
cheilitis (Image). He endorsed decreased soft-touch sensation 
in a radial distribution in his upper extremities and the 
distribution of his fifth lumbar nerve in his lower extremities. 
Bilateral Achilles reflexes were absent. Strength and reflexes 
were otherwise preserved in his lower extremities. He was 
administered one liter of Ringer’s lactate, and the 
tachycardia improved. 
Computed tomography of his head showed no masses or 
evidence of bleeding. Neurology was consulted and per their 
recommendation we obtained magnetic resonance imaging of 
his brain, which demonstrated no lesions, masses, or 
evidence of edema. A lumbar puncture was performed; it 
revealed albumin-cytological dissociation of cerebrospinal 
fluid (CSF), which is an increased protein with normal cell 
counts. Polymerase chain reaction did not detect any 
common bacterial or viral meningitis organisms. His 
complete blood count, comprehensive metabolic panel, and 
erythrocyte sedimentation rate were all within normal limits. 
The patient was given 10 milligrams dexamethasone 
intravenously in the ED, and blood cultures were obtained 
prior to admission. 
With a presumptive diagnosis of GBS the patient was 
admitted to the hospital for serial negative inspiratory flow 
measurements and intravenous immune globulin (IVIG), while 
awaiting further diagnostic testing by neurology. Serum and CSF 
studies detected none of the following organisms: Borrelia 
burgdorferi, Zika virus, West Nile virus, varicella-zoster virus, 
Treponema pallidum, human immunodeficiency virus, or 
Mycobacterium tuberculosis. Based upon the exam findings and 
diagnostic testing, the diagnosis of facial diplegia (GBS variant) 
was confirmed with the etiology most likely post-vaccinal. The 
patient received four days of IVIG and was discharged from the 
hospital. He returned to training with 4/5 strength and decreased 
light touch in his bilateral face and complete resolution of the 
paresthesia in his extremities. He was started on long-term daily 
corticosteroids by the neurologist with continued 4/5 strength and 
light touch in his bilateral face noted on his one month follow-up.
 
DISCUSSION
Facial diplegia is a rare disorder, accounting for less than 
2% of all patients with facial paralysis.1 The differential of 
facial diplegia includes Lyme disease, meningitis, and trauma. 
While Lyme disease is the most common etiology, GBS 
accounts for about 5% of cases (Table).1-3 Although facial nerve 
paralysis is involved in 27-50% of GBS cases (50% of those 
Image. Patient with facial diplegia attempting to both wrinkle 
forehead and smile during neurologic exam.
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patients having bilateral involvement), facial diplegia is a rare 
presentation, occurring in 0.25-0.8% of all GBS patients. 
Causes are thought to be the same as in other variants of GBS.2,4
Common features of GBS include the following: subjective 
peripheral paresthesia (88%); a preceding illness one to two 
weeks prior to symptoms (75%); and CSF albumin-cytological 
dissociation (88%).4 The diagnostic criteria include core features 
of facial weakness, absence of ophthalmoplegia or truncal/
cervical ataxia, and monophasic disease course with 12 hours to 
28 days between onset and nadir. Supportive features include 
antecedent infectious symptoms, presence of distal paresthesia 
prior to facial diplegia, electrophysiological evidence of 
neuropathy, and CSF albumin-cytological dissociation.5
The prognosis for the facial diplegia subtype of GBS is 
generally favorable, as diaphragmatic paralysis has never been 
documented.2 Corticosteroids, although classically given, have 
not been shown to be effective in GBS.2 Although there have 
been no GBS-variant specific trials of treatment that show IVIG 
efficacy, the recommended standard of practice is still admission 
for observation, IVIG, and serial negative inspiratory force.2
CONCLUSION 
Facial diplegia is a rare variant of GBS that presents a 
very challenging diagnosis to make in the ED due to its wide 
differential diagnosis. When presented with bilateral facial 
palsy emergency providers should consider autoimmune, 
infectious, idiopathic, metabolic, neoplastic, neurologic, and 
traumatic etiologies in addition to the much more common 
neurologic Lyme disease. Facial diplegia is a clinical 
diagnosis that is bolstered by the presence of albumin-
cytological dissociation in the cerebral spinal fluid.2 Treatment 
is the same as for other variants of GBS: observation; serial 
negative inspiratory force; and IVIG if the patient’s condition 
begins to deteriorate. 
Documented patient informed consent has been obtained and 
filed for publication of this case report.
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Category Diagnosis
Autoimmune Guillain-Barré syndrome
Sarcoidosis
Myasthenia gravis
Amyloidosis
Infectious
Lyme disease
Herpes simplex virus
Varicella-zoster virus
Human immunodeficiency virus 
Syphilis  
Human T-cell leukemia virus-1
Poliomyelitis
Influenza
Cytomegalovirus
Botulism
Epstein-Barr virus
Idiopathic
Idiopathic intracranial hypertension
Bell’s palsy
Metabolic
Diabetes
Neoplastic
Leukemia
Porphyria
Meningioma 
Neurological
Multiple sclerosis
Trauma
Skull fracture
Parotid surgery
Mastoid surgery
Table. Differential diagnosis of acute onset bilateral facial paralysis.
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A sinus of Valsalva aneurysm (SOVA) is usually a silent entity until one of its complications 
arises, such as heart failure. SOVA itself is uncommon, but it is more frequently associated with 
a supracristal ventricular septal defect (SVSD). We present a 67-year-old man with a history of 
an asymptomatic SVSD who presented to the emergency department with signs and symptoms 
of heart failure. He was subsequently found to have a ruptured SOVA and underwent urgent 
surgical repair. [Clin Pract Cases Emerg Med. 2020;4(2):154–157.]   
INTRODUCTION
Clinical presentations consistent with heart failure, 
conduction abnormalities, and acute coronary syndrome are 
frequently encountered in the emergency department (ED).  
A patient with a sinus of valsalva aneurysm (SOVA) may 
present with one of the above manifestations. SOVA is a 
rare cardiac condition usually resulting from a congenital 
incomplete fusion of the aortic media and the aortic 
valve annulus. It can also be caused by processes that 
compromise the septal wall, such as supracristal ventricular 
septal defects (SVSD), endocarditis, syphilis, cystic medial 
necrosis, and chest trauma. If ruptured, SOVA presents with 
symptoms of a large left-to-right shunt causing severe heart 
failure, necessitating urgent surgical intervention. 
CASE REPORT
A 67-year-old Caucasian male presented to the ED with a 
three-day history of worsening dyspnea, cough, chills, and body 
aches. He denied chest pain, fever, recent travel, leg swelling, sick 
contacts, and syncope. His past medical history, prior to his ED 
presentation, included a ventricular septal defect (VSD), chronic 
atrial fibrillation, left ventricular hypertrophy, hypertension, and 
dyslipidemia; he denied any surgical history. During his last 
visit with his cardiologist six months prior to presentation, the 
Long Island Community Hospital, Department of Medicine, Patchogue, New York
Long Island Community Hospital, Department of Cardiology, Patchogue, New York
*
†
VSD was stable, and he  was asymptomatic. In the ED, his blood 
pressure was 131/60 millimeters of Mercury (mmHg), heart rate 
was 102 beats per minute, respiratory rate was 27 breaths per 
minute and arterial oxygen saturation was 95% on two liters of 
supplemental oxygen. The remainder of the physical exam was 
significant for end-expiratory wheezing, an irregularly irregular 
pulse, and a loud, precordial continuous systolic murmur with 
right-sided prominence; no cyanosis, clubbing or lower extremity 
edema was noted. Laboratory results were significant for an 
elevated troponin-I of 0.063 nanogram/milliliter (ng/ml) (normal 
range: 0.0-0.045 ng/ml) and brain natriuretic peptide of 744 
picogram/milliliter (pg/ml) (100-400 pg/ml); a complete blood 
count and a basic metabolic panel were within normal limits. An 
electrocardiogram revealed atrial fibrillation with left ventricular 
hypertrophy and a chest radiograph was unremarkable. The 
patient was admitted for presumed bronchitis and diastolic 
congestive heart failure exacerbation and subsequently treated 
with diuretics, bronchodilators, and antibiotics.
Despite the aforementioned treatment, the patient did 
not clinically improve. The following day, a transthoracic 
echocardiogram (TTE) revealed a small-to-moderate sized 
supracristal VSD with a left-to-right shunt. The TTE also showed 
a moderately dilated left ventricle cavity  with a left ventricular 
ejection fraction (LVEF) of 50%, bilateral atrial and aortic 
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What do we already know about this clinical 
entity? 
 Sinus of Valsalva Aneurysm (SOVA) is a rare, 
often congenital, cardiac condition resulting from 
incomplete fusion of the aortic media and the 
aortic valve annulus.
What makes this presentation of disease 
reportable? 
 Our presentation involves an elderly male 
with history of asymptomatic supracristal 
ventricular septal defects and confounding 
cardiac history who presents with signs and 
symptoms of heart failure.
What is the major learning point? 
Physicians should consider ruptured SOVA 
in the differential for patients with a history 
of ventricular septal defects presenting with 
cardiopulmonary symptoms.
How might this improve emergency medicine 
practice? 
Awareness of the various disease manifestations 
of SOVA and performing an early 
echocardiogram can lead to early recognition 
and prevent delays in appropriate therapy.
enlargement and a severely elevated resting pulmonary artery 
(PA) pressure of 55 mmHg with preserved contractility of the 
right ventricle. A subsequent transesophageal echocardiogram 
(TEE) showed a mild-to-moderately dilated aortic root at 
the level of the sinuses of Valsalva, with normal aortic valve 
annular dimensions. The right coronary sinus of Valsalva was 
eccentrically aneurysmal and ruptured, extending anteriorly 
and inferiorly into the right ventricle outflow tract (RVOT) near 
the patient’s membranous VSD, exhibiting a “windsock effect” 
(Image 1,2).
A high-velocity turbulent flow was visualized from the 
aortic root to the RVOT. There was a small restrictive supracristal 
membranous VSD with a minimal shunt flow. The left ventricle 
was globular and Left Ventricle Ejection Fraction (LVEF) was 
estimated to be 25%. The right ventricle function was impaired 
with significant pulmonary artery hypertension. 
The patient underwent an urgent right-and-left sided cardiac 
catheterization, which confirmed the presence of a right SOVA 
rupture into the RVOT with blood flow into the PA on left 
ventricular and aortic root angiogram (Image 3). The PA was 
dilated with a Pulmonary-Systemic flow ratio (Qp/Qs) of 5.33 
due to the left-to-right shunt. Additionally, moderate pulmonary 
hypertension and moderate global left ventricular dysfunction 
(ejection fraction 40%) were noted.
The patient was transferred to a tertiary care facility for 
urgent surgical repair of the acute left-to-right SOVA-RVOT 
shunt. During the surgery, the aortic root was accessed via a 
transaortic route. The right coronary sinus had a 4-millimeter 
tear with an aneurysmal dilation to the RVOT. The aneurysm 
was resected and the area was reconstructed with a bovine 
pericardial patch; the SVSD was also repaired with a bovine 
pericardial patch. The aortic valve was not involved and did not 
need repair. The patient performed well postoperatively and was 
eventually discharged. 
DISCUSSION
A supracristal ventricular septal defect is a subtype of 
VSD that results from the absence of the subpulmonary 
muscular infundibulum, leaving a fibrous continuity between 
the aortic and pulmonic valves.1,2 SVSD affects the Asian 
population to a greater degree than the Caucasian population 
(5:1). The SVSD produces a left-to-right shunt with a venturi 
effect that results in an acquired aortic valve deformity, 
including the herniation of the right aortic sinus with the 
possible development of an aneurysm.3 The prevalence of 
aortic valve prolapse is around 1% at 1 year of age and 70% at 
15 years of age.4
SOVA is an aneurysmal dilatation of one or more aortic 
sinuses between the annulus of the aortic valve and the 
sinotubular junction. SOVA can be classified as congenital 
Image 1. Transesophageal echocardiogram demonstrating an 
eccentrically aneurismal right sinus of Valsalva (star).
LA, left atrium; LVOT, left ventricle outflow tract; Ao, aorta; RVOT, 
right ventricle outflow tract; SOVA, sinus of valsalva aneurysm.
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when there is a deficiency of lamina elastica and muscular 
tissue surrounding the aorta or there is the presence of an 
acquired weakness of the aforementioned structures.5,6  
They frequently co-occur with ventricular septal defects, 
aortic valve dysfunction, or other cardiac abnormalities. 
Although unruptured ASVs are usually asymptomatic, 
ruptured ASVs often cause symptoms similar to those of 
heart failure and produce a continuous, mechanical-sounding 
murmur. Transsternal or transesophageal echocardiography 
is usually effective in detecting ASVs. Because symptomatic 
ASVs pose significant risks for the patient, and because the 
repair of asymptomatic ASVs generally produces excellent 
outcomes, surgery is indicated in most cases. The primary 
goals of surgical repair are to close the ASV securely, remove 
or obliterate the aneurysmal sac, and repair any associated 
defects. Operative mortality is generally low except in patients 
with concomitant bacterial endocarditis or other infections. 
Late events are uncommon and tend to be related to aortic 
valve prothesis or Marfan syndrome.”The most frequent 
etiologies of congenital SOVA are Marfan’s Syndrome, 
Ehlers-Danlos Syndrome, a bicuspid aortic valve and other 
connective tissue disorders. An acquired SOVA can result 
from degenerative connective tissue diseases, chest trauma, 
atherosclerosis, and infections such as syphilis, bacterial 
endocarditis, and tuberculosis.
The incidence of SOVA in the western population is 
approximately 0.09%, occurring predominantly in the male 
population. It represents 0.1-3.5% of all congenital heart 
diseases.7 ASVs occur much more frequently in the right 
coronary sinus of Valsalva. Previous reports, based on necropsy 
and cardiac surgery findings, estimated that 20% of ASVs 
are unruptured. Patients with an unruptured ASV may remain 
asymptomatic for a long period of time until rupture. They may 
also present with dyspnea, palpitation, and angina-like chest 
pain. Aortic insufficiency in the patients with unruptured ASVs 
is common, and other valvular lesions can be observed in these 
patients as well. Echocardiography, as a noninvasive and portable 
tool, is widely used to detect ASVs. Additionally, computed 
tomography and cardiac magnetic resonance imaging, alone or in 
combination, can provide precise information about its anatomic 
extension and intrinsic characteristics of the pathology.”8 
Between the ages of 30 to 45 years, 80% of patients with a SOVA 
will become symptomatic; its detection is usually triggered by 
the manifestation of a SOVA complication. An unruptured SOVA 
can cause an obstruction of the RVOT, a conduction block, aortic 
regurgitation and/or a transient ischemic attack. A moderate-to-
severely dilated SOVA can lead to blood stasis and predisposes 
to thrombus formation; thrombus occlusion of the coronary 
arteries can mimic an acute coronary syndrome.9 A ruptured 
SOVA typically presents with an audible continuous machine-like 
murmur, bounding pulses, aortic regurgitation and a left-to-right 
shunt leading to acute heart failure.4 Rupture typically occurs in 
30% of the patients, with 30-40% of ruptures occurring between 
20 and 40 years of age.1,6,10
Traditionally, TTE and TEE are the initial diagnostic tests 
for SOVA.11,12  Both techniques can assess for a shunt; however, 
they lack sensitivity in detecting shunts less than 3 millimeters. 
It can be technically challenging to assess for ventricular defects, 
as the prolapsed cusp can occlude the shunt, resulting in a missed 
diagnosis in 9% of patients. Prior to surgery, contrast magnetic 
resonance imaging  and aortography are the diagnostic tests of 
choice in order to better characterize the shunts.13
For an unruptured SOVA, the timing of surgical 
intervention depends on the size of the aneurysm, the rate 
Image 2. Tranesophageal echocardiogram demonstrating a 
ruptured sinus of valsalva aneurysm (star). 
MV, mitral valve; Ao, aorta; RVOT, right ventricle outflow tract; 
LVOT, Left ventricle outflow tract. Image 3. Aortic root angiogram. Intravenous contrast shows 
blood flowing into the pulmonary artery (PA) from the left ventricle 
outflow tract.
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of progression, and any associated cardiac abnormalities, 
such as bicuspid valves or connective tissue diseases. An 
unruptured SOVA with any of the following characteristics 
requires surgery: greater than 5.5 centimeters (cm) in size; 
a yearly growth rate greater than 0.5 cm; 5.0 cm-5.5 cm 
in the presence of bicuspid valves or 4.0 cm-5.5 cm in the 
setting of connective tissue disease.14 Yearly follow up, with 
either cardiac computed tomography or magnetic resonance 
imaging, is recommended for an unruptured SOVA.
A ruptured SOVA requires urgent surgical or 
percutaneous correction. Percutaneous correction is 
increasingly favored in both elective repair of an unruptured 
SOVA and in urgent repair of ruptured SOVA.15 Surgical 
SOVA repair is performed via either primary closure or 
bovine patch; primary closure is preferred for repairing a 
small SOVA and patch closure is generally used for larger 
defects. The mortality rate associated with the surgery varies 
from 1.9% to 3.6% and the survival rate is approximately 
90% at 15 years.16
CONCLUSION
Emergency physicians should keep a ruptured SOVA in 
the differential for patients with a known history of ventricular 
septal defects who present with acute heart failure, acute 
coronary syndrome, conduction abnormalities or transient 
ischemic attacks. Performing an early echocardiogram 
when the clinical picture is unclear can help delineate 
between diagnoses and prompt further investigation into 
the etiology. This can increase the probability of early 
identification of a SOVA and facilitate an appropriate 
management plan.
Documented patient informed consent and/or Institutional Review 
Board approval has been obtained and filed for publication of this 
case report.
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Bladder scanners allow for quick determination of bladder volumes (BV) with minimal training. BV 
measured by a machine is generally accurate; however, circumstances exist in which falsely elevated 
BVs are reported. This case details a patient with a significant small bowel obstruction (SBO) due to 
superior mesenteric artery syndrome causing a falsely elevated BV. We believe this is the first case 
report of a SBO causing an elevated BV by bladder scanner. Emergency physicians should be aware 
of the pitfalls of using bladder scanners, and use their point-of-care ultrasound skills when possible to 
expand their differential. [Clin Pract Cases Emerg Med. 2020;4(2):158–160.]
INTRODUCTION
Bladder scanners have seen widespread use in emergency 
departments (ED) due to their ease of use and relatively low cost 
of application.1 They can be used by registered nurses (RN), and 
are helpful in determining the presence of acute urinary retention, 
saving patients the discomfort of undergoing unnecessary bladder 
catheterization.1 However, their use is not without diagnostic 
pitfalls. Previous case reports have documented inaccurate 
bladder volume (BV) measurements attributed to pelvic 
structures such as ovarian cysts and uterine myomas.2,3,4,5 In the 
following case, we present a previously unreported cause of 
falsely elevated BV due to abdominal pathology.
CASE REPORT
A 56-year-old female with a history of latent tuberculosis, 
stage IIIA non-small cell lung cancer status post right lower and 
middle lobectomy and lymph node dissection four months prior, 
was transferred from an outside hospital with concern for sepsis. 
She spoke only Mandarin; limited history was provided by her 
daughter at the bedside. Her daughter reported that the patient 
came to the hospital after two episodes of syncope. Her review 
of systems was positive for one week of worsening nausea, 
abdominal discomfort, poor oral intake, several episodes of 
bilious vomiting, and difficulty urinating. She had not had a 
bowel movement in the prior three days but was passing flatus. 
Beth Israel Deaconess Medical Center, Department of Internal Medicine, 
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Boston Medical Center, Department of Emergency Medicine, 
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Abnormal vital signs at the outside hospital included a blood 
pressure of 80/53 millimeters of mercury (mmHg) and a heart 
rate of 124 beats per minute.
Relevant abnormal laboratory results from outside hospital 
records included a leukocyte count of 16.7x10^9 cells per 
liter (L) (reference: 4.0-11.0 x10^9 cells/L), a lactate of 6.1 
millimoles (mmol)/L (reference: 0.9-1.7 mmol/L), and a sodium 
of 124 milliequivalents (mEq)/L (reference: 135-145 mEq L). 
Her electrocardiogram was significant for sinus tachycardia. 
Outside hospital (OSH) chest radiography revealed unchanged 
chronic right hydropneumothorax without infiltrate, and an 
OSH abdominal radiograph report showed no evidence of 
an ileus or an obstruction. Prior to arrival at our institution, 
the patient received two liters of normal saline along with 
intravenous vancomycin, ceftriaxone and metronidazole. 
Upon examination in our ED she was noted to be afebrile, 
and her blood pressure had improved to 97/54 mmHg. Her 
tachycardia had resolved. The patient appeared chronically ill 
and lethargic with a tense, diffusely tender abdomen. Repeat 
laboratory investigations demonstrated resolution of her 
elevated lactate and stable leukocytosis. A tentative diagnosis of 
urosepsis was made.
Given the need for a urine sample and concern for urinary 
retention per history, an RN performed a bladder scan in 
preparation for catheterization, which estimated a volume of 900 
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What do we already know about this clinical 
entity? 
There are many causes of falsely elevated bladder 
volumes on bladder scanners including ovarian 
cysts, renal cysts, ascites, or uterine myomas.
What makes this presentation of disease 
reportable? 
This was the first report of falsely elevated 
bladder volume due to small bowel obstruction.
What is the major learning point? 
Falsely elevated volumes as measured by bladder 
scanners occurs in up to 9% of bladder scans.
How might this improve emergency medicine 
practice? 
Although bladder scanners are an extremely 
useful tool, physicians should recognize that 
there are several causes of falsely elevated 
bladder volume.
milliliters (mL). A Foley catheter was placed with removal of 600 
mL of urine. On repeat bladder scan, a value of 900mL was again 
obtained. Discordance between bladder scan and catheterization 
prompted the physician to perform a point-of-care ultrasound 
(POCUS), which showed severely dilated bowel loops filled with 
fluid, concerning for a small bowel obstruction (SBO) (Image 1).
A computed tomography (CT) was ordered to confirm 
the diagnosis and showed marked fluid distention of the distal 
esophagus, stomach, and proximal duodenum to the level of 
the superior mesenteric artery (SMA) consistent with a SBO 
(Image 2). Given the distribution, findings were attributed to 
SMA syndrome.
A nasogastric tube was placed, which returned three liters of 
fecalized fluid. The patient was admitted under the general surgery 
service. She underwent initial lysis of her ligament of Treitz, and 
ultimately required duodenal jejunostomy to treat her obstruction.  
DISCUSSION
Dedicated bladder scanners are a useful, non-invasive, 
and accurate tool for the evaluation of patients with suspected 
urinary retention.1 By incorporating automated algorithms 
that calculate BVs, these machines have become easier to 
use and are essentially user-independent.6 This allows novice 
operators, including RNs, to be easily and quickly trained in 
their use. However, this convenience has also come at the cost 
of specificity, with false positive rates cited as high as 9%.2,7 
Possible reasons for falsely elevated BVs include ovarian 
and renal cysts,2,4 uterine myomas,3 and ascites.5 These 
elevations are likely due to an inability of bladder scanners to 
differentiate between fluid in the bladder and other hypoechoic 
areas in the pelvis. This has important implications, as falsely 
elevated BVs can lead to unnecessary catheterizations and a 
delay in diagnosis, as was evident in this case. Fortunately, the 
physician was able to use POCUS to visualize the bladder and 
adjacent structures to suggest the alternate diagnosis of SBO 
and expedite management. POCUS has been previously shown 
to have high sensitivity (94-100%) and specificity (81-100%) 
for the detection of SBO.8 While the current gold standard for 
diagnosing SBO is CT, diagnosis requires an elevated index 
of suspicion, and delays in obtaining CT imaging may occur.9 
As shown in the case, POCUS was used to resolve diagnostic 
inaccuracies by bladder scanner and abdominal radiography. 
CONCLUSION
This case represents the first report of a falsely elevated 
bladder volume by bladder scanner attributed to a bowel 
obstruction. This emphasizes the importance of further workup 
in cases of discordance between volumes obtained by bladder 
scanner and catheterization. SBO is a potentially life-threatening 
condition and a delay in diagnosis can lead to increased morbidity 
and mortality.10 Therefore, physicians should be aware of the 
pitfalls of routine automated bladder scanners, and use their 
POCUS skills when possible to expand their differential. 
Documented patient informed consent and/or Institutional Review 
Board approval has been obtained and filed for publication of this 
case report.
Image 1. Transverse ultrasound view of abdomen demonstrating 
a large amount of fluid and fecal matter within a massively 
distended loop of bowel. Arrow is within a distended loop of bowel.
Clinical Practice and Cases in Emergency Medicine 160 Volume IV, no. 2: May 2020
False Elevation Determined by Bladder Scanner Schowalter et al.
Address for Correspondence: Zaid Altawil, MD, Boston University 
School of Medicine and Boston Medical Center, 1 Boston Medical 
Center Place, Boston, MA 02118. Email: zaid.altawil@bmc.org.
Conflicts of Interest: By the CPC-EM article submission 
agreement, all authors are required to disclose all affiliations, 
funding sources and financial or management relationships that 
could be perceived as potential sources of bias. The authors 
disclosed none.
Copyright: © 2020 Schowalter et al. This is an open access article 
distributed in accordance with the terms of the Creative Commons 
Attribution (CC BY 4.0) License. See: http://creativecommons.org/
licenses/by/4.0/
Image 2. (a) Coronal computed tomography(CT) image 
demonstrating a markedly distended loop of bowel; (b) Sagittal CT 
image demonstrating a markedly distended loop of bowel, as well 
as partial view of the bladder. Black arrows represent the loop of 
bowel. White arrow points to the bladder.
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We report a case of a 44-year-old male with an uncommon case of an open dorsal proximal 
interphalangeal (PIP) dislocation. Although open PIP dislocations are often volar, dorsal dislocations 
are fraught with complications due to the potential for infection and damage to supportive structures. 
Features of this case are discussed together with its implications, including lack of standardized 
management in the literature, use of a closed reduction following copious irrigation, and requirement 
for antibiotic use. [Clin Pract Cases Emerg Med. 2020;4(2):161–163.]
INTRODUCTION
Dislocations to the proximal interphalangeal (PIP) joint 
are common in athletes and are typically dorsal, resulting from 
an axial load on a hyperextended digit.1 Open dislocations are 
more commonly seen with volar dislocations and less 
commonly with dorsal ones.2 Open injuries may not respond to 
normal manual reduction techniques, and therefore require 
surgical, open reduction.2,3,4,5 
CASE REPORT
A 44-year-old man, right-hand dominant, presented to our 
emergency department with pain and deformity to his right 
index finger. The injury had occurred just prior to arrival when 
his finger was struck while playing basketball. Radiographs 
from triage revealed a dorsal dislocation of the second PIP 
joint without evidence of fracture (Image 1).
On exam, the middle phalanx was displaced dorsally and 
there was a transverse laceration to the volar surface of the PIP 
joint exposing the flexor tendon (Images 2 and 3). This was 
consistent with an open PIP dislocation. Since the patient was 
neurovascularly intact and orthopedics was readily available, 
immediate reduction was not attempted and the consulting 
service contacted. Orthopedics evaluated the patient, 
anesthetized the digit, copiously irrigated the wound, reduced 
the dislocation, sutured, and applied a splint. Orthopedics did 
not recommend antibiotics, and the patient was closely 
followed by the orthopedics service as an outpatient. At 
two-month follow-up, the patient continued to have mild 
swelling, stiffness, and decreased flexion range of motion of 
the affected PIP joint.
Madigan Army Medical Center, Department of Emergency Medicine, 
Tacoma, Washington
Image 1. Lateral radiograph of right index finger demonstrating 
dorsal dislocation of the proximal interphalangeal joint without 
evidence of fracture (arrow).
DISCUSSION
There are no clear guidelines or consensus for the 
treatment and management of open dorsal PIP dislocations, 
including antibiotic use. A literature search revealed a 
paucity of current literature dedicated specifically to this 
type of injury; most were orthopedic review articles 
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What do we already know about this clinical 
entity? 
Open proximal interphalangeal (PIP) 
dislocations are often resistant to usual 
manual reduction techniques and may 
require surgical reduction.
What makes this presentation of disease 
reportable? 
Open PIP dislocations are most commonly 
volar; dorsal dislocations can result in 
numerous complications.
What is the major learning point? 
Open dorsal PIP dislocations may appear 
innocuous but are fraught with complications 
due to the potential for infection and damage 
to supportive structures.
How might this improve emergency 
medicine practice? 
This case helps illustrate the need for 
specialist consultation and follow-up.
regarding closed PIP injuries with only a cursory mention of 
open dislocations. The most relevant papers were two case 
series from the 1980s4,5; however, these were reported from 
an orthopedic perspective and most of the patients were 
treated operatively.
Although open dorsal PIP dislocations may require open 
reduction, some are amenable to standard closed reduction, 
such as in our case. Preferably, anesthesia should be obtained 
via digital block after neurovascular assessment and prior 
to manipulation. As with closed dorsal dislocations, the PIP 
joint should be hyperextended (exaggerating the injury) 
while maintaining axial traction, applying volar-directed 
pressure on the middle phalanx, followed by gently flexing 
the PIP joint.1,6 
There are some differing recommendations in the 
orthopedic/sports medicine literature regarding splinting 
vs “buddy taping” the finger after successful reduction.1,7,8 
However, most of these are in the context of closed 
dislocations with a stable PIP joint following reduction. A 
conservative and safe approach would be splinting at 20-
30 degrees flexion6 and ensuring prompt follow-up with 
a hand specialist, since prolonged splinting is associated 
with increased stiffness and contractures and early range of 
motion is essential.2
Although the laceration may appear superficial and 
innocent, it represents a direct communication to the PIP joint 
and surrounding structures.5 If grossly contaminated, surgical 
washout is required.9 In our case, the wound was relatively 
clean and washout was accomplished in the ED with copious 
irrigation. Antibiotics were deferred per orthopedic 
recommendation since the wound was not grossly contaminated 
and had been thoroughly irrigated, and open reduction was not 
required. However, many authors do recommend empiric 
antibiotics in cases of open dislocations.5,6,9
Image 2. Dorsal displacement and deformity to right index finger 
with laceration to volar portion of the finger (arrow).
Image 3. Laceration over volar proximal interphalangeal joint, 
exposing flexor tendon (arrow).
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CONCLUSION
Open dorsal PIP dislocations may appear innocuous but are 
fraught with complications due to the potential for infection and 
damage to supportive structures.5 It is important for emergency 
providers to recognize the significance of an open injury and 
obtain appropriate specialty consultation. Patients should be 
educated regarding potential sequelae including infection, 
stiffness, swelling, pain, and contractures.7 Discharge 
instructions should also emphasize the importance of close 
follow-up with a hand specialist and compliance with rehab. 
The signed attestation by the corresponding author that this 
institution does not require Institutional Review Board approval 
for case reports has been obtained and filed for publication of this 
case report.
Address for Correspondence: CPT Ryan Derrah, MD, Madigan Army 
Medical Center, Department of Emergency Medicine, 9040 Jackson 
Ave., Tacoma, WA 98431. Email: ryan.r.derrah.mil@mail.mil.
Conflicts of Interest: By the CPC-EM article submission agreement, 
all authors are required to disclose all affiliations, funding sources 
and financial or management relationships that could be perceived 
as potential sources of bias. The authors disclosed none. The views 
expressed here are those of the authors and do not reflect the official 
policy of the Department of the Army, the Department of Defense, or 
the US Government.
Copyright: © 2020 Derrah et al. This is an open access article 
distributed in accordance with the terms of the Creative Commons 
Attribution (CC BY 4.0) License. See: http://creativecommons.org/
licenses/by/4.0/
REFERENCES
1. Bindra RR and Foster BJ. Management of proximal interphalangeal 
joint dislocations in athletes. Hand Clin. 2009;25(3):423-35.
2. Freiberg A. Management of proximal interphalangeal joint injuries. 
Can J Plast Surg. 2007;15(4):199-203.
3. Muraoka S, Furue Y, Kawashima M. Irreducible open dorsal 
dislocation of the proximal interphalangeal joint: a case report. Hand 
Surg. 2010;15(1):61-4.
4. Green SM and Posner MA. Irreducible dorsal dislocations of the 
proximal interphalangeal joint. J Hand Surg Am. 1985;10(1):85-7.
5. Stern PJ and Lee AF. Open dorsal dislocations of the proximal 
interphalangeal joint. J Hand Surg Am. 1985;10(3):364-70.
6. Franko OI. Dislocation reduction of the PIP and DIP joints. 2012. 
Available at: http://www.proceduresconsult.com/medical-procedures/
dislocation-reduction-of-the-pip-and-dip-joints-IM-025-procedure.
aspx#. Accessed November 2, 2018.
7. Mangelson JJ, Stern P, Abzug JM, et al. Complications following 
dislocations of the proximal interphalangeal joint. J Bone Joint Surg 
Am. 2013;95(14):1326-32.
8. Paschos NK, Abuhemoud K, Gantsos A, et al. Management of 
proximal interphalangeal joint hyperextension injuries: a randomized 
controlled trial. J Hand Surg Am. 2014;39(3):449-54.
9. Freiberg A, Pollard BA, Macdonald MR, et al. Management of 
proximal interphalangeal joint injuries. J Trauma. 1999;46(3):523-8.
Clinical Practice and Cases in Emergency Medicine 164 Volume IV, no. 2: May 2020
Case report
 
An Atypical Presentation of Cystic Echinococcosis
 
Bhavana Tetali, BS*†
Daniel C. Grahf, MD*‡
Elian D. Abou Asala, MD*
Daniel Axelson, MD‡
Section Editor: Scott Goldstein, MD         
Submission history: Submitted November 10, 2019; Revision received January 7, 2020; Accepted January 6, 2020
Electronically published February 24, 2020         
Full text available through open access at http://escholarship.org/uc/uciem_cpcem   
DOI: 10.5811/cpcem.2020.1.45842
Cystic echinococcosis (CE) is an infection caused by the Echinococcus granulosus tapeworm. CE 
generally manifests in the liver, but it may present in any organ. These patients often first present to the 
emergency department. Mortality over 10 years is significant for those who go undiagnosed. We report 
the case of a 34-year-old patient who immigrated from Yemen six years earlier. She presented with 
acute onset dysuria, suprapubic pain, and fever. Imaging revealed a primary multicystic mass on the 
right renal pole with a secondary lesion in the right hepatic lobe. On further investigation, the patient’s 
serum was positive for echinococcus antibodies. [Clin Pract Cases Emerg Med. 2020;4(2):164–166.]   
INTRODUCTION
Cystic echinococcosis (CE) is an infection caused by the 
Echinococcus granulosus tapeworm, which results in the creation 
of cystic structures within a range of visceral organs. Ninety 
percent of these cysts are in the liver or lungs. The cysts can be 
filled with thousands of “brood” capsules that in definitive hosts 
evaginate and invade surrounding host tissues. The definitive 
host is most often canines with intermediate hosts being sheep, 
cattle, and pigs.1 Humans are incidental hosts for CE; they most 
frequently ingest eggs via the fecal oral route from contaminated 
food or water. In the United States, cases are quite rare and most 
are found in immigrants from endemic countries. It is estimated 
that these cysts enlarge by about 1-5 centimeters (cm) per 
year, although rates are highly variable.2,3 Patients may remain 
asymptomatic for years. Those that develop symptoms may go 
undiagnosed for a long period of time, especially given the low 
prevalence of CE in the US and the nonspecific symptoms that 
arise. If left unidentified and untreated, mortality from CE is 
estimated to be 90% by 10 years.4
In this case, we discuss a patient who presented to the 
emergency department (ED) with genitourinary complaints and 
was diagnosed with cystic echinococcosis (CE) of primary renal 
involvement, a rare anatomic location. The case exemplifies the 
diagnostic workup and acute management of extrahepatic CE in 
the ED in a high-risk patient.
CASE REPORT
A 34-year-old female with no past medical history 
presented to the ED complaining of dysuria, suprapubic pain, 
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*
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generalized myalgias, and subjective fever for one-day duration. 
The patient denied recent travel, sick contacts, or contact with 
animals, but she had immigrated from Yemen six years prior. 
On presentation, the patient was febrile to 38.8º Celsius and 
tachycardic to 133 beats per minute. Complete blood count and 
lactic acid were within normal limits, and urinalysis was not 
consistent with a urinary tract infection. 
On imaging, ultrasound revealed a complex cystic 
mass originating from the right upper renal pole (Image A). 
Evaluation by computed tomography (CT) showed a large 
subcapsular multicystic mass with hyperdense internal septation 
on the right kidney suggestive of CE, as well as a small, 
hypoattenuating lesion in the right lobe of the liver (Image B).5 
Further imaging by magnetic resonance (MRI) confirmed the 
subscapular multicystic mass along the right kidney measuring 
7 x 5.2 x 6.1 cm consistent with CE stage III and a 1.7 cm cystic 
lesion in the right hepatic lobe also consistent with CE (Image 
C). Serum immunoglobulin G (IgG) for echinococcus was 
positive. The patient was diagnosed with echinococcal disease 
and was initiated on albendazole 200 milligrams twice a day for 
3-4 months, with future plans for surgical intervention.
DISCUSSION
Echinococcal disease is caused by infection with the 
Echinococcus granulosus tapeworm with the majority of cases 
originating in the Middle East, South and Central America, 
and some sub-Saharan African countries. The clinical 
presentation of Echinococcus infection is largely dependent on 
the location and size of the cysts. Small or calcified cysts may 
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What do we already know about this clinical entity? 
Cystic echinococcosis is a parasitic infection that 
results in the creation of cystic structures in visceral 
organs, most commonly in the liver or lungs.
What makes this presentation of disease reportable? 
We discuss a patient who was diagnosed with cystic 
echinococcosis of primary renal involvement, a rare 
anatomic location.
What is the major learning point? 
Although these cysts are often found in the liver or 
lungs, they can arise in almost any organ and symptoms 
are often specific to the organ system affected.
How might this improve emergency medicine 
practice? 
This case reports a rare presentation of an 
uncommon disease in the United States and reviews 
diagnostic and treatment guidelines.
be asymptomatic, whereas larger cysts may cause mass effect, 
obstruction to blood or urine flow, or may present as toxic-
appearing with rupture or secondary bacterial infection.5-7 
Ruptured cysts can cause an anaphylaxis-like reaction of 
varying severity. Some cysts present with symptoms up to 
several decades after initial infection or remain asymptomatic 
indefinitely.5-7 Our patient had immigrated to the US from 
Yemen six years earlier, suggesting that her disease has been 
asymptomatic for a minimum of six years, if not longer.
The most common sites of cystic involvement are the 
liver (approximately 66%), followed by the lungs (25%). Less 
commonly reported sites include the brain, kidneys, muscle, 
bone, and heart.5-7 Cysts in the kidneys are rare, and have been 
reported to cause hematuria and flank pain and can potentially 
result in glomerulonephritis and secondary amyloidosis.5-7 Our 
patient’s primary renal cyst was large enough to cause mass 
effect, leading to dysuria and suprapubic pain. At the time of 
presentation, she did not complain of hematuria or flank pain. 
Generally, diagnosis of echinococcal disease is made 
with both imaging and serology. With regard to imaging, 
ultrasonography is 90-95% sensitive for CE, and CT is only 
moderately better at 95-100% sensitivity; however, CT is 
superior to ultrasonography for evaluation of extrahepatic 
cysts. MRI offers no major advantage over CT. Our patient 
had imaging by all three modalities, with CT and MRI 
both providing better results on the size and nature of cysts 
than ultrasonography (Image). When considering serology, 
antibody detection has greater sensitivity than antigen 
detection.9 Our patient tested positive for echinococcal IgG. 
IgE and IgM were not pursued as echinococcal IgG is known 
to have better sensitivity. 
Management of these cysts are based on the WHO 
classification criteria and typically use a combination of 
observation, albendazole, PAIR (percutaneous puncture, 
aspiration, injection, re-aspiration), and surgery.10 Our 
patient’s renal cyst was classified as WHO stage III, for which 
the recommended treatment is albendazole followed by either 
PAIR or surgery. Alcohol injection was not pursued given the 
size of the cyst and risk of rupture. She was discharged on 
albendazole and scheduled follow-up with infectious disease, 
urology, and general surgery.
CONCLUSION
Though echinococcal disease is uncommon in the US, 
careful attention should be paid in individuals who have 
emigrated from endemic countries within the prior 10 years given 
that the mortality of unidentified and untreated individuals is 
significant. While the liver and lungs are the most common sites 
of involvement, it is important to note that cysts can be found 
Image. Large, subscapular multicystic renal mass with internal septations as indicated by the arrow on (A) renal ultrasound, (B) 
computerized tomography, and (C) magnetic resonance imaging T2.
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in almost any anatomic location and the symptoms are often 
specific to the organ system affected. Cyst rupture can result 
in an anaphylaxis-like reaction of varying severity. The best 
imaging modality for extrahepatic cysts in particular is by CT. 
The majority of these patients should be started on albendazole 
in the ED, with definitive treatment often requiring evaluation 
by several subspecialists including those in infectious disease, 
interventional radiology, and surgery.
Documented patient informed consent and/or Institutional Review 
Board approval has been obtained and filed for publication of this 
case report.
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Simultaneous hemorrhagic and ischemic strokes have been previously reported in the literature. 
Typically, these occur in patients secondary to dialysis, cerebral amyloid angiopathy, or thrombotic 
thrombocytopenic purpura.1,2,3 However, this is the unique case of a 62-year-old Asian female who 
presented with a hemorrhagic stroke suspected to be secondary to refractory hypertension from 
intracranial large vessel atherosclerotic flow limiting stenosis, with rapid subsequent large vessel 
occlusion and ischemic stroke. Questions arise such as ideal blood pressure parameters for dual 
management, timeliness of computed tomography angiography imaging in the emergency department for 
detection of large vessel occlusion during intracranial hemorrhage, and subsequent selection of treatment 
plan in the dual-lesion patient population. [Clin Pract Cases Emerg Med. 2020;4(2):167–170.]
INTRODUCTION
The occurrence of ischemic stroke in those with flow-
limiting intracranial atherosclerotic stenosis is well documented 
and continues to be one of the most common causes of stroke 
worldwide.4,5,6 The incidence of intracranial atherosclerotic 
disease is known to be higher in the Asian and African-
American populations.7 While cases of dual strokes with both 
hemorrhagic and ischemic components due to other etiology 
have been previously described, there is a paucity of literature 
in regard to intracranial hemorrhage (ICH) due to refractory 
secondary hypertension resulting from intracranial flow-limiting 
atherosclerotic occlusion. This is a case of a patient who 
arrived to the emergency department (ED) with a hypertensive-
appearing brainstem intraparenchymal hemorrhage who was 
subsequently found to have severe flow-limiting intracranial 
stenosis that developed into ischemic cerebral infarction. 
CASE REPORT
A 62-year-old, right-handed, Asian female with history 
of known refractory hypertension and diabetes mellitus 
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was brought into the ED via emergency medical services 
(EMS) as a stroke alert soon after experiencing sudden onset 
of neurologic symptoms. The patient was driving with her 
husband from San Francisco to Miami when she experienced 
confusion, slurred speech, and right-sided weakness, which 
subsequently progressed to unresponsiveness. En route to the 
ED, EMS reported a blood pressure of 240/120 millimeters 
of mercury (mmHg) and a glucose level of 133 milligrams 
per deciliter (mg/dL). 
Upon arrival, her Glasgow Coma Scale was seven. Her 
neurologic examination demonstrated right-sided hemiplegia, 
left-sided withdrawal to pain, a rightward gaze preference, 
and reactive pupils. The patient was immediately intubated 
in the ED for airway protection. Initial vital signs following 
intubation were as follows: blood pressure 270/159 mmHg; 
pulse 78 beats per minute; temperature 36.7 degrees Celsius; 
respiratory rate 18 breaths per minute (on ventilator); pulse 
oximetry 100% (on 100% fraction of inspired oxygen); and 
body mass index of 23.5 kilograms per meter squared (kg/
m2) (reference range 18.5-24.9 kg/m2). The patient was started 
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What do we already know about this clinical 
entity? 
There are established guidelines for blood 
pressure management, imaging modalities, and 
definitive treatment options to manage either 
ischemic or hemorrhagic stroke.
What makes this presentation of disease 
reportable? 
This report discusses the novel presentation of a 
patient with simultaneous ischemic and hemorrhagic 
strokes secondary to hypertension from intracranial 
atherosclerotic stenosis.
What is the major learning point? 
Clarity is needed for clinical parameters and 
treatment options in the dual-lesion patient.
How might this improve emergency medicine 
practice? 
Care will be improved with better-defined 
management standards and other special 
consideration, given the unique pathophysiology 
in dual ischemic and hemorrhagic lesions.
on a nicardipine infusion with a goal systolic blood pressure 
less than 190-200 mmHg and a propofol infusion for sedation 
before being taken for imaging. 
Initial non-contrast computed tomography (CT) of 
the brain revealed an ICH that arose in the pons and 
extended into the fourth ventricle. Her only risk factor 
for developing the hemorrhagic stroke was the known 
refractory hypertension. The size of the hemorrhage 
measured 3.4 centimeters (cm) by 2.0 cm with a volume 
less than 30 milliliters (mL) (Image 1). An ICH score of 
three was given, suggesting a 72% mortality. The initial 
complete blood count and coagulation studies were within 
normal limits. Intracranial pressure-lowering management 
was initiated, which included the following: 3% hypertonic 
saline bolus; 30-degree head of bed elevation; and 
hyperventilation to target partial pressure of carbon dioxide 
of 35 mmHg (reference range 35-45 mmHg). Strict systolic 
blood pressure control to less than 140 mmHg was started 
with nicardipine infusion as part of the management for 
ICH. After initiating these measures, an emergent CT 
angiogram (CTA) was obtained to rule out aneurysm or 
arteriovenous malformation.
CTA showed a near occlusion of the left M1 (horizontal 
proximal) segment of the middle cerebral artery (MCA), 
which appeared to be chronic (Image 2). The patient was 
admitted to the intensive care unit with cerebral angiogram 
scheduled for the following morning to evaluate for left MCA 
stenosis or cryptogenic malformation. The cerebral angiogram 
revealed a nearly occluded left M1 MCA with surrounding 
stenosis involving the proximal M1, multiple M2 branch 
points, A2 (vertical, post communicating, infracallosal), 
and A3 (precallosal) anterior cerebral artery branch points 
consistent with severe intracranial atherosclerosis (Image 
3). There was evidence of neovascularization suggesting 
chronicity of stenosis. Revascularization of the stenotic lesions 
at this time was considered extraordinarily high risk with the 
concurrent ICH due to the need for aspirin and clopidogrel 
during these procedures. 
On hospital day three, due to concern for developing 
hydrocephalus, an external ventricular drain was placed, 
which measured normal intracranial pressure. On hospital 
day five, increased lethargy was noted while the patient 
was off of sedative medication. A repeat non-contrast CT 
of the brain at this time demonstrated a new, low attenuated 
area involving the high posterior aspect of the left frontal 
lobe in a MCA watershed area (Image 4). The patient’s 
neurologic condition continued to decline, and her course 
was further complicated by aspiration pneumonia. The 
family ultimately elected to withdraw care, and she passed 
peacefully on hospital day nine.
Image 1. Non-contrast computed tomography brain demonstrating 
pontine hemorrhage with fourth ventricle involvment (circle).
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DISCUSSION
Some of the common risk factors for developing 
intracranial atherosclerotic disease are hypertension, smoking, 
diabetes mellitus, and hyperlipidemia.6 Race and gender 
also play a major role in the development of extracranial vs 
intracranial atherosclerotic disease.8  Higher incidence of 
intracranial atherosclerotic disease is seen in Asians from 
China, Japan, and Korea.9 In the Caucasian population, there 
was a decline in stroke incidence between 1990 and 2005. 
However, no such decline was seen in the African-American 
population, whose stroke rates are higher compared to both 
Caucasian and Southeast Asian groups.10 
Intracranial arteries are made up of endothelium with 
smooth muscle cells and an extracellular matrix comprised 
mostly of collagen and elastin. Stroke due to intracranial 
atherosclerotic disease is caused by hemodynamic failure, 
in-situ thrombus from plaque disruption, and/or distal 
thromboembolism.11 Secondary hypertension due to 
intracranial atherosclerotic disease is a common compensatory 
mechanism to maintain adequate cerebral perfusion.
Previous reports have discussed the occurrence of 
simultaneous hemorrhagic and ischemic events in patients 
secondary to dialysis, cerebral amyloid angiopathy, or 
thrombotic thrombocytopenic purpura.1,2,3 Examples of events 
include expanding hemorrhagic intracranial hematoma with 
subsequent edema that causes compression of adjacent vessels 
leading to ischemic stroke. There are many other mechanisms 
for developing ischemic stroke, which can be attributed to 
embolism, thrombosis, or systemic hypoperfusion.12 In this 
particular patient, however, the ischemic event occurred in the 
Image 2. Computed tomography angiogram demonstrating left 
middle cerebral artery occlusion (arrow).
Image 3. Cerebral angiogram demonstrating near occlusion 
of left M1 (long arrow) and stenosis of left M2 middle cerebral 
artery (short arrow).
contralateral side of the hemorrhage and in a watershed pattern 
consistent with hypoperfusion from the underlying stenotic 
lesion after the lowering of blood pressure to manage the 
ICH. The concurrent presence of cerebral edema refractory to 
conventional intravenous treatments may have also contributed 
to the hemodynamic changes resulting in ischemic stroke. 
This patient had severe refractory secondary hypertension 
due to flow-limiting intracranial atherosclerotic disease. We 
hypothesize this to be the major contributing factor to her 
hypertensive ICH. This has implications regarding ideal blood 
pressure management in the emergent setting. Questions 
arise whether to decrease blood pressure to limit hemorrhage 
extension and rebleeding or whether to maintain blood pressure 
to allow perfusion of the oligemic watershed parenchyma. Ideal 
blood pressure parameters in patients with both intracranial 
atherosclerotic disease and intracranial hemorrhage is currently 
unknown. Current American Stroke Association guidelines 
for ICH recommend lowering systolic blood pressure to 140 
mmHg.13 However, patients who have ICH and flow limiting 
stenosis may benefit from higher blood pressure parameters to 
maintain adequate cerebral perfusion.
Another important point concerns the timing of CTA in the 
ED for patients with ICH. The common benefits of routine CTA 
imaging would include evaluation for aneurysm, malformations, 
and other intracranial vascular anomalies often seen in 
spontaneous hemorrhage. CTA also assists in the selection of 
aneurysmal treatment planning. An additional benefit of CTA in 
the ED during ICH would be identifying intracranial stenosis, 
similar to this case, which may be the underlying cause of 
secondary hypertension.
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Image 4. Non-contrast computed tomography brain demonstrating 
a low attenuated area of the left frontal lobe in a middle cerebral 
artery watershed area (circle).
CONCLUSION
This is a case of intracranial hemorrhage secondary to 
refractory hypertension due to severe intracranial atherosclerotic 
stenosis. Further exploration is needed of the critical questions that 
arise, such as ideal blood pressure parameters for management, 
timeliness and routine use of CTA in the ED, and subsequent 
selection of treatment plan in the dual-lesion patient populations.
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As more states legalize marijuana, the potential of marijuana abuse could lead to an increase in the 
number of emergency department (ED) visits. We describe two patients who presented to the ED 
with dilated pupils, rigidity in both lower extremities, and clonus in both feet after inhaling the vapor 
of a highly potent form of marijuana. Serotonin syndrome diagnosis was initially considered in the 
differential diagnosis. Ultimately, high-potency marijuana abuse was the final diagnosis. Therefore, 
marijuana toxicity should be considered in ED patients who present with signs and symptoms similar to 
that of serotonin syndrome. [Clin Pract Cases Emerg Med. 2020;4(2):171–173.]   
INTRODUCTION 
As the legalization of cannabis becomes prevalent in the 
United States, effects from its abuse will result in an increase 
in emergency department (ED) visits.1 We have witnessed 
a growing trend in our community ED among adolescents 
abusing a highly potent form of marijuana, butane hash oil 
(BHO). BHO is a concentrated form of tetrahydrocannabinol 
(THC) that is created by using liquid butane as a solvent 
to extract THC from marijuana plants. As butane is highly 
flammable, reports of burns and explosions have been reported 
from the synthesis and use of BHO. A popular trend called 
“dabbing” involves heating the concentrated oil and inhaling the 
resultant vapors. These vapors contain very high concentrations 
of THC, as high as 90% pure. Adolescents may use e-cigarette 
devices to abuse BHO as a delivery device. Such devices are 
easily concealed and produce almost no odor, thus leading to 
the potential for abuse at school and in the home.2,3
Previous case reports have shown BHO abuse may lead 
to agitation along with neurotoxicity and cardiotoxicity.3,4 
Since THC may activate serotonin receptors and inhibit 
serotonin reuptake, its abuse in high concentrations may 
mimic serotonin syndrome.5  We present two cases of 
adolescents with recent “dabbing” use who exhibited signs 
and symptoms of serotonin syndrome.
CASE REPORT
Case 1 
A 17-year-old female presented to a large community 
ED by emergency medical services (EMS) from her home for 
CoxHealth System, Department of Emergency Medicine, Springfield, Missouri
CoxHealth System, Department of Pharmacy, Springfield, Missouri
*
†
a possible seizure. EMS providers had witnessed agitation, 
altered mental status, tachycardia, muscle stiffness and 
tremors in the limbs, and administered 10 milligrams (mg) of 
midazolam intranasally. History was obtained from the EMS 
providers and the patient’s parents who were present in the 
room. The patient had been taking sertraline 50 mg daily and 
had also been prescribed a short course of cyclobenzaprine 
5 mg every eight hours, as needed, for “muscle aches.”  
According to the parents, the patient had taken “a few” but 
stopped the cyclobenzaprine as it was not effective. No history 
of drug overdose or recent illness was obtained. 
Upon arrival to the ED, the patient was obtunded (likely 
secondary to benzodiazepine), but would occasionally follow 
commands. Her Glasgow Coma Score was eight, scoring two 
points for eye-opening response, two points for verbal response, 
and four points for motor response. Vital signs revealed blood 
pressure of 135/81 millimeters of mercury (mmHg), pulse 124 
beats per minute (bpm), rectal temperature of 99.6 degrees 
Fahrenheit (F), and 97% pulse oximetry on room air. Physical 
exam revealed dilated pupils of six millimeters (mm), normal 
neck exam, normal lung sounds, a soft and non-tender abdomen, 
and normal heart sounds. A neurological exam revealed rigidity 
in both lower extremities with a sparing of rigidity in the arms. 
Deep tendon reflexes showed sustained clonus in both feet, and 
the presence of hyper-reflexivity in the patella tendons bilaterally 
but with normal reflexes in the upper extremities. 
Lab results showed a normal complete blood count, 
normal creatine kinase, normal comprehensive metabolic 
profile, normal arterial blood gas, normal prolactin level, 
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What do we already know about this clinical 
entity? 
Serotonin syndrome and marijuana abuse are 
recognizable conditions encountered in the practice 
of emergency medicine. 
What makes this presentation of disease reportable? 
We report two cases of high-potency marijuana abuse 
that mimicked serotonin syndrome. 
What is the major learning point? 
When encountering potential serotonin syndrome, 
a thorough social history and drug testing may be 
needed to rule out a disease mimic.
How might this improve emergency medicine 
practice? 
As legalized marijuana becomes more prevalent, 
emergency physicians should be aware of this 
disease mimic.
and a urine drug screen positive for THC. Electrocardiogram 
showed sinus tachycardia, and a non-contrasted head 
computed tomography was normal. Serotonin syndrome 
was considered in the differential diagnosis. After pediatric 
critical care and pediatric neurology consultation, one 
oral dose of cyprohepatidine 4 mg was administered. The 
patient was admitted to the pediatric intensive care unit. 
Magnetic resonance imaging of the brain was normal, and 
an electroencephalogram showed no epileptic activity. The 
patient rapidly improved and was discharged the following 
day. Prior to discharge, the patient admitted to “dabbing” 
about 30 minutes prior to arrival to the hospital.  The same 
patient returned to the ED the following night with a similar 
presentation, once again associated with dabbing. 
Case 2
 A 16-year-old male took “a hit from a dab pen” while 
on the bus to school. He developed altered mental status and 
was transported to the ED. On arrival he was mildly obtunded, 
Glasgow Coma Score was 13 (three for eye-opening response, 
four verbal response, and six motor response). Vital signs were 
recorded as blood pressure 152/86 mmHg, pulse 116 bpm, oral 
temperature 98.6° F and 100% pulse oximetry on room air. 
Physical exam showed dilated pupils to five mm, tachycardia, and 
rigidity of the lower extremities with non-sustained clonus in the 
legs bilaterally. Lab results were normal with the exception of a 
drug screen positive for THC. This patient slowly improved over 
six hours of observation in the ED and was discharged home.
DISCUSSION 
Psychotic states, cardiac toxicity, and neurotoxicity have 
been reported as clinical sequelae of THC-induced toxicity.4,6 
Our cases show additional harmful side effects of highly 
concentrated THC when abused by adolescents in its vapor, 
or “dabbing” form. Although the cases did not show all of the 
hallmarks of a true serotonin syndrome, some overlap existed 
in physical exam findings. Serotonin syndrome may show 
vital sign abnormalities such as tachycardia, hypertension, and 
hyperthermia. Physical exam findings of serotonin syndrome 
may reveal agitation, ocular clonus, dilated pupils, tremor, deep 
tendon hyper-reflexia, muscle clonus, dry mucus membranes, 
and flushed skin with diaphoresis.7 
The most striking exam finding in these two ED patients was 
the lower extremity rigidity with hyper-reflexivity. Animal studies 
have demonstrated that potent cannabinoid receptor agonists 
may activate the serotonin receptors (5-hydroxytryptamine1A and 
5-hydroxytryptamine2A), and THC inhibits serotonin re-uptake.
5, 8 
Therefore, it is likely that emergency physicians may see some of 
the hallmarks of serotonin syndrome in “dabbing” users.
CONCLUSION 
Medical marijuana and cannabidiol have been used 
and proved to be medically safe and effective; however, as 
marijuana use grows there is increased access of cannabinol 
products, including high-concentrate THCs. Our cases reflect 
that adolescents who abuse THC by heating and then inhaling 
the concentrated vapor, can present with signs and symptoms 
that mimic serotonin syndrome. For that reason, high-potency 
marijuana abuse should be considered when encountering young 
adults in the ED with these exam findings.
Documented patient informed consent and/or Institutional Review 
Board approval has been obtained and filed for publication of this 
case report.
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Introduction: Pyogenic flexor tenosynovitis is an unusual complication of dyshidrotic eczema. The 
diagnosis has traditionally been made by Kanavel’s signs. Point-of-care ultrasound can be a useful 
adjunct in the diagnosis of this surgical emergency. 
Case Report: We report the case of a 23-year-old male who presented with right middle finger pain 
and swelling and an overlying eczematous rash. The use of point-of-care ultrasound was performed 
to aid in the diagnosis of pyogenic flexor tenosynovitis. An incision and drainage was performed with 
deep wound cultures positive for Staphylococcus aureus. 
Discussion: The presentation of pyogenic flexor tenosynovitis with underlying concomitant 
dermatological disease can complicate this challenging diagnosis. Point-of-care ultrasound can 
be an effective adjunct in revealing pyogenic flexor tenosynovitis rather than relying solely on the 
classical Kanavel’s signs, leading to earlier treatment. 
Conclusion: Our case demonstrates that point-of-care ultrasound can be a rapid and effective tool 
for the diagnosis of pyogenic flexor tenosynovitis in the setting of superimposed dermatological 
diseases. [Clin Pract Cases Emerg Med. 2020;4(2):174–177.]
Keywords: flexor tenosynovitis; pyogenic; eczema; dyshidrotic; ultrasound.
INTRODUCTION 
Pyogenic flexor tenosynovitis (PFT) is an acute infection 
of the synovial flexor tendon sheath often presenting first to the 
emergency department (ED). This aggressive, closed-space 
infection is classically diagnosed in patients presenting with 
the four Kanavel’s signs: uniform swelling; tenderness at the 
flexor tendon sheath; the digit held in flexion; and pain on 
passive extension.1 The natural history of PFT usually presents 
two to five days after a penetrating injury and rarely by 
hematogenous spread.2 Bacterial introduction into the skin is a 
common occurrence in those with predisposing dermatologic 
diseases as a result of self-induced skin breakdown or skin 
microbiome alterations owing to an imbalance of staphylococci 
over streptococcus.3 However, the large majority of cases result 
in cellulitis and not in PFT. The diagnosis of PFT is 
Mount Sinai Medical Center, Department of Emergency Medicine, Miami Beach, Florida
challenging but one that must be made at the patient’s first 
encounter as it is a surgical emergency. In conjunction with the 
clinical exam findings, point-of-care ultrasound POCUS) can 
assist with the diagnosis of PFT and, therefore, avoid loss of 
hand function or amputation in severe cases.4 
CASE REPORT
A 23-year-old right-handed male presented to the ED with 
right middle finger pain and swelling throughout the day. The 
swelling rapidly progressed over four hours predominately at 
the palmar aspect of the middle finger. The patient reported 
working as a chef and wore gloves on a daily basis. He denied 
trauma, fever, chills, sore throat, joint pain, penile discharge, or 
genital sores. He had a history of eczema mainly affecting the 
bilateral palmar hands and had allergies to dust, pollen, and cat 
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What do we already know about this clinical 
entity? 
Pyogenic flexor tenosynovitis (PFT) 
has traditionally been diagnosed using 
Kanavel’s signs and requires emergent 
surgical intervention.
What makes this presentation of disease 
reportable? 
PFT is a vital but rare diagnosis in 
the setting of concomitant overlying 
dermatological diseases.
What is the major learning point? 
Point-of-care ultrasound (POCUS) can be 
used as an adjunct to diagnose PFT in the 
setting of an uncertain clinical picture.
How might this improve emergency 
medicine practice? 
Emergency physicians can use clinical 
findings with the aid of POCUS to solidify 
the diagnosis of PFT.
dander. The patient reported using Cetaphil cream and took 
loratadine and diphenhydramine often. He denied any allergies 
to medication and had no surgeries in the past. The patient had 
been sexually active with one female partner for the prior six 
years and denied any history of sexually transmitted infections. 
He smoked half a pack of cigarettes per day for three years but 
quit one month prior. He also drank alcohol twice per month 
and smoked marijuana once per month. 
His vitals in the ED were oral temperature 98.4 degrees 
Fahrenheit, heart rate of 77 beats per minute, blood pressure 
128/76 millimeters of mercury, respiratory rate of 17 breaths per 
minute, and oxygen saturation of 99% on room air. He was well 
appearing and in no acute distress. His right middle finger was 
held in slight flexion with fusiform swelling and tenderness at 
the flexor surface (Image 1). He had pain with passive extension 
of his finger but sensation was intact. He also had a scaly 
erythematous skin eruption with desquamation and excoriations 
of his bilateral palms with several one-millimeter pustules. 
Laboratory testing revealed a leukocytosis of 12.69 x 103 cells 
per liter (L) (reference range: 4.8-10.8 x 103 cells/L) with left 
shift and plain film radiographs of the right hand and fingers 
were unremarkable. An ED POCUS of the right middle finger 
was performed showing anechoic fluid within the flexor tendon 
sheath (Images 2 and 3).
Based on clinical exam and ultrasound findings, the patient 
was diagnosed with flexor tenosynovitis of the right middle 
finger and started on vancomycin and ceftriaxone intravenously. 
The patient was admitted to the hospital with hand surgery 
consultation. He subsequently underwent an incision and 
drainage. Deep wound cultures were positive for 
Staphylococcus aureus with blood cultures producing no 
growth. Subsequent gonorrhea, syphilis, and human 
Image 1. Palmar aspect of the patient’s right hand. There is 
erythema and swelling (black arrow) of the right middle finger 
held in slight flexion. An associated scaly eczematous skin 
eruption is shown. 
Image 2. Transverse ultrasound view of the right middle finger. 
The image displays anechoic fluid (white arrows) surrounding the 
flexor tendon within the tendon sheath. 
Clinical Practice and Cases in Emergency Medicine 176 Volume IV, no. 2: May 2020
PFT as a Rare Complication of Dyshidrotic Eczema Nimjareansuk et al.
immunodeficiency virus-1/2 testing was negative. Dermatology 
was consulted and the patient was diagnosed with atopic 
dermatitis with dyshidrotic eczema. Dermatology recommended 
that the patient be treated with triamcinolone 0.1% ointment 
once a day, clobetasol 0.05% ointment once a day, and 
hydroxyzine 25 milligrams at bedtime as needed. The patient 
improved and was discharged home on hospital day three status 
post incision and drainage with amoxicillin-clavulanic acid for 
five days and outpatient follow-up with hand surgery. 
DISCUSSION 
Flexor tenosynovitis is a time-sensitive diagnosis that can 
result in severe morbidity due to complications such as 
adhesions, deep space infection, tendon rupture, or 
amputation.2,4,5 Although traditionally diagnosed by the classic 
Kanavel’s signs, there is no published study validating these 
signs. Dailiana et al showed that only 54% of patients had all 
four signs in a retrospective review.6 Two studies have evaluated 
the individual signs among patients with PFT. Pang et al 
showed that fusiform swelling was the most common sign in 
patients diagnosed with PFT and that pain along the flexor 
tendon sheath was a late sign.7 In addition, Neviaer and Gunther 
proposed that the earliest Kanavel’s sign was pain on extension 
and also proposed that the inability to flex the finger entirely to 
the palm was an additional sign of PFT.8
To further complicate a challenging clinical diagnosis, 
most cases of PFT are caused by direct inoculation from 
trauma to the finger and may appear minor or even innocuous 
from a scrape or a scratch.9 This was likely the case in our 
patient with dyshidrotic eczema. Secondary bacterial infection 
of dyshidrotic eczema resulting in cellulitis is not 
uncommon.10 Thus, POCUS in the ED can be a useful adjunct 
to elucidate the diagnosis of PFT vs cellulitis. 
The normal flexor tendon sheath does not have an 
appreciable amount of fluid when visualized on ultrasound as 
the parietal and visceral layers of the sheath form a sealed 
synovium.11,12 Hypoechoic or anechoic fluid within the flexor 
tendon sheath has been shown to correlate with purulent 
discharge upon surgical intervention.13,14 A study published 
by Jardin et al showed ultrasound findings of peritendinous 
effusion, and thickened synovial sheath had a sensitivity of 
94%, specificity of 74%, and negative predictive value of 
96.7%.15 Therefore, the presence of fluid within the flexor 
tendon sheath can aid in the diagnosis of PFT. 
CONCLUSION
Pyogenic flexor tenosynovitis may not present with all 
the typical Kanavel’s signs. To make the detection of the 
disease even more challenging, overlying dermatologic 
diseases may mask this diagnosis. Performing a POCUS in 
the ED is an effective and timely adjunct to support the 
diagnosis of PFT, leading to earlier treatment with antibiotics 
and/or surgical intervention. 
The documented Institutional Review Board policy has been 
obtained and filed for publication of this case report.
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Image 3. Longitudinal ultrasound view of the right middle finger. 
The image displays the striated flexor tendon with anechoic fluid 
(white arrows) above and below the tendon.
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Introduction: Heterotopic pregnancies are rare. However, they are occurring with increasing 
frequency. Unfortunately, diagnosis is frequently delayed, with patients presenting in extremis.
Case Report: We present a case of a heterotopic pregnancy diagnosed by point-of-care ultrasound 
(POCUS) in a woman presenting with lower abdominal pain, who had a documented normal first 
trimester ultrasound the day prior to presentation.
Discussion: Given the increasing rates of heterotopic pregnancies, we can no longer be reassured 
by the presence of an intra-uterine pregnancy (IUP) in a patient with concerning signs and symptoms 
of a ruptured ectopic pregnancy. A thorough POCUS evaluation of the uterus and adnexa is essential 
for the diagnosis of heterotopic pregnancy in the emergency department.
Conclusion: This case highlights the value POCUS brings to the emergency department evaluation 
of patients in early pregnancy. [Clin Pract Cases Emerg Med. 2020;4(2):178–180.]   
Keywords: Heterotopic pregnancy; Point-of-care ultrasound; POCUS; Emergency Medicine.
INTRODUCTION
A heterotopic pregnancy occurs when there is an intrauterine 
pregnancy (IUP) as well as an extrauterine, or ectopic, pregnancy. 
Traditionally, heterotopic pregnancies have been thought to be 
extremely rare. This was based on early theoretical calculations 
from 1948, which estimated the incidence of heterotopic 
pregnancy to be 1 in 30,000 pregnancies.1 However, more recent 
data estimates rates as high as 1:100 – 1:8000,2–4 with the highest 
rates occurring in patients undergoing assisted reproductive 
technologies (ART), such as in vitro fertilization, super ovulation, 
and intrauterine insemination. 3  
Unfortunately, owing to the diagnostic challenges, the 
majority of heterotopic cases present late, with patients presenting 
in hemorrhagic shock or with an acute abdomen after the ectopic 
pregnancy ruptures.5 Many heterotopic pregnancies are missed 
on routine emergency department (ED) and obstetrics (OB) 
ultrasounds after visualization of an IUP.2-4,7 In this report we 
present a case of a patient diagnosed with a ruptured heterotopic 
Washington University School of Medicine in St. Louis, Department of Emergency 
Medicine, St. Louis, Missouri
pregnancy via point-of-care ultrasound (POCUS) in the ED 
following a documented normal IUP on routine OB ultrasound 
the preceding day.
CASE REPORT
A 27-year-old female, gravida 3, para 1, at eight-weeks 
gestation and a remote history of treated cervicitis, presented 
to the ED with a two-day history of diffuse, crampy abdominal 
pain without vaginal bleeding or urinary symptoms. The patient 
had been seen in clinic the day prior to ED presentation where 
she underwent a transvaginal ultrasound and was documented to 
have a live IUP at eight-weeks gestation with normal uterus and 
adnexa, and a small amount of free fluid in the cul-de-sac.
In the ED she was tachycardic at 116 beats per minute and 
normotensive. Her abdomen was diffusely tender. A point-of-
care transabdominal pelvic ultrasound was performed to evaluate 
the pregnancy, which noted a live IUP and left adnexal ectopic 
pregnancy (Image and Video) with free fluid noted in the pelvis 
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What do we already know about this clinical 
entity? 
Heterotopic pregnancies are occurring with 
increasing frequency, and when missed result 
in significant morbidity for the patient.
What makes this presentation of disease 
reportable? 
We describe a heterotopic pregnancy diagnosed 
on emergency department point-of-care 
ultrasound one day after a documented normal 
outpatient obstetrics ultrasound. 
What is the major learning point? 
Pregnant patients with abdominal pain require 
complete ultrasound assessment of the uterus 
and adnexa. The presence of intrauterine 
pregnancy (IUP) does not rule out an ectopic.
How might this improve emergency 
medicine practice? 
Early identification and management of 
heterotopic pregnancy can provide improved 
outcomes for both the mother and the IUP.
and Morison’s pouch. OB was consulted and agreed with the 
diagnosis. The patient was taken emergently to the operating 
room and underwent a left salpingectomy, and 800 milliliters of 
intra-abdominal blood was evacuated. The patient was able to 
carry the IUP to term without further complications.
DISCUSSION
Given the rarity of heterotopic pregnancies, the finding of 
an IUP on ultrasound may lead to false reassurance, resulting 
in missed extrauterine masses.1-5 This may explain why a 
majority of heterotopic pregnancies are often missed on initial 
ultrasound imaging.2-4,6 While the increased use of ART may 
attribute to the increased rates of ectopic pregnancies in recent 
years, up to one half of patients with ectopic pregnancies have 
no identifiable risk factors.2-4,6 
Diagnosis of ectopic pregnancies can be difficult, and 
diagnosing heterotopic pregnancies are even more so. It is 
important that providers adopt a thorough evaluative process 
for women presenting with abdominal and pelvic pain in 
early pregnancy, with particular focus on physical exam and 
diagnostics, including POCUS.  Physical exam findings in the 
setting of a ruptured extrauterine pregnancy include diffuse 
abdominal tenderness to light palpation or cough and cervical 
motion tenderness, with positive likelihood ratios of 4.2-4.5 and 
4.9, respectively.7  
Findings on ultrasound of an extrauterine pregnancy include 
the “blob” (extrauterine mixed echogenic mass) and “bagel” 
(extrauterine sac-like structure) signs in early pregnancy, fetus 
with measurable heart rate if presenting later,2,8 and signs of 
rupture, including fluid in the pelvis and Morison’s pouch. 
Ultrasound evaluations in early pregnancy should include 
evaluation in longitudinal and transverse planes throughout 
the uterus, as well as the adnexa. An initial evaluation using a 
transabdominal approach with a low-frequency curvilinear probe 
is appropriate, but should be followed by a transvaginal approach 
with a high-frequency endocavitary probe when concerning, but 
non-diagnostic, findings are noted.
Image.  A) Visualized intrauterine pregnancy (arrow); B) Uterus (star) with ectopic pregnancy (arrowhead) seen in the left adnexa; C) 
Uterus (star) with M-mode through the ectopic pregnancy (arrowhead) demonstrating a fetal heart rate of 158 beats per minute.
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2. Kwok TC and Morgan G. Think Heterotopic: A Case Report of 
Heterotopic Pregnancy Detected on Thorough Ultrasonography. J 
Medical Cases. 2012;3(5):326-8.
3. Breyer MJ and Costantino TG. Heterotopic gestation: another 
possibility for the emergency bedside ultrasonographer to 
consider. J Emerg Med. 2004;26(1):81-4.
4. Avitabile NC, Kaban NL, Siadecki SD, et al. Two cases of 
heterotopic pregnancy: review of the literature and sonographic 
diagnosis in the emergency department. J Ultrasound Med. 
2015;34(3):527-30.
5. Press GM and Martinez A. Heterotopic pregnancy diagnosed by 
emergency ultrasound. J Emerg Med. 2007;33(1):25-7.
6. Mihmanli V, Kilickaya A, Cetinkaya N, et al. Spontaneous 
Heterotopic Pregnancy Presenting with Hemoperitoneum. J Emerg 
Med. 2016;50(1):44-6.
7. Crochet JR, Bastian LA, Chireau MV. Does this woman have an 
ectopic pregnancy? the rational clinical examination systematic 
review. JAMA. 2013;309(16):1722-9.
8. Wang PS, Rodgers SK, Horrow MM. Ultrasound of the First 
Trimester. Radiol Clin North Am. 2019;57(3):617-33.
9. Louis-Sylvestre C, Morice P, Chapron C, et al. The role of 
laparoscopy in the diagnosis and management of heterotopic 
pregnancies. Hum Reprod. 1997;12(5):1100-2.
Once the heterotopic pregnancy is diagnosed, treatment 
is surgical. Unlike in ectopic pregnancy, there is no role 
for methotrexate given the concomitant IUP.9  The surgical 
approach varies based on location of the ectopic, most 
commonly a laparoscopic approach if stable or laparotomy if 
unstable.9  As with other early-pregnancy bleeding or ectopic 
rupture, Rhesus negative mothers should be given Rho(D) 
immune globulin. 
CONCLUSION
Heterotopic pregnancy can present a diagnostic 
challenge in the OB clinic and ED. The increased frequency 
of heterotopic pregnancy, due to increased use of ART for 
hopeful mothers, makes it imperative that the era of  “an IUP 
rules out an ectopic” come to an abrupt end. Providers caring 
for pregnant women should adopt a thorough, formalized 
evaluative process and consider heterotopic pregnancy in 
all pregnant women, particularly in those with risk factors, 
significant symptoms, or concerning ultrasound findings, 
despite the presence of an IUP. 
Video.  A transabdominal pelvic ultrasound demonstrating an 
intrauterine pregnancy (IUP) and a left adnexal mass. M-mode, 
which is used to determine fetal heart rate, demonstrates heart rates 
for the IUP and left adnexal mass of 156 beats per minute (bpm) and 
158 bpm, respectively. Free fluid is visible in the right upper quadrant 
in Morrison’s pouch.
Documented patient informed consent has been obtained and 
filed for publication of this case report.
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Introduction: Cardiac memory refers to T-wave inversions that result when normal ventricular 
activation resumes following a period of abnormal ventricular activation. 
Case Report: We present a case of a 29-year-old man with a pacemaker who presented with new, 
deep symmetric T-wave inversions caused by cardiac memory. 
Discussion: Abnormal ventricular activation is most commonly induced by ventricular pacing but 
can also occur in the setting of transient left bundle branch blocks, ventricular tachycardia, and 
intermittent ventricular pre-excitation. 
Conclusion: Recognition of this phenomenon may help to reduce unnecessary admissions, cardiac 
testing, and cardiac catheterizations. [Clin Pract Cases Emerg Med. 2020;4(2):181–184.]  
Keywords: ECG; cardiac memory; T-wave inversions.
INTRODUCTION
The differential for new T-wave inversions (TWI) 
includes myocardial ischemia, ventricular overload syndromes 
(i.e., strain), Takotsubo cardiomyopathy, myopericarditis, 
and cerebrovascular injury.1 Here we present a case of deep, 
symmetric TWI induced by a phenomenon known as cardiac 
memory. Cardiac memory is characterized by transient T-wave 
inversion after a period of abnormal ventricular activation. It 
is generally considered to be a benign finding, in contrast to 
many other causes of TWIs, although other etiologies should 
be ruled out prior to diagnosing cardiac memory.
CASE REPORT
A 29-year-old man with a history of second-degree Mobitz 
type II atrioventricular block and a dual-chamber right ventricular 
pacemaker (placed five weeks prior to presentation) presented to 
the emergency department for one week of sharp, intermittent, 
unprovoked, left-sided chest pain over his pacemaker site. On 
arrival, his pulse rate was 78 beats per minute, blood pressure 
171/99 millimeters of mercury, respiratory rate 16 breaths per 
McGovern Medical School at the University of Texas Health Science Center at 
Houston (UTHealth), Department of Emergency Medicine, Houston, Texas
minute, oxygen saturation 98% on room air, and temperature 
98.3º Fahrenheit (36.7º Celsius). The patient appeared 
comfortable and had reproducible chest pain over the pacemaker 
site. A 12-lead electrocardiogram (ECG) was obtained (Image 1). 
Electrolytes and complete blood count were within normal 
limits, and the troponin I level was undetectable. The patient 
was given 324 milligrams of aspirin, started on a heparin drip, 
and admitted to the coronary care unit for further work-up. A 
repeat ECG performed four hours after presentation showed a 
ventricular-paced rhythm (Image 2). 
The troponin I level remained undetectable for three 
serial measurements spanning 11 hours, and the heparin drip 
was discontinued. A transthoracic echocardiogram showed 
normal left ventricular size and function without wall motion 
abnormalities, and mild concentric hypertrophy. The pacemaker 
was interrogated, revealing adequate function and battery life. 
An ultrasound of the left chest wall excluded a hematoma 
or fluid collection around the pacemaker. He was started on 
oral nifedipine for newly diagnosed hypertension, remained 
asymptomatic and was discharged the following morning. A 
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What do we already know about this clinical 
entity? 
Cardiac memory refers to T-wave inversions 
(TWI) that result when normal ventricular 
activation resumes following a period of 
abnormal ventricular activation.
What makes this presentation of disease 
reportable? 
Deep and symmetric TWIs prompted concern for 
acute coronary syndrome, but the distribution 
of the TWIs in the setting of recent ventricular 
pacing is most consistent with cardiac memory.
What is the major learning point? 
Cardiac memory refers to T-wave changes 
that result when normal ventricular activation 
resumes and is most commonly induced by 
ventricular pacing.
How might this improve emergency medicine 
practice? 
Recognition of this phenomenon may help to 
reduce unnecessary admissions, cardiac testing, 
and cardiac catheterizations.
Image 1. Initial electrocardiogram on presentation revealing deep and symmetric T-wave inversions in the inferior leads (II, III, aVF) and 
precordial leads V4-V6 (arrows).
repeat ECG two months later revealed a return to his normal 
baseline T-wave morphology (Image 3). 
DISCUSSION
While the presenting history and physical examination 
were not alarming, the initial ECG finding of deep and 
symmetric TWIs prompted concern for acute coronary 
syndrome. The differential diagnosis of new TWIs includes 
myocardial ischemia, ventricular overload syndromes (i.e., 
strain), Takotsubo cardiomyopathy, myopericarditis, and 
cerebrovascular injury.1 Morphologic features of TWIs that 
prompt concern for acute coronary syndrome include narrow, 
deep amplitude and symmetry.1,2 The TWIs in the presenting 
ECG would certainly meet these criteria. The TWIs were new 
when compared to a prior ECG (Image 3); however, serial 
undetectable troponin I levels, an echocardiogram failing to 
reveal wall motion abnormalities, lack of concerning historical 
elements, and reproducible chest wall pain at the pacemaker site 
all refuted coronary ischemia. The distribution of the TWIs in 
the setting of recent ventricular pacing was most consistent with 
cardiac memory. 
Cardiac memory refers to T-wave changes that result when 
normal ventricular activation resumes following a period of 
abnormal ventricular activation (i.e., wide QRS complexes). 
Abnormal ventricular activation is most commonly induced by 
ventricular pacing, but can also occur in the setting of transient 
left bundle branch blocks (LBBB), ventricular tachycardia, 
and intermittent ventricular pre-excitation.3,4 The T-wave 
“remembers” the vector of prior abnormal ventricular activation 
and reflects the direction of the wide QRS complexes after 
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Image 2: The electrocardiogram obtained four hours after presentation revealed a paced rhythm (pacing spikes demonstrated by arrows).
Image 3. Baseline electrocardiogram obtained one month prior to presentation, similar to the electrocardiogram performed two months 
later, showing resolution of T-wave inversions (arrows).
restoration of normal ventricular activation.4,5 This results 
in positive T-waves in leads that had wide, positive QRS 
complexes during abnormal activation, and negative T-waves in 
leads that had wide, negative QRS complexes. 
It has been shown that the duration of the T-wave changes 
persists for longer periods of time with increasing duration 
of the abnormal ventricular activation. For example, when 
human subjects were electrically paced for 10 minutes, 
transient TWIs lasted for 15 minutes after pacing was stopped. 
However, when paced for two years, TWIs persisted for up to 
18 months. The prevailing mechanism for the development 
of cardiac memory is thought to involve mechanical myocyte 
stretch leading to increased angiotensin II and subsequent 
internalization of a subunit of transient outward potassium 
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channels (Ito). Ito channels are responsible for the outward flow 
of potassium following depolarization; therefore, disruption 
of this process leads to repolarization abnormalities and 
morphologic changes of the T-wave.6 
Identification of TWIs caused by cardiac memory may 
help to reduce unnecessary admissions, cardiac testing, and 
cardiac catheterizations.4,6 Certain characteristics in the T-wave 
can help to differentiate TWI caused by cardiac memory from 
those caused by ischemia. Shvilkin et al found 92% sensitivity 
and 100% specificity for diagnosing cardiac memory when the 
following two criteria are met:
1. A positive T-wave in aVL combined with a positive or 
isoelectric T-wave in lead I 
2. Precordial TWI with larger magnitude than any TWI in 
lead III.3
Additionally, having access to an ECG with a preceding 
wide QRS can help diagnose cardiac memory by comparing 
the location of the wide QRS complexes during abnormal 
activation to those of the TWI during sinus rhythm.4 However, 
the diagnosis of cardiac memory should only be made after 
other causes of TWI are reliably ruled out.4,6
Although cardiac memory has traditionally been thought 
of as benign, recent studies have called this into question.5,6 
There are multiple case reports of torsades de pointes (TdP) 
in patients who experience cardiac memory. Changing from 
a pattern of abnormal ventricular activation to sinus rhythm 
can prolong the QT interval, placing patients at risk for TdP.5,6 
Additionally, in patients without pacemakers, TWIs caused by 
cardiac memory may indicate intermittent LBBB, paroxysmal 
ventricular tachycardia, or intermittent ventricular preexcitation, 
which may be important considerations, especially in patients 
presenting with syncope, presyncope, or palpitations.6   
CONCLUSION
Cardiac memory is a pattern of TWIs that occurs 
following resolution of wide QRS complexes. While most 
commonly seen in patients with ventricular pacemakers, it can 
be seen with intermittent LBBB, ventricular tachycardia, and 
intermittent ventricular preexcitation. Cardiac memory should 
not be diagnosed as the cause of TWI until other causes are 
reliably ruled out, but recognition of this phenomenon may 
help to reduce unnecessary admissions, cardiac testing, and 
cardiac catheterizations.
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Introduction: With the incredibly high incidence of Type 2 Diabetes in the current population of 
emergency department patients, it is critical for clinicians to understand the possible complications of the 
treatment of this disease. Medication like canagliflozin are more common to encounter on patient’s home 
medication lists and clinicians should be aware of how these medications, alone or combined with dietary 
modifications, can result in significant pathology and even mortality if not appropriately treated.
Case Report: We report a case of a patient with type II diabetes mellitus who presented with 
euglycemic diabetic ketoacidosis in the setting of concurrent use of canagliflozin, a sodium-
glucose transporter-2 (SGLT-2) inhibitor, and strict adherence to a low-carbohydrate ketogenic diet 
for weight control. 
Discussion: Euglycemic ketoacidosis has previously been observed in both diabetic and non-
diabetic patients following strict ketogenic diets, as well as in diabetic patients being treated with 
SGLT-2 inhibitors. 
Conclusion: As more patients choose ketogenic diets for weight control and diabetes management, 
clinicians should be aware of this potentially life-threatening complication in patients concurrently 
taking SGLT-2 inhibitors. [Clin Pract Cases Emerg Med. 2020;4(2):185–188.]  
Keywords: SGLT-2 Inhibitors; Ketoacidosis; Low-carbohydrate; Ketogenic.
INTRODUCTION
Very low-carbohydrate, or ketogenic, diets originated in 
the realm of fad weight-loss diets, but the practice has moved 
into the armamentarium of medicine in controlling weight, 
epilepsy, and diabetes. Sodium-glucose transporter-2 (SGLT-2) 
inhibitors have also become more heavily used in the control of 
diabetes, leading to an increased incidence of concomitant use 
of ketogenic diets and SGLT-2 inhibitors to control weight in 
diabetic patients.1,2 Given that both ketogenic diet and SGLT-
2 inhibitors alone can result in euglycemic ketosis,3,4 there is 
likely an increased risk of developing this derangement when 
the diet and medication are combined. We report here the case 
of a patient who developed life-threatening euglycemic ketosis 
University of Nevada Las Vegas, Department of Emergency Medicine, Las Vegas, Nevada
while adhering to a strict ketogenic diet with concomitant 
canagliflozin use.
CASE REPORT
A 31-year-old female with a history of type II diabetes 
mellitus (T2DM) presented to a primary care office with 
dizziness and shortness of breath worsening over one week. 
She also noted slurring of her speech, nausea, pain radiating 
down the posterior aspect of both legs, and constipation. She 
had no history of previous episodes of diabetic ketoacidosis 
(DKA) or hyperosmolar hyperglycemic state (HHS). The 
patient had been attempting to control her T2DM by following 
a very low-carbohydrate, ketogenic diet for about two weeks, 
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What do we already know about this clinical 
entity? 
Euglycemic diabetic ketoacidosis (EDKA) and its 
relation to sodium-glucose transporter-2 (SLGT-2) 
inhibitors has been previously acknowledged and 
cases reported.
 
What makes this presentation of disease 
reportable? 
Our case represents a novel combination of 
extreme EDKA in a patient on an SLGT-2 inhibitor 
in combination with a very-low carbohydrate (or 
ketogenic) diet. 
What is the major learning point? 
Ketogenic diets and SGLT-2 inhibitor use, both 
singly and in combination, can lead to severe, life-
threatening EDKA.
How might this improve emergency medicine 
practice? 
Clinicians should consider EDKA in acidotic patients 
for whom new dietary trends can lead to significant 
medication interactions and morbidity.
during which she had restricted her carbohydrate intake to 10-
15 grams per day. Fluid intake included 3-4 liters of water per 
day and pickle juice. Over this time, she had a 12.2 kilogram 
weight loss. She had previously used long-acting insulin 
(insulin detemir) to control her glucose but had not needed to 
use insulin to maintain normoglycemia in weeks and was not 
using insulin at presentation. She stopped using insulin at the 
time of starting the ketogenic diet. 
At the time of presentation, her T2DM management regime 
consisted solely of canagliflozin and dietary modifications. The 
patient initially presented to her primary care physician, where 
she was found to have a blood glucose of 133 milligrams per 
deciliter (mg/dL) on fingerstick and positive urine ketones. 
She was sent to the emergency department (ED) for further 
evaluation. Initial vital signs in the ED were blood pressure 
126/78 millimeters of mercury, pulse 137 beats per minute, 
temperature 97.7º Fahrenheit (36.5º Celsius), respirations 24 
breaths per minute, and oxygen saturation 100% on room air. 
On physical exam, the patient appeared acutely ill. Neurological 
exam on presentation was notable for Glasgow Coma Scale of 
15, drunken affect, gait instability, and mildly slurred speech 
without aphasia. 
Initial electrocardiogram showed sinus tachycardia with 
normal intervals. Chest radiograph was normal. Laboratory 
evaluation showed a pH on a venous blood gas of 7.056 with 
a bicarbonate of 8.0 milliequivalents per liter (mEq/L), blood 
glucose of 139 mg/dL, blood ketones of 80 mg/dL, lactate 
of 1.4 millimole per liter (mmol/L), and an anion gap of 29. 
The remainder of lab results are displayed in the Table. The 
patient was treated with a bolus of one L of lactated Ringer’s 
solution, followed by an additional of one L 5% dextrose 
(D5) normal saline and an intravenous potassium bolus of 20 
mEq. After administration of approximately 200 milliliters of 
D5-containing solution, the patient had normalization of her 
neurological deficits, with no further speech slurring or feelings 
of intoxication. An insulin infusion was not started emergently, 
in order to facilitate transfer to an appropriate facility that could 
provide intensive care unit (ICU) admission and management.
The patient was transferred for admission to ICU level of 
care for severe metabolic acidosis, ketosis, and tachycardia. 
The patient had an uneventful course over the next few days 
with normalization of her ketones and acidosis while being 
treated with an insulin infusion with concomitant glucose-
containing fluids to maintain euglycemia. She was discharged 
at baseline health and was lost to follow-up.
DISCUSSION
This case demonstrates the occurrence of euglycemic 
ketoacidosis in a patient with T2DM concurrently following 
a low-carbohydrate, ketogenic diet and using an SGLT-2 
inhibitor. This is an uncommon cause of altered mental status, 
and it is important for emergency physicians to be aware of 
this potential complication of diabetes management. 
Canagliflozin is an oral sodium-glucose cotransporter-2 
(SGLT-2) inhibitor approved by the United States Food and 
Drug Administration (FDA) for treatment of T2DM and has 
been shown to improve glycemic control, weight loss, and 
hemoglobin A1c levels. SGLT-2 inhibitors decrease serum 
glucose concentrations by preventing glucose reabsorption 
in the proximal renal tubule of the kidney, thereby promoting 
glucosuria. SGLT-2 inhibitors also stimulate glucagon secretion 
from the alpha cells of the pancreas, minimizing the potential 
for hypoglycemic events. Although SGLT-2 inhibitors have 
shown efficacy in diabetes management, serious adverse events 
have been associated with their use. In 2017 the FDA initiated 
a boxed warning regarding the increased risk of leg and foot 
amputations in patients taking canagliflozin. Large surveillance 
studies have also noted increased risk of diabetic ketoacidosis 
with SGLT-2 inhibitors.4  
Euglycemic diabetic ketoacidosis (EDKA) is a 
previously rare clinical condition now showing increasing 
prevalence with the use of SGLT-2 inhibitors. The 
pathogenesis of EDKA involves an increased glucagon to 
insulin ratio, in which ketogenesis is stimulated without 
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hyperglycemia. Increased glucagon levels contribute to 
gluconeogenesis, glycogenolysis and fatty acid metabolism 
to mobilize energy substrates.5 In diabetic patients, however, 
the relative shortage of insulin precludes intracellular 
glucose utilization, further exacerbating metabolic acidosis. 
SGLT-2 inhibitors promote ketoacidosis by increasing 
glucagon secretion and limit available circulating glucose 
by promoting glucosuria. SGLT-2 inhibitors also exacerbate 
the osmotic diuresis of ketoacidosis. Normally, glucosuria 
occurs when blood glucose concentrations exceed 225 mg/
dL. SGLT-2 inhibitors block reabsorption of glucose in the 
proximal renal tubule even at physiologic serum glucose 
concentrations and cause glucosuria and osmotic diuresis 
even in normoglycemia. 
Low-carbohydrate, ketogenic diets significantly restrict the 
dietary supply of carbohydrates, promoting a ketogenic state 
of fatty acid metabolism. Although ketogenic diets induce a 
state of ketosis, they are not commonly associated with diabetic 
ketoacidosis.6,7 However, a previous case of ketoacidosis 
during a low-carbohydrate diet has been reported.8 Treatment 
for EDKA is not fundamentally different from the treatment 
of hyperglycemia DKA, using fluid resuscitation and insulin 
administration as the mainstays of therapy.9,10 However, patients 
will likely require earlier administration of glucose-containing 
fluids and should have the SGLT-2 inhibiting medication held. 
At discharge, consideration should be given to discontinuing the 
SGLT-2 inhibitor.
Since both low-carbohydrate, ketogenic diets and SGLT-
2 inhibitors increase glucagon secretion while limiting serum 
glucose levels, a synergistic effect increasing the risk for EDKA 
is plausible. Cases of severe ketoacidosis associated with a 
low-carbohydrate diet and use of ipragliflozin and dapagliflozin 
have previously been reported.11,12 Low-carbohydrate/high-fat 
meals stimulate glucagon production and fatty acid metabolism 
while limiting serum glucose availability. This physiologic state 
is likely exacerbated by the concurrent glucagon upregulation 
and depletion of serum glucose caused by SGLT-2 inhibitors, 
leading to severe acidosis with ketosis. The limited supply of 
dietary carbohydrates combined with SGLT-2 inhibitor-induced 
glucosuria may create a state of diabetic ketoacidosis without 
elevated serum glucose. This association will require further 
study for validation.
The patient’s initial altered mental status and speech 
changes may be attributable to her relative depletion of 
intracellular and intravascular glucose stores. Similar changes 
in mental status in patients with alcoholic ketoacidosis (AKA) 
have been previously attributed to intracellular hypoglycemia. 
As discussed above, this patient also experienced relative 
hypoglycemia due to her low relative insulin levels, creating 
a similar state as that of AKA.13 Thus, the treatment with 
the glucose-containing fluids likely terminated the patient’s 
neurologic symptoms by resolving her relative hypoglycemia.
CONCLUSION
Euglycemic diabetic ketoacidosis is a recognized 
complication of SGLT-2 inhibitor use for weight and 
glucose control in patients with diabetes. However, there 
have been few if any previous published cases that were 
complicated by a concomitant ketogenic diet. Our goal is 
not to defame the practice of using ketogenic diets in an 
effort to control body weight and blood glucose, but to 
caution clinicians that ketogenic diets and SGLT-2 inhibitor 
use, both singly and in combination, can lead to severe, 
life-threatening EDKA. 
Lab Value RR Units
Sodium 139 136-145 mEQ/L
Potassium 3.5 3.5-5.1 mEQ/L
Chloride 102 98-107 mEQ/L
Carbon 
Dioxide
8 22-30 mEQ/L
Anion Gap 29 3-11 NA
BUN 12 7-18 mg/dL
Creatinine 0.85 0.6-1.3 mg/dL
Glucose 139 70-99 mg/dL
Lactate 1.4 0.4-2.0 mMol/L
Serum 
Osmolality
295 280-295 mOSM/kg
Ammonia 27 <32 µMol/L
ß-Hcg NEG NA NA
Total Protein 8 6.4-8.2 g/dL
WBC 10.6 4-10 k/mm3
Hemoglobin 16.1 11-15 g/dL
Platelets 287 150-400 k/mm3
INR 0.8 NA NA
Urine Ketones 80 NEG mg/dL
Urine Glucose 500 NEG mg/dL
Urine Blood NEG NEG NA
Urine Protein 100 NEG mg/dL
RR, reference range; mEQ, milliequivalents; NA, not applicable; 
BUN, blood urea nitrogen; mg, milligrams; dL, deciliter; mMol, 
millimoles; L, liter; mOSM/kg, milliosmoles per kilogram; µMol, 
micromoles; ß-Hcg, human chorionic gonadatropin beta-subunit; 
NEG, negative; g, gram; WBC, white blood count; K/mm3, thousand 
per cubic millimeter; INR, international normalized range.
Table. Initial laboratory values of patient who presented to the 
emergency department with dizziness, shortness of breath, and 
slurred speech.
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2 inhibitors and risk of serious adverse events: nationwide register 
based cohort study. BMJ. 2018;363:k4365.
4. Taylor SI, Blau JE, Rother KI. SGLT2 Inhibitors may predispose to 
ketoacidosis. J Clin Endocrinol Metab. 2015;100(8):2849-52. 
5. Taborski GJ. The physiology of glucagon. J Diabetes Sci Technol. 
2010;4(6):1338-44.
6. Goday A, Bellido D, Sajoux I, et al. Short-term safety, tolerability and 
efficacy of a very low-calorie-ketogenic diet interventional weight 
loss program versus hypocaloric diet in patients with type 2 diabetes 
mellitus. Nutr Diabetes. 2016 Sep;6(9):e230.
7. Yabe D, Iwasaki M, Kuwata H, et al. Sodium-glucose co-
transporter-2 inhibitor use and dietary carbohydrate intake in 
Japanese individuals with type 2 diabetes: a randomized, open-
label, 3-arm parallel comparative, exploratory study. Diabetes Obes 
Metab. 2017;19(5):739-43.
8. Shah P. Ketoacidosis during a low-carbohydrate diet. N Engl J Med. 
2006;354(1):97-8.
9. Lucero P and Chapela S. Euglycemic diabetic ketoacidosis in the ICU: 3 
case reports and review of literature. Case Rep Crit Care. 2018:1-6.
10. Ghazal NM, Souk KM, Hajj Boutros RA, et al. Euglycemic diabetic 
ketoacidosis in a patient with type II diabetes mellitus, ascites and 
poor nutrition on SGLT2 inhibitor. Archives of Medicine. 2015;7(6:3).
11. Hayami T, Kato Y, Kamiya H, et al. Case of ketoacidosis by a sodium-
glucose cotransporter 2 inhibitor in a diabetic patient with a low-
carbohydrate diet. J Diabetes Investig. 2015;6(5):587-90.
12. Tougaard NH, Faber J, Eldrup E. Very low carbohydrate diet and 
SGLT-2-inhibitor: double jeopardy in relation to ketoacidosis. BMJ 
Case Rep. 2019;12(4). 
13. Wrenn KD, Slovis CM, Minion GE, et al. The syndrome of alcoholic 
ketoacidosis. Am J Med. 1991;91(2):119-28.
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Introduction: We report one of few documented cases of a severe anaphylactic reaction with 
angioedema to polyethylene glycol (PEG). 
Case Report: The patient presented 30 minutes after onset of his symptoms and quickly 
developed hypoxia and hypotension refractory to intramuscular epinephrine, intravenous fluids, 
methylprednisolone, and supplemental oxygen via non-rebreather mask. He ultimately required 
intubation, an epinephrine infusion, and admission to the medical intensive care unit. 
Discussion: This case depicts a clinical reaction to PEG, a medication rarely implicated in severe 
anaphylaxis or angioedema. 
Conclusion: The allergenic potential of PEG-containing products should be raised, and providers 
should have a heightened awareness of these potential side effects. [Clin Pract Cases Emerg Med. 
2020;4(2):189–192.]   
Keywords: Polyethylene glycol; PEG; allergic; angioedema.
INTRODUCTION
Polyethylene glycol (PEG) is a compound found in a variety 
of products classically viewed as chemically inert substances.1 
In the medical community, it is recognized most frequently 
as the active ingredient in bowel-cleansing regimens such 
as Miralax, Go-Lytely, or Half-Lytely. It is also an additive 
in numerous other medications and substances ranging from 
intramuscular (IM) depo-provera to antibiotic tablets and 
ultrasound gel.2 Upon review of the literature, we present only 
the second published case of a severe allergic reaction involving 
both anaphylactic shock and angioedema to PEG, particularly 
unique in its severity despite typical anaphylaxis treatment. 
Fourteen cases of anaphylactic shock secondary to substances 
containing PEG have been reported; however, only one of these 
was further complicated by angioedema.3,4  In the emergency 
department (ED), this additional complication can drastically 
change management of patients, necessitating an awareness of the 
severity of this reaction to this commonly prescribed medication.
University of Texas at Houston, McGovern Medical School, Department of 
Emergency Medicine, Houston, Texas
CASE REPORT
A 76-year-old obese Caucasian male with past medical 
history of hypertension controlled with hydrochlorothiazide, 
chronic obstructive pulmonary disease on ipratropium 
bromide and albuterol, diabetes mellitus type II on metformin, 
atrial fibrillation on diltiazem and warfarin, gastroesophageal 
reflux disorder, and benign prostatic hypertrophy on 
tamsulosin presented to the ED with acute-onset shortness of 
breath. On initial examination, the patient was in respiratory 
distress, unable to speak greater than two-word phrases, with 
diffuse erythema and associated severe pruritus. He described 
an acute onset of these symptoms approximately 30 minutes 
prior to arrival to the ED. On initial evaluation, he gave us a 
piece of paper on which he had written “polyethylene glycol,” 
implicating this as the new and only medication or substance 
he had ingested in the three hours prior to presentation. 
At the time of arrival, the patient’s blood pressure (BP) 
was 177/143 millimeters of mercury (mmHg), heart rate (HR) 
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What do we already know about this clinical 
entity? 
Histaminergic angioedema and anaphylaxis are 
similar disease processes, commonly seen in 
the emergency department in various states of 
severity. 
What makes this presentation of disease 
reportable? 
Polyethylene glycol (PEG) is thought to be 
minimally immunogenic; however, this case 
report shows it may have severe allergic 
potential in some patients.
What is the major learning point? 
All medications should be considered in an 
anaphylactic reaction. 
How might this improve emergency medicine 
practice? 
Emergency physicians may more readily anticipate 
severe reactions and a difficult airway if patients 
present with signs and symptoms of allergy to 
products containing PEG.
163 beats per minute (bpm), respiratory rate (RR) 23 breaths 
per minute, oxygen saturation of 93% on room air, weight 103 
kilograms (kg). He was in acute respiratory distress in tripod 
position, with an urticarial eruption on his trunk. Auscultation 
was significant for inspiratory and expiratory wheezes in all lung 
fields. Oropharyngeal exam revealed an edematous soft palate 
with a brawny texture and elevation of his tongue to the hard 
palate, with associated difficulty tolerating his oral secretions. 
The patient immediately received 0.3 milligrams (mg) of 
IM epinephrine, 125 mg intravenous (IV) methylprednisolone, 
50 mg IV diphenhydramine, 20 mg IV famotidine, and 
one liter 0.9% normal saline. Despite these interventions, 
the patient deteriorated rapidly, demonstrating signs of 
anaphylactic shock. His BP decreased to 63/42 mmHg, with 
a HR of 173 bpm, RR of 34 breaths per minute, and oxygen 
saturation of 78% on room air. It was determined that the 
patient would need intubation and further resuscitation with 
IV fluids and an epinephrine infusion to maintain his blood 
pressure in the setting of respiratory failure and anaphylactic 
shock. His oxygenation improved to 93% with application of 
supplemental oxygen via a non-rebreather mask at 15 liters 
per minute, and he maintained his mentation; thus, we elected 
to use fiberoptic nasopharyngoscopy to evaluate the airway for 
concern of significant oropharyngeal edema and the potential 
for a complicated endotracheal intubation.
The patient’s oropharynx was prepped with topical 
benzocaine spray, and a 6.0 endotracheal tube (ETT) was 
loaded on the fiberoptic scope in preparation for emergent 
nasotracheal intubation if necessary during the procedure. 
On visualization of the pharynx, he was noted to have edema 
extending to the area of the hypopharynx, sparing the epiglottis 
and vocal cords. We elected to proceed with rapid sequence 
endotracheal intubation after evaluation of his airway. The 
intubation was performed with 200 mg IV ketamine and 200 
mg IV succinylcholine. Video laryngoscopy using a 7.0 ETT 
resulted in first-pass success. An in-line albuterol nebulizer was 
then initiated. To allow for central hemodynamic monitoring 
and accurate titration of the patient’s epinephrine infusion, 
right femoral central and arterial lines were placed with goal 
to maintain a mean arterial pressure of greater than 65 mmHg. 
The patient was subsequently admitted to the medical intensive 
care unit in critical condition.
DISCUSSION
PEGs are polymers composed of ethylene oxide that are 
non-ionic and hydrophilic and are thought to be chemically 
inert.1 They are commonly used in industry production of 
medications, medical products, and cosmetics.1 Given its 
chemical structure as a large hydrophilic polymer, it is effective 
as a bowel regimen as it does not readily cross the mucosal 
surface of the gastrointestinal tract.4,6 Due to this inherent 
quality, the compound has generally been viewed as minimally 
antigenic or reactive.6 However, larger PEG polymers (>1000 
atomic mass units) have immunogenic properties as they are 
likely large enough to elicit immune responses.6 While in 
general these are poorly absorbed, it has been demonstrated 
that PEG polymers can be recovered in the urine and would, 
therefore, be able to elicit immune responses in these subjects.7 
Of those cases with reported reactions to PEG-containing 
products, the majority of patients present with simple urticaria 
or meet criteria of anaphylaxis with greater than two body 
systems involved.3,8 However, more severe reactions involving 
anaphylactic shock and occurrences of ventricular arrhythmias 
have been documented.3,9 Wenande et al recently reported a 
summary of the known cases of allergic reactions to PEG-
containing products.3 Of those reported, fewer than 20 patients 
experienced cardiovascular collapse indicative of anaphylactic 
shock and only one with co-existing angioedema.3 All cases 
reported with discussion of patient management detailed 
resolution of anaphylactic symptoms and angioedema over 
the course of hours with recurrent dosing of epinephrine, 
antihistamines, and steroids.3
Our case differed in severity to those cited above, as the 
patient’s quick decompensation necessitated an escalation 
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in treatment. The primary change in management was 
introduction of continuous IV epinephrine to support BP. 
Current guidelines support administration of IM epinephrine 
to stable patients demonstrating anaphylaxis; however, they 
recommend administration of IV epinephrine if anaphylaxis 
appears to be severe with an immediate life-threatening 
manifestation. The recommended starting infusion rate 
is between 1-4 micrograms per minute.10 Other treatment 
modalities remained the same, including steroid dosing and 
use of H1 (histamine type 1) and H2 antagonists. 
The case reported here also presented a potentially difficult 
endotracheal intubation secondary to the significant angioedema 
visualized on his initial bedside oropharyngeal exam. It was 
presumed to be resultant of a histaminergic reaction given the 
concurrent anaphylaxis, as opposed to a non-histaminergic 
cause, such as bradykinin-mediated or hereditary angioedema, 
which would require a different treatment regimen.11 The 
patient was not actively taking angiotensin-converting-
enzyme inhibitors for hypertension, one of the most implicated 
substances in bradykinin-mediated angioedema.12 He had not 
previously had an allergic reaction or edema of his lips or 
oropharynx to any other substance per his report. He also had 
no personal or family history of similar presentations, which 
makes it unlikely that he suffers from hereditary angioedema.12
 Histaminergic angioedema is a subtype of angioedema 
caused by a deep tissue reaction initiated by histamine 
release from mast cells, and by subsequent immunoglobulin 
E-mediated complement activation.2 It causes vasodilation 
and vascular permeability, typically affecting the perioral 
and periorbital regions, but can also be seen as a non-pitting 
edema of the extremities and abdomen.5 When this reaction 
localizes to the oropharyngeal structures, endotracheal 
intubation may become extremely challenging due to severe 
hypopharyngeal and vocal cord edema. 
Studies vary on prevalence of airway obstruction with 
angioedema; however, in general about 15% of all types of 
angioedema cases require intubation, and 50% of those needing 
a definitive airway require cricothyrotomy or tracheostomy.12 
We identified no recent studies with a PubMed search on rates 
of intubation in histamine-mediated angioedema specifically. 
Histaminergic angioedema is mediated by the cytokine and 
histamine activation implicated in anaphylaxis, and the use 
of antihistamines, steroids, and epinephrine is regarded as the 
standard of care.12 Treatment regimens for bradykinin-induced 
and hereditary angioedema continue to be controversial.2,11 
Regardless of the cause, ensuring establishment of a definitive 
airway, when needed, is paramount.
CONCLUSION
The exact mechanism of PEG-induced anaphylaxis has 
not yet been fully elucidated. It is likely initiated by uptake 
of PEG molecules across the gastrointestinal mucosa, and 
its large molecular weight and hydrophilicity prolongs this 
process. We suspect that the patient was therefore able to 
tolerate a significant ingestion prior to onset of symptoms, 
and the amount ingested was likely the cause of his rapid 
deterioration to anaphylactic shock, despite the appropriate 
initial management for anaphylaxis. Although the associated 
side effects of PEGs are commonly restricted to abdominal 
discomfort, bloating, cramping, and nausea, case reports 
like this one suggest a need for increased awareness in 
all specialties that regularly prescribe these medications. 
Emergency providers should be especially aware of this 
reported complication of PEG-containing products as rapid 
identification and resuscitation is key to improving morbidity 
and mortality in these patients.
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Introduction: Infective endocarditis (IE) is a life-threatening condition with significant morbidity and 
mortality, and can require surgical repair. 
Case Report: A 36-year-old man presented to the emergency department for worsening dyspnea and 
chest pain. Point-of-care echocardiography demonstrated a mobile oscillating mass on the aortic valve 
with poor approximation of the valve leaflets, suggesting aortic valve insufficiency secondary to IE as the 
cause of acute heart failure. The patient underwent emergent aortic valve replacement within 24 hours. 
Discussion: While point-of-care echocardiography has been well documented in identifying tricuspid 
vegetations, aortic valve involvement and subsequent heart failure is less well described. Earlier 
recognition of aortic valve vegetations and insufficiency can expedite surgical intervention, with 
decreased complication rates linked to earlier antimicrobial therapy. 
Conclusion: This case report highlights the ability of point-of-care ultrasound to identify aortic 
vegetations, allowing for the earlier diagnosis and therapy. [Clin Pract Cases Emerg Med. 
2020;4(2):193–196.]   
Keywords: infective endocarditis; point-of-care-ultrasound; aortic valve vegetation; cardiac 
valve regurgitation.
INTRODUCTION
Infectious endocarditis (IE) is a life-threatening condition 
that carries significant morbidity and mortality requiring prompt 
diagnosis, therapy, and sometimes-invasive interventions1 The 
proportion of IE patients undergoing surgery has increased over 
time to about 50%.1 Valve replacement rates due to IE have 
increased steadily from 2000-2007 from about 15 per 1000 cases 
to 25 per 1000 cases of IE, and then plateaued from 2007-2011.2 
Between 2000 and 2011 there were 457,052 IE hospitalizations 
with a steady rise in incidence from 29,820 in 2000 to 47,134 in 
2011.2 This rise is likely related to an increase in the prevalence 
of risk factors for IE including invasive procedures, intravenous 
drug use, human immunodeficiency virus, and diabetes.1 Also 
contributing to this rise is increased survival of predisposed 
populations such as those with congenital heart disease and 
prosthetic implants.2 Other contributing factors to the increased 
University of Kansas Health System, Department of Emergency Medicine, Kansas 
City, Kansas
incidence of IE may be improvements in diagnostic methods as 
well as less-stringent recommendations for prophylactic antibiotic 
regimens by the American Heart Association in 2007.3,4
Duke criteria for the diagnosis of IE include pathologic 
specimens, typical organism growth on blood cultures, and 
evidence on echocardiography. As neither blood culture nor 
pathology results are available in the emergency department 
(ED), the diagnosis will always require evidence on point-
of-care echocardiogram to be made. With patients in need of 
prompt antibiotic therapy and potentially emergent surgical 
intervention, this then raises the question of the capability of 
point-of-care ultrasound to detect IE. 
CASE REPORT
A 36-year-old man with no past medical history 
presented to the ED for worsening dyspnea, orthopnea, and 
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What do we already know about this clinical 
entity? 
Infectious endocarditis is a life-threatening 
condition that carries significant morbidity 
and mortality, requiring sometimes-
invasive interventions.
What makes this presentation of disease 
reportable? 
While point-of-care echocardiography has 
been documented in identifying tricuspid 
vegetations, aortic valve involvement and 
subsequent heart failure is less well described.
What is the major learning point? 
Point-of-care echocardiography is useful in 
undifferentiated heart failure, allowing for 
quicker diagnosis of  underlying etiology and 
direction of therapy.
How might this improve emergency 
medicine practice? 
Earlier recognition of aortic valve 
vegetations can expedite surgical 
intervention, with fewer complication rates 
linked to earlier antimicrobial therapy.
chest pain in the context of three months of night sweats, 
unintentional weight loss, migratory arthralgia, myalgias, 
and recent palmar lesions (Image 1). 
Outpatient rheumatologic and infectious workup had shown 
only an elevated erythrocyte sedimentation rate. Initial vital 
signs were notable for a blood pressure of 124/41 millimeters 
of mercury, heart rate 127 beats per minute, respiratory rate 20 
breaths per minute, oxygen saturation of 98% on room air, and 
a temperature of 37.4 degrees Celsius. He appeared to be in a 
minimal amount of respiratory distress. Physical examination 
revealed a new pandiastolic murmur, lower lung field crackles, 
and bounding peripheral pulses. Electrocardiogram revealed 
sinus tachycardia without ST-segment abnormalities. Point-of-
care echocardiography was performed, which noted a mobile 
oscillating mass on the aortic valve with poor approximation 
of the aortic valve leaflets on diastole (Image 2, Video). 
The constellation of findings was suggestive of acute heart 
failure from aortic insufficiency due to likely IE of the aortic 
valve. IE was felt more likely because the finding met the 
Duke minor criteria of palmar lesions consistent with Janeway 
lesions, with the diagnosis fully confirmed when three blood 
cultures subsequently revealed Streptococcus sanguinis. The 
patient was admitted and underwent emergent aortic valve 
replacement less than 24 hours later with surgery describing 
the two coronary aortic valve cusps as obliterated by infection 
with greater than 1.5 millimeters mobile vegetation on the 
remaining non-coronary cusp. 
DISCUSSION
Point-of-care echocardiography provided key information, 
enabling the timely diagnosis of IE involving the aortic valve. 
While point-of-care echocardiography has previously been 
described as capable of identifying tricuspid vegetations,5,6 
sensitivity in aortic vegetations is not well described. Further 
study would be needed to compare point-of-care transthoracic 
echocardiography (TTE) to cardiology TTE, which has been 
estimated to have a sensitivity for IE around 70% for native 
valves and 50% for prosthetic valves with a specificity of around 
90%, according to the European Society of Cardiology in 2015.7 
Similarly, a meta-analysis of 16 articles in 2017 on TTE found 
a sensitivity of 66% and a specificity of 95% for detecting IE on 
native valve8. These studies demonstrate the value of TTE in the 
workup for IE, despite not being as accurate as transesophageal 
echocardiography.8 Specific situations where TTE may not 
identify vegetations include underlying valvular thickening or 
calcification, prosthetic shadowing, recent vegetation migration 
or embolization, and poor acoustic windows secondary to obesity, 
hyperinflated lungs, or narrow interspaces.
The potential for an emergency physician to achieve 
earlier recognition of cardiac valve vegetations is 
valuable because patients may require emergent surgical 
Image 1. Palmar rash: Photograph of palmar lesions (arrows) 
provided by the patient consistent with Janeway lesions.
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intervention, such as the valve replacement in this case, 
and as decreased complication rates have been linked to 
the earlier initiation of antimicrobial therapy. In a series 
of 1437 patients from the International Collaboration on 
Endocarditis in 2007, the embolic stroke rate decreased 
from 4.8 to 1.7 per 1000 patient years from the first to the 
second week of antibiotic treatment.9 
Point-of-care echocardiography may also be useful for the 
detection of secondary valvular complications of endocarditis, 
obtaining prognostic indicators, and supporting the need 
for surgical intervention. The valvular complications that 
may be seen on echocardiography are regurgitation, valve 
perforation, and abscess or fistula formation due to destruction 
of tissue by bacterial invasion and proliferation.1 The main 
risk factor for complications is the length of the vegetation, 
with one retrospective cohort study finding the probability of 
sustaining a complication to be 10% when vegetations were 
6 millimeters (mm) in size, 50% when lesions were 11 mm, 
and almost 100% when lesions were greater than or equal to 
16 mm.10 Mortality has also been linked to vegetation length 
with one study of intravenous drug users with right-sided 
endocarditis demonstrating an increased mortality rate of 33% 
in patients with vegetations greater than 2 centimeters (cm) 
in length, compared to a mortality rate of only 1.3% in those 
with vegetations less than 2 cm in length.11 
CONCLUSION
Given the elusive nature of infective endocarditis, point-
of-care echocardiography may not be used early enough in 
the diagnostic work-up. Point-of-care ultrasound was an 
invaluable bedside diagnostic tool in this patient with IE of 
the aortic valve. With a low index of suspicion to evaluate for 
Image 2. Aortic vegetation: Parasternal long-axis view showing a 
mobile oscillating mass on the aortic valve (arrow).
vegetations and the knowledge that it is possible to find them 
on both the tricuspid and aortic valves, a critical diagnosis can 
be made in a timelier manner.
Video. Aortic vegetation: Parasternal long-axis and apical four-
chamber view showing a mobile oscillating mass on the aortic 
valve.
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Introduction: Painful neck swelling is a common emergency complaint but can present diagnostic 
challenges. Eagle syndrome is a rare clinical entity in which a pathologically elongated styloid process 
or ossified stylohyoid ligament produces a constellation of symptoms in the head and neck region. 
Case Report: We present the case of a 50-year-old male with a spontaneous, atraumatic fracture 
of an elongated styloid process associated with hematoma formation and radiological findings of 
airway impingement. 
Discussion: The classic triad for Eagle syndrome consists of unilateral cervicofacial pain, globus 
sensation, and dysphagia. Diagnosis of Eagle syndrome should be made based on a combination of 
physical examination and radiological findings. Treatment options vary based on severity of symptoms. 
Conclusion: Although more likely to be an indolent and progressive complaint, providers in the 
acute care setting should be familiar with Eagle syndrome due to the potential for a spontaneous 
fracture of an elongated styloid process to cause acute, painful neck swelling and life-threatening 
airway compromise. [Clin Pract Cases Emerg Med. 2020;4(2):197–200.] 
 
Keywords: Eagle syndrome; atraumatic; fracture; airway impingement; hematoma.
INTRODUCTION  
Painful neck swelling is a common emergency complaint 
but can present diagnostic challenges. The complex anatomy 
of the neck makes isolating the cause of the swelling and pain 
a challenge for clinicians. History is critical in determination 
of the cause, especially the timing of onset of symptoms. 
While infection and trauma are common causes of painful 
cervical neck swelling, less common causes should also 
be considered in any differential diagnosis. Patients with 
acute, atraumatic pain and swelling of the cervical tissues 
(immediate to <24 hours) should also undergo investigation 
for pathology within other specific anatomic structures in 
this area of the neck including the following: sudden salivary 
gland obstruction; arterial rupture or dissection; thrombosis 
Virginia Tech Carilion School of Medicine, Roanoke, Virginia
Virginia Tech Carilion, Department of Emergency Medicine, Roanoke, Virginia
Virginia Tech Carilion Clinic School of Medicine, Division of Otolaryngology, 
Department of Surgery, Roanoke, Virginia
*
†
‡
of deep (superior vena cava syndrome) or superficial veins 
(Lemierre’s syndrome); and possibly acute thyroid disease.1,2
When faced with this diagnostic dilemma, emergency 
physicians and specialists often turn to a computed tomography 
(CT) with intravenous (IV) contrast for assistance. While 
spontaneous injury to the cervical structures or ligamentous 
rupture or tear are rarely considered, and not routinely discussed 
in emergency medicine textbooks, fracture of the styloid process 
can occur spontaneously as part of a more complex constellation 
of symptoms known as Eagle syndrome, which leads to cervical 
neck pain and swelling.1 Here we present the first reported case 
of Eagle syndrome with a spontaneous, atraumatic fracture of an 
elongated styloid process resulting in hematoma formation and 
radiological findings of airway impingement.3
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What do we already know about this clinical 
entity? 
Eagle syndrome is a rare clinical entity in 
which a pathologically elongated styloid 
process or ossified stylohyoid ligament 
produces a constellation of symptoms in the 
head and neck region. 
What makes this presentation of disease 
reportable? 
This is the first reported case of Eagle syndrome 
with a spontaneous, atraumatic fracture of 
an elongated styloid process resulting in 
hematoma formation and airway impingement. 
What is the major learning point? 
There is a potential for Eagle syndrome 
to present as a spontaneous, atraumatic 
fracture of an elongated styloid process 
leading to acute neck swelling and life-
threatening airway compromise. 
How might this improve emergency 
medicine practice? 
This report highlights an important differential 
in the workup of painful neck swelling that 
has the potential to lead to life-threatening 
complications if not promptly recognized.
CASE REPORT 
A 50-year-old man presented to the emergency 
department (ED) complaining of progressively worsening 
swelling over the angle of his left jaw associated with 
difficulty speaking, described as hoarseness and pain 
with phonation, as well as difficulty swallowing. It began 
spontaneously one day previously, right after he felt a snap 
or pop. There were no triggering incidents, although he 
was unclear if he was talking or swallowing at the time. 
It was associated with a non-radiating, moderate intensity 
pain, just below the angle of the mandible on his left 
side that increased in severity when he moved his jaw to 
speak, turn, or swallow. Over the course of 12 hours he 
developed worsening anterior cervical neck swelling and 
progressive odynophagia, dysphagia, and hoarseness. His 
medical history was significant for hypertension and left-
sided Bell’s palsy since 2014, which was associated with 
ipsilateral tinnitus. 
On examination, he was hypertensive with a blood 
pressure of 187/105 millimeters of mercury, heart rate 91 
beats per minute, temperature 98.4° Fahrenheit, and oxygen 
saturation 100% on room air. The patient’s physical exam 
was unremarkable with the exception of palpable and visible 
swelling to the soft tissues below the left side of the mandible 
and clear discomfort on swallowing. Concern for a vascular 
abnormality such as aneurysm or thrombosis prompted 
immediate CT of the neck with IV contrast. This imaging 
revealed a fracture though an elongated, calcified left styloid 
process (Image 1) with hematoma formation causing mass 
effect on the left lateral hypopharyngeal wall (Image 2).
The patient was preliminarily diagnosed with a 
spontaneous fracture of an elongated calcified styloid 
ligament with hematoma formation and was admitted to 
observation with otolaryngology (ENT) consultation for 
airway monitoring and the potential for surgical intervention 
if worsening airway impingement. He did well with no 
further progression of symptoms and was discharged after 
24 hours. At follow-up with ENT services one week post-
ED visit, swelling was markedly reduced and his pain had 
fully resolved. The spontaneous fracture was thought to be 
corrective and no further surgical intervention was required.4,5 
He has had no further symptoms one year from his injury.
DISCUSSION
The styloid process is a slender bony extension of 
the temporal bone projecting immediately anterior to the 
Image 1. Computed tomography of the neck with intravenous 
contrast in sagittal view showing an elongated left styloid process 
with associated atraumatic fracture, indicated by arrow.
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stylomastoid foramen. In a normal adult, the styloid process 
is approximately 2.5 cm in length, whereas an elongated 
styloid process is defined as > 3 cm.6 While it is estimated 
that approximately 4-28% of the general population have 
an elongated styloid process, few are symptomatic.7 
Reasons for the elongation are poorly understood. Possible 
pathophysiological mechanisms include the following: 1) 
a congenital elongation of the styloid process due to the 
persistence of a cartilaginous element connecting it to the 
temporal bone; 2) ossification of the stylohyoid ligament; and 3) 
growth of osseous tissue at the insertion of the styloid ligament.4
Eagle syndrome is an uncommon and often-confusing 
clinical entity, likely due to the variable constellation 
of symptoms that can develop.8 It is characterized by a 
pathologically elongated styloid process or ossified stylohyoid 
ligament producing symptoms in the head and neck region. 
As first described by Watt W. Eagle in the 1930s, Eagle 
syndrome classically presents as a triad of globus sensation, 
dysphagia, and unilateral cervicofacial pain typically 
occurring after tonsillectomy.6 He proposed that scar tissue 
that developed as a consequence of the surgery around the 
mineralized complex resulted in compression of surrounding 
cranial nerves V, VII, IX, and X leading to chronically 
progressive symptoms.6 However, the current definition 
of Eagle syndrome has evolved to include a myriad of 
additional symptoms including carotid compression resulting 
in syncope and transient ischemic attacks, otalgia, tinnitus, 
odynophagia, and generalized cervicofacial pain that all derive 
from a pathologically elongated styloid process or calcified 
stylohyoid ligament.8,9,10 
In the acute care setting, painful cervical neck swelling 
should include a differential of infection or trauma, 
as well as less common etiologies including sudden 
salivary gland obstruction, arterial rupture or dissection, 
thrombosis (Lemierre’s syndrome), acute thyroid disease, 
and ligamentous injury.1,2 In our patient, accompanying 
symptoms of dysphonia and dysphagia likely resulted from 
the compression of the left lateral hypopharyngeal wall 
and associated neurovasculature due to the hemorrhage 
and swelling in the parapharyngeal space from the styloid 
process fracture. Our patient did extremely well, but 
expanding hematomas, especially in the anticoagulated 
patient, make this uncommon and benign condition 
potentially life threatening in the acute phase of injury.
Diagnosis of Eagle syndrome should be made based 
on a combination of physical examination and radiological 
findings. The imaging method of choice is CT of the neck 
with IV contrast. Panoramic radiography may be diagnostic, 
although it does not narrow the differential in the acute 
setting.11 Treatment options for Eagle syndrome vary based 
on severity of symptoms. Non-surgical interventions ranging 
from simple reassurance to local corticosteroid injections 
can be successful for mild to moderate symptoms. For 
severe cases, surgical excision of the elongated styloid 
process or ossified stylohyoid ligament is recommended via 
a transcervical (extraoral) approach for proper visualization 
of anatomical structures and a decreased incidence of deep 
cervical space infection.4,5
CONCLUSION
Spontaneous fracture or ligamentous injury of the 
styloid process should be considered in a patient presenting 
with acute onset, atraumatic, painful cervical neck 
swelling. The classic triad for Eagle syndrome consists 
of unilateral cervicofacial pain, globus sensation, and 
dysphagia. Although more likely to be an indolent and 
progressive complaint, providers in the acute care setting 
should be familiar with Eagle syndrome due to the potential 
for a spontaneous fracture of an elongated styloid process 
to cause acute painful neck swelling and life-threatening 
airway compromise. While history and physical exam 
findings are critical in suspecting the condition, CT 
imaging is required to confirm the diagnosis, exclude 
alternate serious clinical entities, and guide management. 
The authors attest that their institution requires neither 
Institutional Review Board approval, nor patient consent for 
publication of this case report. Documentation on file.
Image 2. Computed tomography of the neck with intravenous 
contrast in axial view showing fluid tracking along the fractured 
left styloid process producing a mass effect on the left lateral 
hypopharyngeal wall, indicated by arrow.
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Introduction: Early stage gastric cancer is usually asymptomatic. It is not until later stages of the disease, 
usually with metastasis, that patients typically develop symptoms that would prompt further evaluation. 
Case Report: We present a case of a patient with chronic back pain who was found to have a gastric 
antral mass as the etiology of her pain. The patient proceeded to have a partial gastrectomy with 
complete surgical excision of her early-stage gastric cancer, after which her chronic back pain resolved.
Conclusion: This case demonstrates the importance of considering significant pathology in patients 
presenting with chronic complaints to the emergency department. [Clin Pract Cases Emerg Med. 
2020;4(2):201–204.]
Keywords: Gastric adenocarcinoma; gastric cancer; back pain; chronic back pain.
INTRODUCTION
In 2016, back symptoms were the sixth most common 
reason for emergency department (ED) visits.1 Patients 
presenting with chronic back pain are often presumed to 
have a musculoskeletal etiology of pain. Multiple limb- or 
life-threatening diagnoses must be considered in these 
patients. Some of those diagnoses include acute spinal cord 
compression, cauda equina syndrome, aortic dissection, 
abdominal aortic aneurysm, and spinal infections, or 
hematomas. Another etiology commonly seen in the ED is 
back pain due to pathologic fractures of the spine secondary to 
metastatic disease. However, to our knowledge no case reports 
have been noted in the literature that describe early gastric 
cancer presenting with a primary symptom of back pain. We 
believe this is a unique case report.
CASE REPORT 
A 76-year-old female former smoker with a past medical 
history of hypertension and hypothyroidism presented to the ED 
at a community hospital with a chief complaint of intermittent 
left upper back pain for one year. The patient reported that she 
HCA Healthcare, St. Lucie Medical Center, Department of Emergency Medicine, 
Port St. Lucie, Florida
was not a local resident and had flown into the area four days 
prior. She reported acute worsening of her left upper back pain 
over the prior two days, localized the pain to underneath her left 
shoulder blade, and rated it as severe. She denied any obvious 
provoking factors and reported minimal relief when lying still 
on a heating pad. She had previously been seen by her primary 
care physician for the same complaint and had been started on 
celecoxib. The patient reported epigastric pain with celecoxib 
and noted that she had discontinued use. 
The patient denied syncope, fever, chills, midline back 
pain, chest pain, dyspnea, cough, hemoptysis, nausea, 
vomiting, dysuria, hematochezia, and melena. She admitted to 
occasional heartburn. She was accompanied by her friend who 
reported that while out shopping the day prior, the patient had 
had a relatively brief episode where she became pale appearing 
and reported feeling weak, lightheaded, and nauseated. The 
patient had no surgical history and denied a history of alcohol 
use. She did report a 10-pound weight loss over the prior six 
months, which she attributed to grief over her husband’s recent 
death. She denied any specific trauma or injury but admitted to 
having lifted her husband multiple times prior to his death. 
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What do we already know about this clinical 
entity? 
Early symptoms of gastric cancer can be 
vague and non-specific.
What makes this presentation of disease 
reportable? 
This is the first presentation reported in 
the literature of a patient with a primary 
complaint of back pain who was found to 
have early gastric cancer.
What is the major learning point? 
This case highlights the importance of 
considering life-threatening diagnoses in 
patients who present with vague and even 
chronic complaints. 
How might this improve emergency 
medicine practice? 
This case demonstrates the importance of 
performing a thorough physical examination 
and having a high index of suspicion for 
serious pathology, especially in the elderly 
with vague complaints.
On arrival to the ED, the patient’s vital signs were reported 
as follows: temperature 36.9 degrees Celsius; heart rate 90 beats 
per minute; blood pressure 101/76 millimeters of mercury; 
respiratory rate 18 breaths per minute; pulse oximetry 100% 
on room air. On examination, the patient was alert, non-
toxic appearing, and seemed to be in mild discomfort. Upon 
examination of the eyes, she was noted to have conjunctival 
pallor. Her lungs were clear to auscultation Although appearing 
mildly dyspneic, she demonstrated no other signs of respiratory 
distress. Her cardiovascular exam revealed a regular rate and 
rhythm with brisk capillary refill and equal pulses. Her abdomen 
was soft, non-distended with mild epigastric tenderness to 
palpation without guarding, rigidity, or evidence of peritoneal 
irritation. There was no palpable or pulsatile mass noted. 
Her back appeared to be atraumatic without rash or 
skin discoloration. She had no midline vertebral tenderness 
to palpation and no tenderness was elicited upon palpation 
around the inferomedial aspect of the left scapula where 
the patient had reported the pain was located. There was no 
paraspinal tenderness or muscle spasm and no costovertebral 
tenderness. The patient had painless range of motion of her 
back. Her neurologic and extremity exams were unrevealing. 
A rectal exam demonstrated external hemorrhoids, normal 
sphincter tone, no saddle anesthesia, and no gross blood. 
The patient’s vague symptoms, history, and the inability 
to duplicate the pain, coupled with the fact that the pain was 
severe and continual raised concern for a potentially serious 
etiology. We included pulmonary embolism, aortic dissection, 
aortic aneurysm, and acute coronary syndrome in the 
differential diagnosis that warranted further investigation. 
A computed tomography angiography of the chest 
showed no evidence of pulmonary embolus, aortic aneurysm, 
aortic dissection, or any other acute pathology. A computed 
tomography of the abdomen and pelvis with intravenous (IV) 
contrast demonstrated stenosis of the celiac artery with post-
stenotic dilation with no evidence of downstream ischemia. The 
only significant lab abnormality was a hemoglobin of 8.4 grams 
per deciliter (g/dL) (13.0–18.0 g/dL) and a hematocrit of 26.8% 
(40.0–52.0%) to which the patient denied a known history of 
anemia. A fecal occult blood test was noted to be positive. 
A bleeding peptic ulcer was suspected as the etiology of 
the patient’s symptoms. However, given the acute worsening of 
pain two days prior, there was concern that a small peptic ulcer 
perforation could not be ruled out. She was treated with 40 
milligrams of IV pantoprazole in the ED and was admitted to 
the hospital where she was evaluated by a gastroenterologist.  
The following day, the patient’s hemoglobin dropped to 7.5 
g/dL and her hematocrit dropped to 23%. The patient underwent 
an esophagogastroduodenoscopy and was found to have erosive 
gastritis with a large, ulcerated, and partially obstructing antral 
mass. The biopsy revealed infiltrating, poorly differentiated 
adenocarcinoma. The patient was subsequently evaluated 
by a general surgeon and underwent a robot-assisted distal 
gastrectomy (approximate 60% gastrectomy) with Billroth-II 
reconstruction. There was no evidence of metastatic disease intra-
abdominally. The distal gastrectomy specimen that was removed 
measured 13 centimeters (cm) x 8 cm x 6 cm. The mucosal 
surface demonstrated a tan, fungating mass, measuring 6 cm x 4 
cm. The final diagnosis was moderately differentiated (grade 2) 
infiltrating adenocarcinoma of intestinal type with tumor invasion 
into the muscularis propria. Thirty-six lymph nodes and all 
margins were free of tumor. The pathologic stage was pT2 pN0. 
Following surgery, the patient underwent chemotherapy 
for three months and eventually stopped given the severity of 
side effects she had experienced. I spoke with her nine months 
following her ED visit and she reported that her chronic back 
pain did in fact resolve following surgical excision of her 
gastric cancer. The patient remains in complete remission. 
DISCUSSION
The American Cancer Society predicts that 27,600 cases 
of stomach cancer will be diagnosed in the United States 
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in 2020 and 11,010 people will die from this type of cancer 
in the US in 2020.2 EDs often serve as the entrance into the 
healthcare system for those labeled with a first-time cancer 
diagnosis.3 Fifty-two percent of patients ultimately diagnosed 
with gastric cancer at one urban institution were admitted to 
the hospital from the ED.3 Those patients who were diagnosed 
after an ED visit were determined to have poorer survival 
estimates as these patients often had later stage disease.3  
Because early symptoms of gastric cancer can be vague and 
non-specific, one should consider this diagnosis in patients 
presenting with poor appetite, weight loss, early satiety, 
nausea, anorexia, abdominal pain, dysphagia, or melena, as 
well as back pain or fatigue.4 
Gastric cancer is not a diagnosis that is typically made in 
the ED, but ED evaluation can lead to admission for further 
evaluation of a potentially malignant process. Consider 
admitting patients who may be presenting with a first-time 
cancer diagnosis especially in those who lack reliable follow-up 
care, as early initiation of the diagnostic process and prompt 
therapeutic intervention can improve patient prognosis. It is 
prudent to keep such a diagnosis in mind and to broaden one’s 
differential diagnosis. While the focus of this case report was to 
highlight a unique presentation of early gastric cancer, we also 
emphasize the importance of a thorough physical examination, 
especially in those patients presenting with chronic complaints. 
For example, if a patient presenting with chronic back pain 
presumed to be of musculoskeletal nature does not have 
abnormalities on examination such as tenderness to palpation, 
significant muscle spasm, or pain on movement, consider that 
there may be some other pathology present. 
A bleeding peptic ulcer with a possible microperforation 
was considered on ED evaluation of this patient, which 
prompted hospital admission. The patient did have multiple 
symptoms at presentation concerning for gastric cancer, 
many of them also consistent with a diagnosis of peptic ulcer 
disease. These symptoms included epigastric pain, occult 
gastrointestinal bleeding, unintentional weight loss, nausea, 
fatigue, and back pain. Fortunately, this patient was found to 
have early-stage gastric adenocarcinoma that was surgically 
resected in a timely fashion.
Upon review of the literature, we found a published case 
report that presents a patient with worsening back pain who 
was found to have lytic lesions in the vertebrae and who was 
ultimately found to have signet-ring cell gastric adenocarcinoma.5 
However, we found no similar case reports of patients presenting 
primarily with back pain due to gastric cancer that were not 
associated with other pathologies, such as bony metastasis.
It seems that our patient’s back pain was likely a referred 
pain from the visceral autonomic nervous system. We already 
know that the nervous system plays a role in the development 
of cancer and that there is a complex relationship between 
pain and carcinogenesis.6 There are many algogenic mediators 
involved in the process of carcinogenesis that alter human 
pain pathways.6 This patient’s back pain resolved following 
excision of her gastric cancer. 
CONCLUSION
This case demonstrates the importance of gathering an 
appropriate history, performing a thorough physical examination, 
and considering non-musculoskeletal, serious pathology in 
elderly patients with a long pain history, vague complaints, and a 
physical examination that is contrary to a simple musculoskeletal 
problem. It is important to note that the function of the history 
and physical examination is to look for confirmatory and non-
confirmatory elements that may help lead one to the correct 
diagnosis. Chronic back pain is a very common complaint in 
the ED. Taking a few extra minutes to listen to a patient and to 
perform a thorough examination can lead to a timely diagnosis of 
a life-threatening illness that can generate a better prognosis for 
the patient. We owe it to our patients to consider life-threatening 
illnesses, including cancer, during ED evaluation. 
The authors attest that their institution requires neither 
Institutional Review Board approval, nor patient consent for 
publication of this case report. Documentation on file.
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Introduction: Chlorine gas is a known irritant of the respiratory tract, which may cause damage to 
various systems depending on time of exposure and concentration of the gas. Current treatments 
are mainly supportive. While no definitive studies have been completed to date, it has been noted 
that treatment with a sodium bicarbonate solution via nebulizer may lead to improved outcomes for 
patients dealing with chlorine gas exposure. 
Case Report: We present a case of a nine-year-old child arriving at the emergency department 
after exposure to chlorine gas. Complete recovery from his symptoms occurred rapidly with the 
administration of nebulized sodium bicarbonate. 
Discussion: Inhaled chlorine gas acts as a mucous membrane irritant, with symptoms usually 
beginning within minutes of exposure. Inhaled nebulized sodium bicarbonate has been suggested as 
a therapy for chlorine exposure. Although its mechanism of action is not well understood, it is thought 
that inhaled sodium bicarbonate neutralizes the hydrochloric acid formed when the chlorine gas 
reacts with the water in the lungs. 
Conclusion: Nebulized sodium bicarbonate solution at a low concentration appeared to rapidly and 
effectively reverse the symptoms due to chlorine gas inhalation in a young child. [Clin Pract Cases 
Emerg Med. 2020;4(2):205–207.]   
Keywords: Chlorine gas exposure; treatment; nebulized sodium bicarbonate; pediatric.
INTRODUCTION
Chlorine gas exposure can occur from multiple sources 
including in-home cleaning products or accidental mixing of 
ammonia and bleach, swimming pool chlorination reactions, 
industrial accidents, and intentional exposures with intent 
to harm as a chemical weapon.1,2 Because of the prolific and 
widespread use of chlorine in both industrial and household 
environments, the gas is one of the most common substances 
involved in toxic inhalation.3 Toxic effects are dependent on 
the time of exposure and the concentration of the gas and are 
Spectrum Health - Michigan State University Emergency Medicine Residency 
Program, Grand Rapids, Michigan
mediated by chlorine’s reaction with water on the mucosal 
surfaces to form hypochlorous and hydrochloric acids.2 The 
most common presenting complaints after exposure to the gas 
are cough and dyspnea, but may also include wheezing, sore 
throat, chest pain, eye and nose irritation, and nausea.2 
Because the respiratory system is generally the most adversely 
affected by this gas, exposure can lead to serious pulmonary 
edema and acute respiratory distress syndrome, respiratory 
failure, pneumomediastinum, and death.1 Treatments 
leading to symptomatic relief and prevention of further 
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What do we already know about this clinical 
entity? 
Chlorine gas inhalation can cause acute injury 
to the respiratory tract that in severe cases 
may result in pulmonary edema, pneumonia, or 
respiratory failure. 
What makes this presentation of disease 
reportable? 
An unusual exposure to chlorine gas caused 
respiratory symptoms in a child with a unique 
and effective means of management in the 
emergency department. 
What is the major learning point? 
Inhaled sodium bicarbonate neutralizes 
hydrochloric acid. Nebulized sodium bicarbonate 
at low concentrations appeared to reverse the 
pulmonary symptoms in our patient.
How might this improve emergency medicine 
practice? 
This case report adds to the emergency physician’s 
toolbox by providing a potential quick and effective 
means of managing an exposure to chlorine gas.
complications are paramount. One such treatment described 
in previous literature is the administration of nebulized 
sodium bicarbonate.3-5 While the mechanism of action is not 
completely understood, it is thought that the bicarbonate 
neutralizes the hydrochloric acid produced when the chlorine 
gas reacts with water in the moist environment of the mucosa 
and epithelium in the respiratory tract. In this report, we 
present a case of a nine-year-old male who presented to the 
emergency department (ED) with respiratory symptoms after 
inhaling the vapors of chlorinated tablets.
CASE REPORT
A nine-year-old male opened a canister of chlorine 
tablets that was kept near the family pool. After accidentally 
inhaling chlorine fumes, he immediately became dyspneic. 
The child had a history of mild asthma. His mother gave 
the patient an albuterol nebulizer treatment at home without 
improvement. He was taken to the ED by emergency medical 
services. On arrival to the hospital, he reported difficulty 
breathing, persistent dry cough, and chest pain. His vital signs 
were pulse 125 beats per minute, respirations 32 breaths per 
minute, blood pressure 102/62 millimeters of mercury, and 
temperature 37.2° Celsius. Oxygen saturation was 91% on 
room air. His face was flushed, and his conjunctivae were 
injected bilaterally. There were no lesions noted in the mouth 
or upper airway. He had coarse, upper airway breath sounds 
without retractions or wheezing. 
The patient had two episodes of desaturation to 89% and 
he was placed on one liter supplemental oxygen via nasal 
cannula with improvement to 98%. He was then given 4 
milliliter (mL) of 3.75% sodium bicarbonate in nebulized saline 
solution over 15 minutes. The nebulized sodium bicarbonate 
was administered approximately 90 minutes after initial 
exposure. Chest radiographs were unremarkable. His symptoms 
significantly improved after administration of the sodium 
bicarbonate; he no longer complained of pain or cough and 
was weaned to room air with oxygen saturations in the upper 
90s. The child was admitted and continued to improve without 
any further interventions and remained on room air. He was 
discharged within 24 hours without any further complication. 
DISCUSSION
In 2012, an estimated 4876 visits to EDs occurred after pool 
chemical–associated health events, such as the one highlighted 
in this report.6 The wide availability of chlorinated compounds 
as household disinfectants and swimming pool chlorinators 
makes these agents potentially hazardous to a large segment 
of the population, especially children. Concentrated chlorine 
gas may be generated when aging swimming pool chlorination 
tablets decompose or are inadvertently introduced to a swimming 
pool while swimmers are present.7 Predisposing factors to 
inhalation injury include asthma, smoking, atopic allergies, and 
chronic exposure to chlorine gas.1 Inhaled chlorine gas acts as 
a mucous membrane irritant, with symptoms usually beginning 
within minutes of exposure.3 As with all irritant gases, the 
airway injuries caused by chlorine gas may result in clinical 
manifestations similar to those of asthma. When the patient 
hyperventilates, an increased amount of chlorine is inhaled into 
the lungs, thereby causing more lung injury. 
Inhaled nebulized sodium bicarbonate has been suggested 
as a therapy for chlorine exposure. Although its mechanism of 
action is not well understood, it is thought that inhaled sodium 
bicarbonate neutralizes the hydrochloric acid formed when 
the chlorine gas reacts with the water in the lungs.3 Although 
oral sodium bicarbonate is not recommended for neutralizing 
acid ingestions because of the problems associated with the 
exothermic reaction and production of carbon dioxide in the 
relatively closed gastrointestinal tract, the rapid exchange 
in the lungs of air with the environment facilitates heat 
dissipation.7 Recommended dose concentrations are between 
3.75–4.25%. A 3.75% concentration is made by combining 
in a nebulizer 3 mL of 8.4% sodium bicarbonate and 3 mL 
of normal saline solution. No one has examined the effect of 
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differing concentrations of sodium bicarbonate solution or the 
optimal therapeutic timing of administration after exposure to 
irritant gases.
Use of inhaled sodium bicarbonate has been advocated in 
case reports and observational studies since 1976.8 Only one 
randomized controlled trial has been performed.3 In 2006, Aslan 
and colleagues treated 44 subjects with nebulized salbutamol (5 
milligrams [mg]), intravenous prednisolone (1 mg per kilogram 
per day), and either nebulized placebo or 4 mL of 4.20 % 
nebulized sodium bicarbonate solution. The only significant 
difference between the two groups was an increase in forced 
expiratory volume in the bicarbonate group at 240 minutes 
(2.9 vs 2.4 L). Although the quality-of-life scores improved 
significantly in both groups of patients after treatment, there 
was no significant difference found between the groups. 
In our case, the patient was not improved after both 
supplemental oxygen and nebulizer treatment prior to arrival and 
thus the use of an adjunctive therapy was warranted. Our patient 
had complete resolution of symptoms with a single treatment 
of 3.75% nebulized sodium bicarbonate. He did not experience 
any adverse effects and was discharged 24 hours later without 
any progression of his symptoms despite his history of asthma. 
This patient likely had a mild chlorine exposure but was still 
significantly symptomatic and, as with the prior case reports, this 
treatment has been shown to be beneficial in both mild and more 
severe cases of chlorine inhalation. In addition, no adverse effect 
or long-term complication of nebulized bicarbonate sodium has 
been reported to date.8
CONCLUSION
Nebulized sodium bicarbonate solution at a low 
concentration appeared to rapidly and effectively reverse the 
symptoms due to chlorine gas inhalation in a young child. As 
there is limited evidence for current treatment modalities for 
this relatively common toxicological emergency, further long-
term prospective clinical trials are needed to add support and 
evidence of safety for this adjunctive therapy. 
The authors attest that their institution requires neither 
Institutional Review Board approval, nor patient consent for 
publication of this case report. Documentation on file.
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Introduction: Both hyperkalemia and pseudohyperkalemia occur in the emergency department. 
True hyperkalemia necessitates emergent treatment while pseudohyperkalemia requires recognition 
to prevent inappropriate treatment. It is imperative that the emergency physician (EP) have an 
understanding of the causes and clinical presentations of both phenomena. 
Case Report: We present a case of an 88-year-old male with chronic lymphocytic leukemia (CLL) 
and suspected blast crisis who was found to have elevated serum potassium levels without other 
manifestations of hyperkalemia and eventually was determined to have pseudohyperkalemia due to 
white cell fragility. 
Discussion: Differentiation of hyperkalemia and pseudohyperkalemia is a critical skill for the EP. 
We discuss multiple causes of hyperkalemia and pseudohyperkalemia in an effort to broaden the 
knowledge base.
Conclusion: We present a case of CLL as an unusual cause of pseudohyperkalemia and review 
common causes of pseudohyperkalemia. [Clin Pract Cases Emerg Med. 2020;4(2):208–210.] 
Keywords: pseudohyperkalemia; hyperleukocytosis; chronic lymphocytic leukemia.
INTRODUCTION
Hyperkalemia is a potentially life-threatening electrolyte 
derangement that requires early diagnosis and prompt 
treatment to prevent significant morbidity and mortality. 
Pseudohyperkalemia is an in vitro increase in serum potassium 
without in vivo increase and thus lacks clinical manifestations 
of hyperkalemia.1 Every emergency physician (EP) has 
encountered pseudohyperkalemia as a result of hemolysis 
from pre-analytical errors.2 Fortunately, the laboratory usually 
identifies hemolysis at the time of reporting. We present a 
case of pseudohyperkalemia without apparent hemolysis in 
a patient with chronic lymphocytic leukemia (CLL), and we 
present a review of pseudohyperkalemia in the literature.
 
CASE REPORT
An 88-year-old male with baseline dementia and known CLL 
diagnosed in 2016 (although he had not been receiving treatment) 
Albany Medical Center Hospital, Department of Emergency Medicine, Albany, New York
Albany Medical Center Hospital, Department of Emergency Medicine and 
Department of Surgery, Division of Surgical Critical Care, Albany, New York
*
†
initially presented to an outside hospital with bilateral lower 
extremity edema. There, he was found to have a white blood cell 
count of 280,000 cells per microliter (cells/μL) (reference range: 
4,400-10,400 cells/μL), an increase from 120,000 cells/μL 10 
months prior. He was subsequently transferred due to concerns 
for transformation. At our institution, the patient denied any 
specific complaints. In discussion with the transferring physician, 
it was determined that the patient initially presented for lower 
extremity pain and fatigue, and was found to have negative 
bilateral deep venous thrombosis studies.
On physical exam, the patient was a cachectic, elderly 
male found to be normothermic at 36.9º Celsius, with a blood 
pressure of 114/68 millimeters of mercury, heart rate of 88 
beats per minute, respiratory rate of 14 breaths per minute, and 
oxygen saturation of 95% on room air. Otherwise, he had an 
unremarkable exam with the exception of symmetric 1+ lower 
extremity edema without evidence of cellulitis. 
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What do we already know about this clinical 
entity? 
Pseudohyperkalemia is an in vitro increase 
in serum potassium associated with 
thrombocytosis and leukocytosis, processes 
that increase cell fragility and lysis.
What makes this presentation of disease 
reportable? 
Reported cases of pseudohyperkalemia, 
especially relating to unusual causes such as 
leukemia, contribute to the limited body of 
knowledge currently in the literature.
What is the major learning point? 
Differentiating true hyperkalemia from 
pseudohyperkalemia is imperative as the 
inappropriate treatment of pseudohyperkalemia 
can lead to devastating hypokalemia.
How might this improve emergency 
medicine practice? 
Maintaining suspicion for 
pseudohyperkalemia in the appropriate 
clinical setting will decrease the frequency of 
inappropriate treatment.
Upon arrival, repeat laboratories demonstrated stable 
hyperleukocytosis of 279,000 cells/μL, but also a potassium 
of 6.7 microequivalent per liter (mEq/L) (reference range: 3.4-
5.2 mEq/L) without reported visible hemolysis. It should be 
noted the patient had a reported potassium of 4.5 mEq/L at the 
outside hospital earlier that day. The patient continued to deny 
any symptoms, and an electrocardiogram (ECG) was obtained 
that did not show evidence of hyperkalemia. One liter of 
normal saline and furosemide 20 milligrams were given 
intravenously with a repeat potassium elevated to 9.4 mEq/L, 
this time with some hemolysis. Given the rapidly escalating 
potassium level despite an initial trial of therapy and a normal 
ECG, a point-of-care potassium was drawn and returned as 
3.8 mEq/L. Since this value was more consistent with the 
outside hospital level and there was a lack of clinical and ECG 
findings to suggest hyperkalemia, no further interventions 
were performed in the emergency department.
Over the course of his hospitalization, the patient had 
multiple elevated potassium levels, usually with interpreted 
hemolysis, although occasionally without reported hemolysis. 
In fact, the patient had his apparently elevated potassium treated 
with a hyperkalemia cocktail of calcium gluconate, insulin, 
dextrose, and sodium polystyrene on at least one occasion during 
his hospital stay. The patient never had physical manifestations of 
hyperkalemia nor were there ECG changes. 
DISCUSSION
In vivo hyperkalemia is a common electrolyte derangement 
typically seen in chronic kidney disease as well as in acute 
processes such as rhabdomyolysis and diabetic ketoacidosis. 
Conversely, pseudohyperkalemia is an in vitro increase in 
serum potassium. Hemolysis can occur during the pre-analytical 
process, particularly with mechanical trauma during venipuncture, 
prolonged tourniquet time, and fist clenching, all of which may 
cause extracellular movement of potassium from myocytes.2
Cases of pseudohyperkalemia associated with 
thrombocytosis and leukocytosis have been reported in the 
literature since the 1950s.1,3 Pseudohyperkalemia has been 
associated with hyperleukocytosis, more commonly in CLL 
in adults, but also acute lymphoblastic leukemia in children.4-9 
It is thought that hyperleukocytosis increases cell fragility, 
making cell lysis more common during specimen collection, 
particularly with smaller-bore needles, as well as transport 
and centrifugation. Since leukocytes are more prone to lysis 
than erythrocytes, laboratory detection may not be apparent 
if erythrocytes are unaffected. This may lead to the spurious 
reporting of elevated potassium without the expected caveat 
of hemolysis and explain why in our case the use of the 
point-of-care test showed a normal potassium. Moreover, at 
our institution, we use a pneumatic tube system to transport 
laboratory specimens, which would further increase the risk of 
fragile cell lysis compared to a bedside test without transport.
Although we highlight pseudohyperkalemia in the setting of 
hematologic malignancy, rarer etiologies of pseudohyperkalemia 
exist in the literature. There are cases of pseudohyperkalemia 
associated with postsplenectomy thrombocytosis following 
trauma as well as hepatosplenic schistosomiasis infection.10-11 
Familial pseudohyperkalemia is an autosomal dominant, 
albeit exceedingly rare, disorder in which erythrocyte plasma 
membranes exhibit temperature-dependent permeability of 
potassium in vitro.12 Although vastly different pathologies, it 
can be inferred that processes that promote cell fragility increase 
the risk of pseudohyperkalemia. Thus, clinical suspicion for 
pseudohyperkalemia should be maintained in patients with 
these predispositions. Likewise, underlying hematological 
disorders should be considered in patients with suspected 
pseudohyperkalemia without known disease.
Differentiating true hyperkalemia from 
pseudohyperkalemia is important as hyperkalemia in 
patients with leukocytosis in the setting of known or 
suspected malignancy is concerning for tumor lysis 
syndrome (TLS), an oncologic emergency involving lysis 
of malignant cells and extracellular release of potassium 
and phosphate as well as the generation of uric acid. 
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Treatment of hyperkalemia in TLS is similar to that of 
hyperkalemia in other patients.
The inappropriate treatment of pseudohyperkalemia 
can lead to devastating hypokalemia. Nevertheless, 
multiple case reports as early as the 1980s have 
cited the inappropriate treatment of hyperkalemia in 
hyperleukocytosis.6,13 We aim to add to the body of 
knowledge of pseudohyperkalemia. Inappropriate treatment 
of pseudohyperkalemia can be detrimental. It is imperative 
that treatment be started with appropriate clinical suspicion 
rather than solely laboratory findings, which have inherent 
limitations and errors.
CONCLUSION
Differentiating true hyperkalemia, a medical emergency, 
from pseudohyperkalemia, where treatment can be detrimental 
is important for the EP. In order to do this, the EP needs to be 
familiar with the plethora of causes of pseudohyperkalemia 
from the more common hemolysis to the much rarer 
thrombosis and extreme leukocytosis or thrombocytosis.
The authors attest that their institution requires neither 
Institutional Review Board approval, nor patient consent for 
publication of this case report. Documentation on file.
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Introduction: High-pressure injection injuries have been chronicled for decades.1 These injuries 
often affect distal extremities as they are most commonly involved in workplace accidents.1 However, 
we discuss a young male with a paint-gun injection injury to his face. 
Case Report: We discuss the case of a young man presenting to the emergency department 
after high-pressure injection injury to the face. He eventually underwent extensive debridement of 
the face. We discuss differences in caring for an injection wound to an extremity versus the face, 
including time sensitivity of treatment, initial stabilizing measures, and critical steps. 
Discussion: This case demonstrates a rare presentation of a high-pressure paint injection injury. 
This injury presented a unique surgical challenge where, despite compartment syndrome being less 
common, cosmetic outcome and infectious complication prevention remained critical priorities.
Conclusion: While similarities exist in management of an injection injury to a limb, due to the rarity 
and deceptive appearance of this particular injury to the face, high suspicion along with urgent 
imaging and surgical consultation is warranted. [Clin Pract Cases Emerg Med. 2020;4(2):211–213.]  
 
Keywords: compartment, pressure, injection injury, plastics, face.
INTRODUCTION
High-pressure injection injuries present unique pathology. 
They cause devastating deep tissue damage despite small, 
innocuous, and usually painless skin lesions most commonly 
occurring on the hands, fingers, or feet. The skin lesions 
associated with these injuries often dwarf the severity of the 
damage occurring below the surface, as foreign chemical 
irritants are introduced into a closed compartment.2 They 
are true surgical emergencies, requiring prompt surgical 
debridement, decompression, and thorough cleansing in the 
operating room to counter the risk of infection and compartment 
syndrome.2 While these injuries are often devastating, they are 
rare. According to a 1991 study, only one in 600 hand traumas 
include an injection injury under high pressure, with injection 
injuries to the feet even more rare.3 Without adequate treatment, 
Wake Forest School of Medicine, Department of Emergency Medicine, Winston-
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surgical intervention, and proper follow-up care, morbidity is 
significant with amputation rates that reach as high as 48%.3
We report the case of a high-pressure injection injury to 
a unique anatomical location: the face. This case serves as a 
platform to explore the importance of the anatomical location 
of these injuries and how the location may guide treatment. 
Regardless of the misleading appearance of the wound and 
the low likelihood of compartment syndrome, high-pressure 
injection injuries to the face require a high level of suspicion 
and a low threshold for imaging and surgical consultation.
CASE REPORT
A 19-year-old male with no significant past medical 
history presented as a transfer to our Level I trauma center 
with a chief complaint of right facial injury. Eight hours prior 
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What do we already know about this clinical 
entity? 
High-pressure injection injuries, while 
appearing innocuous, are dangerous. 
Usually affecting distal limbs, they can cause 
compartment syndrome and necrosis.
What makes this presentation of disease 
reportable? 
A pressure injection injury to the face is rare, 
with no current guidelines for management. 
This case may provide guidance in 
presentation and care.
What is the major learning point? 
There are distinct differences in caring for 
an injection wound to extremity vs face, such 
as time sensitivity of treatment and initial 
stabilizing measures.
How might this improve emergency 
medicine practice? 
Due to the rarity and deceptive appearance 
of this injury, high suspicion along with 
urgent imaging and surgical consultation 
is warranted.
to arrival to our emergency department (ED), the patient 
accidentally discharged a pressurized, spray-paint gun while 
attempting to troubleshoot his equipment at work. Due to 
a language barrier, an interpreter was used throughout the 
patient encounter. The history was obtained from the patient 
interview and a review of medical records provided by an 
outside hospital. The patient endorsed right facial pain and 
dysphagia. He denied any eye pain, dysarthria, decreased vision, 
or trouble breathing. At the outside hospital, the patient was 
administered a dose of ampicillin/sulbactam for broad-spectrum 
antibiotic coverage and underwent computed tomography of 
the face and sinuses with contrast (Image 1). The imaging 
demonstrated “soft tissue hematoma/contusion involving right 
premolar and premandibular soft tissue regions,” as well as 
“hyperdense material likely paint [and] no infraorbital injury.”
Review of systems demonstrated facial swelling, sinus 
pain, sinus pressure, and trouble swallowing. The rest of 
review of systems was negative.
On arrival to our ED, the patient was hemodynamically 
stable with normal vital signs and was in no acute distress. His 
physical exam revealed swelling of the right face extending 
from his cheek just below the eye to the right upper lip (Image 
2). The affected area was tender to palpation. The ocular exam 
was normal. Laboratory studies revealed a mild leukocytosis 
but were otherwise normal. Otorhinolaryngology was 
consulted for bedside evaluation. Upon review of the patient, 
they attempted an incision and drainage at the bedside with 
normal saline flushes of the region and decided to admit him 
for observation and eventual operative management. 
The patient underwent excision and debridement of 
the face. He received his nutrition via nasogastric tube. 
Antibiotics were given and all cultures were pan-negative 
for bacterial and fungal pathogens. Pain was managed with 
oxycodone and acetaminophen. He was discharged one week 
after admission without issue.
DISCUSSION
This case demonstrates a rare presentation of a high-
pressure paint injection injury. The anatomical location of this 
injury presented a unique challenge to the management of this 
patient because the region of the injury was distinct from the 
more common presentations of paint injection injuries. Most 
often located on the hand or digits, paint injection injuries are 
surgical emergencies warranting debridement in a sterile setting 
and separation of fascial layers with the hope of preventing 
infections such as necrotizing fasciitis.2 The presentation of our 
patient differed significantly as his injection injury was located 
in the maxillofacial region lateral to the nose, medial to the 
temporomandibular joint, inferior to the orbits, and superior 
and anterior to the maxillary sinuses. This facial location of the 
injury greatly decreased the risk for compartment syndrome and 
Image 1. Computed tomography horizontal view demonstrating soft 
tissue hematoma/contusion and hyperdense material (arrowheads).
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allowed time for both the otorhinolaryngology and emergency 
medicine teams to properly evaluate the injury to determine 
the best course of action for this patient. This injury presented 
a unique surgical challenge where, despite compartment 
syndrome being less common, cosmetic outcome and infectious 
complication prevention remained critical priorities.
Initially the decision to attempt bedside incision and 
drainage (I&D) was made with the hope that irrigation 
would help flush out the region of the paint and alleviate the 
need for an invasive surgical debridement. It was quickly 
discovered that with such an elevated pressure of injection 
into the region, the paint was affixed very firmly to the 
surrounding tissue. Bedside irrigation was not thorough 
enough to address the extent of this injury. The patient was 
admitted to the hospital to the otorhinolaryngology service 
in stable condition. While official guidelines do not exist 
as to whether I&D is indicated for this injury, several case 
reports suggest that I&D is not successful in fully addressing 
the extent of paint injection injuries and surgery is indicated 
regardless of the injury location.1,4,5 
The management of this patient was unique given the 
rarity, acuity, and severity of his presentation and the lack 
of concrete guidelines for a high-pressure paint injection 
injury to the face. Based on our literature review, there have 
only been two prior cases reporting high-pressure injection 
injury to the face, neither of which underwent acute surgical 
management from the ED. One case was observed and 
discharged as the high- pressure injury was only to the upper 
lip and the second case detailed granulomatous changes 
years later due to retained paint in the tissue causing a 
foreign body reaction.6,7
CONCLUSION
High-pressure injection injuries to the face have a 
lower risk of compartment syndrome than high-pressure 
injection injuries to extremities; however, due to the rarity 
of reported cases, it is impossible to determine the risk of 
infectious complications, long-term neurovascular sequelae, 
or anatomical deformity. This case highlights the high level 
of suspicion emergency physicians must have despite the 
deceptive appearance of craniofacial high-pressure injuries 
and emphasizes the need for a low threshold for imaging and 
immediate surgical consultation. 
Documented Institutional Review Board approval has been 
obtained and filed for publication of this case report.
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Image 2. Demonstrated swelling and facial distortion on the right 
side from high-pressure paint injection injury.
REFERENCES
1. Booth CM. High pressure paint gun injuries. BMJ. 1977;2(6098):1333-5.
2. Verhoeven N and Hierner R. High-pressure injection injury of the 
hand: an often underestimated trauma: case report with study of the 
literature. Strategies Trauma Limb Reconstr. 2008;3(1):27-33.
3. Neal NC and Burke FD. High-pressure injection injuries. Injury. 
1991;22(6):467-70.
4. Zook EG and Kinkead LR. Pressure gun injection injuries of the 
hand. Am J Emerg Med. 1979;8(7):264-6.
5. Yazar M, Gül Z, Günenç AC, et al. High pressure paint gun 
injury of the index finger: a case report. Plast Aesthet Res. 
2015;2(6):350.
6. Chu FY, Wu KC, Lin HJ. Craniofacial high-pressure air injection 
injury. Ann Emerg Med. 2007;49(1):113-5.
7. Mushtaq J, Walker A, Hunter B. Under pressure: progressively 
enlarging facial mass following high-pressure paint injection injury. 
BMJ Case Rep. 2016. doi: 10.1136/bcr-2015-212817.
Clinical Practice and Cases in Emergency Medicine 214 Volume IV, no. 2: May 2020
Case report
 
Rare External Jugular Vein Pseudoaneurysm
 
Patrick J. Wallace, DO, MS
Jordana Haber, MD 
Section Editor: Rick A. McPheeters, DO           
Submission history: Submitted September 4, 2019; Revision received December 20, 2019; Accepted December 18, 2019 
Electronically published March 2, 2020         
Full text available through open access at http://escholarship.org/uc/uciem_cpcem   
DOI: 10.5811/cpcem.2019.12.45076
External jugular vein pseudoaneurysm is a very rare cause of a neck mass due to the low pressure 
venous system. This case demonstrates a 27-year-old female who presented to the emergency 
department with a non-tender, compressible, left-sided neck mass that enlarged with valsalva and 
talking, and intermittent paresthesias. Upon workup, she was diagnosed with an external jugular vein 
pseudoaneurysm. Complications of this diagnosis are mentioned in the literature; however, most 
patients with an external jugular vein pseudoaneurysm or aneurysm can be safely discharged with 
close follow-up with a vascular surgeon. [Clin Pract Cases Emerg Med. 2020;4(2):214–218.] 
INTRODUCTION
Venous aneurysms are very rare compared to arterial 
aneurysms.1-7 This is postulated to be related to the low pressure 
system in the superior vena cava.2,3,6,8 Because of this 77% of 
venous aneurysms are located in lower extremities.7 In addition, 
pseudoaneurysms of the external jugular vein are less common 
than aneurysms of the internal jugular vein, making them an 
exceedingly rare entity.3,5,7 
An aneurysm is defined as a dilation of all three layers 
of the vein wall. The histology of an aneurysm may show 
thinning of the elastic fiber wall, decreased smooth muscle 
in the media, and replacement of smooth muscle by fibrous 
tissue,7,9,10 whereas pseudoaneurysm is a tear through the outer 
layers of venous wall, the tunica adventitia and tunica media. 
The histology of a pseudoaneurysm shows collection of blood 
and thrombus in the wall.
CASE REPORT
An otherwise healthy 27-year-old African-American 
female presented to the emergency department complaining 
of a left neck mass with associated paresthesias radiating 
up her left lateral neck and down the left arm. These 
paresthesias were intermittent and positional. She noticed 
the mass present suddenly about two months prior to 
presentation and endorsed gradual increase in size, in 
addition to intermittent and positional paresthesias. The 
mass was painless and enlarged with talking and valsalva 
maneuvers. She denied any recent interventions including 
University of Nevada Las Vegas, Department of Emergency Medicine, 
Las Vegas, Nevada
massage, chiropractics, or neck manipulation. She had no 
known personal or family history of connective tissue 
disease. The patient also denied social history including 
smoking, alcohol, or substance use. However, she had been 
in a motor vehicle accident about four months prior without 
any significant injuries or immediate complications. This 
was a low-speed crash and the patient was able to self-
extricate and self-ambulate without assistance immediately 
after the injury. No medical evaluation or imaging was 
completed at that time. 
On physical exam, she had a 2-centimeter (cm) soft, 
compressible, non-pulsatile, nontender mass that enlarged 
with valsalva and talking along the antero-lateral left neck 
(Image 1). The mass was soft and mobile. It did not move 
or change in size with respirations or swallowing. There 
was no overlying erythema, warmth, ecchymosis, 
induration, or surrounding lymphadenopathy. Strength and 
sensation were intact in all extremities. Adson’s, Allen’s, 
and Roo’s tests were all normal. Her paresthesias were not 
exacerbated with movement of her neck or arm, 
compression or distraction of the neck, or with Spurling’s 
maneuver. Her neck was non-tender without restriction of 
motion, hypertonicity of muscles, or edema.  
Basic blood work showed no abnormal findings. 
Computed tomography (CT) of the neck with contrast 
showed a 1.7 cm x 1.4 cm x 2 cm pseudoaneurysm of the 
left external jugular vein (Images 2 and 3). The case was 
discussed with the vascular surgeon on call. The patient had 
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What do we already know about this clinical 
entity? 
External jugular venous pseudoaneurysm is a 
rare presentation. It is rarely symptomatic and 
often caused by trauma or cannulation of the 
internal jugular vein.
What makes this presentation of disease 
reportable? 
Although ultrasound or computed tomography 
(CT) with angiography is recommended, in 
this case we demonstrate CT with contrast is 
sufficient to make the diagnosis.
What is the major learning point? 
Ultrasound is the standard of care imaging 
modality. If asymptomatic, most pseudoaneurysms 
can be safely discharged and follow up with 
vascular surgery as an outpatient.
How might this improve emergency medicine 
practice? 
Complications are very rare and often not life-
threatening and can be managed as an outpatient.
no signs that the pseudoaneurysm was expanding, causing 
airway compromise, had active extravasation, or was 
causing emergent neurological involvement at that time. 
We agreed she was safe for discharge at that time and could 
follow up with vascular surgery as an outpatient. 
DISCUSSION
We found minimal literature on the topic of external 
jugular vein aneurysm and pseudoaneurysm, with only two 
other case reports of pseudoaneurysm published. We could not 
find any articles that had performed a formal review of the literature. The table below compares the case reports available 
in this field of research.
The most common presentation for aneurysm and 
pseudoaneurysm is a pulsatile, palpable mass that enlarges 
with valsalva.1,10 Other symptoms include pain, dysphagia, 
hoarseness, and neurological findings.1,6 Doppler ultrasound is 
the gold standard and recommended first imaging technique 
for aneurysms and pseudoaneurysms.5,11 
Ultrasound can show turbulent flow and dilation with 
95% accuracy for pseudoaneurysm.1 It is non-invasive and 
helps differentiate vascular from non-vascular causes. 
Arterial pseudoaneurysms are seen as pulsatile and 
turbulent waveform on Doppler ultrasound.4 (CT 
angiography, magnetic resonance imaging, and magnetic 
resonance venography can more accurately demonstrate 
size and extent, but are not first line.5,6,8,11,12 Additionally, 
CT with intravenous contrast may be a suitable imaging 
modality in cases where ultrasound or clinical uncertainty 
requires a CT without angiography. To our knowledge this 
is the only case in the literature where an external jugular 
vein pseudoaneurysm was diagnosed with a contrast CT 
without angiography.
Image 1. Two-centimeter left external jugular pseudoaneurysm as 
seen on physical exam.
Image 2. Computed tomography with contrast coronal view of left 
external jugular venous pseudoaneurysm (arrow).
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Venous aneurysms are classified as primary (congenital) 
and secondary (acquired).2,5,8 Causes of primary venous 
aneurysms are not fully understood,9,13 while possible etiologies 
for secondary aneurysms within the venous system include 
thoracic outlet obstruction, trauma, chronic inflammation, 
degeneration, and increased venous pressure.2,4,5,11,14 Known risk 
factors for secondary venous aneurysms include recent trauma, 
cardiovascular disease, and age.3 
Pseudoaneurysms in the arterial system of the neck have 
similar underlying etiology to include trauma,1,3 venous valve 
insufficiency,3 tumor,3 and iatrogenic causes such as surgical 
interventions or central line complications.1 There are currently 
only two other case reports on external jugular vein 
pseudoaneurysm.5,12 Shah et al discusses one of these case 
reports, specifically a fusiform dilation. This patient had no past 
medical history and no evidence of trauma other than repeated 
irritation to the neck by the sling and buckle of his rifle.12
Venous aneurysms and pseudoaneurysms are a rare cause 
of neck masses.4,15 The differential diagnosis includes 
lymphocele, cavernous hemangioma, hygroma, abscess, cyst, 
laryngocele, lymph node, tumor, thyroglossal cyst, and 
branchial cleft cyst.4,5,12,15 Enlargement of the mass with valsalva 
or excursion is suspicious for laryngocele, aneurysm, or 
pseudoaneurysm.8,10
Complications may include pulmonary embolism, 
thrombus formation or thrombophlebitis, and rupture.5,6,8,10,12 
The research suggests there is risk of major embolic 
complications from jugular vein aneurysms. However, 
McCready et al states: “Based on the few cases in the literature, 
rupture or thromboembolic complications in patients with 
axillary or subclavian venous aneurysms do not appear to occur. 
Conservative therapy is appropriate for patients with axillary 
and subclavian venous aneurysms.”10 At the time of this 
publication there were no reports in the literature of any of the 
above-mentioned complications from external jugular vein 
pseudoaneurysm. These complications are mostly seen in the 
lower extremities from popliteal and femoral aneurysms.7,10,14
Surgical indications include large aneurysms compressing 
nearby structures, potential for thrombus, cosmetic reasons, or 
presence of symptoms.7,10 Venous aneurysms of the neck are often 
asymptomatic requiring no intervention and can be monitored.1,2,5 
Approximately 89% of iatrogenic pseudoaneurysms will heal 
spontaneously without intervention.1 Upon our review, the case 
reports where patients underwent surgery were all for cosmetic 
reasons. Management can include supportive care and outpatient 
follow-up with surgery. Symptomatic patients may need to be 
admitted for observation if there are concerns for rapidly 
enlarging pseudoaneurysm, rupture, or signs of hemodynamic 
instability. As noted in the table below, none of the patients 
discussed in these case reports had concerning symptoms that 
would warrant admission and we believe the majority of patients 
with jugular vein pseudoaneurysms can be safely discharged and 
follow-up with a vascular surgeon.
CONCLUSION
Pseudoaneurysms of the external jugular vein are very rare 
with only two other case reports published in the literature. 
Pseudoaneurysm presents as a pulseless mass that enlarges with 
valsalva and exertion. No complications have been reported in the 
literature and no intervention is indicated in the asymptomatic 
patient. If asymptomatic, patients can be safely discharged with 
outpatient referral to surgery for cosmetic excision.
Documented patient informed consent and/or Institutional Review 
Board approval has been obtained and filed for publication of this 
case report.
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Image 3. Computed tomography with contrast sagittal view of left 
external jugular venous pseudoaneurysm (arrow).
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Background: In December 2019 the coronavirus disease of 2019 (COVID-19), caused by the severe 
acute respiratory syndrome coronavirus 2, was identified in Wuhan, China. In the ensuing months, the 
COVID-19 pandemic has spread globally and case load is exponentially increasing across the United 
States. Emergency departments  have adopted screening and triage procedures to identify potential 
cases and isolate them during evaluation. 
Case Presentation: We describe a case of COVID-19 pneumonia requiring hospitalization that 
presented with fever and extensive rash as the primary presenting symptoms. Rash has only been 
rarely reported in COVID-19 patients, and has not been previously described. [Clin Pract Cases 
Emerg Med. 2020;4(2):219–221.]  
Keywords: COVID-19; coronavirus; rash. 
CASE PRESENTATION
A 20-year-old previously healthy male originally 
presented to an urgent care center with a chief complaint 
of fever and rash. He was diagnosed with a viral upper 
respiratory infection and sent home with supportive care. Six 
days later, the patient presented to the emergency department 
(ED) with continued fever and rash. Vital signs included 
a temperature of 103.0˚ Fahrenheit, heart rate 115 beats 
per minute, blood pressure 93/54 millimeters of mercury, 
respiratory rate 24 breaths per minute, and an oxygen 
saturation of 91%. Physical examination revealed a diffuse, 
morbilliform rash across the trunk and extremities, sparing 
the face (Images 1 and 2). There was no mucosal or ocular 
involvement. Chest radiograph revealed bilateral infiltrates 
consistent with multifocal pneumonia (Image 3). Labs 
included a normal leukocyte count (8300 units per liter [uL], 
reference range 4200-9100/uL) with an absolute lymphocyte 
count of 800/uL (reference range 1300-3600/uL). A 
C-reactive protein was elevated at 118.5 milligrams per liter 
(mg/L) (reference range 0-5 mg/L). A rapid strep test and an 
human immunodeficiency virus test were both negative, as 
was a respiratory viral panel. The patient required escalating 
New York University School of Medicine, Department of Emergency Medicine, New 
York, New York
Bellevue Hospital Center, Department of Emergency Medicine, New York, New York
Image 1. Image of the anterior trunk and upper extremities 
(A) and anterior lower extremities (B) demonstrating a diffuse, 
morbilliform, maculopapular rash.
amounts of supplemental oxygen during his ED course and 
was admitted to the intensive care unit (ICU). A severe 
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) 
polymerase chain reaction test resulted positive on hospital 
day two. The patient remains hospitalized in the ICU on 
hospital day six.
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What do we already know about this clinical 
entity? 
Coronavirus disease of 2019 (COVID-19) 
typically initially presents with symptoms 
similar to other viral respiratory infections, 
most commonly with fever, cough, fatigue, 
myalgias, and congestion.
What is the major impact of the image(s)?
This case describes a COVID-19 patient who 
presented with a full body rash, which is a rare 
presenting symptom in previous studies and has 
not been described previously in the literature.
How might this improve emergency medicine 
practice?  
COVID-19 may rarely present with an associated 
morbilliform viral eruption and should not be 
discarded as a diagnostic possibility in patients 
with viral syndrome and rash.DISCUSSION
We describe a case of COVID-19 pneumonia in a young, 
healthy male requiring hospitalization, which presented 
with fever and extensive rash. The rash was morbilliform, 
maculopapular, and nonpruritic, and appeared consistent with 
a viral exanthem. The clinical characteristics of COVID-19 
have been described in several publications, most thoroughly 
in a case series of 1099 patients by Guan et al. Fever, cough, 
congestion, and dyspnea are the most common presenting 
symptoms. Only 2/1099 patients were noted to have any skin 
Image 3. A chest radiograph demonstrating bilateral infiltrates 
consistent with bilateral multifocal pneumonia.
rash, and the rash was not described1; no other publications 
have noted or described skin manifestations as a presenting 
symptom.1-5 Rash may be a rare presenting symptom of 
COVID-19 and should be kept in mind by front-line providers.
Documented patient informed consent has been obtained and 
filed for publication of this image in emergency medicine.
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Image 2. Image of the posterior trunk similarly demonstrates a 
diffuse, maculopapular morbilliform rash.
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Ebstein’s anomaly is a congenital heart defect that when left untreated can lead to unique physical 
exam and ultrasound findings. This case describes a patient who presented with dyspnea and 
was found to have cyanosis, clubbing, and dilation of right-sided chambers on point-of-care 
ultrasound. The series of images highlights findings in late-stage Ebstein’s anomaly and serves 
as a springboard for the discussion of the pathophysiology, diagnosis, and treatment of this rare 
congenital heart disease. [Clin Pract Cases Emerg Med. 2020;4(2):222–224.]
Highland Hospital, Alameda Health System, Oakland, California
Hospital Nacional Dos de Mayo, Department of Emergency Medicine, Lima, Peru 
*
†
CASE PRESENTATION 
A 20-year-old male presented to the emergency 
department with progressive dyspnea. He was noted to have 
hypoxemia, clubbing of the fingers (Image 1), and perioral 
cyanosis (Image 2). Point-of-care ultrasound revealed a severe 
anatomic abnormality of the heart consistent with Ebstein’s 
anomaly (Image 3 and video). 
DISCUSSION 
Ebstein’s anomaly is caused by a congenital insufficiency 
of the tricuspid valve due to the apical displacement of the 
annulus. This leads to a dilated atrium and atrialization of the 
right ventricle as seen in this ultrasound image of a standard 
apical 4-chamber view.1 Other cardiac anomalies are 
commonly associated, such as atrial septal defect and 
ventricular septal defect.2 
Ebstein’s anomaly accounts for less than 1% of congestive 
heart failure (CHF) and varies in severity.3 If tricuspid 
regurgitation is severe, symptoms such as CHF and cardiomegaly 
may develop in the neonatal period.1 Mild cases of Ebstein’s 
anomaly may remain undiagnosed until late childhood or 
adulthood, when presenting symptoms may include cyanosis and 
decreased exercise tolerance, as with this case. Adults also have a 
high risk of atrial tachyarrhythmia and ventricular pre-excitation, 
which predisposes patients to lethal arrhythmias.4 
Patients with Ebstein’s anomaly may require medical or 
surgical treatment for atrialization of the right ventricle.5 Medical 
Image 1. Fingers of patient (arrow) demonstrating cyanosis and 
clubbing.
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What do we already know about this 
clinical entity? 
Ebstein’s anomaly is a form of congenital 
heart disease caused by insufficiency of the 
tricuspid valve, leading to a dilated atrium 
and atrialization of the left ventricle. 
What is the major impact of the image(s)?
These images show physical exam findings 
and point-of-care ultrasound (POCUS) 
features of late-stage Ebstein’s anomaly in a 
patient in Peru. 
How might this improve emergency 
medicine practice?  
In settings with limited access to pediatric 
cardiac surgery, patients may present with 
late manifestations of the disease. POCUS 
ultrasound may help in the diagnosis. 
treatment includes diuresis, angiotensin-converting enzyme 
inhibitors, and digoxin. Tricuspid valve repair or replacement 
may be indicated in patients experiencing deteriorating exercise 
capacity, cyanosis (finger oxygen saturation <90%), paradoxical 
embolism, cardiomegaly, or reduction of right heart function.5 
Surgical intervention should not be delayed until right heart 
failure occurs as this is associated with poor outcomes.4 Most 
cases of Ebstein’s anomaly fare well, especially when surgically 
corrected, with the majority of patients living to at least age 60.3 
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Image 2. Mild cyanosis of lips (arrow) demonstrating chronic 
hypoxemia.
Image 3. Point-of-care ultrasound apical 4-chamber view of 
patient with Ebstein’s anomaly demonstrating the dilated right 
heart chambers. The left ventricle is demonstrated by the arrow.
RV, right ventricle; RA, right atrium; LA, left atrium.
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Documented patient informed consent and/or Institutional Review 
Board approval has been obtained and filed for publication of this 
case report.
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A 19-year-old Asian male presented to our emergency department with atraumatic right hip pain radiating 
to the right groin associated with pain on ambulation. Magnetic resonance imaging of the right hip with 
and without contrast revealed the diagnosis. Pigmented villonodular synovitis is a rare, monoarticular 
benign tumor originating from the synovium of the joint. The treatment is synovectomy of the pathological 
joint to prevent further disease progression. [Clin Pract Cases Emerg Med. 2020;4(2):225–226.]   
CASE PRESENTATION
A 19-year-old Asian male presented to our emergency 
department (ED) with a one-day history of atraumatic right 
hip pain radiating to the right groin associated with pain 
on ambulation. The patient denied weakness or numbness 
of his extremity, fever, chills, or recent illness. Physical 
examination only revealed decreased range of motion and 
pain with internal rotation and flexion of the right hip. ED 
labs consisting of complete blood count, complete metabolic 
profile, C-reactive protein, and erythrocyte sedimentation 
rate were within normal limits. Ultrasound with Doppler 
of the patient’s scrotum was unremarkable. Computed 
tomography of the abdomen and pelvis with intravenous 
contrast demonstrated a right hip fluid collection consistent 
with inflammation or infection. Magnetic resonance imaging 
(MRI) of the right hip with and without contrast suggested the 
diagnosis (Image).    
DISCUSSION
Pigmented villonodular synovitis. Pigmented villonodular 
synovitis (PVNS) is a rare, monoarticular benign tumor 
originating from the synovium of the joint.1,2 More commonly, 
this tumor is slow-growing, involving a localized portion of 
the joint or, in rarer cases, diffuse with malignant-type features 
(ie, involving the entire joint, or extra-articular lesions).3-5 The 
incidence of intra-articular PVNS predominately occurs in 
Broward Health, Department of Emergency Medicine, Coral Springs, Florida
Broward Health, Department of Diagnostic Radiology, Coral Springs, Florida
Broward Health, Department of Internal Medicine, Coral Springs, Florida
Florida Atlantic University, Boca Raton, Florida
*
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young adults (median age of 30 years) and has been reported 
to be 1.8 per million with equal gender distribution.4 The hip 
is the second most common joint affected (15% of all cases), 
with the knee the most prevalent of joints affected. MRI is the 
Image. Coronal magnetic resonance imaging (T1-weighted) of the 
patient’s right hip demonstrating the hypointense lesion caused 
by the hemosiderin deposition in the hyperplastic synovium 
characteristic of pigmented villonodular synovitis (white arrow).
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What do we already know about this 
clinical entity? 
Pigmented villonodular synovitis (PVNS) 
is a rare, monoarticular benign tumor 
originating from the synovium of the joint.
What is the major impact of the image(s)?
The image demonstrates the hypointense 
lesion caused by the hemosiderin 
deposition in the hyperplastic synovium 
characteristic of PVNS.  
How might this improve emergency 
medicine practice?  
This case illustrates the necessity of 
a broad differential diagnosis in a 
very common patient chief complaint 
(arthralgia) for optimum patient outcome.
radiographic study of choice to identify hyperplastic synovium 
lesion(s) characteristic of PVNS.4 The treatment is complete 
synovectomy of the pathological joint to prevent further 
disease progression; with a recurrence rate of 7.7 to 17.8%.1 
This case illustrates the necessity of a broad ED differential 
diagnosis (i.e., neoplasms, infection, etc.) accompanied with 
multiple diagnostic modalities for optimum patient outcome.
Documented patient informed consent and/or Institutional Review 
Board approval has been obtained and filed for publication of this 
case report.
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Case Presentation: We describe the presentation to the emergency department of a patient with 
recurrent ovarian cancer treated with bevacizumab with the complication of bowel perforation. 
Discussion: We review the frequency and outcomes of bevacizumab-related bowel perforation. We also 
report the patient’s imaging findings, including the radiologic presentation of free intraperitoneal air and 
portal venous gas, both indicative of bowel perforation and the need for emergent surgical evaluation. 
Our case also illustrates the potentially catastrophic side effects of bevacizumab and other targeted 
oncologic therapies of which emergecny physicians may not be aware. [Clin Pract Cases Emerg 
Med. 2020;4(2):227–229.]
Keywords: bevacizumab; oncologic emergency; bowel ischemia.
CASE PRESENTATION
A 69-year-old, African-American female with recurrent 
stage IIIC ovarian carcinoma treated with bevacizumab 
presented to the emergency department (ED) with 
abdominal pain, distention, vomiting, and hypotension. 
After initial stabilization, an upright abdominal radiograph 
(Image 1) revealed peritoneal free air and portal venous gas 
concerning for bowel perforation, which was confirmed by 
computed tomography (CT) of the abdomen and pelvis 
(Images 2 and 3). 
The patient was admitted to the gynecology oncology 
service and maintained on crystalloids and antibiotics. She 
had minimal symptoms. In accordance with her wishes, no 
further aggressive intervention was pursued, and she died 
on hospital day three.
DISCUSSION
Bevacizumab is a monoclonal antibody targeting the 
vascular endothelial growth factor receptor used in multiple 
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Birmingham, Alabama
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Birmingham, Alabama
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Image 1. Upright abdominal radiograph revealing free air along the 
lateral margin of the liver (arrows) and branching gas in the liver 
(triangles), concerning for portal venous gas.
cancer types, including ovarian.1, 2 Complications include 
bowel perforation and gastrointestinal (GI) bleeding.3 The 
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What do we already know about this 
clinical entity? 
Bevacizumab is an increasingly used 
targeted chemotherapeutic agent 
with infrequent, severe complications 
including gastrointestinal perforation.
What is the major impact of the image(s)?
Severe ischemic bowel related to 
bevacizumab therapy and widespread 
diagnostic findings of mesenteric 
ischemia, portal venous gas, and free air 
are demonstrated.
How might this improve emergency 
medicine practice?  
Early recognition and diagnosis for bowel 
perforation in patients on bevacizumab is 
essential to allow prompt surgical evaluation 
and therapy.
incidence of bowel perforation in ovarian cancer treated 
with bevacizumab is estimated to be 2-3%,4 with a relative 
risk of 2.57 compared to ovarian cancer alone.5 Bowel 
perforation and other severe GI pathologies are seen with 
other commonly-used targeted therapies such as sunitinib, 
sorafenib, everolimus, and temsirolimus.6 This patient had 
Image 3. Computed tomography of the abdomen revealing 
intraperitoneal free air (arrows), bowel wall pneumatosis 
(triangles), and air in the mesenteric vasculature (*).
Image 2. Computed tomography scan of the abdomen revealing 
extensive ascites (*), intraperitoneal free air (arrows), and extensive 
branching portal venous gas (triangles), indicative of bowel 
ischemia, necrosis, and perforation.
other independent risk factors for perforation including 
bowel resection-reanastamosis, peritoneal carcinomatosis, 
and partial small bowel obstructions.
Bowel perforation secondary to bevacizumab has an 
estimated 60-day mortality of 25%.2 The diagnosis is 
confirmed by radiographs or CT of the abdomen 
demonstrating intraperitoneal free air, pneumatosis 
intestinalis, or portal venous gas. While management is 
generally surgical, supportive care, including antibiotics, 
parenteral nutrition, and fluid resuscitation, has been 
successful in poor surgical candidates. 
In summary, we report a case of bowel perforation 
related to bevacizumab therapy. This case demonstrates the 
potentially life-threatening side effects of bevacizumab and 
other frequently-used, targeted therapies requiring ED 
diagnosis and resuscitation, and the complex imaging 
findings associated with the diagnosis of bowel perforation 
in a patient with recurrent ovarian cancer.
The documented Institutional Review Board Policy has been 
obtained and filed for publication of this case report.
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Case Presentation: An 83-year-old woman was admitted to the intensive care unit for septic 
shock at which point an internal jugular central venous line was placed. The patient’s common 
carotid artery was visualized in an atypical location, lateral to the internal jugular vein. Further 
inspection revealed the common carotid artery travelling in a rotational trajectory around the 
internal jugular vein. 
Discussion: For at least two decades, point-of-care ultrasound has become the standard of 
care for placing central venous lines. This surprising anatomical orientation is rare and cautions 
physicians to fully explore a patient’s anatomy prior to placing central lines. [Clin Pract Cases 
Emerg Med. 2020;4(2):230–231.]
Keywords: Ultrasound; central venous access; internal jugular vein; anatomy.
CASE PRESENTATION
An 83-year-old woman was admitted to the intensive 
care unit for septic shock. During central venous catheter 
placement, ultrasonography was used to guide insertion. When 
the probe was placed on the left side of the neck in a neutral 
position, the internal jugular vein (IJV) was noted to be medial 
to the common carotid artery (CCA) (Image, Panel A). Upon 
scanning caudad approximately eight centimeters, the CCA 
coursed medially in a rotational trajectory nearly 180 degrees 
(Video) ending up in its typical orientation, medial to the IJV 
(Image, Panel B and C). 
DISCUSSION
The variability in CCA and IJV orientation has been 
studied with multiple imaging modalities. In a series of 
188 patients undergoing ultrasonography, only one patient 
demonstrated an IJV in the medial position.1 Rotation of 
the CCA and IJV has not been described to our knowledge. 
However, one case report describes a duplicated IJV, with 
the medial branch crossing the CCA.2 A magnetic resonance 
angiography study found increasing age to be positively 
correlated with vessel tortuosity.3 Although it did not comment 
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Image. (A) Ultrasonography of patient’s left neck in a neutral 
position showing the common carotid artery (CCA) lateral to the 
internal jugular vein (IJV), (B) coursing posteriorly as it travels 
caudad in a rotational trajectory, and (C) ultimately reaching its 
typical orientation medial to the IJV.
on position of the CCA in reference to the IJV, this study 
suggests that the anatomy of the carotid artery in an elderly 
patient, such as the patient in this case, may not follow 
the typical configuration. Delineating the full extent of the 
patient’s particular anatomy prior to needle insertion, perhaps 
Volume IV, no. 2: May 2020 231 Clinical Practice and Cases in Emergency Medicine
Busack et al. Ultrasonography of a Helical Left Common Carotid Artery
CPC-EM Capsule
What do we already know about this 
clinical entity? 
The anatomic location of the common carotid 
artery is typically medial to the internal 
jugular vein, however may lie posteriorly, 
anteriorly, or rarely laterally. 
What is the major impact of the image(s)?
The image reiterates the importance of using 
multiple modalities, rather than location 
alone, to ensure proper identification of the 
internal jugular vein prior to cannulation.
How might this improve emergency 
medicine practice?  
The image encourages physicians to fully scan 
the neck prior to venous cannulation in order 
to identify the correct vessel and delineate 
atypical venous anatomy.
particularly in older patients, helps to avoid inadvertent 
arterial puncture and increase successful venipuncture. 
Additional parameters, such as vessel compressibility and wall 
thickness, should be used in conjunction with the traditional 
anatomic orientation to properly identify the vein from the 
artery prior to cannulation.
Video. With the provider at the head of the bed with the 
ultrasound probe on the patients left neck, we initially see the 
common cartoid lateral to the internal jugular vein. Sliding the 
probe caudad, the artery dives in a spiral trajectory posterior to 
the vein, ultimately reaching its typical orientation medial to the 
vein just above the clavicle.
Documented patient informed consent has been obtained and 
filed for publication of this case report.
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Case Presentation: A 55 year-old female presented to the emergency department with left 
sided abdominal pain and hematuria. Computed tomography scan of her abdomen and pelvis 
demonstrated a large left renal mass with extension into the left ureter, left renal vein, and inferior 
vena cava. She was admitted and treated for presumed renal cell carcinoma (RCC).
Discussion: RCC may present with abdominal or flank pain and hematuria, but more commonly 
presents with vague symptoms. RCC should be suspected in a patient presenting with hematuria 
and abdominal or flank pain, especially if vague symptoms such as fatigue or anorexia are also 
present. [Clin Pract Cases Emerg Med. 2020;4(2):232–233.]  
Keywords: hematuria; flank pain; renal cell carcinoma.
CASE PRESENTATION 
A 55 year-old female with a history of lymphoma, 
paroxysmal nocturnal hematuria, and undifferentiated renal 
masses presented to the Emergency Department with left 
sided abdominal and flank pain, fatigue, and hematuria. 
Abdominal examination demonstrated mild left upper 
quadrant tenderness. Complete blood count revealed a 
hemoglobin of 6.6 grams per deciliter and platelet count of 
5,000 per microliter. Urinalysis demonstrated large (3+) blood 
and >182 red blood cells per high- powered field. Computed 
Tomography (CT) scan with intravenous (IV) contrast of her 
abdomen and pelvis was obtained (Image). 
DISCUSSION 
CT scan was notable for an 8.2- centimeter necrotic 
mass in the left kidney with extension into the left renal vein, 
inferior vena cava (IVC), and left ureter. The patient was 
admitted to the hospital and transfused with 2 units of packed 
red blood cells and 1 unit of platelets. Oncology and urology 
services were concerned for renal cell carcinoma (RCC). 
The patient was scheduled for outpatient palliative radiation 
therapy and started on rituximab and eculizumab. 
RCC is the most common type of kidney cancer in adults, 
responsible for 90-95% of cases.1 The classic triad of hematuria, 
flank pain, and a palpable flank mass occurs in 5-10% of cases.2 
San Antonio Military Medical Center, Department of Emergency Medicine, Fort Sam 
Houston, Texas
Image. Coronal view of Computed Tomography of abdomen/pel-
vis with intravenous contrast demonstrating a necrotic mass in the 
left kidney with extension into the inferior vena cava (black arrow) 
and ureter (white arrow).
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What do we already know about this 
clinical entity? 
Renal cell carcinoma (RCC) is the most 
common type of kidney cancer in adults. 
It may present with hematuria or flank 
pain, but more commonly presents with 
vague symptoms. 
What is the major impact of the image(s)?
This image depicts RCC invading 
surrounding anatomic structures, leading to 
the clinical manifestation of hematuria. 
How might this improve emergency 
medicine practice?  
Emergency clinicians must suspect this 
diagnosis in adult patients with vague 
symptoms, especially if they have hematuria 
or flank pain.
When present, this triad indicates a more advanced stage of 
the disease. More commonly, patients with RCC present with 
nonspecific symptoms such as fatigue, anorexia, weight loss, or 
fever of unknown origin.3
It is estimated that RCC invades the IVC and forms a 
venous tumor thrombosis in up to 10% of cases,4 as seen 
in the presented patient. CT scan with IV contrast is highly 
sensitive for detecting both RCC and invasion into either the 
ureter or IVC.5 The Emergency Physician must consider this 
diagnosis in a patient with hematuria, especially in the setting 
of abdominal or flank pain, fatigue, anorexia, or weight loss. 
The authors attest that their institution requires neither Institutional 
Review Board approval, nor patient consent for publication of this 
case report. Documentation on file.
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Introduction: Emergency physicians are trained to treat a variety of ailments in the emergency 
department (ED), some of which are emergent, while others are not. A common complaint seen in 
the ED is a sore throat. While most sore throats are easily diagnosed and treated, less common 
causes are often not considered in the differential diagnoses. Therefore, the purpose of this case 
study was to present an atypical case of sore throat and discuss differential diagnoses.     
Case Presentation: The patient was a 45-year-old female who presented to the ED with a three-
day history of sore throat that was exacerbated by eating and drinking. The patient was not on any 
prescription medications, but tried over-the-counter medications for the sore throat without any 
improvement in symptoms. Review of systems was positive for sore throat, fevers, and chills. Physical 
examination of her oropharynx revealed mildly dry mucous membranes with confluent plaques and 
white patchy ulcerative appearance involving the tongue, tonsils, hard palate, and soft palate. Rapid 
streptococcal antigen, mononucleosis spot test, and KOH test were performed and found to be negative. 
Discussion: After initial testing was negative, a follow-up complete blood count with differential and 
complete metabolic profile were ordered. The patient was found to have decreased lymphocytes 
and platelets. Based upon those results, a diagnosis was made in the ED, the patient was started 
on medication, and further laboratory workup was ordered to confirm the diagnosis. ED providers 
should consider non-infectious as well as infectious causes for a sore throat, as this might lead to a 
diagnosis of an underlying condition. [Clin Pract Cases Emerg Med. 2020;4(2):234–240.]
Keywords: HIV; AIDS; oral hairy leukoplakia; oral lesion.
CASE PRESENTATION 
A 45-year-old African-American female presented to the 
emergency department (ED) of a rural, academic medical center 
with a three-day history of “sore throat.” The patient rated her 
pain as a 7/10 and described the pain as a “burning pain and a 
Sacred Heart Hospital, Department of Emergency Medicine, Pensacola, Florida
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Texas Tech University Health Sciences Center, Department of Emergency Medicine, 
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raw sensation,” which was exacerbated by eating and drinking. 
She stated that she had tried over-the-counter (OTC) ibuprofen, 
lozenges, and oral benzocaine throat spray without any 
improvement in her symptoms. The patient admitted to a past 
medical history of hypertension, gastroesophageal reflux disease 
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(GERD), depression, and bipolar disorder.  However, she 
denied taking any medications for her medical conditions. She 
admitted to a one-pack-per-day smoking history and occasional 
alcohol use, but denied illicit drug use, specifically intravenous 
drug use (IVDU). The patient informed the practitioners that 
she had recently moved to the area; therefore she did not have a 
primary care physician, hence coming to the ED. 
A review of her systems was negative for nausea, vomiting, 
diarrhea, shortness of breath (SOB), pain while taking a breath, 
cough, chest pain (CP), and skin lesions. She also denied any 
muscular pain, muscular weakness, or joint pain. The patient 
also denied any vaginal ulcerations or vaginal discharge. She 
did, however, admit to fevers and chills, and stated that the 
highest recorded temperature at home was 39.2°C. Vital signs 
upon presentation were as follows: temperature 38.1°C; blood 
pressure 108/73 millimeters of mercury; pulse 108 beats per 
minute; respiratory rate 16 breaths per minute, and oxygen 
saturation 99% on room air. 
Physical examination revealed an African-American 
female sitting comfortably on the stretcher in no apparent 
respiratory distress. The patient appeared non-toxic, and 
conversation revealed no evidence of hoarse or muffled speech. 
A focused head, eyes, ears, nose, and throat exam revealed no 
oropharyngeal masses or uvular deviation, and no submental 
induration or tenderness were appreciated on examination. 
A bluish discoloration was appreciated on the tongue, but the 
patient admitted to using lozenges just prior to examination. 
A focused examination of her oropharynx demonstrated 
mildly dry mucous membranes with confluent plaques and 
a white, patchy, ulcerative appearance of the uvula, tonsils, 
tonsillar pillars, hard palate, anterior one-third of the soft 
palate, and the side of her tongue (Images 1 and 2).
Given the patient’s pyrexia and symptomology, rapid 
streptococcal antigen and a mononucleosis spot (Monospot) 
test were obtained. The results for the Monospot test and rapid 
group A strep antigen screen were negative. KOH testing was 
performed on the posterior pharyngeal lesion for a possible fungal 
etiology and was found to be negative. Given the negative test 
results and appearance of the lesion, the patient was interviewed 
again. We specifically inquired about high-risk sexual behavior, 
IVDU, and using immunosuppressive medication, all of which 
the patient denied. She was then offered basic lab work consisting 
of a complete blood count (CBC) with differential and complete 
metabolic profile (CMP) (Table 1). 
Based upon those results, a diagnosis was made in the 
ED, the patient was started on medications, and further 
laboratory work was ordered to confirm the diagnosis. 
CASE DISCUSSION 
This 45-year-old African-American patient presented 
with a history of increasing sore throat over the course of 
three days, which was not relieved with OTC medications. 
The patient’s odynophagia led to decreased oral intake, which 
was accompanied by fevers and chills over those same three 
days. Causes for pharyngitis can be broadly placed into two 
categories: infectious and non-infectious causes. 
Non-Infectious 
I initially considered non-infectious causes; however, 
as this was a clinicopathological case, I wanted to 
expand my differential diagnosis, and I felt those could 
be quickly excluded given her history and presentation 
(H&P) and the fact that the patient had a fever. A drug-
induced presentation such as dental decay secondary to 
Image 1. Raised corrugated plaques that could not be scraped off 
on exam, located on the oropharynx, soft palate, hard palate, and 
the side of her tongue.
Image 2. White, confluent, fluffy, hyperkeratotic lesions in a 
patient presenting with complaint of sore throat. 
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methamphetamine use was quickly excluded, as this mostly 
involves the teeth. I briefly considered ingestion of a 
foreign body, caustic or alkaline burns, and thermal burns, 
but this was quickly ruled out as this was not consistent 
with her H&P and by the fact that she had white plaques 
on examination. Stevens-Johnson syndrome and fixed drug 
reactions do have oral involvement, but can be quickly 
ruled out as there were no skin rashes on this patient. 
I next turned my attention to autoimmune disorders, 
which can have oral involvement, and I considered serositis, 
myositis, and Sweet’s syndrome, but I quickly dismissed these 
diagnoses as the patient did not have systemic symptoms 
seen with these disorders. Specifically, she had denied the 
following: a) SOB, CP, and abdominal pain (serositis); b) 
muscular pain or weakness (polymyositis, dermatomyositis); 
and c) skin rash (dermatomyositis, Sweet’s syndrome). 
The final causes I considered in the non-infectious category 
were neoplastic causes. Leukemia can present with thrush, but 
I quickly ruled this out, as this patient had a normal total white 
blood cell count, no systemic symptoms, and the scrapings 
of the oropharyngeal lesions had yielded a negative KOH 
preparation. The patient did admit to a history of smoking and, 
therefore, I strongly considered oropharyngeal cancer. While 
this diagnosis remained high on my differential diagnosis, I felt 
that the precipitous onset of symptoms in addition to the fever 
made this diagnosis less likely than an infectious cause and, 
therefore, I turned my attention to infectious causes. 
Infectious Causes
The most common causes for pharyngitis are of viral 
etiology, including infections due to rhinovirus, adenovirus, 
coxsackie, influenza, and Epstein-Barr virus (EBV). 
Considering the patient’s age and the extensive involvement of 
the lesions (Images 1 and 2), a simple viral infection was less 
likely. However, an infection with EBV causing mononucleosis 
should remain on the differential, keeping in mind that the 
heterophile test (Monospot test) can take over one week until 
it turns positive and in this case the patient’s symptoms have 
been present for only three days. However, mononucleosis often 
presents with monocytosis, which was not the case with this 
patient (Table 1), making mononucleosis a less likely diagnosis. 
Bacterial causes of pharyngitis are very common, with 
the most common pathogen being Streptococcus pyogenes, 
aka group A beta-hemolytic streptococcal infection (GABHS), 
which can ultimately lead to rheumatic fever. However, 
considering the patient’s age, the negative rapid group A strep 
antigen screen, and the extensive involvement of the lesions, 
especially the hard palate and tongue, make a bacterial etiology 
unlikely. Further, the Centor Score on this patient was found to 
be only 2, giving the patient a low risk of 11-17% of GABHS.  
Sore throat and odynophagia can also be a presentation of 
bacterial infection leading to a peritonsillar abscess, infection 
of the floor of the mouth such as Ludwig’s angina, or infection 
Table 1. Complete blood count with differential and complete 
metabolic panel.
Complete blood count Reference range
WBC 4.6 4.5-11.0 x 109/ L
RBC 4.03 L 4.20-5.40 x1012cell/ L
Hgb 14.4 12.0-16.0 g/L
Hct 40.0 37-47%
MCV 99.3 81-101 fL
MCH 35.8 H 26-34 pg
MCHC 36.0 32-36 g/L
RDW 11.7 11.5-14.5%
Plt Count 117 L 130-400 x 109/L
Granulocyte  88.2 H 42.2-75.2 %
Lymphocytes 7.6 L 20.5-51.1 %
Monocytes 3.8 1.7-9.3 %
Eosinophils 0.1 0-5 %
Basophils 0.3 0-3 %
Absolute Granulocytes 4.0 1.4-6.5 x 109/L
Absolute Lymphocytes 0.3 1.2-3.4 x 109/L
Absolute Monocytes 0.17 0.0-0.82 x 109/L
Absolute Eosinophils 0.0 0.0-0.52 x 109/L
Absolute Basophils 0.01 0.0-0.2 x 109/L
Complete metabolic panel 
Sodium 138 137-145 mmol/L
Potassium 3.7 3.5-5.2 mmol/L
Chloride 99 98-107 mmol/L
Carbon dioxide 30 22-30 mmol/L
Anion gap 9 3 and 10 mEq/L
BUN 11 7-17 mg/dL
Creatinine 0.71 0.52-1.04 mg/dL
BUN/CR ratio 15.5 10-20
Calculated osmolality 262 L 275-295 
mOsm
Glucose 85 74-106 mg/dL
Calcium 8.5 8.4-10.2 
mg/dL
T. Bilirubin 0.7 0.2-1.3 mg/dL
AST 24 14-36 U/L
ALT 18 9-52 U/L
Alkaline Phosphate 95 38-126 U/L
Albumin 3.3 L 3.5-5.5 g/dL
WBC, white blood cell count; RBC, red blood cell count; HgB, 
hemoglobin; Hct, hematocrit; MCV, mean corpuscular volume; fL, 
femtoliter; MCH, mean corpuscular hemoglobin; pg, picogram; 
MCHC, mean corpuscular hemoglobin concentration; RDW, red 
cell distribution width; Plt, platelet count; BUN, blood urea nitrogen, 
CR, creatinine; mOsm; milliosmole; T, total; AST, aspartate 
aminotransferase; ALT, alanine aminotransferase; mmol, mllimole; 
mg, mlligrams; dL, deciliter; U, units; L, liter; g, grams.
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of the retropharyngeal or submandibular spaces. On physical 
examination, the patient did not have uvular deviation, tongue 
elevation, or signs of airway compromise, such as stridor, 
drooling, inability to tolerate secretions, muffled voice, or 
hypoxia, making these diagnoses less likely. These physical 
findings, in addition to the fact that the patient was up to date 
on her immunizations, made diagnoses such as epiglottitis, 
bacterial tracheitis, and diphtheria also less likely. 
Another rare presentation to consider in this patient 
would be Lemierre’s syndrome, which is also known as 
infectious thrombophlebitis of the internal jugular vein 
caused by Fusobacterium necrophorum. In general, this 
disease is associated with lethargy, swollen lymph nodes, 
and a prolonged disease course leading to sepsis. This patient 
did not have any lymphadenopathy and while tachycardic 
with a mild fever, did not appear septic. Since this was a 
clinicopathology case, there was likely nothing common about 
it, and therefore the zebras had to be considered. It is unclear 
in this case whether recent orogenital contact exposure had 
occurred; therefore, I added gonococcal and herpes simplex 
virus (HSV) pharyngitis to the differential diagnosis. 
At this point in time, I had almost ruled out the majority 
of my working differential diagnosis while a possibility 
for mononucleosis, oropharyngeal cancer, and possible 
gonococcal or HSV pharyngitis persisted, which led me to 
question what I was missing and if there were any further 
clues from this patient. The patient is a smoker, which 
increased the risk of oral or systemic cancers, but she 
denied IVD and alcohol use. She also denied risky sexual 
behavior and any current prescription medications or being 
immunosuppressed, thus making many of the above “less 
common causes” less likely.
In addition, while the patient denied using any 
prescription medications, I was wondering if there was a 
component of medication non-compliance that could point 
us in the right direction. Upon further exploration, I learned 
the patient had a history of bipolar disorder, depression, 
hypertension, GERD, and had no primary care physician, 
meaning she had no regular screenings or check-ups. These 
together call into question the reliability of the history 
of present illness (HPI), and whether she might have a 
higher risk of any type of infectious, immunosuppression, 
precancerous, or cancerous process. However, since I was 
unable to further derive much information from her HPI, I 
next focused on the laboratory results. The patient was found 
to have a normal absolute WBC cell count. Interestingly, the 
differential of the CBC results revealed lymphopenia with 
a lymphocyte percentage of 7.6%, which raised concern 
for immunosuppression given that the normal percent of 
lymphocyte count for an adult female CBC should fall in 
the range of 20-51% (Table 1). Further, while the normal 
absolute lymphocyte cell count in a healthy adult should be 
approximately 1.2-3.4 X 109/L, the absolute lymphocyte count 
result in this case was 0.3 X 109/L (Table 1). Furthermore, her 
low platelet counts of 117 x 109/L (normal: 130-400 x 109/L) 
sparked my interest. It is well known that thrombocytopenia is 
very common in patients with human immunodeficiency virus 
(HIV) and acquired immune deficiency syndrome (AIDS) and 
is often associated with disease progression.1
In conclusion, after pulling together the HPI, social 
history, patient’s fever, and physical exam findings, along 
with the finding of lymphopenia and thrombocytopenia, I was 
convinced that these were consistent with HIV/AIDS defining 
illness, likely HIV oral lesions (HIV-OL), specifically oral 
hairy leukoplakia (OHL).
CASE OUTCOME 
The patient was clinically diagnosed with OHL, and 
discharged with a prescription for high-dose acyclovir. The 
patient was informed that we suspected immunosuppression to 
be the cause of her lesions and further laboratory workup was 
ordered and sent for serological and immunological analysis. 
The earlier suspicion of HIV infection was confirmed a few 
days later, when infectious disease (ID) serologies detected 
HIV-1 RNA with a HIV-1 viral load totaling 192,000 copies/
mL. Further, the patient was found to have reactive hepatitis-C 
antibodies (Table 2). The patient was also tested for syphilis, 
chlamydia, gonorrhea, and hepatitis A and B, all of which 
were found to be negative (Table 2).
The patient was contacted immediately and was referred to 
the local ID physician for further evaluation and treatment.  She 
was started on antiretroviral therapy (ART). Further follow-up 
showed that the patient’s symptoms resolved after she was started 
on STRIBILD (elvitegravir/cobicistat/emtricitabine/tenofovir) 
and that she continued to follow up with the ID physician. Five 
months after the patient was started on STRIBILD, her absolute 
CD4 count had improved from her initial count of 192 cells/mm3 
to 1029 cells/mm3. Her HIV-1 viral load had declined at that point 
in time to 131,000 copies/mL.
RESIDENT DISCUSSION
Chief complaint of pharyngitis, or sore throat, represents 
one of the most common reasons for ED visits and accounts 
for a total of 2.6 million ED visits annually.2 The patient’s 
complaint is often manifested as a constellation of symptoms 
consisting of throat pain exacerbated by swallowing, which 
may or may not radiate to the ears and neck, prompting 
patients to present to the ED for evaluation. Various subtypes 
of pharyngitis are more prevalent among different patient 
populations. Swelling, erythema with or without exudate, and 
inflammation involving the soft tissues of the oropharynx are 
the causes for the clinical symptoms of pharyngitis, but any 
involvement of the anatomic structures in the hypopharynx or 
nasopharynx can also lead to a sore throat.3
Acute pharyngitis has a wide range of pathological 
etiologies, thus emergency physicians should consider a broad 
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differential when encountering a patient with pharyngitis, 
especially if the H&P does not fit the presenting clinical picture. 
While some physicians choose to empirically treat pharyngitis 
with antibiotics, other emergency physicians use a variety of 
scoring systems to differentiate between viral, fungal, and 
bacterial etiology. A common decision tool used in the ED is the 
Centor Score decision tool to guide the diagnosis and treatment 
of GABHS. Most patients presenting to the ED with a sore throat 
will be diagnosed with uncomplicated infectious pharyngitis 
with a benign disease course. However, there is a small subset 
of patients who either present with an atypical presentation of 
pharyngitis or have a suspicious past medical history, which must 
prompt the practitioner to expand his or her differential diagnosis 
and diagnostic approach. One such subset is comprised of 
immunocompromised patients who can present with a variety of 
oral lesions. Unfortunately, in developed countries, and in the era 
of ART, physicians often do not consider differential diagnoses 
for oral lesions where undiagnosed HIV infection could be the 
underlying cause for such lesions. 
Worldwide, infection with HIV is the most common cause 
leading to an immunocompromised physical state in patients 
and it presents a major global health issue. The prevalence 
of HIV-infected people worldwide in 2018 was estimated to 
be 37.9 million with an incidence rate of 1.7 million.4 In the 
United States, the prevalence is estimated to be 1.1 million 
with an incidence rate of ~40,000 people.5 In 2018, only 23.3 
million infected individuals had access to ART worldwide, 
and the death toll secondary to AIDS-related illnesses was 
estimated to be 770,000 people.4 Further, it is estimated that 
21% of all people worldwide and 14% of people in the US 
living with HIV do not know their HIV status and do not 
receive any treatment.4
The World Health Organization published a classification 
for HIV-OL, which has been the mainstay of defining lesions 
that are commonly observed in patients with HIV. The 
classification system separates HIV-OL into three categories: 
1) oral lesions strongly associated with HIV-infection; 2) 
lesions less commonly associated with HIV infection; and 3) 
lesions directly observed in HIV infection.6 Oral candidiasis 
(OC) and OHL are the two most prevalent HIV-OL lesions 
that are observed in the group of oral lesions strongly 
associated with HIV infection.6 This was validated in a study 
that assessed oral lesions in ART naïve patients and found that 
OC followed by OHL have the highest incidence of HIV-OL.7 
It is known that certain HIV-OL observed in patients with 
diagnosed or undiagnosed HIV have a positive correlation 
predicting the progression to AIDS.8-10  
OHL is a clinical presentation that is found almost 
exclusively in untreated patients with advanced HIV. Further, 
OHL is the result of an acute EBV infection or reactivation 
of a latent EBV infection and results from an impaired oral 
mucosal cell-mediated immunity.11,12 This malfunction of oral 
mucosal immunity is believed to be multifactorial. It has been 
reported that the HIV virus indirectly impairs nitric oxide and 
lysozymes production and IgA synthesis and secretion by the 
oral mucosa that normally function as bactericidal, fungicidal, 
and viricidal agents leading to OHL.12 Most recently, it has 
been suggested that HIV impairs the oral mucosal barrier in 
addition to suppressing CD4+ T cells by also suppressing the 
Th17 T-cells, which secrete IL-17 and IL-23 cytokines, which 
further weakens the oral mucosal immunity and predisposes it 
to opportunistic infections.12,13
Grossly, OHL appears as white, patchy, raised, corrugated 
tissue overgrowth present on the lateral surfaces of the tongue, 
hard palate, and oropharynx, and the projected material present 
on the surface contributes to the “hairy” appearance.14,15 The 
visualized lesions are more common on the tongue, and are 
often more prevalent in males as compared to females.16 
Pathognomonically, these lesions are unable to be scraped 
away during examination, which is often useful in separating 
it from OC.14,15 Microscopically and histologically, OHL 
is characterized by a benign stratified squamous epithelial 
hyperplasia with characteristic pallor.14,15 While OHL is 
considered a “benign” oral manifestation of HIV infection, it 
is of the utmost importance to diagnose this lesion due to the 
fact that it can represent the first physical sign of significant 
immunosuppression in HIV-infected patients. Clinical 
Table 2. Infectious disease serology and immunology of patient 
with suspected immunosuppression.
Test Result Reference range
Treponema pallidum Ab Nonreactive Nonreactive
C. trachomatis RNA Not Detected Not detected
Cryptococcus Ag Screen Not Detected Not detected
Hepatitis A IgM Ab Nonreactive Nonreactive
Hepatitis B Antigen Nonreactive Nonreactive
Hepatitis B Core IgM Ab Nonreactive Nonreactive
Hepatitis C Antibody Reactive H Nonreactive
HIV-1 RNA log copies/mL 5.28 H 1.30-7.00 log 
copies/mL*
HIV- RNA PCR copies/mL 192000 H 20-10,000 
copies/mL*
HIV Genotype Detected Not detected
HIV-2 Antibody Conf Negative Negative
Infectious Mono Assay Negative Negative
N. Gonorrhoeae RNA Not Detected Not detected
Absolute CD4 Count 192 L 600-1,200 cell/mm3
HLA-B57.01 Negative Negative
*Assay quantification result range.
C, chlamydia; RNA, ribonucleic acid; H, high; L, low; HIV, human 
immunodeficiency virus; PCR, polymerase chain reaction; mono, 
mononucleosis; N, Neisseria.
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appearance alone is often sufficient for diagnosis. However, 
if confirmation is required, liquid-based cytology with in 
situ hybridization for EBV can be used for diagnosis and is a 
simple, noninvasive tool that is equivalent to traditional punch 
biopsy of the lesion.17 OHL usually resolves after the patient 
is started on ART therapy, but some clinicians have advocated 
starting a patient on acyclovir or valacyclovir upon diagnosis 
OHL, especially if the patient is symptomatic.10,15
HIV viral load has been shown to have a positive 
correlation to the development of oral lesions, as a viral load 
of 30,000 copies/mm3 exhibited oral lesions related with HIV, 
independent of a patient’s total CD4 cell count.18 Commonly, 
the median CD4+ count when OHL is first visualized by 
practitioners ranges between 235-468 cell/mm3.2,9 Oral lesions 
are generally an early sign of HIV infection, but could also 
be used to predict the clinical manifestations and progression 
of HIV/AIDS infections in patients.4 Literature demonstrates 
an inverse relationship between the development of OHL 
and declining CD4 + counts and it has been shown that HIV 
infection with OHL often progresses to AIDS with CD4 
counts of less than 200 cell/mm3.5,10 Further elucidating 
the inverse relationship between the presence of OHL and 
declining CD4+ counts, one study found that “the probability 
of developing AIDS at the time of HIV diagnosis with the 
presence of OHL when not receiving ART is 48% by 16 
months and 83% at 31 months, respectively.”13,18
While some oral lesions observed with OHL have 
historically been identified as an “AIDS defining illness,” it 
should be noted that in recent years patients have presented 
with OHL and other oral lesions who were not infected with 
HIV.15 Patients with immunosuppression secondary to various 
etiologies, such as solid organ transplant on maintenance anti-
rejection medications, chronic steroids use, or hematologic 
malignancies, have all presented clinically with OHL.7,15 This 
case report demonstrates that atypical pharyngeal lesions should 
prompt the treating physician to consider immunosuppression 
as a possible etiology. It is noteworthy to add that some 
emergency physicians have been hesitant in the past to perform 
HIV testing in the ED for various reasons including difficulty 
following up on results, inability to counsel patient on results, 
and lack of access to follow-up.19-22 The authors disagree with 
this notion and, as is demonstrated in this case, it is the duty of 
the emergency physician to order testing so that an appropriate 
diagnosis and treatment referral can be given to the patient. 
In 2006 the CDC updated the HIV testing guidelines 
to include testing all patients who present to healthcare 
facilities with concern for possible infection, including 
the ED.19-22 It is recommended that counseling should be 
provided to the patient prior to HIV testing, and also after 
testing, if the results are in fact positive.19-22 A cross-sectional 
analysis using data from two large national healthcare 
surveys from the years 2009-2014 was performed and found 
that HIV testing in EDs was nationally low, despite the 
updated CDC recommendation in 2006.20 The conclusion 
reached by the authors is that testing for HIV should be 
performed in the ED, especially in patients who solely rely 
on ED visits for their healthcare.20 In conclusion, emergency 
physicians must be reminded that HIV-OL may present in 
the ED setting and physicians should consider serological 
testing while in the ED so that the appropriate follow-up and 
treatment for the patient can be initiated. 
FINAL DIAGNOSIS 
Oral hairy leukoplakia, presenting as an AIDS defining 
illness. Reactive hepatitis C antibody, indicating current or 
prior hepatitis C infection.
KEY TEACHING POINTS
• Pharyngitis is common in the emergency department (ED), 
accounting for 2.6 million visits annually, and is most often 
caused by viral, bacterial, and fungal pathogens.
• Atypical presentations of pharyngitis should prompt the ED 
provider to expand their differential diagnosis, especially if 
there are concerns for possible immunosuppression.
• Oral hairy leukoplakia (OHL) is the second most 
prevalent HIV defining oral lesion, after candida.
• OHL is typically a white, patchy area on oral mucosa that 
is unable to be scraped off, and may have pedunculated 
tissue, hence the “hairy” descriptor.
• OHL has historically been an “AIDS defining 
illness,” but can also been seen with solid organ 
transplant immunosuppression, chronic steroid use, or 
hematologic malignancies.
Documented patient informed consent and/or Institutional Review 
Board approval has been obtained and filed for publication of this 
case report.
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Introduction: Immunoglobulin A vasculitis (IgA vasculitis), formerly Henoch-Schonlein purpura, is 
the most common vasculitis in children.
Case Report: A 6-year-old female presented with low back pain and swelling, difficulty ambulating, 
and rash two weeks after a respiratory infection. She was approached with a broad differential and 
ultimately diagnosed with IgA vasculitis.
Discussion: Cutaneous manifestations, arthralgias, renal and gastrointestinal involvement are the 
most common presenting signs of IgA vasculitis. Only two cases of IgA vasculitis associated with 
lumbar pain and swelling were identified in the literature. 
Conclusion: While rash and joint pain are common presenting signs of IgA vasculitis, practitioners 
should be aware it can present atypically. [Clin Pract Cases Emerg Med. 2020;4(2):241–243.] 
Keyword: IgA vasculitis; Henoch-Schonlein purpura; HSP; lumbar swelling.
INTRODUCTION
Immunoglobulin A (IgA) vasculitis is the most common 
vasculitis in children.1 IgA vasculitis, formerly known as 
Henoch-Schönlein purpura, is comprised of a clinical tetrad 
of palpable purpura, arthralgias, abdominal pain, and renal 
disease, all in the absence of thrombocytopenia or 
coagulopathy.1 Subcutaneous edema, either periorbital or 
dependent edema in the hands, feet, and genitals, are all well 
documented in the literature.1-3 The diagnosis of IgA 
vasculitis is typically made by clinical examination and 
presence of the palpable purpuric rash along with two to 
three of the other classical findings of the clinical tetrad, 
although IgA deposition can aid the diagnosis.1 We present a 
case of a six-year-old female who presented to the 
emergency department (ED) due to non-traumatic back pain, 
swelling, and refusal to ambulate. 
Prisma Health - University of South Carolina School of Medicine, Department of 
Emergency Medicine, Columbia, South Carolina
West Virginia School of Osteopathic Medicine, Lewisburg, West Virginia
Ohio Valley Medical Center, Department of Emergency Medicine, Wheeling, West Virginia
*
†
‡
CASE REPORT
A six-year-old female was brought by a family member to 
the ED complaining of low back pain and swelling. The 
patient’s symptoms had been ongoing for several days. She 
denied any history of trauma. She was refusing to ambulate 
secondary to pain in the joints of the lower extremities.  She 
also noted mild nausea, ankle swelling, and a rash on her 
lower extremities bilaterally. The patient’s family also 
described her as having a previous upper respiratory infection 
approximately two weeks prior. The patient was fully 
immunized and had an unremarkable past medical, surgical, 
and family history. She had been taking ibuprofen for her 
symptoms, but otherwise took no medications.  
She was afebrile with a temperature of 99.0° Fahrenheit, 
and had a heart rate of 112 beats a minute, a blood pressure 
of 123/81 milligrams of mercury, a respiratory rate of 18 
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What do we already know about this clinical 
entity? 
Immunoglobulin A (IgA) vasculitis is a common 
pediatric disease that is a combination of a 
rash, arthralgias, abdominal pain, and renal 
disease with varying penetrance.
What makes this presentation of disease 
reportable? 
This presentation of IgA vasculitis is a rare 
presentation only previously described in the 
literature twice. 
What is the major learning point? 
The major learning point is that IgA vasculitis 
will commonly have atypical presentations and 
should be considered in unusual cases. 
How might this improve emergency medicine 
practice? 
This article helps highlight the importance 
to consider IgA vasculitis in the differential 
while treating the pediatric patient in the 
emergency department.breaths per minute, and 99% pulse oximetry on room air.  She was refusing to ambulate secondary to pain but was 
otherwise nontoxic appearing. There was an oval area of 
cutaneous edema, similar in shape to an American football, 
approximately 10 centimeters (cm) vertically and 8 cm 
transversely, stretching from her lower thoracic spine down 
to her lower lumbar spine over which she had moderate 
tenderness (Image 1). She had mild, non-pitting pedal edema 
and was noted to have a palpable purpuric rash over her 
ankles and lower legs. Abdominal and neurologic 
examinations were benign, and the remainder of the physical 
exam was unremarkable.
Laboratory studies included an unremarkable complete 
blood count, prothrombin time, partial thromboplastin time, 
and complete metabolic panel. Urinalysis was significant for 
hematuria with 10-15 red blood cells seen per high-powered 
field on microscopy and without proteinuria. The patient was 
also noted to have an elevated erythrocyte sedimentation rate 
at 44 millimeters per hour (normal is <30) and an elevated 
C-reactive protein at 1.8 milligrams per liter (normal is <1.0). 
Radiographs of the lumbar spine demonstrated subcutaneous 
edema but were otherwise unremarkable (Image 2).
The patient was treated with a weight-based dose of 
ibuprofen and was observed ambulating without difficulty 
around the ED.  She was discharged with a 48-hour follow-up 
in the ED.  At her follow-up it was noted that she no longer 
had any pain or swelling of her lower back and the remainder 
of her symptoms were resolving as well.
DISCUSSION
IgA vasculitis is known to have varying presentations, 
sometimes including edema of the hands, feet, and even 
genitals.2,3,6 Varying penetrance of clinical features appears to be 
somewhat common and is well documented.2,6 In one 
retrospective study of 150 patients diagnosed with IgA vasculitis, 
all had cutaneous manifestations, whereas 74% had arthralgias, 
54% had renal involvement, and 51% had abdominal 
involvement.2 Gastrointestinal symptoms occur in approximately 
50% of cases and can range from nausea and vomiting to 
intestinal bleeding or intussusception.1 Renal involvement can 
range from a small amount of hematuria or proteinuria to 
nephrotic-range proteinuria and elevated creatinine.1 Diagnosis is 
usually clinical and based on the presence of classical symptoms, 
but can be aided by skin and renal biopsy demonstrating IgA 
deposits.1 Complications of IgA vasculitis include chronic kidney 
disease or, rarely, intussusception.2 Treatment is generally aimed 
at symptom relief; use of corticosteroids is controversial.1,2 
After a literature review, we identified only two previous 
cases of IgA vasculitis associated with lumbar pain and swelling 
in a child diagnosed with IgA vasculitis.4,5 In one of these cases, 
Image 1. Photograph of the patient’s lower back demonstrating 
lumbar soft tissue swelling indicated by the arrow.
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the patient’s presenting symptoms were abdominal pain rather 
than back pain. This patient had hemoccult-positive stool and 
only later developed the lumbar swelling on day 3 of 
hospitalization.4 The lumbar swelling resolved after two days; 
however, that patient did develop facial edema that required 
ongoing corticosteroid treatment.4  In the second case, the 
patient’s presenting symptom was back pain and refusal to 
ambulate after a febrile illness and development of a rash. 
Magnetic resonance imaging was performed, which 
demonstrated edema of the lumbosacral fascial planes.5 
The lumbar swelling noted in those two cases and in our 
case is likely the same mechanism of dependent edema, which 
commonly leads to swelling of the hands and feet. We 
approached our patient with a broad differential diagnosis. 
After a thorough physical examination and laboratory studies, 
she was diagnosed with IgA vasculitis, treated accordingly, 
and discharged home. 
CONCLUSION
This case illuminates an atypical presentation of IgA 
vasculitis that is notable for its comparative rarity, having been 
noted only twice previously in the literature.4,5 The patient’s 
atraumatic low back pain and swelling elicited a wide 
differential diagnosis on her presentation. Only after a 
thorough examination and laboratory studies did we determine 
that it was a presentation of IgA vasculitis. This case 
demonstrates the importance for clinicians to be aware that 
this common diagnosis can present in uncommon ways.
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nor patient consent for publication of this case report has been 
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Image 2. Lateral radiograph of the lumbar spine with noted 
subcutaneous edema and soft tissue swelling noted by the arrow.
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Introduction: Brugada syndrome is an arrhythmogenic disorder that is a known cause of sudden 
cardiac death. It is characterized by a pattern of ST segment elevation in the precordial leads on an 
electrocardiogram (EKG) due to a sodium channelopathy.
Case Report: This case report highlights the case of a five-year-old female who presented to the 
emergency department with a febrile viral illness and had an EKG consistent with Brugada syndrome.
Discussion: Fever is known to accentuate or unmask EKG changes associated with Brugada due to 
temperature sensitivity of the sodium channels. 
Conclusion: Febrile patients with Brugada are at particular risk for fatal ventricular arrhythmias and 
fevers should be treated aggressively by the emergency medicine provider. Emergency medicine 
providers should also consider admitting febrile patients with Brugada syndrome who do not have an 
automatic implantable cardioverter-defibrillator for cardiac monitoring. [Clin Pract Cases Emerg Med. 
2020;4(2):244–246.]
Keywords: Brugada; pediatric; viral illness; arrhythmias; fever.
INTRODUCTION
Brugada syndrome is an important cause of sudden 
cardiac death and is prevalent in a young patient population. 
Nevertheless, the classic electrocardiogram (EKG) findings 
associated with the disease may not always be present in 
individuals with Brugada syndrome.1 The characteristic ST-
segment elevations in the precordial leads are caused by a 
loss of function mutation of sodium channels involved in 
phase 0 of the cardiac cycle.2 A new hypothesis is that these 
sodium channels are also temperature sensitive. As a result, a 
fever accentuates impaired sodium channels influx to not only 
unmask classic Brugada EKG changes, but may also induce 
potentially fatal ventricular arrhythmias.1 As demonstrated in 
this case report, a young female presented to the emergency 
department (ED) for the evaluation of a febrile viral illness 
and was found to have this life-threatening cardiac anomaly 
on her EKG.
Midwestern University, Department of Emergency Medicine, Downers Grove, Illinois
CASE REPORT
A five-year-old African-American female presented to a 
community hospital ED with two days of subjective fevers. 
This fever was associated with nasal congestion, a productive 
cough, a sore throat, and injected conjunctiva. She also 
complained of nausea, and her mother reported decreased oral 
intake. Her mother denied any history of syncopal episodes. 
The patient was born full term and had no past medical 
history. Her immunizations were up to date with the exception 
of an annual influenza vaccine. Furthermore, she had no 
notable family medical history and, specifically, no family 
history of sudden cardiac death. 
In the ED she was ill appearing, but she was well-hydrated 
and non-toxic in appearance. Her vitals were as follows: 
temperature 101 degrees Fahrenheit, heart rate 118 beats per 
minute, blood pressure 105/70 millimeters of mercury, respiratory 
rate 20 breaths per minute, saturating 98% on room air. 
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What do we already know about this clinical 
entity? 
Brugada syndrome is an important cause of 
sudden cardiac death as a result of a loss of 
function mutation of sodium channels.
What makes this presentation of disease 
reportable? 
Fever provokes electrocardiogram (ECG) changes 
in asymptomatic individuals with Brugada and 
the ECG may revert to normal when the patient 
becomes afebrile.
What is the major learning point? 
The impaired sodium channels are thought to 
be temperature sensitive. Fever is the state most 
likely to induce ventricular arrhythmia in children 
with Brugada.
How might this improve emergency medicine 
practice? 
Physicians must be cognizant of the potentially life-
threatening complications of fevers in this patient 
population and have a low threshold for admission.
On physical exam, her ears, nose and throat exam were 
only notable for congestion and an erythematous pharynx. Her 
lungs were clear to auscultation bilaterally. On cardiac exam, 
she was tachycardic with an irregular rhythm. There were no 
murmurs, rubs, or gallops heard. Her abdomen was soft and 
non-tender. Lastly, her skin exam was unremarkable. 
Her complete blood count (CBC), complete metabolic 
panel (CMP), magnesium, and troponin were within normal 
limits, but did test positive for influenza A. Her chest 
radiograph was negative. Her EKG (Image) showed a sinus 
rhythm with frequent premature ventricular contractions, a 
right axis, and coved ST elevation in V1-V2. 
Upon recognition of the Brugada pattern on her EKG, 
it was determined that she required higher level of care than 
was available at the community hospital. She was transferred 
to a children’s hospital and evaluated by pediatric cardiology. 
While there, an echocardiogram was performed and was 
negative for structural heart disease. She also underwent an 
electrophysiology study, which was negative for inducible 
arrhythmias. Thus, the decision was made to defer automatic 
implantable cardioverter-defibrillator (AICD) placement. 
The patient and her family were referred for genetic testing, 
but they chose not to complete the testing. Currently, she is 
followed regularly by a pediatric cardiologist and has had no 
adverse cardiac events to date. 
DISCUSSION
Brugada syndrome was first recognized in 1992 and has 
since been identified as an autosomal dominant, inherited 
sodium channelopathy.3 Specifically, a loss of function 
mutation of the SCN5A gene causes an impairment of sodium 
influx during phase 0 of the cardiac cycle.2 Classic EKG 
findings include three types of ST elevations in V1-V3: coved, 
saddleback, or a combination.3 The diagnostic criteria for 
Brugada syndrome is the presence of a type I pattern (coved 
Image. Patient’s electrocardiogram showing Brugada pattern coved ST elevation in V1-V2 (arrows).
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ST elevation) on EKG with one of the following: documented 
ventricular arrhythmia; family history of sudden cardiac 
death; type I pattern EKG in a family member; induced 
ventricular arrhythmia with electrical stimulation; or history of 
unexplained syncope.4
Fever provokes these EKG changes in asymptomatic 
individuals with Brugada and the EKG may revert to 
normal when the patient becomes afebrile. While the exact 
mechanism is unknown, it is postulated that the sodium 
channels are temperature sensitive and thus fever exacerbates 
the impairment of sodium influx through the channel.1 This 
leads to nonhomogeneous repolarization of the right ventricle 
and thus creates a potential for re-entry arrhythmias.3 In 
fact, fever has been associated with 18% of cardiac arrests 
in patients with Brugada.4 In children, symptomatic Brugada 
is most frequently associated with fever.7 As clinicians, it 
is important to recognize that fever is the state most likely 
to induce ventricular arrhythmia in children with Brugada.5 
Parents need to be educated to treat fevers aggressively 
and hospital admission for cardiac monitoring should be 
considered for patients without an AICD. Furthermore, EPs 
should not be falsely reassured by the normalization of the 
EKG in this patient population.6
Treatment of asymptomatic patients with Brugada is 
controversial in adults and not well studied in pediatrics. 
Symptomatic patients with a history of arrhythmia, 
syncope, or family history of sudden cardiac death 
should all receive an AICD. Those who are asymptomatic 
commonly undergo electrophysiology studies and if no 
inducible arrhythmia is found, they are typically managed 
conservatively with close follow-up.3 
CONCLUSION
Brugada syndrome is primarily reported in adults, with 
limited data on its presentation in pediatrics. In both adults 
and pediatrics, a febrile illness may unmask an underlying 
Brugada pattern EKG, even in individuals with previously 
normal EKGs. The impaired sodium channels are thought 
to be temperature sensitive, and thus fever exaggerates 
the impaired sodium influx. This not only emphasizes the 
EKG changes, but also places the patient at risk for fatal 
arrhythmias. This case report demonstrates an instance in 
which these EKG changes were only revealed as a result of 
a febrile illness. While there have been a handful of similar 
case reports published in the literature, it is still a novel 
concept for many clinicians. EPs in particular must be 
cognizant of the potentially life-threatening complications 
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of fevers in this patient population and have a low 
threshold for admission. 
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Introduction: We present a case of hyperkalemia secondary to excessive dietary intake of hard 
caramel candies. 
Case Report: An 88-year-old male who presented with acute abdominal pain and vomiting 
was found to have hyperkalemia of 6.9 milliequivalents per liter. He was stabilized, treated, and 
discharged the following day after resolution. The cause was identified as his daily consumption of 
200 hard caramel candies.
Discussion: The patient had been consuming sugar-free candies, which induced a chronic diarrhea. 
This led to potassium wasting and augmentation of his home medications. When he transitioned to 
eating regular caramel candies, he retained too much potassium leading to his presentation. 
Conclusion: While often overlooked, dietary history is a crucial part of history-taking to ensure 
that the underlying cause for illness is discovered and addressed. [Clin Pract Cases Emerg Med. 
2020;4(2):247–250.]
Keywords: Hyperkalemia; diet; history taking; dietary habits; sorbitol and diarrhea.   
INTRODUCTION
In this case of hyperkalemia a patient with previous, 
stable, chronic kidney disease (CKD) and regular primary 
care induced his own hyperkalemia secondary to obscure 
dietary habits. Dietary habits and nutrition are an often-
neglected aspect of medical education, especially for the 
emergency physician. However, for our patient’s health, it is 
imperative that we discover the causative factor for his or her 
presentation to best prevent the condition from reoccurring. 
This is much more critical in the setting of hyperkalemia as 
mild elevations have been associated with short- and long-
term increased mortality.1 
Hyperkalemia is often associated with CKD with 
prevalence as high as 20%. It has been suggested that in 
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CKD above-normal potassium concentrations are present to 
induce stress on the remaining functional renal cells, which 
respond to additional diuresis of the potassium.2 This delicate 
system is able to maintain homeostasis in the absence of any 
additional insult. The insult may come from acute changes in 
renal excretion, fecal excretion, dietary intake, or metabolic 
acidosis.1 While dietary potassium has been implicated in the 
past, no previous literature suggests sugar substitutes in food 
as a causative factor.2 
CASE REPORT
An 88-year-old male presented to the emergency 
department (ED) with a one-day history of nausea and 
vomiting associated with severe, crampy, and diffuse 
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What do we already know about this clinical 
entity? 
Hyperkalemia is a potentially fatal 
abnormality that is often caused by 
medications or kidney disease. 
What makes this presentation of disease 
reportable? 
Underlying cause in this patient is dietary 
source which is often an overlooked piece in 
the patient history.
What is the major learning point? 
Do not overlook the diet as a cause, and 
remember to search for the underlying 
etiology when treating pathology.
How might this improve emergency 
medicine practice? 
As a reminder to pause and take more inclusive 
histories from our patients, which can become 
underrated in the busy ED setting.
abdominal pain beginning that morning. The patient also 
reported daily diarrhea for longer than one month, but it 
was never problematic and had spontaneously resolved 
approximately one week prior to arrival. He described his 
pain as similar to what he had experienced in a previous 
episode of peritonitis as a young man, which required 
an exploratory laparotomy; he also reported a history of 
multiple abdominal surgeries. The vomit was non-bilious and 
non-bloody; he stated it looked just like the tea he regularly 
drinks. He denied any associated symptoms of fever, chills, 
weakness, or body aches. 
The patient’s last primary care visit was two weeks 
prior to arrival where routine labs including renal function 
and electrolytes were performed. All studies were reported 
within his baseline. He had an extensive medical history 
that included diet-controlled type 2 diabetes mellitus, 
hypertension, hyperlipidemia, coronary artery disease, 
chronic obstructive pulmonary disease, and stable stage 3A 
CKD. Baseline renal function was recorded as creatinine 
1.60 milligrams per deciliter (mg/dL) (normal range 0.6-1.3 
mg/dL) and glomerular filtration rate (GFR) of 45 milliliters 
per minute per 1.73 meters squared (mL/min/1.73 m2) 
(rnormal range for non-African American ≥ 60).
While he had spontaneous improvement of his abdominal 
pain prior to emergency physician assessment he continued 
to have generalized tenderness to palpation, without rebound. 
We obtained a complete blood count with differential, a 
comprehensive metabolic panel, and a computed tomography 
(CT) of the abdomen and pelvis. The initial laboratory results 
revealed hyperkalemia of 6.9 milliequivalents per liter (normal 
3.6-4.9 mmol/L, critical high >6.0 mmol/L), which was 
not included on the original differential diagnosis. We also 
noted mild worsening of his baseline renal function with an 
increase of creatinine to 1.75 mg/dL, and decrease of GFR 
to 35 mL/min/1.73m2. Once the hyperkalemia was identified 
as a non-hemolyzed sample, therapy was initiated with one-
gram intravenous (IV) calcium gluconate, performance of an 
electrocardiogram (ECG), one liter normal saline fluid bolus, 10 
units IV insulin, 25 grams D50, plus 7.5 mg nebulized albuterol. 
The ECG revealed a paced rhythm at 60 beats per minute 
and T-wave inversions in leads V3-V6 without hyperacute T 
waves (Image). The CT revealed no acute process, and the 
patient was admitted to the hospital for further management and 
treatment of his hyperkalemia. 
Once admitted, the patient reported a long history of 
xerostomia, which he self-treated by eating hard caramel 
candies throughout the day for many months. His medication 
list included clopidogrel, atorvastatin, enalapril, and 
spironolactone. At this time a lengthy conversation ensued in 
an attempt to determine the cause of his sudden, symptomatic 
hyperkalemia. It was determined that he previously had 
been taking supplemental potassium while he was taking 
furosemide. In November he discontinued the supplemental 
potassium because his serum level was “borderline high.” In 
December, he switched from furosemide to spironolactone 
due to a recurrence of hypokalemia. His monthly follow-up in 
January revealed a normal potassium, but he was subsequently 
admitted two weeks later for this episode of hyperkalemia 
with abdominal pain (Figure).
His diet consisted primarily of canned soups, 
sandwiches, and one gallon of sugar-free peach iced tea 
daily. He further reported consuming a large quantity of hard 
caramel candies each week. When asked about the candy he 
stated that he bought a 10-pound bag weekly for himself, 
roughly 200 candies consumed daily. During his primary 
care visit in December, he switched to sugar-free caramel 
candies as part of an attempt at improving his glucose 
control. Also, at this visit furosemide was discontinued, and 
he was started on spironolactone (Figure 2). This happened 
to coincide with the onset of his reported chronic diarrhea. 
One week prior to ED presentation, he stopped eating the 
sugar-free candies because the taste “just wasn’t the same,” 
and switched back to the original caramel candies. This 
resolved his diarrhea, although he had never noticed the 
correlation until after his conversation with care providers.
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DISCUSSION
Potassium regulation is dependent on dietary intake and 
renal and bowel excretion. In a patient without CKD this 
likely would not have caused the dramatic response seen here. 
While high dietary potassium can overcome the body’s ability 
to adapt to excess excretion, the patient was also augmenting 
his own reserve by the amount of sorbitol-induced diarrhea 
prior to his cessation from sugar-free candies. Review of diet 
discovered the patient had an abnormally high daily intake 
of both 200 caramel candies and one gallon of sugar-free, 
peach iced tea. From the tea, he was consuming approximately 
16 servings of potassium-based sweetener daily. Although 
no data was available on the true quantity of potassium 
in each serving, there is literature to suggest potassium-
based sweetener substitutes have higher bioavailability than 
natural potassium and are often under-reported quantities of 
dietary potassium.1 In the caramel candy there is no reported 
potassium, nor evidence of potassium in the ingredients 
list; however, the sugar-free version contains sorbitol as the 
sweetener. Sorbitol is known to induce osmotic diarrhea.4 
The quantity of intake (200 candies/day) explained 
his chronic diarrhea from mid-December until one week 
prior to arrival. Osmotic diarrhea is also associated with 
increased fecal loss of potassium.5 The patient likely would 
have developed hyperkalemia initially when switched from 
furosemide to spironolactone as it was coupled with enalapril 
in the setting of CKD.6 The presentation was delayed and 
offset initially by the co-initiation of sorbitol intake from 
sugar-free caramel candies, which increased fecal potassium 
loss and allowed his previous outpatient potassium level 
to result within normal limits. Once the excess potassium 
loss was stopped by switching back to original caramel 
candies (which contain no sorbitol), the diarrhea resolved, 
and the medication combination and elevated dietary intake 
of potassium culminated in the patient’s presentation. If 
untreated, his renal function would likely have deteriorated 
further and his potassium may have continued to elevate to 
fatal levels.
CKD places a patient at increased risk for hyperkalemia, 
especially in the setting of concurrent use with potassium-
sparing diuretics.2,6 As a dietary cause, salt substitutes are a 
well-known source of potassium.3 This case presents an entirely 
new class of food, sugar-free items, as a causative factor for 
hyperkalemia. It also includes a unique case of self-temporizing 
potassium normalization with increased excretion due to the 
patient’s consumption of sugar-free candies until his abrupt 
discontinuation in favor of the original versions made with real 
sugar. The increasing abundance of sugar substitutes in food 
items may pose a threat to patients in the future. If this patient 
had not had such high dietary intake of potassium from his 
potassium-laden, sugar-free tea, he likely would have been found 
hypokalemic earlier from the sugar-free caramel candy, sorbitol-
induced, chronic osmotic diarrhea. Both sugar-free foods in this 
case can create concerning electrolyte abnormalities on their own 
and require the attention of the astute provider in history-taking to 
determine the underlying cause. 
Image. Electrocardiogram of 88-year-old man who presented with sudden, symptomatic hyperkalemia.
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Figure. Timeline of medications and caramel candy type in a patient whom developed hyperkalemia.
CONCLUSION
This case highlights the importance of good history-
taking, as it can mean the difference in diagnosing the 
underlying cause of a disease and preventing future 
complications.7 More specifically, this case highlights the 
importance of a dietary history, something too often ignored in 
the ED. It can be easy to focus on the immediate treatment and 
stabilization of patients, but we must also be advocates for our 
patients and remember to search for the underlying cause.
Documented Institutional Review Board exemption has been 
obtained and filed for publication of this case report.
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Introduction: Brugada syndrome is a genetic disorder of the heart’s electrical system that increases 
a patient’s risk of sudden cardiac death. It is a syndrome most prevalent in Southeast Asians and is 
found 36 times more commonly in Asians than in Hispanics.
Case Report: We report and discuss a case of a 68-year-old Hispanic male who presented with 
clinical and electrocardiogram abnormalities consistent with Brugada syndrome.
Discussion: The patient’s age and ethnicity represents an atypical presentation of this rare 
syndrome and the lack of reported studies in the literature pertaining to these demographics 
reflect this.
Conclusion: Further studies and characterizations are necessary as manifestations continue to 
be unearthed. As such, Brugada Syndrome should be considered in the differential diagnosis for a 
myriad of patient populations. [Clin Pract Cases Emerg Med. 2020;4(2):251–254.] 
Keywords: syncope; ventricular tachycardia; ventricular fibrillation; emergency department; sudden 
cardiac death.
INTRODUCTION
Brugada syndrome, an autosomal dominant disorder 
of the heart’s electrical system, was first described in 
medical literature in 1992 as a frequent cause of syncope, 
ventricular tachyarrhythmia, and sudden cardiac death.2, 
3 An extremely rare phenomenon affecting an estimated 
0.05% of people worldwide, it presents at an average age 
of 41 years and tends to affect men and those of Asian 
ancestry most frequently.3, 4 The electrocardiogram (ECG) 
of a patient with this syndrome classically demonstrates 
ST-segment elevations in leads V1 to V3 and a right bundle 
branch block pattern.3 Here we discuss a case of an elderly 
Hispanic patient with no significant past medical history who 
presented to the emergency department (ED) with first-time 
signs and symptoms consistent with Brugada syndrome. 
Henry Ford Wyandotte Hospital, Department of Emergency Medicine, Wyandotte, Michigan 
Burrell College of Osteopathic Medicine at New Mexico State University, Department of 
Emergency Medicine, Las Cruces, New Mexico
CASE REPORT
A 68-year-old Hispanic male with no significant past 
medical history was brought to the ED by emergency medical 
services (EMS) for confusion and altered mental status. EMS 
reported that they were called by the patient’s wife when she 
discovered him breathing erratically and could not rouse him. 
Upon arrival to the ED, the patient was obtunded and began 
to experience cardiac arrest with ventricular fibrillation. He 
was subsequently intubated and given Advanced Cardiac 
Life Support where cardiopulmonary resuscitation was 
administered and the patient was defibrillated. He went on 
to experience return of spontaneous circulation. An ECG 
obtained in the ED during this event demonstrated ST-segment 
elevations in V1-V3 and specific repolarization abnormalities 
in V1 and V2 (Image).
*
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What do we already know about this clinical 
entity? 
Brugada syndrome is a rare genetic disease 
of the heart associated with arrhythmia and 
sudden cardiac death.
What makes this presentation of disease 
reportable? 
Our Hispanic patient represents an atypical 
presentation of a disease most prevalent in 
Asians and lends credence to the need for 
further evaluation of this disorder.
What is the major learning point? 
Brugada syndrome should be considered 
in the differential diagnosis for various 
patient populations.
How might this improve emergency 
medicine practice? 
Broadening the differential diagnosis  will 
aid early recognition, particularly in the 
elderly with unremarkable cardiac histories.
Additional ECG findings included the following: first-
degree atrioventricular (AV) block, PR interval of 220 
milliseconds (120-200 milliseconds), and QRS duration of 
0.11 seconds (0.08-0.12 seconds).
The patient was placed on an amiodarone infusion and 
transferred to a medical facility with a cardiac catheterization 
laboratory. Emergent cardiac catheterization was performed 
due to concerns for ST-elevation myocardial infarction 
(STEMI), but no acute findings were discovered. Laboratory 
values from the initial blood draw in the ED demonstrated 
the following: sodium 132 milliequivalent per liter (meq/L) 
(normal 136-145 meq/L); potassium 3.3meq/L (normal 3.5-
5.0 meq/L); magnesium 3.3 milligram per deciliter (mg/dL) 
(normal 1.5-2.4 mg/dL); glucose 197mg/dL; troponin <0.02 
nanograms per milliliter;  brain natriuretic peptide (BNP) 65; 
prothrombin time (PT) 13.6 seconds (normal 11-13 seconds); 
international normalized ratio (INR) 1.3 seconds; and thyroid 
stimulating hormone (TSH) 59.4 milliunits per liter (mU/L) 
(normal 0.5-5.0 mU/L). 
Following cardiac catheterization, the patient was 
transferred to the intensive care unit where all vital signs 
remained stable and within normal limits. With members 
of the patient’s immediate family at bedside, information 
pertaining to his personal history was elicited for the first time. 
They reported that the patient had been in good health prior 
to the onset of his confusion and at no point did he complain 
of any discomfort or associated symptoms. Furthermore, they 
denied any significant past medical or surgical events in the 
patient’s history, including any personal or family history 
of heart disease or sudden cardiac death. They stated that 
the patient had no allergies, did not take any medications, 
never used tobacco or illicit drugs, and consumed alcohol 
occasionally during social events. 
The following day, the patient was extubated with 
excellent response and was found to have no focal deficits 
on physical exam. Thyroid replacement therapy was initiated 
for severe hypothyroidism discovered incidentally during the 
aforementioned care. Although no additional adverse cardiac 
events would occur for the duration of his hospital stay, the 
patient agreed to placement of an implantable-cardioverter 
defibrillator (ICD) as recommended for secondary prevention 
of Brugada syndrome. 
Further work-up of the patient during his hospital 
course included the following: magnetic resonance imaging 
of the brain, which demonstrated multiple small areas of 
infarct in the bilateral cerebral hemispheres and no other 
significant findings. Computed tomography angiography 
of the head and neck were found to be normal. After 
demonstrating an ability to ambulate 300 feet with front-
wheel walker, the patient was discharged home on aspirin 
and statin medication.
Left heart catheterization was performed 18 days 
later as recommended by the patient’s electrophysiologist. 
The right coronary artery was found without stenosis or 
blockage; the left anterior descending artery was patent; 
and overall coronary circulation and left ventricular 
function were normal. These findings, coupled with the 
patient’s presenting symptoms and findings found on ECG 
in the ED, ultimately corroborated a diagnosis of Brugada 
syndrome with a type 1 pattern. 
DISCUSSION
The average age of presentation of Brugada syndrome 
is 41 years, and men are affected far more frequently than 
women (9:1 ratio).3 This syndrome is believed to affect 
0.5 per 1000 people worldwide, with Asians affected 
nine times more often than Caucasians and 36 times 
more often than Hispanics.1 All patients, regardless of 
ethnicity, are predisposed to suffering from ventricular 
tachycardia, ventricular fibrillation, and sudden cardiac 
death.3 Moreover, patients are predisposed to suffering 
from concurrent cardiac abnormalities that include right 
bundle branch block, first-degree AV block, intraventricular 
conduction delay, and sick sinus syndrome.4 
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Several mechanisms have been implicated in the 
pathophysiology of Brugada syndrome. In the inherited, 
autosomal dominant form of the syndrome, a gene mutation 
alters the structure and function of sodium ion channels 
found in the heart. Impaired ion channels prevent the flow of 
sodium into the cardiac cell, which adversely affects the heart 
rhythm.4 One proposed mechanism is through mutation of 
the SCN5A gene, which is responsible for the production of 
cardiac sodium channels. The SCN5A gene is by far the most 
commonly affected gene found in as many as 30% of affected 
individuals. Conversely, other individual gene mutations are 
responsible for less than one percent of all presentations.4  In 
the acquired form of the syndrome, exposures from drugs 
and other environmental instigators alter ion levels in the 
blood, resulting in altered cardiac conductivity.5 Implicated 
electrolyte abnormalities include hypercalcemia, as well as 
hyperkalemia and hypokalemia.5 
Diagnosis of Brugada syndrome is based on classic ECG 
findings that include ST-segment elevations in leads V1 to V3 
and right bundle branch block patterns on ECG in conjunction 
with one of the following: history of ventricular tachycardia 
or fibrillation; family history of sudden cardiac death or a 
coved pattern on ECG; or agonal breathing during sleep.3 Our 
patient’s diagnosis was corroborated by way of ventricular 
fibrillation occurring in the ED and ST-segment elevations in 
leads V1 to V3 found on ECG.3 
Unfortunately, Brugada syndrome predisposes a patient to 
a lifetime risk of sudden cardiac death, and there are currently 
no pharmacologic treatments to reduce this risk.6 Thus, ICD is 
often recommended and was the treatment modality of choice 
used in our patient. ICD has the greatest efficacy in averting 
sudden cardiac death, but the decision to use the device 
depends on the patient’s ability to tolerate it.7 If a patient 
cannot tolerate an ICD, pharmacologic therapy then serves as 
a second-line treatment modality. Pharmaceuticals can be used 
in the acute management of an arrhythmic storm, to prevent 
arrhythmia in patients with an implanted ICD requiring 
multiple shocks, and in cases where ICD implantation is 
contraindicated or not feasible – as may be the case in children 
or upon patient refusal.8 
The following drugs have been found to be of great 
benefit: quinidine, disopyramide, quinine sulphate, beta 
agonists, phosphodiesterase inhibitors, bepridil, and 
traditional Chinese medicines such as wenxin keli and 
dimethyl lithospermate B.8 In contrast, contraindicated 
drugs that serve as sodium channel blockers with the 
ability to induce cardiac arrhythmias in Brugada syndrome 
include the following: ajmaline, procainamide, flecainide, 
propafenone and pilsicainide.8 Thus, it is imperative that 
physicians maintain Brugada syndrome atop the differential 
diagnosis for patients presenting with syncope, ventricular 
fibrillation, or STEMI, so as to avoid treating presentations 
with potentially underlying Brugada syndrome with a 
contraindicated medication.
Anticipation of Brugada syndrome in a particular patient 
demographic or age group should not be expected. Although 
it rarely presents in the geriatric and Hispanic populations 
and is not well studied in these individuals, it is a life threat 
Image. Initial patient electrocardiogram obtained in the ED. Black arrows demonstrate ST-segment elevation in a coved pattern consistent 
with a Type 1 Brugada pattern.
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necessitating clarity in presentation, modes of treatment, and 
overall mortality risk for this particular patient demographic.9 
Further compounding this issue is the profound increase in 
the incidence of syncope associated with Brugada syndrome 
during the seventh decade of life.9 As the various causes 
of syncope are complex and multifactorial, a diagnosis of 
Brugada syndrome can be missed or even veiled by comorbid 
causes of syncope such as arrhythmias, AV blocks, and atrial 
fibrillation found in the elderly.9 
There have been rare reports of SCN5A gene mutation 
variants that are capable of inducing Brugada syndrome 
under hypothyroid conditions. This is explained by thyroid 
hormone affecting cardiac myocyte action potential duration 
and repolarization currents.10 It remains a possibility that 
our patient’s clinical deterioration was incited by untreated 
hypothyroidism, but the association remains unclear. Future 
studies elucidating the relationship between hypothyroidism 
and Brugada syndrome are needed.
CONCLUSION
Our patient’s age and ethnicity represent an atypical 
presentation of Brugada syndrome, and the lack of reported 
studies in the literature pertaining to this demographic reflect 
this. It is critically important to establish a diagnosis of 
Brugada syndrome in a patient lacking a personal or family 
history of this syndrome, as a first- time diagnosis in a 
single individual implicates their entire family. Furthermore, 
patients must be cautioned about the use of anesthetics, 
antihistamines, cocaine, antiarrhythmics, and psychotropic 
drugs as they have been found to provoke Brugada 
syndrome.11 Brugada syndrome’s abrupt symptomatology, 
high mortality rate, and ability to present atypically make 
this a challenging disorder to manage. It is for all of these 
reasons that Brugada syndrome will continue to serve as 
a significant life threat that emergency physicians will be 
relied upon to recognize and manage.
The signed attestation by the corresponding author that this 
institution does not require Institutional Review Board approval 
for case reports has been obtained and filed for publication of this 
case report.
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Introduction: Carotid artery dissection (CAD) is a critical diagnosis in the emergency department (ED). 
Trigeminal neuralgia, while not uncommon, may cause the patient significant discomfort but generally 
is not attributed to severe morbidity and mortality. 
Case Report: We present a case of spontaneous CAD presenting with the classic intermittent 
“lightning-like” jaw and head pain suggestive of trigeminal neuralgia that was ultimately diagnosed 
utilizing computed tomography angiogram after multiple visits to the ED. 
Discussion: Coincidentally the patient had been started on anticoagulation a few days prior and no 
additional intervention was required. 
Conclusion: This case report discusses current recommendations for diagnosis, treatment, and long-
term prognosis of CAD. [Clin Pract Cases Emerg Med. 2020;4(2):255–258.]
Keywords: Carotid Artery Dissection; Trigeminal Neuralgia.
INTRODUCTION
Carotid artery dissection (CAD) occurs when the 
integrity of the arterial wall is compromised, allowing 
blood to collect between layers of the arterial wall forming 
an intramural hematoma. This can result in cerebral 
ischemia due to mechanical obstruction of blood flow or 
thromboembolism formation. CADs are categorized as 
spontaneous or traumatic based on history of antecedent 
trauma. Arterial dissections are a common cause of stroke 
in young patients; however, they can occur in all ages. 
We describe a patient who presented to the emergency 
department (ED) on two consecutive days with complaint 
of intermittent, sudden, “lightning-like,” left lower face 
pain. Initial non-contrast neuroimaging was unremarkable, 
and the patient did not have any objective neurological 
Midwestern University, Chicago College of Osteopathic Medicine, Department of 
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deficits. Upon second visit to the ED, her pain returned 
and was significantly worse. Computed tomography 
angiography (CTA) of head and neck revealed the patient 
had a left internal CAD. This case describes an atypical 
presentation of a potentially serious condition in a patient 
presenting with trigeminal neuralgia-type symptoms, which 
could have led to life-threatening consequences if not 
identified and treated.
CASE REPORT
A 76-year-old Caucasian female with a past medical 
history of atrial fibrillation (not on anticoagulation), 
hypertension, chronic obstructive pulmonary disease, and 
obstructive sleep apnea presented to the ED complaining of 
intermittent, left-sided jaw and lower face pain onset that 
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What do we already know about this clinical 
entity? 
Carotid artery dissection can present in a variety 
of ways, ranging from unilateral headache 
to Horner’s syndrome, and can be a severely 
debilitating disease.
What makes this presentation of disease 
reportable? 
The pain associated with carotid artery dissection is 
usually not described as “lightning-like” jaw pain, 
mimicking trigeminal neuralgia or dental pain.
What is the major learning point? 
Always expand your workup and differential 
diagnosis on patients who return multiple times 
for the same complaint, or with progression of 
disease process
How might this improve emergency medicine 
practice? 
Including carotid artery dissection in our 
differential for unilateral jaw pain in patients 
with no intraoral, dental, or facial abnormalities 
on physical exam. 
particular morning. She described her pain as “sharp and 
lightning-like,” causing her to wake up in the middle of 
the night. Patient reported similar symptoms three months 
prior after she had “dental work” completed; however, she 
denied any recent dental procedures. She also denied any 
other symptoms during initial presentation. Neurologic 
exam was normal, including cranial nerve testing, upper 
and lower extremity sensorimotor function, and cerebellar 
testing. The patient had mild tenderness over the left side 
of her mandible and the jaw opened and closed without 
palpable clicking or grinding. Vital signs revealed a 
temperature of 36.4° Celsius, heart rate of 105 beats 
per minute, respirations of 18 breaths per minute, blood 
pressure of 151/101 millimeters of mercury, and pulse 
oximetry of 96% on room air.
The differential diagnosis included acute myocardial 
infarction, trigeminal neuralgia, temporal arteritis, 
temporomandibular joint dysfunction, herpes zoster, 
subarachnoid hemorrhage, dentalgia, and other causes of 
acute jaw pain in an elderly female patient. CTA of the head 
and facial bones without intravenous (IV) contrast were 
grossly normal. Electrocardiogram revealed rate-controlled 
atrial fibrillation without acute ischemic changes. Chest 
radiograph was clear. Laboratory analysis revealed an 
erythrocyte sedimentation rate of 34 millimeters per hour 
(mm/hr) (reference range 0-30 mm/hr); the remainder of the 
complete blood count, complete metabolic panel, thyroid 
stimulating hormone, troponin-I, urinalysis, and magnesium 
level were unremarkable.
The patient was restarted on apixaban after speaking 
with her cardiologist, given her history of atrial fibrillation. 
Neurology was consulted about the possibility of these 
symptoms being representative of trigeminal neuralgia and 
starting carbamazepine; however, neurology requested no 
medication changes and for the patient to follow up with her 
dentist prior to outpatient neurology follow-up to rule out 
dental causes. Patient was ultimately discharged home with 
outpatient neurology and dental follow-up. 
The patient returned to the ED with complaints of 
similar pain two days later; however, this time her left 
lower face and jaw pain was present leaving the patient 
in moderate to severe distress. Given the repeat visit and 
failure of outpatient therapy, early neurology consultation 
was obtained regarding analgesic recommendations 
while the workup ensued. The consulting neurologist 
recommended methylprednisolone 250 milligrams (mg) IV 
Image 1. Sagittal view of computed tomography with angiography 
of the head and neck identifying an intimal flap in the left internal 
carotid artery consistent with a carotid artery dissection.
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and ketorolac for analgesia. The patient’s pain remained 
refractory and IV fentanyl was given; we considered other 
diagnoses including CAD. CTA of the head and neck was 
obtained, which revealed a CAD of the left internal carotid 
artery (Images 1 and 2). The patient still did not exhibit any 
neurologic findings. Neurosurgeons whom we consulted 
at a tertiary-care hospital recommended continuing 
anticoagulation with close follow-up at their outpatient 
specialty clinic. 
During hospitalization, the patient did not develop 
any neurologic deficits. Pain was controlled with IV 
hydromorphone and methylprednisolone 125 mg every 12 
hours. She was ultimately discharged within 24 hours and 
continued on oral apixaban and steroids.
DISCUSSION
This patient’s presenting symptoms resembled trigeminal 
neuralgia. Had the CTA not been performed, the CAD might 
have been missed. It is unclear whether the CAD was the true 
etiology of the patient’s “lightning-like” pain or was merely a 
concomitant or incidental finding.
 The average annual incidence rate for spontaneous 
internal CAD is 1.72 per 100,000 population (95% 
confidence interval, 1.13 to 2.32).1 However, incidence is 
thought to be underestimated due to many patients being 
asymptomatic.1 While the pathophysiology of CAD is not 
well understood, a common theory is a multifactorial cause 
involving both genetic predisposition and environmental 
factors, such as infection or minor trauma acting as a trigger. 
Some evidence suggests that up to 50% of patients with 
CAD have autosomal dominant, skin connective-tissue 
abnormalities. 2 It is also common for patients with CAD 
to have concomitant arterial abnormalities suggesting a 
constitutional arteriopathy.2 The inciting trauma for CAD 
has been reported to be as minor as practicing yoga, painting 
a ceiling, coughing, sneezing, or vomiting.3 Many patients 
do not recall a trauma or inciting event.3 History of recent 
upper respiratory infection has been suggested as a potential 
trigger for dissections due to the seasonal variation of their 
incidence, peaking in the fall.3
The most frequently encountered symptoms in CAD are 
headache, neck pain, cerebral ischemia (transient ischemic 
attack or infarct), Horner syndrome, and cranial nerve palsies.3 
Recent-onset unilateral headaches with continuous pain have 
been considered the most important paucisymptomatic of cervical 
(vertebral and carotid) artery dissections.4 The diagnostic criteria 
for headache attributed to cervical artery dissection includes 
two of the following: temporal pain that evolves to encompass 
other signs of cervical artery dissection; pain that improves/
resolves after one month of onset or worsens contemporarily 
with other signs of cervical arterial lesions; pain that is severe and 
continues for days (most sensitive finding) or precedes signs of 
acute retinal/cerebral ischemia; and/or pain that is unilateral and 
ipsilateral to dissected cervical artery.4 Unilateral neck pain is 
seen in about 25% of patients, and unilateral facial/orbital pain in 
about 50% of patients.3 Approximately 10% of pain is isolated to 
the face or neck; most pain will progress to a unilateral headache 
in the temporal and frontal regions.3 
Cerebral or retinal ischemic symptoms are reported in 
50-95% of patients with a spontaneous dissection of the 
carotid artery and are commonly preceded by transient 
monocular blindness.3 Sudden onset Horner syndrome is 
seen in less than half of patients with CAD, but is considered 
to be specific for CAD when it occurs in conjunction with 
unilateral headache or facial pain. Cranial nerve palsies 
are a relatively rare finding, occurring in 7-12% of CAD 
cases.2,3 When they do occur, the hypoglossal nerve is 
most commonly affected, but the oculomotor, trigeminal, 
and facial nerves may also be involved. In a retrospective 
study of 245 patients who were diagnosed with spontaneous 
cervical artery dissections, only 8% presented with pain as 
their only symptom.5 The pain was most often described 
as having a gradual onset and progressing into a steady 
ache or sharp pain.3,5 However, four patients reported a 
sudden “thunderclap” headache at the presumed time of 
onset.3,5 Literature search by the authors did not identify 
any previously published reports of vertebral or CAD 
Image 2. Coronal view of computed tomography with angiography 
of the head and neck identifying an irregular 50-60% narrowing of 
proximal mid-cervical segment of left internal carotid artery with 
intimal flap consistent with carotid artery dissection.
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presenting with only the paroxysmal “lightning-like” pain 
resembling that of trigeminal neuralgia, making our patient’s 
presentation unique.
Diagnosis of CAD can be made on magnetic resonance 
imaging (MRI) with angiography, CTA, or conventional 
angiography, the latter of which has been largely replaced.2 MRI 
with angiography is generally the preferred method; however, 
CTA can be used when there is limited access to MRI, such 
as in the ED. The acute phase of CAD is treated with either 
anticoagulant or antiplatelet drug therapy to prevent ischemic 
events. Research indicating which is better is unclear and 
ongoing. 6 Treatment plans are largely made on a case by case 
basis.6 Prognosis is generally good with a mortality rate of less 
than 5%, and ischemic event recurrence rate of less than 13%.2
CONCLUSION
Carotid artery dissection, while uncommon, is a critical 
diagnosis that emergency providers should consider in 
patients presenting with head, neck, or jaw pain with a focal 
neurological deficit. When no deficit is identified, it should 
still be considered when risk factors such as reported trauma 
and genetic factors are present. It is imperative that providers 
maintain a broad differential and consider CTA when this 
diagnosis is considered, especially in the patient with multiple 
presentations when a causative lesion contributing to their 
symptoms has not yet been identified.
The signed attestation by the corresponding author that this 
institution does not require Institutional Review Board approval 
for case reports has been obtained and filed for publication of this 
case report.
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Introduction: Anion gap metabolic acidosis is a common disorder seen in the emergency 
department. The differential can include toxicological, renal, endocrine, infectious, and cardiogenic 
disorders. Ketosis, however, is one of the rarer causes of metabolic acidosis seen by the emergency 
physician in developed nations. 
Case Report: A 53-year-old female presented after starting a low-carbohydrate ketogenic diet for 
weight loss. She reported xerostomia, nausea with abdominal pain and a 17-pound weight loss over 
the previous 22 days. Labs revealed an anion-gap metabolic acidosis with ketosis. She was treated 
with 5% dextrose in normal saline and a sliding scale insulin coverage. Her anion gap corrected 
during her hospital course and was discharged on hospital day three. 
Discussion: The ketogenic diet typically consists of a high-fat, adequate protein and low carbohydrate 
diet that has previously been thought to be relatively safe for weight loss. However, when 
carbohydrates are completely removed from the diet an overproduction of ketones bodies results in 
ketoacidosis. Treatment should be aimed at halting the ketogenic process and patient education. 
Conclusion: Although rarely included in the differential for metabolic acidosis, diet-induced ketosis 
should be included by the emergency physician when faced with a patient who recently changed 
their eating patterns. [Clin Pract Cases Emerg Med. 2020;4(2):259–262.] 
Keywords: Anion-Gap Metabolic Acidosis; Ketosis; Diet-Induced Ketosis.
INTRODUCTION
Anion gap metabolic acidosis is a common, life-
threatening diagnosis in the emergency department (ED) with 
various potential etiologies. CAT MUD PILES is a mnemonic 
often used to help remember the most common causes of 
anion gap metabolic acidosis (Table 1). However, starvation 
ketosis is one of the rarer causes of ketoacidosis. Ketosis is 
typically prevented with diets that consist of 100 grams (g) of 
carbohydrates per day, and as little as 7.5 g of glucose a day 
can decrease ketone production. We present a case of a 
53-year-old female with a high anion gap metabolic acidosis 
whose history and workup did not correlate with traditional 
causes. She was found to have a ketoacidosis caused by a zero 
carbohydrate diet used for weight loss. It is important to raise 
awareness of this disease, as the popularity of protein- and 
Midwestern University, Kingman Regional Medical Center, Department of Emergency 
Medicine, Kingman, Arizona
fat-rich diets that minimize carbohydrate intake are becoming 
increasingly popular.
CASE REPORT
A 53-year-old female presented to the ED with six days of 
nausea and vomiting. She also noted feeling progressively 
weak with xerostomia and lower abdominal pain for several 
days prior to presentation. Further history revealed that she 
was a previous vegetarian who over the prior 22 days was 
attempting to lose weight by eating solely meat and eggs. She 
reported a 17-pound weight loss over the time period and 
noted that she was consuming only minimal carbohydrates. 
She took no medications and denied chronic alcohol use.
Her vitals upon arrival were as follows: temperature 97.1 
degrees Fahrenheit, heart rate 77 beats per minute, respiratory 
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What do we already know about this clinical 
entity? 
The ketogenic diet consists of a high-fat, 
adequate protein and low carbohydrates. When 
carbohydrates are removed however, ketone 
bodies can form, causing ketoacidosis. 
What makes this presentation of disease 
reportable? 
Although ketoacidosis is common with other 
disorders, diet-induced ketoacidosis is 
typically not included in the differential of most 
emergency physicians (EP). 
What is the major learning point? 
Diet-induced ketoacidosis should be included in 
patients with an unexplained metabolic acidosis 
and further history should be gathered into any 
recent dietary changes. 
How might this improve emergency medicine 
practice? 
The EDP should keep a broad differential when 
faced with a patient with metabolic acidosis and 
search for the underlying cause.
and her symptoms greatly improved. By the time she was 
admitted to the hospital, her gap had closed to a level of 12. She 
continued to receive an infusion of 5% dextrose in normal saline 
(D5NS) at 150 cc an hour as well as insulin subcutaneously on a 
sliding scale after admittance to the hospital.  Her anion gap 
remained within the normal limits while in the hospital and her 
insulin was discontinued. After returning to a normal diet, her 
glucose remained stable and she was discharged after three days 
with only potassium supplement prescriptions. Since discharge, 
she established a balanced diet and symptoms ceased.
DISCUSSION
The ketogenic diet is a high-fat, adequate protein, low-
carbohydrate diet that could be beneficial for diseases such as 
epilepsy, but the emergency provider is most likely to see its use 
during episodes of weight loss.1 After only several days of 
low-carbohydrate dieting, the body depletes its glucose stores 
and adipose cells begin ketogenesis to supply the brain with 
glucose.1 During this process, there is an overproduction of 
acetyl-CoA, which produces beta-hydroxybutyrate, 
C
carbon monoxide
cyanide
congenital heart failure
A
aminoglycosides
T
Theophylline 
Toluene
M
Methanol
U
Uremia
D
Diabetic Ketoacidosis
Alcoholic Ketoacidosis
Starvation Ketoacidosis
P
Paracetamol/acetaminophen
Phenformin
Paraldehyde
I
Iron
Isoniazid
Inborn errors of metabolism
L
Lactic acidosis
E
Ethanol
Ethylene glycol
S
Salicylates
Table 1. Common causes of metabolic acidosis presented as a 
mnemonic CAT MUD PILES.
rate 16 breaths per minute, blood pressure 160/106 millimeters of 
mercury, and oxygen saturation 97% on room air. She weighed 
73 kilograms with her stated height of 5 feet 6 inches and had a 
body mass index of 26. The physical exam revealed dry mucous 
membranes and a benign abdominal exam.
The patient was given two liters (L) of normal saline 
intravenously (IV) and four milligrams of ondansetron IV for 
nausea. Labs were drawn due to a concern for abnormal 
electrolytes as well as her change in diet. Labs revealed an 
anion gap acidosis with ketosis (Table 2). 
In the ED she received antiemetics, two L of normal saline 
and an infusion of D5NS at 150 cubic centimeters (cc) an hour, 
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mEQ, milliequivalent; L, liter; mg, milligram; dL, deciliter; N/A, not available; mOs, milliosmoles; kg, kilogram; g, grams; ug, micrograms; 
mL, milliliter; mmol, millimole; pCO2, partial pressure of carbon dioxide; mm Hg, millimeters of mercury; pO2, partial pressure of oxygen. 
Variable
Reference range, 
adults
On presentation to the 
emergency department
On admission to 
the hospital
Hospital 
day 2
Hospital day 3/
discharge
Sodium (mEq/L) 137–145 139 141 139 139
Potassium (mEq/L) 3.5–5.1 4.8 3.8 2.8 2.8
Chloride (mEq/L) 100–1 08 103 111 105 97
Carbon dioxide (mEq/L) 22–30 8 18 26 34
Glucose (mg/dL) 74–1 06 163 179 159 102
Urea nitrogen(mg/dL) 6–20 12 10 6 6
Creatinine (mg/dL) 0.52–1.04 0.70 0.60 0.50 0.50
Calcium (mg/dL) 8.4–10.2 10.2 9.1 9.0 8.8
Phosphorus (mg/dL) 2.5–4.5 N/A 2.1 1.9 2.8
Magnesium (mg/dL) 1.6–2.3 N/A 2.0 1.9 1.9
Anion gap 1–12 28 12 8 8
Osmolality, calculated (mOs/kg) 225–285 281 285 279 275
Osmolality, serum 275–295 302 N/A N/A N/A
Albumin (g/dL) 3.5–5.0 5.3 N/A N/A N/A
Alcohol, (ethanol) (mg/dL) 0–10 < 10 N/A N/A N/A
Acetaminophen (ug/mL) 10-30 <10 N/A N/A N/A
Salicylate (mg/dL) 0–2 <1 N/A N/A N/A
Acetone (mmol/L) 0.0-.06 4.9 3.4 N/A N/A
Lactic acid (mmol/L) 0.7–2.0 1.4 N/A N/A N/A
Urinalysis      
  Leukocyte esterase Negative Negative N/A N/A N/A
  Nitrites Negative Negative N/A N/A N/A
  Protein (mg/dL) Negative 100 N/A N/A N/A
  Glucose (mg/dL) Negative 50 N/A N/A N/A
  Ketones (mg/dL) Negative 80 N/A N/A N/A
  Specific gravity 1.003–1.035 1.024 N/A N/A N/A
Arterial blood gas      
  pH 7.35–7.45 7.289 N/A N/A N/A
  pCO2 (mm Hg) 35.0–45.0 23.7 N/A N/A N/A
  pO2 (mm Hg) 80.0–100.0 93.2 N/A N/A N/A
  Bicarbonate (mEq/L) 22.0–26.0 11.1 N/A N/A N/A
Hemoglobin A1c (%) 4.0–5.6 5.8 N/A N/A N/A
Table 2. Laboratory data.
acetoacetate, and acetone in the liver.1 These ketone bodies are 
then used as a source of energy for the body, but their 
overproduction could lead to ketoacidosis.1  
Diet-induced ketosis is more likely to occur in children, 
and pregnant or lactating females due to lower glycogen 
stores, inherent insulin resistance, and increased lipolysis from 
pregnant and lactating females.2 While starvation ketosis 
usually does not result in a bicarbonate level less than 18 
milliequivalents per liter (mEq/L),3  our patient’s initial 
bicarbonate level was 8 mEq/L. Based upon the patient’s 
medical history and risk factors, she should not have reached 
the stage of ketoacidosis. However, the lack of carbohydrates 
in her diet increased the possibility of a component of 
starvation ketosis. 
Ketogenic diets have been proven to be safe and effective 
in treating obesity and have shown that patients do not develop 
anion gap acidosis due to the diet.4 A similar case related to the 
Atkins diet was reported in 2004 and had a similar 
presentation.5 There have been at least four more cases of 
low-carb, high-protein diets causing high anion gap metabolic 
acidosis with associated ketones in the blood or urine.6 All cases 
involved women and had a similar positive outcome.  
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Treatment should be aimed at halting the ketogenic process 
through the consumption of carbohydrates or providing the 
patient with intravenous fluids that contain dextrose. Patients 
with any underlying conditions that may cause them to be prone 
to ketoacidosis should avoid a ketogenic diet regimen. These 
conditions would include, but are not limited to, chronic 
alcoholism, pregnancy, lactation and diabetes. In addition, any 
person on the ketogenic diet should eat at least 100 g of 
carbohydrates a day to avoid ketoacidosis.
CONCLUSION
Diet-induced ketoacidosis is a rare disease and may be 
difficult to diagnose due to incomplete diet history and similarity 
to other common diseases. To avoid this, the patient should be 
asked about diet history especially in those who present with 
vomiting, diarrhea, and symptoms similar to diabetic ketoacidosis 
without a history of diabetes. Prevention is imperative with this 
disease and can be avoided by eating a minimum amount of 
carbohydrates daily. Also patients who are chronic alcoholics, 
pregnant, lactating, or diabetic should not participate in this diet 
due to a high risk of ketoacidosis. 
Reference values are affected by many variables, including 
the patient population and laboratory methods used. The range 
was comprised from Kingman Regional Medical Center adults 
who were not pregnant and did not have medical conditions that 
could affect the results. Therefore, they may not be appropriate 
for all patients.
The authors attest that their institution requires neither 
Institutional Review Board approval, nor patient consent for 
publication of this case report. Documentation on file.
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Introduction: Portal venous thrombosis is a life-threatening cause of abdominal pain. In younger 
patients, heritable thrombophilias, pregnancy, tobacco use, and oral contraceptives are associated.
Case Report: A 26-year-old woman prescribed contraceptive vaginal ring presented with abdominal 
pain and was diagnosed with an extensive portal venous thrombosis. Management included heparin 
and later an oral anticoagulant with good short-term outcome.
Discussion: Women using hormonal contraception are approximately four times more likely to 
develop thromboembolism. Risk of thromboembolism is similar between users of intravaginal and 
oral contraceptives.
Conclusion: Portal venous thrombosis must be considered in women presenting with abdominal 
pain who are prescribed hormonal contraceptives, including intravaginal forms. [Clin Pract Cases 
Emerg Med. 2020;4(2):263–266.]    
Keywords: portal venous thrombosis; etonogestrel/ ethinyl vaginal ring; contraception; complications.  
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INTRODUCTION
Abdominal pain continues to be one of the most 
common complaints evaluated in the emergency department 
(ED) in the United States. According to Meltzer et al 
abdominal pain comprised approximately 23 million visits 
to the ED in one year.1 Comparatively, mesenteric venous 
thrombosis is a relatively rare condition, accounting for 
less than 0.02% of all hospital admissions.2,3 The mean 
age of mesenteric thrombosis is 45-60 years, with a large 
proportion occurring in the sixth and seventh decades.2-4 
In younger individuals, mesenteric thrombosis is often 
associated with the following: heritable thrombophilias (e.g., 
protein C or protein S deficiency);  acquired thrombophilias 
(e.g., pregnancy or medication use, commonly oral 
contraceptives); intra-abdominal causes (e.g., cirrhosis or 
trauma); or idiopathic causes.2 This is a case of a 26-year-
old woman who presented to the ED with right upper 
quadrant abdominal pain due to extensive thrombus within 
the superior mesenteric, main portal, distal splenic, and 
intrahepatic portal veins. After extensive diagnostic testing, 
the only identified thrombotic risk factor was the use of an 
etonogestrel/ethinyl estradiol vaginal ring (NuvaRing). 
CASE REPORT
A 26-year-old woman without medical history presented 
to the ED due to abdominal pain for approximately 12 
hours. The patient reported no tobacco use, and her only 
prescribed medication was the etonogestrel/ethinyl estradiol 
intravaginal ring. The patient had been evaluated earlier in 
the day at an urgent care facility; the urgent care provider 
then sent the patient to the ED for an apparent abnormal 
urinalysis (UA). In the ED, she was complaining of 
mid-epigastric and right upper quadrant abdominal pain 
along with continued nausea. She also noted back pain, a 
headache, and bilateral upper extremity numbness since that 
morning. She noted her bilateral upper extremity numbness 
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What do we already know about this clinical 
entity? 
Portal venous thrombosis is well studied in the 
literature and has known risk factors such as 
age, heritable and acquired coagulopathies, and 
idiopathic causes.
What makes this presentation of disease 
reportable? 
This patient’s only risk factor predisposing 
her to a large portal venous thrombosis was 
the use of an etonogestrel/ ethinyl estradiol 
vaginal ring contraceptive.
What is the major learning point? 
Emergency physicians should be cognizant 
that all forms of contraception with exogenous 
hormones expose patients to a risk of 
significant thrombosis.
How might this improve emergency medicine 
practice? 
Practitioner awareness regarding thrombotic 
risk related to all forms of hormonal 
contraception, including intravaginal forms, 
may assist in accurate diagnosis.
and headache had become intermittent. She denied any 
associated diarrhea, constipation, dysuria, fever, chills, 
recent travel, or trauma. 
The patient’s vital signs included the following: 
temperature 98.0º Fehrenheit; heart rate 76 beats per minute; 
respirations 18 breaths per minute; blood pressure 129/53 
millimeters of mercury; and pulse oximetry 98% on room 
air. On physical exam, she exhibited moderate tenderness to 
palpation of the right upper quadrant and epigastric area. The 
remainder of the physical exam was unremarkable. 
There were no considerable lab abnormalities except 
for “small” bilirubin noted on the UA. Urine pregnancy 
test was negative. The patient had a computed tomography 
(CT) of the abdomen/pelvis with intravenous (IV) contrast, 
which demonstrated an extensive thrombus within the 
superior mesenteric vein, extending into the main portal 
vein, intrahepatic portal veins, and distal splenic vein (Image 
1). She was administered IV heparin 5800 units bolus and a 
continuous IV heparin infusion of 18 units per kilogram per 
hour. She was then transferred to a tertiary care center.
At the tertiary care center, the patient was maintained 
on the heparin infusion until she was later transitioned to 
rivaroxaban. The patient underwent extensive hematologic 
testing including the following: protein C; protein S; anti-
thrombin III; alpha fetoprotein, homocysteine; factor 5 
gene mutation; prothrombin gene mutation; anti-cardiolipin 
antibody IgG and IgM by ELISA; anti-beta2-GP I antibody; 
JAK2 V617F mutation; and mutation in exon 12 of JAK2. 
No abnormalities were detected. The patient also had 
normal venous Doppler studies of the bilateral upper and 
lower extremities. Ultimately she was discharged home 
on hospital day 3 on rivaroxaban 15 milligrams twice 
daily with hematology follow-up and discontinuation of 
hormonal contraception. 
DISCUSSION
The clinical presentation, diagnosis, and management 
of portal and mesenteric venous thrombosis has been 
thoroughly investigated in the literature. In the acute 
setting, mesenteric venous thrombosis most commonly 
causes abdominal pain in 91-100% of cases.5 The test of 
choice for the diagnosis of mesenteric venous thrombosis 
is a contrast-enhanced CT.6 Laboratory testing is not 
especially helpful as most tests do not correlate specifically 
to the diagnosis of mesenteric thrombus.5 Once the 
diagnosis is established, treatment includes resolving the 
current thrombus and preventing further thrombotic events. 
Anticoagulation with low-molecular-weight heparin as 
soon as the diagnosis is made has been shown to improve 
survival.7 Transitioning to an oral anticoagulant is then 
performed. According to the 2016 CHEST guidelines, 
patients with venous thromboembolism should be 
treated for a minimum of six months. These guidelines 
are commensurate with those set forth by the European 
Image. Axial image of abdominal/pelvis computed tomography with 
contrast demonstrates the thrombus, indicated by the black arrows, in 
the superior mesenteric vein and extending toward the splenic vein.
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Association for the Study of the Liver, specifically for 
mesenteric thrombus.8,9 After the acute thrombotic event 
has been stabilized, the patient requires hematologic testing 
to assess for prothrombotic diseases.5
Women using hormonal contraception are approximately 
four times more likely to develop venous thromboembolism 
compared to women not prescribed hormonal contraception.10 
Studies report the association between hormonal contraception 
and increased risk of thromboembolism is related to 
the alteration of procoagulant factors and endogenous 
anticoagulant proteins. The estrogen components of hormonal 
contraception seem to cause an increase in the procoagulant 
factors II, VII, VIII, X and fibrinogen, and a decrease in 
antithrombin and tissue factor pathway inhibitor activity.11,12 
It should be noted that the formulation, administration route, 
dose, and progesterone type (in combined formulations), all 
affect the overall risk of thrombosis.11,12 There is a general 
misnomer that non-oral forms of hormonal contraception (e.g., 
etonogestrel/ethinyl estradiol vaginal ring) have a lower risk 
of thrombotic events compared to oral contraception. 
The Transatlantic Active Surveillance on 
Cardiovascular Safety of NuvaRing study, published in 
2013, did not specifically report episodes of mesenteric 
venous thrombosis, although it did report that episodes 
of venous and arterial thromboembolism were similar 
between clinical users of intravaginal contraceptive rings 
and oral contraceptives.13 While mesenteric thrombosis 
associated with intravaginal contraception is rare, two 
similar cases have been reported in the literature.14,15 
In addition, when obtaining medication history from 
patients, non-oral medications can often be missed or 
discounted by clinicians. Although research is somewhat 
limited, the etonogestrel/ethinyl estradiol vaginal ring does 
appear to have the same amount of cardiovascular risk 
associated with its use as its well-studied counterpart, oral 
contraceptive pills.13 
CONCLUSION
This case highlights that women without known, primary 
thrombotic risk factors can still suffer major, life-threatening 
thrombosis when using hormonal contraception, regardless 
of form. The diagnosis of mesenteric and portal venous 
thrombosis must be considered in women presenting with 
abdominal pain who are prescribed hormonal contraceptives, 
including intravaginal forms.
The documented attestation from the authors that their 
institution requires neither Institutional Review Board approval, 
nor patient consent for publication of this case report has been 
obtained and filed.
REFERENCES
1. Meltzer AC, Pines JM, Richards LM, et al. US emergency department 
visits for adults with abdominal and pelvic pain (2007-13): Trends 
in demographics, resource utilization and medication usage. Am J 
Emerg Med. 2017;35(12):1966-9.
2. Harnik IG and Brandt LJ. Mesenteric venous thrombosis. Vasc Med. 
2010;15(5):407-18.
3. Russell CE, Wadhera RK, Piazza G. Mesenteric venous thrombosis. 
Circulation. 2015;131(18):1599-603.
4. Acosta S, Alhadad A, Svensson P, et al. Epidemiology, risk and 
prognostic factors in mesenteric venous thrombosis. Br J Surg. 
2008;95(10):1245-51.
5. Hmoud B, Singal AK, Kamath PS. Mesenteric venous thrombosis. J 
Clin Exp Hepatol. 2014;4(3):257-63.
6. Grant PJ, Courey AJ, Hanigan S, et al. Special topics in venous 
thromboembolism [Internet]. Ann Arbor (MI): Michigan Medicine 
University of Michigan. 2019. Available at: https://www.ncbi.nlm.nih.
gov/books/NBK544377/. Accessed July 28, 2019.
7. Condat B, Pessione F, Denninger MH, et al. Recent portal or 
mesenteric venous thrombosis: increased recognition and 
frequent recanalization on anticoagulant therapy. Clin Liver Dis. 
2003;32(3):466-70.
8. Intagliata NM, Caldwell SH, Tripodi A. Diagnosis, development, 
and treatment of portal vein thrombosis in patients with and without 
cirrhosis. Gastroenterology. 2019;156(6):1582-99.
9. Kearon C, Akl EA, Ornelas J, et al. Antithrombotic therapy for 
VTE disease: CHEST guideline and expert panel report. Chest. 
2016;149(2):315-52.
10. Sitruk-Ware R. Hormonal contraception and thrombosis. Fertil Steril. 
2016;106(6):1289-94.
11. Klok FA and Barco S. Optimal management of hormonal 
contraceptives after an episode of venous thromboembolism. Thromb 
Res. 2019;181 Suppl 1:S1-S5.Tc.
12. Tchaikovski SN and Rosing J. Mechanisms of estrogen-induced 
Address for Correspondence: Katelynn E. Bailey, DO, MSc, 
Charleston Area Medical Center, Department of Emergency 
Medicine, 3110 MacCorkle Ave SE, Charleston, WV 25304. 
Email: Katelynn.Bailey@camc.org.
Conflicts of Interest: By the CPC-EM article submission agreement, 
all authors are required to disclose all affiliations, funding sources 
and financial or management relationships that could be perceived 
as potential sources of bias. The authors disclosed none.
Copyright: © 2020 Bailey et al. This is an open access article 
distributed in accordance with the terms of the Creative Commons 
Attribution (CC BY 4.0) License. See: http://creativecommons.org/
licenses/by/4.0/
Clinical Practice and Cases in Emergency Medicine 266 Volume IV, no. 2: May 2020
PVT Associated with Etonogestrel/ethinyl Estradiol Vaginal Ring Bailey et al.
venous thromboembolism. Thromb Res. 2010;126(1):5-11. 
13. Dinger J, Mohner S, Heinemann K. Cardiovascular risk associated 
with the use of an etonogestrel-containing vaginal ring. Obstet 
Gynecol. 2013;122(4):800-8.
14. Eilbert W, Hecht B, Zuiderveld L. Acute mesenteric venous 
thrombosis with a vaginal contraceptive ring. West J Emerg Med. 
2014;15(4):395-7. 
15. Voora D and Vijayan A. Mesenteric vein thrombosis associated with 
intravaginal contraceptives: a case report and review of the literature. 
J Thromb Thrombolysis. 2003;15(2):105-8.
Volume IV, no. 2: May 2020 267 Clinical Practice and Cases in Emergency Medicine
aCoep Case report
 
Subacute Presentation of Central Cord Syndrome Resulting 
from Vertebral Osteomyelitis and Discitis: A Case Report
 
Thomas Dang, BA*
Fanglong Dong, PhD*
Greg Fenati, DO*†
Massoud Rabiei, BS*
Melinda Cerda, MM*
Michael M. Neeki, DO, MS*† 
Section Editor: John Ashurst, DO           
Submission history: Submitted June 21, 2019; Revision received none; Accepted August 30, 2019 
Electronically published April 23, 2020         
Full text available through open access at http://escholarship.org/uc/uciem_cpcem   
DOI: 10.5811/cpcem.2019.8.44201 
Introduction: Central cord syndrome (CCS) is a clinical syndrome of motor weakness and 
sensory changes. While CCS is most often associated with traumatic events. There have been few 
documented cases being caused by abscesses resulting from osteomyelitis.
Case Report: A 56-year-old male presented to a regional trauma center complaining of excruciating neck 
and bilateral upper extremity pain. Computed tomography of the cervical and thoracic regions revealed 
severe discitis and osteomyelitis of the fourth and fifth cervical (C4-C5) with near-complete destruction 
of the C4 vertebral body, as well as anterolisthesis of C4 on C5 causing compression of the central 
canal. Empiric intravenous (IV) antibiotic therapy with ampicillin/sulbactam and vancomycin was initiated, 
and drainage of the abscess was scheduled. After the patient refused surgery, he was planned to be 
transferred to a skilled nursing facility to receive a six-week course of IV vancomycin therapy. A month 
later, patient returned to emergency department with the same complaint due to non-compliance with 
antibiotic therapy.
Discussion: Delayed diagnosis and treatment of osteomyelitis can result in devastating neurological 
sequelae, and literature supports immediate surgical debridement. Although past evidence has 
suggested surgical intervention in similar patients with presence of abscesses, this case may suggest 
that antibiotic treatment may be an alternative approach to the management of CCS due to an infectious 
etiology. However, the patient had been non-compliant with medication, so it is unknown whether there 
was definite resolution of the condition.
Conclusion: In patients presenting with non-traumatic central cord syndrome, it is vital to identify 
risk factors for infection in a thoroughly obtained patient history, as well as to maintain a low 
threshold for diagnostic imaging. [Clin Pract Cases Emerg Med. 2020;4(2):267–271.]   
Keywords: central cord syndrome; vertebral osteomyelitis; discitis; case report.
INTRODUCTION
Central cord syndrome (CCS) is a clinical syndrome of 
motor weakness and sensory changes that presents 
disproportionately greater in the upper extremities as 
compared to the lower extremities.1–3 While CCS is most 
often associated with traumatic events, there also have been 
Arrowhead Regional Medical Center, Department of Emergency Medicine, Colton, California
California University of Science and Medicine, Department of Emergency Medicine, San 
Bernardino, California
a few documented cases being caused by other types of 
lesions such as demyelination or abscesses resulting from 
osteomyelitis.4 Cases of cervical osteomyelitis and the 
associated CCS are rare. We present a unique case of 
subacute CCS in a 56-year-old male with cervical vertebral 
osteomyelitis and discitis who recovered from his 
*
†
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What do we already know about this clinical 
entity? 
Central cord syndrome (CCS) is a clinical 
syndrome of motor weakness and sensory 
changes that can result in potentially devastating 
neurological sequelae.
What makes this presentation of disease 
reportable? 
While CCS is associated with traumatic events, 
patients may present with subtle neurological 
deficits without an obvious inciting event. 
What is the major learning point? 
CCS requires timely diagnosis and treatment to 
prevent further neurological damage. In patients 
with risk for infection, early diagnosis may 
prevent increased morbidity.
How might this improve emergency medicine 
practice? 
Early diagnosis of CCS caused by infection may 
allow alternative, non-surgical management that 
improves patient outcome.
symptoms with conservative management and without any 
recommended surgical intervention.
CASE REPORT
A 56-year-old male presented to a regional trauma center 
complaining of excruciating neck and bilateral upper extremity 
pain. He described a progressive weakness for the preceding 
month and specifically noted being unable to flex or abduct his 
bilateral shoulders without lying supine, necessitating assistance 
to complete activities of daily living. Patient history revealed 
poorly controlled type II diabetes mellitus, hepatitis C, 
methamphetamine use, and a history of remote intravenous (IV) 
heroin use. He reported progressively worsening generalized 
fatigue and constipation over the prior few months. In addition, 
he was experiencing mild persistent odynophagia without 
dysphagia. He denied any fevers, chills, bowel or bladder 
incontinence, shortness of breath, or focal weakness in the 
lower extremities. 
On presentation, the patient was oriented and presented 
with a blood pressure 123/80 millimeters of mercury, heart rate 
89 beats per minute, respiratory rate 18 breaths per minute, 
temperature 98.3° Fahrenheit, and oxygen saturation 99% on 
room air. Physical examination revealed tenderness to palpation 
of the cervical region midline at the levels of the C3-C5 spinous 
processes. No step off or any obvious abnormality was noted in 
the cervical region. Motor strength was noted to be 4+/5 in the 
bilateral upper extremities with decreased shoulder abduction 
and flexion, as well as decreased sensation to pinprick over the 
right C4 and C5 dermatomes. The rest of the physical and 
neurological exam was within normal limits. 
Complete blood count revealed normal white blood cell 
count, elevated erythrocyte sedimentation rate of 52 millimeters 
per hour (mm/h) [normal range 0-15 mm/h], normal C-reactive 
protein level, and mild anemia with a hemoglobin of 12.5 grams 
per deciliter (g/dL)  [normal range 13.5-17.5 g/dL] and 
hematocrit of 36.7 [normal range 41%-50%]. Additional tests 
provided evidence of poorly controlled diabetes, including 4+ 
glucose in urine, random serum glucose of 219 milligrams per 
deciliter, and HgbA1C of 9.7%.
Computed tomography (CT) of the cervical and thoracic 
regions without contrast revealed evidence of severe discitis 
and osteomyelitis of C4-C5 with near-complete destruction 
of the C4 vertebral body, as well as anterolisthesis of C4 on 
C5 causing narrowing of the central canal (Image 1). 
Additionally, there appeared to be prevertebral, soft tissue 
swelling that was concerning for retropharyngeal abscess. 
Follow-up magnetic resonance imaging (MRI) with and 
without gadolinium of the cervical, thoracic, and lumbar 
spine confirmed the earlier CT findings of C4-C5 discitis and 
osteomyelitis with confirmation of surrounding prevertebral 
and epidural abscess (Image 2). In addition, MRI confirmed 
evidence of cord compression, although there was no signal 
change within the cord itself. Given these findings, the 
neurosurgery service recommended biopsy of the area 
Image 1. Computed tomography scan of sagittal plane of 
cervical spine showing fourth and fifth cervical osteomyelitis 
(arrow) upon admission.
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around the cervical spine and to defer the initiation of 
antimicrobial therapy until after the biopsy was obtained.
Following the neurosurgery recommendation, interventional 
radiology was consulted to perform the biopsy but declined the 
procedure, citing risks associated with any interventions around 
the cervical spine. Subsequently, empiric IV antibiotic therapy of 
3 gram (g) of ampicillin/sulbactam (every six hours) daily and 
1.25 g of vancomycin twice daily was initiated for 10 days per 
infectious disease recommendations, and incision and drainage of 
the abscess with concurrent vertebral lesion biopsy was scheduled 
by neurosurgery. 
On the day of the scheduled surgery, the patient stated that 
he no longer wished to proceed with the planned procedure. 
Given the patient’s refusal to proceed with surgical 
intervention, the decision was made to discharge him to a 
skilled nursing facility (SNF) with a peripherally inserted 
central catheter for a six-week treatment of IV antibiotics of 
vancomycin 1 g twice daily via peripherally inserted central 
line, along with strict cervical spine precautions that included 
cervical orthosis. Blood cultures remained negative throughout 
the course of the patient’s SNF stay, and infectious workup 
including chest radiograph, urine culture, and echocardiogram 
were noncontributory in identifying the primary source of 
infection. By the time of his discharge, 10 days later, the 
patient’s bilateral upper extremity weakness improved, and he 
reported decreased neck and arm pain.
About a month later, he once again returned to the 
emergency department with complaints of neck and back 
pain, which revealed he had been noncompliant with the 
antibiotic regiment previously prescribed. He refused any 
further workup and signed himself out against medical 
advice. Two years after the event, the patient presented to the 
same facility with complaint of chronic cervical pain, and a 
cervical CT without contrast revealed fusion of C4-C5 
vertebrae (Image 3).
DISCUSSION 
Patients with CCS differ widely in presentation with 
varying sensory loss below the level of injury and may present 
with or without bladder dysfunction.1,2,5 It is most commonly 
associated with traumatic injuries, as approximately 9% of all 
traumatic spinal cord injuries result in CCS. It is particularly 
prevalent in older patients suffering cervical hyperextension 
injuries in the setting of high-velocity trauma.1,2,5–8 Despite its 
association with traumatic causes, there have been 
documented cases of CCS resulting from infection such as 
osteomyelitis and discitis.4 
Osteomyelitis is a serious condition that rarely affects the 
spine, representing about 1% of all bone infections.3 
Osteomyelitis presents a significant risk to patients, as infection 
can extend to a contiguous site, leading to discitis or abscesses.9 
Among these incidents, cases confined to the cervical region 
represent only 3-6% of cases of spinal osteomyelitis.3 Despite 
their lower incidence, cervical infections are often associated 
with worse neurological outcomes, which may be related to the 
potential for more dynamic motion of the cervical spine 
compared to the thoracic or lumbar spine.10 
There have been documented incidences of cervical 
epidural abscesses in literature, but very scant presentations 
Image 2. Magnetic resonance imaging of sagittal plane of 
cervical spine showing fourth and fifth cervical osteomyelitis 
(arrow) upon admission. 
Image 3. Computed tomography scan of sagittal plane of cervical 
spine showing fourth and fifth cervical fusion (arrow) two years after 
initial presentation. 
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with the subacute nature of this case of CCS (Table). 
Trombly and Guest documented a CCS secondary to an 
underlying vertebral osteomyelitis and epidural abscess, but 
the patient had the abrupt onset of symptoms secondary to 
minor trauma.11 Schimmer et al retrospectively studied 15 
patients with osteomyelitis of the cervical spine and of the 
nine patients presenting with neurological symptoms, only 
one had been experiencing neurologic symptoms for at least 
Table. Summary of previous published case reports involving cervical spine abscess with sub-acute neurological symptoms, detailing 
age and gender, relevant comorbidities, level of infection, presentation, outcome, and duration of original onset.*
Author(s)
Age/
gender
Relevant 
comorbidities
Level of 
infection Presentation Treatment Outcome
Primary 
source of 
infection Onset
Trombly 
and Guest, 
200711 
60M 80 Pack-
years 
smoking
C5-C7 Loss of 
sensation in 
arms bilaterally, 
unable to move 
arms or legs
Surgery, 6 
Weeks of 
antibiotics
Independent 
walking in 2-3 
weeks
None 
identified
One month of 
non-specific 
neurological 
symptoms
Schimmer 
et al, 20023 
65M Unknown C4-C5 Tetraplegia Surgery Continued 
complete 
neurological 
injury
Unknown Tetraplegia for 
at least two 
days
Ahlback et 
al, 197012 
44F Diabetes 
mellitus
C1-C2 Cervical pain, 
stiffness, 
limited ROM, 
neurological 
symptoms
Cervical collar, 
antibiotics
Residual 
cervical 
stiffness and 
limited ROM at 
7-year follow-up 
Left otitis 
media
6-weeks post-
tonsillectomy
Zigler et al, 
198712 
56F Chronic renal 
failure, CHF
C1-C2 Hyperreflexia, 
positive Babinski 
sign
Soft collar, 
surgery
Full recovery, 
died shortly 
later due 
to CHF/
Pneumonia
Cat 
scratch 
in left leg 
leading to 
septicemia
2 Weeks
Limbird et 
al, 198812 
61M Hypertension, 
Renal Failure
C1-C2 Neck pain, 
central cord 
syndrome
Halo traction, 
antibiotics
Death 
secondary to 
myocardial 
infarction
None 
identified
3 Months
Azizi et al, 
199512 
65M Diabetes 
mellitus, 
cranial nerve 
abnormalities
Clivus-C1 Right ptosis, 
abducens nerve 
palsy, left facial 
weakness, 
cervical/
shoulder pain
Halo neck 
stabilizer, 
antibiotics
Residual 
abducens 
palsy with 
otherwise full 
recovery
Left otitis 
externa
6 Months
Fukutake 
et al, 
199812 
74M Cervical 
spondylosis
C1-C2 Fever, cervical 
pain, difficulty 
ambulating, 
numbness in 
upper extremity
Antibiotics, 
surgery
Full resolution 
at 3 months
Post-
TURP 
procedure, 
pneumonia
1 Month
Kuriomoto 
et al, 
199812 
72F Diabetes 
mellitus
C2 Afebrile, cervical 
pain and 
stiffness, right 
hemiparesis
Steroids, 
insulin, 
Antibiotics, 
Surgery
Right 
hemiparesis 
persisted
Non 
identified
2 Weeks
Yuceer et 
al, 200012 
72M HIV C2-C3 Neck pain and 4 
limb weakness
Decompression 
and antibiotics
Full resolution 
by 6 months
Bilateral 
pneumonia
20 Days
*M, male; F, female; C, cervical; ROM, range of motion; TURP, transurethral resection of the prostate; CHF; congestive heart failure; 
HIV, human immunodeficiency virus.
two days – the remaining eight had sought medical attention 
within 24 hours of onset of neurological deficit.3 However, 
over a third of the patients had been experiencing worsening 
neck pain over several weeks with one of them experiencing 
pain for as long as four months, although these were present 
without coinciding neurological symptoms.3 Similarly, Khalid 
et al reviewed cases of upper cervical epidural abscesses, and 
few were associated with neurological symptoms that were 
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subacute in onset.12 Of the cases that had at least two weeks of 
neurological symptoms prior to presentation, only one 
presented with CCS similar to the patient described above.12 
Although rare, cases of pyogenic spinal vertebrae infections 
are on the rise, which is associated to increased life expectancy 
and higher prevalence of comorbidities with aging that result in 
immunosuppression.13,14 Misdiagnosis and delayed diagnosis can 
lead to devastating neurological sequelae, which is more 
significant when the cervical spine is involved; therefore, 
appropriate treatment should be initiated as soon as possible.15 
Literature supports immediate surgical debridement in traumatic 
cases of osteomyelitis and epidural abscesses, even in the absence 
of neurological symptoms.3,15 While past studies suggest surgical 
intervention in this patient due to the presence of abscesses, he 
ultimately refused the procedure, and treatment consisting of 
antibiotic therapy provided initial relief of symptoms. However, it 
should be taken into consideration that the patient had been 
non-compliant with medication and follow-up, so it is unknown 
whether there was definite resolution of the condition. 
Nevertheless, this case may suggest that conservative antibiotic 
treatment may be an alternative approach to immediate surgical 
intervention in CCS due to infectious etiology.
CONCLUSION
Pyogenic spinal vertebrae infections are rare, but they can 
present as a subacute cause of neurological symptoms, especially 
when the cervical spinal cord is affected. In patients presenting 
with non-traumatic central cord syndrome, it is vital to identify 
risk factors for infection in a thoroughly obtained patient history, 
as well as to maintain a low threshold for diagnostic imaging.
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